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Abstract 
This thesis investigates the role of hydrogen-bonding in sulfonamido ligands to 
assess the importance of ligand association prior to or accompanying complexation 
to Co(ll), Ni(II), Cu(II) and Zn(II), making comparisons with commercial phenolic 
oxime copper extractants in which the strength and selectivity are thought to be due 
to the formation of a hydrogen-bonded pseudo-macrocycle formed around the metal 
ion. 
A series of relatively simple bidentate monosulfonamidodiamine ligands of the 
formula R2NHRNHS02R' has been prepared from the parent diamines. R is a 
bridging group of two or three methylene units, R' is a tolyl group or a p- tBu-phenyl 
group, and R2 is a hydrogen atom or a benzyl, an n-butyl or a 2-ethyihexyl group. 
The solid state structures of these ligands are difficult to predict and indicate that a 
surfeit of hydrogen-bond donors and acceptors incorporated into a relatively flexible 
ligand leads to a variety of hydrogen-bond interactions in the solid-state and hence a 
range of complicated secondary structures including two and three dimensional 
arrays. The ethane-bridged ligands form pseudo-macrocycles around copper(H) and 
nickel(II) centres in the complexes [Cu(L-H) 2] and [Ni(L-H)2], but not in the 
analogous zinc complex {Zn(L-H) 2]. The ligands are quite weak extractants, pH v. 4-
6, when used in a pH-swing process. Increasing the size of the chelate ring from five 
to six leads to a weaker extractant. 
A series of sulfonamido-oxime ligands 1- { 2-[N-(4-R-benzenesulfonamido)]-R' 
which have an N2 chelating unit analogous to the N0 unit in the commercial ortho-
phenolic oximes has been synthesised and characterised. R is a methyl, propyl, 
'butyl or pentyl group and R' is an ethan-l-one oxime, ethan-l-one 0-methyloxime, 
or a (phenyl)methanone oxime. The majority of solid-state structures contain 
hydrogen-bonded dimers and appear to be independent of small substituent changes 
in the ligand. However the E, Z isomerism of the oxime is important. The Z isomer 
only forms polymeric species. Complex formation by the sulfonamido-oxime 
ligands is less predictable than with the monosulfonamidodiamines and both 2:1 and 
111 
1:1, ligand to metal complexes are observed for 1-{2-[N-(4-methylbenzene 
sulfonamido)]-phenyl}ethan-1-one oxime forming the complexes [Cu(L-H) 2], [Ni(L-
H)2], [Cu4(L-H)2(L-2H)2(MeOH)2(MeO)2], [Ni2Na2(L-H)2(L-2H)2(MeOH)4] and 
[Ni4(OH)2(L-H)2(L-2H)2(MeOH)5] from methanol solution. In addition to the 
expected bonding of the sulfonamido and oximic nitrogen atoms, the bonding of the 
sulfonamido oxygen atoms and the deprotonated oximic oxygen atom to metal ions 
is also observed. 
ESI-MS shows evidence for dimer formation for both the monosulfonamidodiamine 
ligands and the sulfonamido-oxime free ligand systems. VPO and IR analyses of 
monosulfonamidodiamines show that self-association occurs in solution and is 
concentration and solvent dependent. VPO shows that this is also the case for 
sulfonamido-oximes and 'H nmr was used to determine the equilibrium constant K 
and AG, tH and AS for a monomer-dimer equilibrium of 1-{2-[N-(4-
methylbenzenesulfonamido)]-phenyl} ethan- 1-one oxime in chloroform-d, and 1-12- 
[N-(4-pentylbenzenesulfonamido)] -phenyl } ethan- 1-one oxime in chloroform-d 1 and 
toluene-d8 . The development of monosulfonamidodiamine and sulfonamido-oxime 
ligands with high solubility in solvents of low polarity such as toluene is described. 
The possibility of replacing the sulfonamido group with a sulfinamido group was 
considered and the synthesis of sulfinyl chlorides and prototype sulfmamido ligands 
is described; the latter are shown to have insufficient stability to be useful ligands 
under conditions required for extraction from aqueous media. 
The attempted development of pseudo-macro cyclic and pseudo-cage structures using 
ternary metal/sulfonamide/amine systems is described. Bidentate sulfhamido ligands 
are of the type R{NHS0 2(4-CH3C6H5)} 2 where R is a 1,2-ethane, a 1,2-trans-
cyclohexane or an o-phenylene group. Tridentate sulfonamido ligands studied of the 
type R{NHS02(4-CH3C6H5)} 3 where R is a N(CH 2CH2-)3 , a cis,cis-1,3,5-
cyclohexane- or a CH 3 (CH2-) 3 unit. Bis- and tris-sulfonamido ligands have been 
synthesised and their solid state structures found to contain complicated arrays of 
hydrogen-bonds. The formation of metal complexes of these ligands proved difficult 
and no ternary complexes were isolated. 
IV 
Ligands combining the monosulfonamidodiamine and phenylketoxime units were 
synthesised in an attempt to develop potentially dinucleating ligands which offer the 
possibility of more efficient metal transport based on higher metal:ligand (2:2) mass 
ratios. 6-Hydroxy-3 -methyl-5 { 2,6-diaza-2-benzyl-6[N-(4-methylbenzenesulfonyl)] 
hex- l-yl } benzaldehyde oxime and its ethane-bridged analogue readily form copper 
complexes. A mononuclear complex [Cu(L-H)2] of the propane-bridged ligand has 
been shown by X-ray crystallography to have a pseudo-macrocyclic structure very 
similar to that in the copper complexes of the commercial phenolic oxime 
extractants; the phenolate oxygen atom and the oximic nitrogen atom are coordinated 
to the metal centre and the oximic hydrogens are hydrogen-bonded to phenolate 
oxygen atoms. 
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Thesis Format 
Each chapter in this thesis is written as a separate entity, such that, figures, tables and 
references are individual to each chapter. However, the numbering of compounds 
runs through the thesis. All X-ray data may be found on the compact disk at the back 
of the thesis. It must be noted that estimated standard deviation values for all 
hydrogen bond lengths are not quoted as it was not possible to determine the exact 
position of some hydrogen atoms. The compound numbering for chapters 2-6 is 
summarised in the following section 
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1.1 Aims 
The aim of the thesis was to establish whether secondary bonding, e.g. hydrogen-
bond formation can be exploited in the design of ligands to be used in metal 
extraction processes. Principles of supramolecular chemistry and crystal engineering 
will be employed in the design of such ligands. It is of particular interest to establish 
whether such secondary bonding can be used to enhance the strength and selectivity 
of metal extractants. If observed this could potentially lead to the development of 
relatively simple, and thus inexpensive, tailor-made extractants. The solid state 
structure of the designed ligands and their complexes will be investigated and the 
colligative properties of the ligands in solution will be studied along with the solvent 
extraction properties of the systems. The class of ligands chosen to begin this 
investigation is based upon a bidentate amine-sulfonamide framework. 
1.2 The science of metal recovery 
Currently there are two main methodologies for the recovery of metals from their 
ores, pyrometallurgy, an ancient practice of removing metal from rock by smelting, 
and hydrometallurgy which involves the recovery of metals via their dissolution as 
ions in water. 
1.2.1 Pyrometallurgy 
Pyrometallurgy is an excellent method of producing metal from ores, which are rich 
in the required metal. Until the 1970s this was the only technology used to produce 
base metals. An example is the production of copper by smelting.' The sulfide ore 
is concentrated using froth flotation methods' where the ore is first crushed to 
produce a slurry which is passed into a flotation tank where it is aerated. An oil 
reagent, to assist frothing, and a surfactant salt which makes the copper sulfide ore 
3 
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particles hydrophobic are added. Air bubbles stick to the copper mineral particles 
causing them to float to the surface and form a froth "concentrate" which is then 
roasted in a flash furnace with lime, CaO, and a converter slag at approximately 
1300°C. This produces two immiscible layers, a slag of molten oxides of iron, 
silicon and other impurities and a second "matte" layer containing C112S and some 
FeS. Air is then blown through the matte layer in a convertor and sand added 
producing a silcate slag from the FeS (Equation 1.1). 
FeS + 1½ 02 + Si02 - FeS103 + SO2 	Eq 1.1 
The C112S is then reduced to copper above 1250 °C (Equation 1.2). 
C112S+02 —>2Cu+S0 2 	Eql.2 
Copper of 98% purity is produced and this can be purified further electrolytically. 
To generate the high temperatures needed to produce molten ores the plant often 
requires a lot of energy. This leads to difficult and hazardous working conditions. 
Pyrometallurgical processing of sulfidic ores creates the potential problem of sulfur 
dioxide being discharged into the atmosphere. If the level of production is high 
enough it can be used to produce acids however when production is low this method 
of disposal is not available and alternative, more expensive, methods must be found 
such as the scrubbing of the gases with water which then must be disposed of. 2 
Some residues of pyrometallurgical processes such as slags in the silicate phase do 
not chemically pollute the environment  but the sheer quantity of material to be 
disposed of and landfill shortages make its disposal a sensitive public relations issue. 
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1.2.2 Hydrometallurgy 
Modern hydrometallurgy began at the end of the I 91h century with the discovery of 
two major processes, the cyanidation process and the Bayer process. 2 It has 
developed significantly since then and has now replaced pyrometallurgical methods 
in some areas. One of the main reasons why the replacement of pyrometallurgical 
methods with hydrometallurgical ones is so attractive is that sulfide ores can 
potentially be treated without the generation of S02. 2 
Hydrometallurgy requires lower operating temperatures than pyrometallurgy. 
Working temperatures are usually less than 100°C compared with approximately 
1200°C used to smelt the ores. 2 This means that less fuel, and less heat management 
technology are needed and in addition that less harmful dust is created. 
There are disadvantages linked specifically with hydrometallurgy. Water pollution 
can be a problem due to sludging after leaching and the draining of liquid waste 
streams. The finely divided waste residues of hydrometallurgy can be difficult to 
dispose of, when exposed to the atmosphere they can create dust problems in dry 
conditions and in wet conditions release metal ions leading to contamination of the 
surrounding area. Also when solvent extraction forms part of the process the toxicity 
and flammability of the hydrocarbon solvents used are of concern. 3 
Metal recovery from primary sources involves four "unit operations"; concentration, 
separation, reduction and refining. Concentration describes the whole process from 
start to finish, an ore of low metal content is converted to pure metal. Separation 
involves the removal of all other materials from the metal, the last stage of which is 
the "reduction" of metal compounds to the metal. The refining of the metal takes 
place when very pure metal is required. The separation and reduction steps can be 
achieved either pyrometallurgically or hydrometallurgically. An example of a 
hydrometallurgical process is the roastlneutral-leachlelectrowinning method used to 
produce zinc. The concentration of the sulfidic ore is achieved by froth flotation and 
the concentrate is then roasted to produce zinc oxide  (Equations 1.3 and 1.4). 
5 
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2ZnS + 302 = 2ZnO + 2S0 2 	Eq 1.3 
4FeS + 702 = 2Fe203 + 4S02 	Eq 1.4 
Sulfuric acid is produced from the sulfur dioxide emitted which is then used to yield 
metal sulfates (Equations 1.5, 1.6 and 1.7). 
2S02 + 02 + 2H20 = 2112 SO4 	Eq 1.5 
ZnO + H2SO4 = ZnSO4 + H20 	Eq 1.6 
Fe203 + 3112SO4 = Fe2(SO4)3 + 31-120 	Eq 1.7 
There are significant amounts of impurities in the ore such as iron, manganese, lead 
and copper which must be removed from the impure solution of metal ions before 
the zinc is electrowon. This involves the selective leaching or precipitation of the 
impurities. Iron is removed by neutral leaching which precipitates the iron in the 
form of natural iron(III) oxides, hydroxides, and oxyhydroxides. (Equation 1.8). 
Fe2(SO4)3 + H20 +3 ZnO = 3 ZnSO4 +2 	FeO(OH) 	Eq 1.8 
The zinc is then electrowon using aluminium cathodes (Equation 1.9). 
2ZnSO4 + 2H20 = 2H2SO4 +02+ 	2Zn 	Eq 1.9 
The most difficult aspect of zinc recovery is the elimination of all other metal salts 
and impurities from the zinc sulfate solution. Solvent extraction "is a separation 
process that depends on the transfer of the component to be separated from one 
liquid phase to a second liquid phase that is immiscible with the first". 6 This 
technique can be used to produce a pure solution of metal ions from an impure leach 
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solution, hence if it were to be applied to zinc production it would enormously 
simplify the separation step by selectively extracting zinc leaving all other metals in 
the raffmate, the depleted solvent. Stripping the loaded organic solution could then 
be used to generate a pure electrolyte for "electrowinning". Concentration would 
also be unnecessary as a strong and highly selective reagent removes the need for a 
concentrated leach solution. Concentration is achieved by the extraction and 
stripping processes. 
Solvent extraction was first used in hydrometallurgy by the Manhattan Project 7 in the 
USA to produce high purity uranyl nitrate solution. HNO 3 was used to dissolve 
uranium concentrate, the uranium was then selectively extracted by diethylether and 
this solution was stripped with water to give a pure uranyl nitrate solution. Other 
pure expensive metals were then produced in this way. In the 1960s this method was 
first applied to the extraction of copper, a relatively cheap metal. 
To explain why hydrometallurgy is replacing pyrometallurgy in the production of 
some metals the economics of the two technologies must be compared. 
Pyrometallurgy can be a very economical method to treat metal rich ores. However, 
for poorer low grade ores this treatment is not as cost effective. The use of selective 
extractants in hydrometallurgy mean that the metal may be recovered in a more 
efficient way. The potential range of extractants makes this process viable for low 
grade ores and more specialised small scale productions. 
In copper production a sulfide ore is required and in most cases deposits are found 
under a layer of oxidic copper ore, CuO. Therefore to recover the sulfidic ore the 
oxidic ore has also to be removed which until the development of the solvent 
extraction process had no known use and was left in heaps as waste. This has meant 
that a ready supply of this ore is available at a lower cost than sulfide ore which is 
becoming less readily available. 
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1.3 The hydrometallurgical procedure of copper 
The hydrometallurgically based process for copper production involves four steps, 
leaching, extraction, stripping and electrowinning (Figure 1.1). The heap leach pad 
(1) consisting of the oxide ore is sprayed with sulfuric acid, thus leaching metal ions 
into what is known as the "pregnant leach solution". This is stored in a pond (2) 
before it is mixed with the immiscible extractant for approximately two minutes. 
The mixture passes over a weir to a settling tank (3). Upon separation the aqueous 
raffinate is returned to the heap leach pad and the organic phase containing pure 
copper is transferred to a second mixer where it is contacted with a second acidic 
stripping solution of low pH. The mixture then passes over a second weir to settling 
tank (4). The separated regenerated organic extractant is recycled and the 
concentrated copper aqueous solution, the "advanced electrolyte", passes into the 








J 	 - 
I 
Figure 1.1: Solvent extraction plant for copper recovery.8 
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1.3.1 Leaching 
In most of the current operations the copper is leached from oxidic ores using 
sulfuric acid (Equation 1.10). 
CuO + H2SO4 = CuSO4 + H20 	Eq 1.10 
Heap leaching was first practiced in the Harz mountains area of Germany and in the 
Rio Tinto mines in Spain in the sixteenth century9 where copper sulfate was leached 
from pyrite containing copper sulfide by an oxidative process involving rainwater 
and air (Equation 1.1 1). 
CuS+2O2 —CuSO4 	Eql.11 
Modem plants use aqueous H2SO4  at pH 2 to leach metals from crushed oxidic or 
"transition ores" (partially oxidised sulfides). The metal oxides react with the 
sulfuric acid according to Equation 1.10. This is not a selective process and many 
metals are dissolved leading to a dilute and impure solution which is referred to as 
the pregnant leach solution. The, solvent extraction step must concentrate and purify 
the solution to provide a copper sulfate solution suitable for use in the electrolysis 
tankhouse. 
1.3.2 Extraction 
The extraction stage is used to selectively transport copper from the aqueous phase 
into the immiscible organic phase (Equation 1.12). 
CUS04(aq) + 2LH(org) = CUL2(org) + H2SO4() 	Eq 1.12 
This is accomplished by the hydrocarbon-soluble acidic ligand, LH, which forms a 
neutral copper complex with a metal to ligand ratio of 1:2 in hydrocarbon solvents. 
This complex must have a very low solubility in the aqueous raffmate. This 
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produces a "loaded-organic" phase containing only copper and regenerates sulfuric 
acid for leaching. 
1.3.3 Stripping 
The third step involves stripping the copper out of the complex into a second 
aqueous phase, the "advanced electrolyte", reversing the complex formation by using 
stronger sulfuric acid with pH = 0, (Equation 1.13). 
CUL2(org) + H2SO4(aq) = CUS04(aq) + 2LH(org) 	Eq 1.13 
The sulfuric acid provides protons to regenerate the extractant which is recycled back 
to the extraction step, and produces a pure and concentrated aqueous solution of 
copper sulfate. 
1.3.4 Electrowinning 
This strip solution, advanced electrolyte, is sent to the tankhouse where the copper is 
electrowon to produce copper of at least 99.99% purity (Equation 1 . 14) . b 0 
CuSO4 + 1120= Cu + H2SO4 + ½02 	Eq 1.14 
Figure 1.2 shows schematically how the reagents used are recycled to make solvent 
extraction an economically favourable process. 
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CuO... 	 CuSO4 	 CuL2 	 CuSO4 	 Cu + 
LEACH 
.dlIE1 	
EXTRACT__() STP 	 ELECTRON 
Residues 	 H2SO4 	 2LH 	 H2SO4 	 Power 
Figure 1.2: The four stages of the solvent extraction process. 
The sulfuric acid used to leach the copper is regenerated in the extraction step, the 
ligand used to extract the metal into the hydrocarbon phase is regenerated when the 
copper is stripped back and finally the sulfuric acid used to strip the metal into the 
advanced electrolyte is regenerated when the copper is electrowon. This leads overall 
to Equation 1.15. 
MO (+ power) = M + Y202 (+ residues) 	Eq 1.15 
The mechanism behind the solvent extraction process is pH swing based. Equation 
1.16 is the important equilibrium to consider. 
M2 + 2LH = ML2 + 2H 	Eq 1.16 
This equation leads to the following equilibrium constant describing the 
transportation of copper between phases (Equation 1.17). 
	
K = [ML2][H]2 	
Eq 1.17 
eq 	[J2+][LH]2 
Whether the metal is transferred to the organic phase or back into an aqueous phase 
depends on the pH of the system. As the concentration of hydrogen ions varies with 
pH the equilibrium is moved to the left or the right to maintain K. The 
concentration of hydrogen ions in the pregnant leach solution is low and so more 
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hydrocarbon soluble metal complex is produced. The reverse occurs during the 
stripping stage when the [H f] is high. 
1.4 P50: Avecia's reagent for copper recovery 
The most important class of copper extractants is based on phenolic oximes. These 
are currently marketed by Avecia and Henkel. The structure of such extractants is 
below in Figure 1.3. Avecia supplies 5-nonylsalicylaldoxime as P50 where R is H 
and R' is a branched nonyl chain. Henkel's extractants are ketoximes where R is a 
methyl and R' a solubilising branched alkyl group. Both companies supply the 
ligands as a mixture of isomeric forms of the solubilising group R' to inhibit 
crystallisation. 
Figure 1.3: A hydrogen-bonded P50 dimer. 
Various factors contribute to why P50 is a very effective copper extractant. The 
Irving-Williams series predicts that the most stable complexes of divalent first 
transition series metals will be formed with copper ions. Secondly, the nitrogen and 
oxygen combination of donor atoms is favoured by copper and finally it benefits 
from the chelate effect. However many bidentate ligand systems with identical 
donor atoms are much weaker extractants than P50 therefore these observations do 
not fully account for the exceptional properties of P50. 
12 
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One difference between P50 and other extractants which may account for its 
superiority is the ability of P50 ligand to preorganise itself into dimers (Figure 1.3) 
and also to form intra-molecular hydrogen-bonds in the copper complex creating a 







Figure 1.4: A 1:2 copper, P50 complex. 
Important features of the phenolic oxime extractants are their very high selectivity 
for copper over iron and a "pHi,'2" value of less than two. The pH at which an 
extractant is loaded to half its maximum capacity is called its pH, /,. A low value of 
pHy. is desirable so that the pH of the pregnant leach solution does not have to 
exceed two, which would create conditions for the unfavourable precipitation of iron. 
The use of P50 in the extraction step of the process has led to the price of copper 
dropping significantly. The price per kilogram 10  of copper obtained by 
pyrometallurgical processing is $2.20 in comparison with 90 cents per kilogram 
when a hydrometallurgical solvent extraction process has been used. 
1.5 The design of an extractant 
When designing a new extractant many things must be considered. First of all cheap 
and accessible precursors of the ligand must be available, the ligands must be able to 
form stable complexes and have the ability to preorganise. Selectivity for one metal 
is very important and this can often be optimised at designated pH ranges. The 
ligands as well as the resulting complexes must have high solubility in hydrocarbon 
solvents. The kinetics of extraction must be fast in order to avoid having to use large 
13 
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holding tanks or reaction vessels. The metal complexation should also be reversible 
so that the metal can be stripped from the organic phase. The reagent should be 
relatively stable so that it can be recycled repeatedly, it should be water insoluble to 
prevent significant loss into the aqueous phase, further the reagent should not cause 
or stabilize emulsions. The reagent should not react with or load significant 
quantities of acid. The structure of the ligands can be modified to try and improve 
these properties. Theories, which help us, make preliminary assumptions about 
ligand behaviour are explained in the following sections. 
1.5.1 The thermodynamic stability of complexes 
The principle factors affecting thermodynamic stability are the nature of the ligand 
and the nature of the metal. Ligand donor atoms are Lewis bases and cationic metal 
centres are Lewis acids, they can be classified as either hard or soft depending on the 
stability of the complex they form with certain acids or bases respectively. Pearson 
first introduced such classification. 12,13  For a soft base the donor atom may be easily 
polarised, has low electronegativity and is easily oxidised. They are also associated 
with empty, low-lying orbitals, examples are r, CN and if. A hard base is of low 
polarisability and high electronegativity, they are difficult to oxidise and are 
associated with empty orbitals of high energy and are hence inaccessible, for 
example F, NH3 and Off. Soft acids have an acceptor atom of low positive charge 
and large size and several easily excited outer electrons, e.g. Cut, Au and Cd2 . 
Hard acids have an acceptor atom of high positive charge and small size and do not 
have easily excited outer electrons. Examples are H +, Na+  and A13+.  Pearson stated 
that "hard acids prefer to coordinate to hard bases and soft acids to soft bases". 12 
Therefore in the ligand design to selectively coordinate one metal of a specific 
oxidation state, the choice of donor atoms is very important. Some Lewis acids and 
bases do not fall easily into either the hard or the soft category and are called 
borderline. The following table gives examples of Lewis acids and bases. 
14 
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Table 1.1: The classification of Lewis acids and bases. 13 
Hard Borderline Soft 
Acids 	H, Li, Na, K, Fe', Co', Ni2 Cu, Ag, Au, Tl, 
Be 2%  Mg2 , Ca 2%  Cr2 , Cu2 , Zn2 ', Pb2 , SO2, 
Hg, Pd2 , Cd2 , Pt2 , 
Cr3 , AI3 , SO,, BF3 BBr3 
Hg 2% B113 
Bases 	F, OW, H20, NH3 , NO2 , S03 2 , Br, N3 , 1-F, R, CW, CO, F, 
C03 2 , NO3 , 02, N2 , C6H5N, SCW SCN, R3P, C6116 , 
S042 , PO 3 , C104 R2S 
For metal ions which are neither particularly hard or soft a series called the 'Irving-
Williams' series 14  has been established to predict the stability of complexes formed 
with a given ligand (Figure 1.5). 
2+ <Fe2 <Co2 <Ni2 < Cu > Zn 
Figure 1.5: The Irving Williams series. 
The series may be explained in terms of two physical properties of the M 2 .' 5 The 
greater the power of M 2 to accept electrons the higher the stability constant of 
complex formation, i.e. if the second ionisation potential of M is high it can be said 
that the metal can accept electrons easily. The series can also be explained by the 
ionic potential of the ion or zlr, where z is the ionic charge and r the ionic radius, 
which indicates the hardness of the acid. 
AG is determined by AS and AH according to Equation 1.18 and shows how stable a 
complex is. 
AG =AH-TAS 	 Eq 1.18 
The Gibbs free energy must be negative for a complex to form spontaneously.' 6 
Many things can affect the entropy and enthalpy of a complex and these are 
summarised in Table 1.2. 
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Table 1.2: Factors influencing solution stability of complexes. 17 
Enthalpy effects 	 Entropy effects 
• Variation of bond strength with 
electronegativities of metal ions and ligand 
donor atoms. 
.Ligand field effects. 
• Steric and electrostatic repulsion between 
ligands in complex. 
• Enthalpy effects related to conformation 
of uncoordinated ligand. 
• Number of chelate rings. 
• Size of chelate rings. 
-Changes of solvation of ligands and 
metal ion on complex formation. 
•Arrangement of chelate rings. 
• Entropy variations in uncoordinated 
ligands. 
• Effects resulting from differences in 
• Other coulombic forces involving chelate 	
configurational entropies of the ligand 
ring formation. 	
in complex compound. 
-Enthalpy of solution of ligands and that of •Entropy of solution of ligands. 
complexes. 
-Entropy of solution of coordinated 
• Changes in bond strength when ligand is 	
metal ions. 
charged (same donor and acceptor atom). 
1.5.2 The chelate effect 
The chelate effect 14  refers to the observation that a complex, which contains  chelated 
rings, is usually more stable than the most similar complex containing only 
monodentate ligands. An example of this can be seen in Figure 1.6. 
[Cu(H20)4] 2 + 2NH3 - [Cu(NH3)2(H20)2] 2 + 21120 
AG = -10.5 KJ/mol All = -11.1 KJ/mol AS = -2 e.u. 10902 = 7.65 
[Cu(H20)41" + en —4 [Cu(en)(H 20)2] 2 + 21120 
AG = -14.6 KJ/mol AH = -13.0 KJ/mol AS = +5.4 e.u. logj3, = 10.64 
[Cu(NH3 )2(H20)2] 2 + en -> [Cu(en)(H20)2] 2 + 2NH3 
AG = -4.1 KJ/mol AH = -1.9 KJ/mol AS = +7.4 e.u. logK = 3.0 
Figure 1.6: An illustration of the chelate effect. 
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The more negative value of AG of (2) than (1) tells us that replacement of two 
coordinated water molecules by the chelating 1,2 diaminoethane (en) ligand is more 
thermodynamically favourable than replacement by two ammonia ligands. As a 
consequence the displacement of two ammonia ligands by 1 ,2-diaminoethane is 
thermodynamically favourable (3). 
The enthalpy change incurred by the substitution of monodentate by bidentate 
ligands into a complex can become positive if significant steric strain is associated 
with forming the chelate ring. Strain depends on the size of the rings involved, five 
membered rings are the most stable followed by six and seven membered rings. In 
these cases AG is only negative when a large positive entropy change occurs. When 
most simple metal salts are dissolved in water the metal ion is in the form of an aqua 
complex and so the formation of a complex involves the displacement of water 
molecules by ligands. 
Complex stability usually increases as the number of rings formed in the complex 
increases and a macrocyclic ligand forms a more stable complex than the similar 
open chain ligand.' 8 Figure 1.7 shows an example of this effect. The entropy change 
involved in this reaction will be positive as two rigid starting materials produce one 
rigid product and the flexible, long chain ligand. The complexation of the 
macrocycle and the displacement of the more flexible ligand is enthalpically 
favourable as enthalpic repulsions between nitrogen lone pairs are greater for the 
macrocyclic ligand as it is unable to move to create the maximum distance between 
the nitrogens unlike the long chain ligand. Other factors to consider are the probable 
proximity of remaining binding sites of a macrocycle when one atom is bound in 
contrast with those of an open chain polydentate ligand or simple monodentate 
ligands. The effects of cooperative binding will however be reduced for open chain 
polydentate ligands with longer backbones as here remaining binding sites will have 
a higher probability of being close to other metal centres forming a bridging ligand. 
17 
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AG = -30 KJ/mol at 300K 	logK = 5.2 
Figure 1.7: Preferential binding of a tetradentate macrocycle over a similar open chain ligand. 
Macrocyclic ligands are known for their selectivity and ability to form very stable 
complexes and consequently could be useful in metal recovery processes. The 
drawback is that they are very expensive to synthesise and the kinetics of metal 
complexationldecomplexation are often poor. By using simpler ligands which are 
easy to synthesise, but which have the possibility to organise themselves into pseudo-
macrocycles it should be possible to develop much cheaper "strong" and selective 
ligands which show good kinetics of metal transport. 
1.5.3 Metal geometry and ligand flexibility 
It is well known that the preferred geometry of complexes vary from metal to metal. 
This is an important factor when we consider which metal complexes would benefit 
from the complexation of a ligand which has been designed to form a planar 
tetradentate pseudo-macrocyclic structure to enhance complex stability. The 
coordination chemistry of four metals, cobalt, nickel, copper and zinc, which are 
commonly found in the leach stream are mentioned briefly below. 
1.5.3.1 The coordination chemistry of cobalt 
Complexes of cobalt in oxidation states I, II, III and IV are known, however cobalt 
tends to be stable in the lower oxidation states and Co(II) complexes are the most 
common. Co(II) forms numerous complexes, most of which are octahedral or 
tetrahedral however five coordinate species are also formed. A tetrahedral geometry 
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is common for Co(II) as a d 7 electron configuration disfavours a tetrahedral geometry 
relative to an octahedral one to a smaller extent by ligand field stabilisation 
energies. 19 Very few low spin Co(II) complexes are encountered, and very strong 
field ligands are necessary to achieve the required ligand field splitting parameter. 20 
A Jahn-Teller distortion is observed for such low spin octahedral compounds. 
In the presence of oxygen and stabilising ligands with strong ligand field 
contributions, in particular those incorporating N donors, the Co(II) ion is quite 
readily oxidised to Co(llI).' 9 Almost all of these compounds are octahedral, however 
tetrahedral, planar and anti prismatic complexes are known. 
1.5.3.2 The coordination chemistry of nickel 
Complexes of nickel in oxidation state Ito IV are known however Ni(II) complexes 
are by far the most common. 21  Unlike cobalt, nickel commonly shows only the +2 
oxidation state in aqueous solution. 22  Most Ni(ll) complexes have coordination 
numbers of four, five and six. Complexes with coordination numbers of three, seven 
and eight are still quite rare. The vast majority of four coordinate Ni(II) complexes 
are planar due to the d 8 configuration. The eight electrons occupy four d orbitals but 
leave the strongly anti-bonding dx 2-dy2 orbital vacant. Therefore only ligands with 
steric bulk are able to force the complexes from planarity. Trigonal bipyramidal and 
square pyramidal five coordinate geometries occur with nickel and the complexes are 
usually low spin. For almost all Ni(II) six coordinate complexes the metal has a 
pseudo-octahedral stereochemistry. 23 Ni(llI) complexes are formed with 
macrocyclic or peptide type ligands. 
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1.5.3.3 The coordination chemistry of copper 
Coordination numbers of up to eight with copper oxidation states of I to IV are 
known, with Cu(I) and Cu(II) oxidation states as the most abundant. 24  Cu(1) is 
readily oxidised to Cu(II) and the stability of Cu(I) complexes depends upon the 
nature of the anions or the ligands present, however further oxidation to Cu(III) is 
more difficult. Cu(I) is a soft acid and prefers sulfur and phosphorus based ligands 
whereas Cu(II) is a borderline hard acid and prefers oxygen and nitrogen based 
ligands. 25 The solid state stereochemistry of Cu(I) is dominated by four 
coordination, which are generally tetrahedral. A significant number of two, three and 
five coordinate complexes are known however six coordination is unknown. 
For Cu(II) the best donor is oxygen followed by nitrogen and chloride ions. 25  The 
majority of six coordinate Cu(II) complexes involve a Jahn-Teller distorted 
octahedral structure. Five coordinate Cu(II) may have regular square pyramidal or 
trigonal pyramidal stereochemistry but generally involve distortion. A regular square 
planar geometry may be achieved however it may involve a slight tetrahedral 
distortion. A regular tetrahedral geometry is not possible and a significant 
compression along the S4 symmetry axis is always involved. 
Cu(III) complexes almost all have square or five-coordination geometry, until quite 
recently only few Cu(III) compounds were known however it has since been 
established that Cu(III) has an important biological role and a number of model 
complexes have been made. 24 
1.5.3.4 The coordination chemistry of zinc 
Zinc is regarded 26  as a non-transition element as it does not form any compounds 
where the d shell is other than full as only the two 4s electrons are readily lost. 
However Zn(II) has some resemblance to d-group elements in its ability to form 
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complexes, particularly with ammonia, amines,  halide ions and cyanide. A large 
number of Zn(II) complexes are known with oxygen, nitrogen, sulfur and to a lesser 
extent phosphorus ligands. 27 Coordination numbers of four, five and six are 
commonly known with five being the most common. Because for Zn(II) complexes 
there is no ligand field stabilization energy (LFSE) their stereochemistry is 
determined solely by considerations of size, electrostatic forces and covalent bonding 
forces. 
1.6 Objectives 
The objective of this thesis was to identify new classes of compounds which have 
hydrogen-bond donor and acceptor sites which can form strong inter-ligand 
hydrogen-bonds in metal complexes, generating pseudo-macrocyclic structures and 
thus beneficially influencing the properties of the extractants. The structures 
produced by secondary bonding were studied both for the free ligand and the metal 
complexed species. 
Assembled systems have been characterised using both solid state and solution 
techniques. The effects of such self-assembly will be evaluated with respect to 
ligand strength and selectivity. This will determine how important preorganisation 
and other design criteria are in the design of new metal extractants. 
1.7 Supramolecular chemistry 
The self assembly of complementary components into designed architectures has 
become an important theme in recent supramolecular chemistry. Many studies have 
been undertaken to try to establish how by careful molecular design the substructural 
units in a supermolecule can be identified and hence the structure of a material can 
be predicted. To quote Jean-Marie Lehn 'supermolecules are to molecules and the 
inter-molecular bond what molecules are to atoms and the covalent bond. 28  Thus in 
supermolecular design inter-molecular bonds have a very important role to play and 
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the tertiary structure within crystals is determined solely by the strength and 
directionality of inter-molecular or inter-ionic interactions. 29 Hydrogen-bonds are 
often used as the inter-molecular link as they are directional enough that the 
orientation of molecules can be predicted with a reasonable degree of accuracy. 
However, there is no absolute correlation between lone-pair regions and acceptor 
angles. 30 By the designed placement of hydrogen-bond donor and acceptor 
functional groups into a molecule a supramolecular synthon can be generated. The 
term supramolecular synthon is used to describe a structural unit within a 
supermolecule which is assembled involving intermolecular interactions. 31 
1.7.1 Crystal engineering 
'Crystal engineering seeks to understand intermolecular interactions and recognition 
phenomena in the context of crystal packing.' 3 ' One type of directional inter-
molecular interaction that has been widely studied in this context is the hydrogen-
bond. Many recent studies into crystal engineering are centred around conventional 
hydrogen-bonding of the OH---O or the NH---O type. 32,33  However studies using 
weaker and possibly less directional interactions have proved successful, for example 
CH---O, I---I, N---Br interactions. 34,35,36,37,38  Methods of predicting packing 
arrangements based on the principle that the strongest hydrogen-bond acceptor 
should be paired up with the strongest hydrogen-bond donor have been proposed. 39 
Studies into the effects of superfluous hydrogen-bond donor or acceptors in 
molecules on the resulting inter-molecular interactions have also been 
conducted .41,41,42  It is more common that the hydrogen-bond acceptor moieties 
should be in excess and when this is the case the acceptors find the next most acidic 
hydrogens, for example, the weaker C-H --- X hydrogen-bonds (X = 0, N) may be 
formed. When there is an excess of hydrogen-bond donors, weak X-H --- it hydrogen-
bonds may be observed. A second method by which the deficiency in H-bond 
acceptors is accommodated is through a change in the hybridisation of the 
molecule. 42  When two NH2 groups are present an NH 2 group can become sp 3 
hybridised and hydrogen-bonds between the sp 2 hydrogens of a second NH 2 group 
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and the sp 3 lone pair are seen. Despite the extensive study of hydrogen-bonding and 
the ability to predict the most likely and thermodynamically stable hydrogen-bonded 
motif for a molecule the precise solid state tertiary structure remains quite 
unpredictable. 29 This is because the effect of other non-covalent interactions or 
crystal packing is not yet predictable with any certainty. The role of solvent 
molecules may also have an important role due to their ability to act as competitive 
hydrogen-bond donor and acceptors or be enclathrated as guest molecules. 29 
1.7.2 The hydrogen-bond 
Although many definitions of the hydrogen-bond have been published it is extremely 
difficult to state in a concise manner what it is. In 1989 Atkins stated that "A 
hydrogen-bond is a link formed by a hydrogen atom lying between two strongly 
electronegative atoms". 43  However, in the last decade researchers have progressed 
from the X-H --- X conventional hydrogen-bond, where X is an electronegative 
element, to explore the chemistry of weaker types of interaction such as the C-H --- O 
bond which is now universally accepted as a hydrogen-bond. This bond along with 
many other weaker interactions falls a long way outside the description of Atkins. 
As the net effect of a hydrogen-bond is to weaken the X-H bond they can be detected 
and their energies determined by a wide range of spectroscopic, structural and 
thermodynamic techniques. A hydrogen-bonding interaction between neutral 
molecules may have a strength in the range of 10-65 kJmoF', however when one 
component is ionic the bond strength rises to between 40 and 190 kJmol. 30 Hence, 
a strong hydrogen-bond, for example HCOOH --- F- has a similar energy to the 
covalent F-F bond. 
Interest in the role of inter-molecular hydrogen-bonding is wide ranging from the 
modelling of the self assembly properties of nucleotide bases to the use of hydrogen-
bonds to control molecular aggregation. 44,45,46,47  An important aim of this thesis was 
to look at the effects which secondary bonding can have on the strength and 
selectivity of metal extractants. Hydrogen-bond donors and acceptors were 
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incorporated into the ligand design and it was therefore very important to be able to 
study the predicted recognition processess of the free ligand and the effect of any 
intra-complex hydrogen-bonding. X-ray crystallography was an extremely useful 
tool to probe the structure of molecules in the solid state however the behaviour of 
the ligand in solution also had to be studied. Recent studies in aprotic solvents have 
shown that hydrogen-bonds can form in solution, but their stabilities are highly 
solvent dependent. 48 ' 49 ' 50' 5 ' There are several ways in which the solution behaviour 
of molcules can be studied including variable concentration 'H nmr, JR. X-ray 
crystallography, vapour pressure bsmmometry, cryoscopy and ESI-MS. 
1.7.3 The design of a supramolecular synthon 
To study the effect which secondary bonding can have on the strength and selectivity 
of metal extractants careful ligand design is required. Primarily the size of the 
chelate ring and the number of donor atoms must afford a favourable metal complex 
geometry and the number of sites for possible deprotonation must result in a neutral 
complex. Hydrogen-bond donor and acceptor atoms must then be introduced so that 
a 'head-to-tail hydrogen-bonded macrocycle may be possible. 
To begin with the most simple system a similar template to P50 was followed of two 
bidentate monoanionic ligands coordinating first row transition metals of oxidation 
state two (Figure 1.8). Each ligand requires two coordinating atoms (X) and one site 
for deprotonation (XII) to produce a monoanionic ligand which is essential to 
generate a neutral complex with solubility in non-polar hydrocarbon solvents. To 
enable a 'head-to-tail' hydrogen-bonded arrangement one hydrogen-bond acceptor 
site (A) and one hydrogen-bond donor site (D) per ligand are also required. R is a 
bridging group. 
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D—X HX—A 
 -2H A—X X—D 
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Figure 1.8: P50 type template for the complexation of divalent metal ions. 
Structural studies of such systems showed that they were able to form pseudo-
macrocycles. The idea of introducing inter-ligand hydrogen-bonding into metal 
complexes by design was then extended to look at similar AB type systems where 
ligand A incorporates two hydrogen-bond donor functions and ligand B two 
hydrogen-bond acceptor functions, see Figure 1.9. 
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Figure 1.9: Bidentate AB type metal chelate systems forpseudo-macrocycle formation. 
It was proposed that such AB type systems could lead to the greater versatility of the 
ligands as solvent extractants if different A type ligands (incorporating hydrogen-
bond acceptor groups) and B type ligands (incorporating hydrogen-bond donor 
groups) may be interchanged. This may permit the fine-tuning of a system for one 
metal, and could also be applied to octahedral systems, Figure 1.10. 
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Figure 1.10: Tridentate AB type metal chelate systems to accommodate an octahedral metal 
geometry. 
A final area proposed for investigation in this thesis was the possibility of increasing 
the ligand:metal ratio of a complex from 2:1 to 2:2. Ligand design included a similar 
ligand template to P50 of one hydrogen-bond donor and acceptor function per ligand 
but with an increased number of donor atoms (X) to coordinate to two metal centres. 
Such a system could increase the efficiency of a ligand as a metal extractant by 
100%. 
1.7.4 The sulfonamide group as a supramolecular synthon 
A sulfonamido moiety was introduced into ligand systems for several reasons. The 
acidic sulfonamido proton is easily lost and deprotonation of the sulfonamido 
nitrogen enhances its nucleophilicity. Finally the sulfonamido oxygens provide a 
total of four hydrogen-bond acceptor sites. 
Reprotonation of sulfonamido ligands should allow the metal to be stripped back into 
aqueous solution at low pH providing that the complex formed is labile. 
Sulfonamides are also able to stabilise highly oxidizing metal centres due to the 
strong a donating deprotonated sulphonamide groups. 52 
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To complete the system a second donor atom and a hydrogen-bond acceptor site was 
introduced. One of two functional groups were used, an amino group or an oxime 
group. Both are able to bind to a metal centre via the nitrogen atom and have 
hydrogen atoms suitable for strong hydrogen-bond formation. 
1.8 Sulfonamides 
Sulfonamides have been widely used for treatment of bacterial or viral infections and 
are also found in drugs such as diuretics, hypoglycemic, antimalarial agents and 
many others. 53  Until relatively recently there had not been a large amount of work 
published on metal complexes of sulfonamides. The nitrogen atom in the neutral 
sulfonamide has always been considered as poorly coordinating due to the electron 
withdrawing ability of the sulfonyl group. The cannomcal form resulting is shown in 
Figure 1.11. 
" H 	II 	_ 	_ _ 	 H 	I 
C—N C—Q—S--R 	 S—R
II 
o 	 0 
Figure 1.11: The electron withdrawing effect of the SO 2 group in sulfonamides. 
This, however, can be used as an attractive feature in molecular design. Primarily 
due to the acidic nature of the sulfonamido proton the group can be readily 
deprotonated to produce an anionic ligand species. Of interest in the design of metal 
extractants is that the low basicity of the nitrogen which will prevent double 
protonation on stripping. Finally, due to the highly electron withdrawing nature of 
the sulfonyl group the sulfonamido nitrogen is a poor electron donor and the 
resulting complexes are Lewis acids. This has led to sulfonamido ligands being used 
to prepare complexes, which are efficient catalysts. 
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1.8.1 Synthesis of sulfonamides 
Sulfonamides are usually prepared by treating ammonia, a primary amine, or a 
secondary amine with a sulfonyl chloride in the presence of some base, Figure 
o 	 0 
II +Base 	 II 
NR2H + R-S-CI 
11 	-HCI 	
R-S-NR2 
11 o 0 
Figure 1.12: The common preparation of sulfonamides. 
It is thought that this reaction proceeds by a simple nucleophilic substitution 
mechanism and mechanistic studies have shown it to be solvent dependent. 54 
Sulfonamides can also be made several other ways, for example from aryl sulfonates; 
here the amine nucleophile substitutes on the sulfur and not on the aromatic carbon. 
Aryl sulfinates may also be used as a precursor to sulfonamides, they are prepared by 
the reaction of aryllithiums with sulfur dioxide, and the subsequent treatment of the 
arylsulfinates produced with chioramine, C 6H4SO2N(Cl)Na or hydroxylamine-O-
sulfonic acid, Figure 1.13. 
II 	chioramine 	II 
_________ 
Ar-Li 	+ 	SO2 	 - ArSOLj 	 Ar5NRFj 
11 
0 
Figure 1.13: Conversion of methylsulfones to sulfonamides. 
However the second step is often incompatible with other existing functional groups 
and so Huang et al developed a novel convenient one-pot synthesis of sulfonamides 
from methyl sulfones under very mild reaction conditions with base and 
trialkylboranes to give sulfinic acid salts which are then converted to sulfonamides 
during an oxidative-amination workup, Figure 
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Figure 1.14: A one-pot synthesis of sulfonamides from methyl sulfones. 
Developments in the preparation of N-alkylaryl sulfonamides have also been made. 
Initial preparations had such drawbacks as the requirement of harsh conditions, only 
para-substituted product formation and several reaction steps were also required for 
the preparation of sulfonamides to build up the functionality. Neumann et al 
developed a new route to N-alkyaryl sulfonamides using a trialkylstannyl leaving 









L1 	Ii 	H 	 11 
Figure 1.15: A route to N-alkylaryl sulfonamides. 
Unsubstituted sulfonamides may be prepared by the hydrolysis of sulfonyl 
isocyanates, the reduction of sulfonyl azides or the treatment of sulfinyl chlorides 
with hydroxylamine. Sulfonamide synthesis has also been achieved by solid phase 
synthesis 
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1.8.2 Sulfonamides as ligands 
The coordination chemistry of sulfonamides has been widely explored over the last 
10 years. Work initially done by Peng aimed to discover if a ligand incorporating a 
sulfonamido group would exhibit as interesting a coordination chemistry as similar 
amide ligands. 58 ' 59 '6° He chose to work with the simple ligand systems in Figure 1.16. 
NHTs 	 NHTs 	 TsHN 	 NHTs 
NH2 	O: NHTs 	 TsHN  
I 	 II 	 Ill 
Figure 1.16: Simple o-phenylenediamine sulfonamide ligands. 
Peng postulated that due to the strong (Y donating deprotonated sulfonyl amido 
groups the complexes would stabilise highly oxidising metal centres. 59  Complexes 
of I with Co(II), Ni(II) and Cu(II) were prepared in dimethylformamide and the 
complex [CuL2(dmf)](dmf) 2 was characterised by X-ray crystallography. 58 
Osmium(VI) produced dinuclear species with II and complexation work was also 
done with Co(II), Ni(II) and Cu(II) in pyridine . 59 Complexation of III with Cu(II) 
and Ni(II) produced dinuclear species where Ill acts as a bridging ligand. 6° This 
work will be described in more detail in chapter two where I is included in the initial 
ligand systems that were prepared. 
The sulfonamido group is often introduced into ligands in view of its ability to 
deprotonate producing an anionic species. An example is seen in other work of 
Peng. 6 ' 2-aminopyridine, IV, is a poor coordination site due the delocalisation of the 
lone pair electrons of the nitrogen atom to the pyridine ring and there are no reports 
of it acting as a bridging ligand. However after sulfonylation and deprotonation to 
yield V the amino pyridine molecule becomes a good anionic ligand capable of 
forming bridged dinuclear species (Figure 1.17). 
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(,I NH2 
Iv 
Ci' N75\ N 
M 	M 
IYA 
Figure 1.17: 2-Aminopyridine (IV) and 4-methyl-N pyridin-2-yI-benzenesulfonamide (V). 
Sulfonamido complexes have several applications. Studies on d' ° metal ions and 
transition metal complexes of sulfonylurea drugs was initiated by Kessissoglou et al 
following the discovery that sulfonyl urea compounds are able to reduce blood sugar 
levels without affecting glucose tolerance and the discovery that Zn(II) had been 
implicated in the release mechanism of insulin. 62  The sulfonamide dansylamide 
(Figure 1.18) has found use in the development of zinc fluorophores, an indicator 
which uses fluorescence, following the discovery that sulfonamides inhibit zinc 
containing carbonic anhydrase. 63 
N 
oI / S\ 
0 HNW 
Figure 1.18: Dansylamide. 
Carbonic anhydrase is a zinc enzyme. It catalyses the reversible hydration of carbon 
dioxide in red blood cells to form the bicarbonate anion and a proton via a tandem 
chemical process (Figure 1 . 19) . 64 
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H0 + CO2 	 — HCO3 
H20 	 Off+H 
H20 + CO2 _______ HCO3 + H 
Figure 1.19: Catalysed reactions of carbonic anhydrase. 
A shift in the dansyl emission peak is observed when zinc is bound to carbonic 
anhydrase, therefore by the incorporation of a dansylamide group into a macrocyclic 
or chelating ligand for zinc leads to a very useful sensor for Zn(II) or carbonic 
anhydrase. 
An area where sulfonamido ligands and in particular disulfonamido ligands have 
found important application is in catalysis. Chiral bis(sulfonamide) ligands are 
known to stereospecifically catalyse Diels-Alder, Claisen, [2+2] cycloaddition, and 
enolisation-amination reactions. Elements used at the core of these catalysts are 
titanium, aluminium, ruthenium, boron, copper, zinc, magnesium and lanthanide 
metals. Titanium bis(sulfonamide) complexes of the type shown in Figure 1.20 are 
known to catalyse the enantioselective formation of C-C bonds through the addition 






+ ZnEt2 	 O2ToI 
Ph J'H Toluene,-135°C, 15h 	 Ph 	H 
Figure 1.20: Enantioselective formation of a C-C bond through the addition of an ethyl group to 
benzaldehyde. 66 
The titanium catalyst is prepared in situ from Ti(O-i-Pr)4 and the disulfonamido 
ligand. The mechanism for the catalysis of this reaction has not been adequately 
explored however it is proposed that the asymmetric reaction involves the initial 
formation of the chiral titanium complex. 69 An interesting feature of disulfonamide-
titanium chemistry is that it is not uncommon that coordination of the sulfonamide 
oxygens to the metal centre should be observed this has also been noted in 
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disulfonamide-lanthanide chemistry, which will be mentioned later. It is thought that 
the coordination of the oxygen atoms may be due to the Lewis acid metal centre, 
however it is also proposed that coordination may be the result of crystal packing 
forces. Corey et al have reported the catalysis of Diels-Alder reactions with similar 
ligands (Figure 1.21) using an aluminium core. 70,71,72,73 
+ 	 NAr 
CF3S02N.. 	
AI 
0 1 H 	II 
Me 	TMS
Toluene, -78°C, 12h 	
NAr 
95% ee 
Figure 1.21: The reaction of 2-((trimethylsilyl)methyl)-butadiene with N-(2-t-butylphenyl) 
maleiimide. 70 
Aluminium complexes with related bis(sulfonamide) ligands (Figure 1.22) are also 
known to catalyse [2+2] cycloadditions. 74 
Ph 	 Ph 
NHSO2R 
+ CH2CO RSO2H AK 	 0 C~—j 	 Et 
jW 
R = p-CH3 -C61141  
C6F6, 	 74% ee 
2,4-(CF1)2C6H3 
Figure 1.22: Asymmetric [2+2] cycloaddition of ketene with benzaldehyde. 
To a stirred solution of the enantiopure bis(sulfonamide) complex in dry toluene an 
aldehyde was added under N 2 at -78°C and after ten minutes ketene was bubbled into 
the mixture for several minutes.  74  The following steric model (Figure 1.23) was 
postulated to explain the observed enantioselectivity. The aldehyde appears to 
coordinate to the catalyst by the lone pair electrons of the carbonyl oxygen in a 
manner anti to the alkyl sustituent. 
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Figure 1.23: A steric model to explain the resulting enantioselectivity of a [2+2] cycloaddition. 74 
Monosulfonamido ligands can be complexed to ruthenium(II) centres in situ to 
generate catalysts for the asymmetric hydrogen transfer to ketones or immes from 







LII'IH 	+ 0 
II 	+ (CH3)2CH01-J 	 30 Ph 	CH3 113C 	CH, 
Ph 	CH, 	 97% cc 
Figure 1.24: Asymmetric hydrogenation of 1 -phenyl-ethanone. 77 
The catalyst is generated in situ from [RuC12(1 6-benzene)]2 and free ligand. 77 The 
real nature of the catalyst remains unknown and the ruthenium complex in Figure 
1.24 is thought to be the catalyst precursor. 
Bis(sulfonamide) complexes of boron have found a wide range of applications. The 
complex in Figure 1.25 is known to catalyse aldol reactions. 73 
34 
Chapter 1: Introduction 






Ar = p-CH 3 -C6H4 
p-NO2-C6H4 	
97% ee 
Figure 1.25: The aldol condensation of benzaldehyde and pentan-3-one. 
Identical complexes where an allylic group replaces the bromide are used to catalyse 
the enantioselective addition of allyl groups to the carbonyl function of aldehydes to 
form chiral secondary homoallylic alcohols (Figure 1.26). 78  
HO 	H 
Ph 	 Ph 	
+ C6H5CHO 	
C6H5 
ToISO2N. r NSo2ToI  
94% ee 
CI-$2CH=CI-12 
Figure 1.26: Enantioselective addition of propene to benzaldehyde. 
Enantioselectivity is explained by a predicted chair-like transition state with 
optimum stereoelectronics and minimum steric repulsion between appendages on the 









Figure 1.27: Postulated transition state for the enantioselective addition of propene to bezaldehyde. 
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Similar boron complexes also catalyse the Claisen rearrangement as illustrated in 
79 Figure 






Ar = 4-mcthylphcnyl 
3,5-bis (trifluoromethyl)phenyl 
Figure 1.28: The Claisen rearrangement of 2-((E)-Hex-2-enyloxy)-phenol. 
The mechanism of enantioselectivity can be explained as follows. 79 The phenoxy 
group binds to the chiral boron reagent followed by coordination of the allylic 
oxygen to the boron atom forming a rigid five-membered cyclic intermediate. The 
re-site of the benzene ring of the substrate may be shielded by one tolyl group of the 
sulfonamide ligand. Therefore, the approach of the allylic moiety should occur on 
the si-face (Figure 1.29). 
>2 
Figure 1.29: The intermediate formed in the Claisen rearrangement. 
Cu(II) complexes with ligands of the type (number) are employed in the asymmetric 
cyclopropanation of olefins with diazoacetate, Figure 1 3Ø•80 
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Figure 1.30: Asymmetric cyclopropanation of vinyl-benzene by a copper-chiral 2-(2-aryl-
sulfonylamino)phenyl- 1 ,3-oxazoline. 
The copper complex in Figure 1.30 is considered to be the pre-catalyst. Upon 
activation with diazoacetate it is proposed that one chiral ligand is lost to form 
copper(I):chiral ligand = 1:1 complexes. The styrene can approach the copper centre 
from above and below and selectivity is thought to be dependent on the bulkiness of 
the ester part. 
Zinc(II) complexes of chiral bis(sulfonamide) ligands are effective catalysts for the 
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Figure 1.31: Enantioselective cyclopropanation of (E)-3-Phenyl-prop-2-en- 1-01. 
The catalyst is generated in situ by the reaction of the disulfonamide ligand with 










H3C 	1 0 
.. 	 X=S02CH3 
Figure 1.32: Transition state rationale for sulfonamide-promoted cyclopropanation. 82 
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Zinc iodide and bis(iodomethyl)zinc react to form (iodomethyl) zinc iodide. The 
simultaneous coordination of the two reactive species, namely the substrate 
ethyizincalkoxide and the reagent iodomethylzinc iodide, by the zinc atom in the 
catalyst implies that it acts as an organisational centre. At the same time the 
reactivity of the methylene group of (iodomethyl) zinc  iodide is enhanced by virtue 
of the electron-deficient and geometrically distorted zinc atom. 
Chiral magnesium bis(sulfonamide) complexes can mediate the enolisation and 
enantioselective electrophilic amination of aryl-substituted carboximides (Figure 
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Figure 1.33: The asymmetric amination of 3-(2-phenyl-ethanoyl)-oxazolidin-2-one. 
The role of N-methyl-p-toluenesulfonamide in this catalytic process is not yet 
completely elucidated however it has been concluded that the catalyst turnover is the 
rate determining step. 
Lanthanide complexes with chiral bis(sulfonamide)ligands were also developed with 
a view to their being used as catalysts, (Figure 1 •34),84  however to date their 
application in this field has not been published. 
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(H3C)2 
LnSc; n= I 
Ln = Y, La, Nd; n = 2 
Figure 1.34: Lanthanide complexes of trans-1,2-bis(2,4,6-triisopropylbenzene sulfonamido 
cyclohexane 
M(IV)Cp*Me3  complexes are known to complex a variety of N 2Hx or NH ligands 
which can be cleaved in il 2-hydrazine to give ammonia in the presence of protons 
and a reducing agent. 85 M(IV)Cp*Me3  complexes are not stable in protic solvents 
and related systems were required which did not contain metal-carbon bonds. 8' The 
complex W(NAr)[N(NT5) 2]C12, (N(NTs)2 = 2,6-NC5H3-(CH2Ntosyl)2 , Ar = 2,6-
C6H3-iPr2) is isolobal, to MCp*Me3.  Fragments are isolobal if their uppermost 
orbitals have the same symmetry, similar energies, and the same electron occupation. 
It was found that upon substitution of the Cl on (VI) with triflate to give VII and 
subsequent reaction with hydrazine gave W(Nar)[N(NTs)2](11 2-NHNH2)Cl (VIII). 
This complex can be reduced by zinc amalgam and subsequent addition of 
concentrated HC1 to the reaction mixture generates 1.19 equivalents of NH 3 to 
produce ammonia. 85 
NAr /TS 	 NAr /TS 	 NAr /Ts 
CI.4..\1 	
-AgCI 	 +2NH2NH 	NCIj,T N 
Ts 	
+ AgOTf 	 C1 	[N2H5][OTf] 
TSaH2 
VI 	 VII 	 VIII 
Figure 1.35: Route to a tungsten complex which upon reduction produces ammonia. 
39 
Chapter 1: Introduction 
1.8.3 Sulfonamide complexes as metal extractants 
Takagi et a186 published a study of several sulfonamide ligands including the 
bis(sulfonamide)phenylenediamine ligand shown in Figure 1.36. 
NHSO2R 
Figure 1.36: Bis(sulfonamide)phenylenediamine [R = Me (IX), R = n-C 8H 17 (X)] 
Neutral complexes of divalent metals (Co, Ni, Cu, Zn) can be formed from the 
disulfonamide ligand (IX, LH 2) in the presence of neutral monodentate or bidentate 
ligands as Equation 1.19 illustrates. 86 
LH2 + A + M(CH3CO2) = [ML.A] + 2CH3CO2H (A = 2NH3 or en or phen) 
Eq 1.19 
The lipophilic ligand (X, with R=n-C8H 17) extracts copper and zinc into toluene in 
the presence of 4-benzylpyridine or 1 ,2-bis(hexylthio)ethane. 
The coordinative behaviour of pyridyl substituted benzene sulfonamide ligands (XI, 
XII and XIII, LH) towards cobalt(II) and iron(III) were studied by Döring et a187 as 
models for the L1X34 (XIV) extractant (Figures 1.37 and 1.38). 
c • j__1 R_N_S_R 
N 	 H 02 
Figure 1.37: Sulfonamide model, [R 1 = CH2 and R = C6H5 orp-CH3C6H4 , XI. R' = (CH2) 2 and R = 
C6H5 XII orp-CH 3C6H4 , XIII. 




Figure 1.38: L1X34 (XIV). 
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The complex formed by XIII with cobalt Co(L) 2 has distorted tetrahedral geometry 
and a sulfonamide bridged tetramer with pentacoordinate cobalt(II) is formed with 
XI. Iron(III) forms complex salts with XII, [Fe(LH)2(L)](NO3)2.xH 201,and XIII, 
[Fe(LH)2(L)](NO3)2 .xH201, which are insoluble in organic solvents. 
Subsequent to the identification of sulfonamide oxime ligands as target molecules an 
exhaustive literature search uncovered a further paper by Doring et a!88 . This paper 
covers a wide range of ligands but of particular interest are results reported on the 
two ligands XV and XVI (Figure 1.39). 
C6H5 	 ,C6H5 
N 






Figure 1.39: Bis [o-(p-toluene sulfonamido)benzophenone]-ethylene diamine (XV) and N-(2- 
hydroxyimino-cyclododecyl)-4-methyl-benzenesulfonamide (XVI). 
Magnetic studies, electronic and JR spectra suggest a distorted tetrahedral structure 
for cobalt(II), copper(II) and nickel(II) complexes of XV. 88 A distorted tetrahedral 
geometry is also proposed for the copper complex of XVI. 
The solvent extraction properties of two industrial extractants, P50 and SME529 are 
compared with those of XV and XVI. The pH values of XV and XVI are claimed 
to be higher than those of the commercial extractants. By using EPR to study the 
copper complexes of these ligands it was concluded that P50 and SME529 are better 
extractants than the sulfonamides due to the planarity of the copper(II) complexes 
and the hydrogen-bonding between ligands in the complex. 88  This type of hydrogen-
bonding is not observed in complexes with XV and XVI due to their distorted 
tetrahedral geometry which causes them to be weaker extractants. Another molecule 
I'll 
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of interest to us (XVII) is also mentioned in the paper and the coordination chemistry 
is briefly described however, no solvent extraction studies were done. 
0 
ToI_SNH 	NOH 
Figure 1.40: 1-{2-[N-(4-methylbenzenesulfonamido)]phenyl}ethan-1-one oxime (XVII). 
A final paper considers the use of macrocyclic ligands containing proton-ionizable 
sulfonamide groups in the transport of alkali metal cations (Figure 1.4 1 )•89 The 
function of the sulfonamido groups is that they can easily be deprotonated and upon 
the incorporation of a divalent metal cation into the macrocyclic cavity a neutral 
coordination compound is produced. 
HNQNH 
bu 'Bu 
Figure 1.41: A sulfonamide extractant for alkali metals. 
Seven patents which cover a wide range of sulfonamido ligands as solvent 
extractants were published by the Henkel Corporation between 1979 and 1981. The 
patents include the detailed molecular structure of the extractants and their solvent 
extraction properties. Their contents, including figures of their basic molecular 
structure are described briefly below. Metal extraction from aqueous solution by all 
of the sulfonamido ligands was found to be dependent upon a number of factors. 
These included, the concentration of the metal ion, the particular anions present, the 
pH of and/or ammonia concentration in the aqueous solutions, as well as the 
particular ligand and its concentration in the organic phase. The first patent 
published covered sulfonamide oxime ligands 9° (Figure 1.42). 
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Figure 1.42: Sulfonamide oxime extractants. 
These ligands were found to be useful for the recovery of Cu(II), Ni(II), Zn(II), 
Co(II) and Co(III) and to a lesser extent to Ag(I), Hg(II), Cd(II) and Pb(II). Copper 
may be extracted from all values of acidic pH, however nickel and cobalt may only 
be extracted at pH values above six. Extraction levels greater that 50% were 
achieved for Cu(II), Co(ll), Ni(II) and Zn(II). 
R1_c___R2 
NHSO2R 
Figure 1.43: Sulfonamido quinoline extractants. 
Sulfonamido quinoline extractants 91 (Figure 1.43) were found to be useful in the 
extraction of Cu(II), Ni(II), Zn(II), Co(II), Cd(II), Hg(II), Ag(I) and Pb(II). The 
ligands have good copper/iron selectivity ratios, and most can be recovered from 
ammoniacal solution. 
IT 
R 1-1 - - 	S02-NH-NH-C-NH-R 
Figure 1.44: Sulfonyithiosemicarbazides ligands. 
Sulfonylthiosemicarbazides 92 (Figure 1.44) were found to be useful reagents for 
Cu(II), Ni(II), Zn(II), Co(II) and Co(III) and may also be applied to a lesser extent to 
Cd(II), Hg(II), Ag(I) and Pb(II) recovery from ammoniacal solution. 
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OH 
_-L_-- R 
Ri 	II I 
-c, 
Figure 1.45: Sulfonamidophenol extractants. 
Sulfonamido phenol extractants 93 (Figure 1.45) may be applied to the recovery of 
Cu(II), Ni(II) and Zn(II). The ligands are also weaker extractants for Cd(II), Hg(II), 
Ag(I), Pb(II) and Co(II) recovery. Sulfonamido phenols readily extract copper(II) at 
acid pH values and copper is also readily extracted from ammoniacal solutions. 






Figure 1.46: Sulfonamidothiadiazole. 
Sulfonamidothiadiazole extractants 94 (Figure 1.46) may be used to extract Cu(II), 
Ni(II), Zn(II), Co(II) and Co(III) and are weaker extractants for Cd(II), Hg(II), Ag(I) 
and Pb(II). Copper(II) may be extracted from acidic aqueous solution at all pH 
values however, Ni(II), Zn(II) and Co(II) require a pH above five. All the previously 
mentioned metals may be extracted from ammoniacal solutions. 
Figure 1.47: Sulfonylhydrazine extractants. 
Sulfonyl hydrazines 95 (Figure 1.47) may be used to extract Cu(II), Ni(II), Zn(II), 
Co(II) and Co(III) and are weaker extractants for Cd(I1), Hg(H), Ag(I) and Pb(II). 
The extractants have also been found to be mildly effective in extracting uranium, 
molybdenum, vanadium and iron. 
R i 
Figure 1.48: Sulfonamido pyrimidine extractants. 
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Sulfonamido pyrimidines96 (Figure 1.48) are useful for the recovery of Cu(II), Ni(II), 
Zn(II), Co(II) and Co(III) and can also be applied to Cd(II), Hg(II), Ag(I) and Pb(II). 
Although the patents have explored the solvent extraction properties of the ligands in 
detail little time was spent investigating complex stoichiometry. Studies of the solid 
state structures of the ligands and their complexes and their behaviour in solution 
were not undertaken. 
45 
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2.1 Introduction 
Bidentate diammo-monosulfonamides have two nitrogen donors for coordination to a 
metal. The acidic sulfonamido hydrogen (pK a -9) can be lost to produce a 
monoamonic ligand which upon coordination to a metal (II) ion, in a ratio of 2 ligands 
to 1 metal, will produce a neutral four coordinate complex. The organisation of two 
ligands through "head to tail" interactions is possible, via hydrogen-bonding between 
the amino group hydrogen donor(s) and the sulfonamido oxygen acceptor sites, to 
form a dimeric centrosymmetric pseudo-macrocycle in an analogous way to P50 
(Figure 2.1). 
R 
R2HN/ \ NHSO2R' 
+2> 
o 	 0 
R2 /R\ 	J R2 /R\ 
H-N HN-S-R 	 H 	N-S-R 
II +M2+ 	 • II 0 	 _____ _ _ _ _ __ 	 0 
° 	 : - 	 M 
II +2H 	 II 	/\ 
	
R-S-N N-H 	 R-S-N N-H 
II 	R \R2 	 II \R 
0 0 
Figure 2.1: Schematic representation of ligand assembly involving monosulfonamidodiamines. 
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2.2 Synthesis of simple monosulfonamidodiamines and their metal 
complexes 
The simple monosulfonamidodiamme ligands prepared in this project are summarised 
m Figure 2.2. 
R2HN NHSO2R 1 
R R' 
1 	 -(CH2)2- tolyl 
2 -(CH2)2- 'BuPh 
3 	 -(CH2)2- tolyl 
4 -(CH2)2- tolyl 
5 	 -(CH2)3- tolyl 
6 -(CH2)3 - 'BuPh 
7 	 -(CH2)3- tolyl 
8 -(CH2) 3 - tolyl 
9 	 -(CH2)3- tolyl 
10 o-phenylene tolyl 
11 	o-phenylene tBuPh 













The complexes which were isolated upon complexation of these ligands are listed in 
Table 2.1. 
Table 2.1: Complexes of simple monosulfonamidodiamine ligands. 
Abbreviation 	12 	 13 	 14 	 15 	 16 
Complex [Zn(1-H)21 [Ni(1-H)21 [Co(1-H)2 '] 	[Cu(1-H) 2'] 	[Cu(2-H)21 
17 	 18 	 19 	 20 	 21' 	 22 
1Nj(4H)2a1 	[Co(4H)2'} 	[Cu(4-H)2 ] 	[Co(5-H) 2'1] 	[Cu(5H)2tC] 	[Cu(5H)2 2 ] 
23 	 24 	 25 	 26 	 27 
[Zn(5-H) 2'] 	[Cu(8-H) 2'] 	[Ni(10-H)20] 	[Cu(10-H) 2'2] 	[Zn(10_H)2a] 
a Formula consistent with C/FL/N analytical data. ' Formula confirmed by X-ray crystallography. C  This complex 
exists in blue and green polymorphs. 
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2.2.1 Free ligands 
Ligands 1, 5 and 10 (Figure 2.3) were prepared in the early stages of the project. 
I-' n 
H2N 	 NMTs 	 NH2 	NHTs 	H2N 	 NHTs 
1 	 5 	 10 
Figure 2.3: The three principle monosulfonamido ligands investigated. 
Literature preparations 2,3  were followed. Conversion of 1 ,2-diaminoethane and 1,3-
diaminopropane into the monotosyl derivatives 1 and 5 was crucially dependent on 
reaction conditions. Kirsanov 2 established that the addition of the diamine to the 4-
methylbenzenesulfonyl chloride (TsC1) leads only to the formation of a disubstituted 
species and that by the addition of the 4-methylbenzenesulfonyl chloride to the 
diamine a monosubstituted species can be obtained. Different ratios of reagents were 
tested and the best yields were found at the diamine to sulfonyl chloride ratio of three 
to one instead of the expected three to two, (Equation 2.1). 
3NH2CH2CH2N}12 + 2ArSO2CI 	2ArSO2NHCH2CH2NH2 + NH2CH2CH2NH2 .2HCI Eq 2.1 
Following this optimisation of reaction conditions, one equivalent of 4-
methylbenzenesulfonyl chloride in toluene was added dropwise to three equivalents of 
diamine in toluene at room temperature to prepare both 1 and 5 (Figure 2.4). 
11 	(I 




Figure 2.4: The synthesis of! and 5. R = -(CH 2)2- (1) or —(CH2)3- (5). (i) Toluene, 25°C. 
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The preparation of 10 was reported  by Cheng in 1991. The ligand was prepared from 
the reaction of o-phenylene diamine and 4-methylbenzenesulfonyl chloride in a ratio 
of 1:1 in a solution of pyridine which was quenched with HC1 (Figure 2.5). 
+ 	
_cI 
(i) 	p 11 
H2 N 	 NH, 	 H2N 	 NHTs 
Figure 2.5: The synthesis of 10. (i) Pyridine, 25°C. 
Molecules 1, 5 and 10 have sufficient solubility for analytical purposes and for studies 
of their complexational behaviour. However, to study their colligative properties and 
to undertake electrochemical and solvent-extraction studies their solubility had to be 
improved. This is discussed further in chapter 4. 
The high number of hydrogen-bond donor and acceptor sites present in these ligands 
means that there are large numbers of possible intra- and inter-molecular interactions. 
In order to investigate these in the solid state, X-ray crystal structures have been 
determined for the ligands where possible. 
2.2.2 Metal complexes 
Metal complexes of simple monosulfonamidodiamines were synthesised by the 
standard method of reaction of two equivalents of the appropriate ligand with one 
equivalent of the appropriate divalent metal acetate, 4 (Equation 2.2). The acetate 
counterions effectively buffer the reaction mixture, promoting the formation of the 
monoanionic ligand. 
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2.3 Characterisation of simple monosulfonamidodiamines 
2.3.1 Infrared Spectroscopy 
Infrared (IR) spectroscopy can be used to confirm the presence of the sulfonamide 
group in the products. One strong band is expected in the 1370-1330 cm' region and 
another in the 1180-1160 cm' region for the -S0 2-N group. 
2.3.2 NMR Spectroscopy 
'H NMR spectroscopy is particularly useful since the p-alkylarylsulfonamides show 
characteristic resonances in the aromatic region of the spectrum. The four aromatic 
protons fall into two magnetically equivalent sets in a and b (Figure 2.6) which have 
sufficiently different chemical shifts to give rise to two doublets, observed around 7.8 
and 7.3 ppm depending on the exact structure, and with a coupling constant 3JHH of 
typically 6 Hz. The a protons were shifted to lower field with respect to the b protons 
due to the deshielding effect of the sulfonyl group. For the p-methylaryl sulfonamides 
a further characteristic singlet was seen around 2.5 ppm for the methyl group, whereas 
for the ptbutyl  group a resonance assigned to nine methyl hydrogens was observed 
around 1.3 ppm. 
As an example, N-(2-aminoethyl)-4-methylbenzenesulfonamide (1), shows further 
triplet resonances at 2.8 and 3.0 ppm assigned to the methylene hydrogens of the 
ethane linkage group (Figure 2.6). The resonance at 3.0 ppm was due to the 
methylene hydrogens (Hf) adjacent to the sulfonamide group as these were more 
deshielded due to the electron withdrawing effect of the sulfonamide group. 
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' 3C NMR is also useful in confirming the structures. Assignments for N-(2-
aminoethyl)-4-methylbenzenesulfonamide (1) are given in Figure 2.6. Spectra are 
easily assigned using DEPT techniques. 5 The methyl signal is usually found at 20 
ppm with the two methylene signals further downfield. The remaining signals are 










Label 13C NMR (ppm) 'H NMR (;pm) 
a 130 7.8 
b 127 7.3 
C 136 - 
d 143 
e 21 2.4 
45 	 3.0 
41 2.8 
Figure 2.6: NMR assignments for N-(2-aminoethyl)-4-methylbenzenesulfonamide (1). 
2.3.3 Mass Spectrometry 
Mass spectrometry was also routinely used for characterisation. Of the techniques 
available (El, FAB and ESI) electron impact has been used primarily. In addition, 
preliminary work has been performed using the gentler ESI technique to probe the 
solution structure of these compounds, this is discussed in chapter 4. 
2.3.4 X-ray crystallography 
Ligands 1, 5, 7, 9 and 10 were also characterised by X-ray crystallography. Bond 
lengths in the central components of the ligands are listed in Figure 2.7. 
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 H 
	iv 
II  H2N 	HN-S-R 1 	N 2 	 SII -R 1 V11 VI V11 VI 	 VIlvi 
0 	 0 	 0 
5/7/9 	 10 
Bond 	 la 	 5 	 7 	 9 	 ioa 
1.464(5) 1.4665(19) 1.469(7) 1.466(4) 1.367(4) 
1.465(5) 1.374(4) 
ii 	1.512(6) 1.522(2) 1.522(7) 1.511(4) 1.399(4) 
1.503(6) 1.399(4) 
1.478(5) 1.4740(18) 1.475(7) 1.471(4) 1.437(4) 
1.486(5) 1.446(4) 
iv 1.515(2) 1.502(7) 1.506(4) 
V 	 1.614(4) 1.6081(12) 1.607(5) 1.610(3) 1.612(3) 
1.593(4) 1.627(3) 
Vi 	 1.763(4) 1.7670(14) 1.759(5) 1.773(3) 1.755(3) 
1.779(5) 1.766(3 
a  In 1 and 10 two independent molecules exist per asymmetric unit 
Figure 2.7: Bond lengths (A) for the central components of sulfonamido diamine ligands I (R 1 = Tol), 
5 (R' = To!, J(2 = H), 7 (R' = Tol, R2 = benzyl), 9 (R' = Tol, R2 = butyl) and 10 (R' = Tol). 
Ligands 1, 5, 7 and 9 have comparable bond lengths. 10 has shorter i, ii and iii bond 
lengths due to the aromatic nature of the ligand backbone. Delocalisation of the 
aromatic it electrons of the phenyl ring over bonds i and iii leads to stronger and thus 
shorter bonds. 
2.4 Solid State structures of ligands and complexes 
2.4.1 Free Ligands 
Although the crystalline structures of ligands 1, 5, 7, 9 and 10 may bear little relation 
to their behaviour in solution, some information on the propensity of these ligands to 
form the desired pseudo-macrocyclic motif (see chapter 1) can be achieved. We 
proposed that this could give rise to increased stability of the metal complexes, as seen 
for phenolic oximes. 
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The principles of crystal engineering have shown that the number of hydrogen-bond 
acceptor and donor sites in the molecule is very important in determining the observed 
structure. Empirical rules of hydrogen-bonding in crystals suggest 6 that the structure 
will be dominated by the strongest hydrogen-bond donor interacting with the strongest 
hydrogen-bond acceptor. Any further acceptors or donors in the system will give rise 
to additional interactions and may lead to unusual crystal architectures. 
Simple monosulfonamidodiamines have several hydrogen-bond donor and acceptor 
functions (Figure 2.8). 
R2HN" HN_—(___R1 
0 
Figure 2.8: The hydrogen-bond donor (blue) and acceptor atoms (red) in simple 
monosulfonamidodiamjnes. 
The number of hydrogen-bond donor and acceptor atoms are tabulated in Table 2.2 
below. Each oxygen atom has two hydrogen-bond acceptor sites as they have two 
lone pairs of electrons. It is easy to see from Table 2.2 that a wide range of hydrogen-
bonded structures are likely to be observed for the free ligands. These are described in 
detail in this section. 
Table 2.2: The numbers of hydrogen-bond donor and acceptor sites in simple 
monosulfonamidodiamine free ligand molecules. 
R'= alkyl /aryl 	R=H 
Number of hydrogen-bond 
acceptor sites 	 6 	 6 
Number of hydrogen-bond 
donor atoms 	 2 	 3 
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2.4.1.1 N-(3-aminopropyl)-4-methylbenzenesulfonamjde (5) 
Of the five determined ligand X-ray structures only two, 5 and 9, exhibit head-to-tail 
hydrogen-bonding to create a pseudo-macrocycle in the solid state. Figure 2.9 shows 
the hydrogen-bonded dimeric unit of 5. 
Figure 2.9: The hydrogen-bonded dimer of N-(3-amino-propyl)-4-methylbenzenesulfonamide (5), 
showing the atom labelling scheme. 
Two hydrogen-bonds between sulfonamido oxygen and amino nitrogen atoms [N(7A)-
H --- O(2A), 3.2610(17) A; N-H-O, 165°] form a pseudo-macrocycle. These dimeric 
units are linked by hydrogen-bonds between an amino hydrogen atom, N(7A)-H, and a 
sulfonamido oxygen atom, 0(1 A), to form a chain parallel to the b axis as depicted in 
Figure 2.10. 
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Figure 2.10: The hydrogen-bonded chain of dimeric units along the b axis. 
Adjacent strands of dimer units run in opposite directions parallel to the b axis and are 
linked by four hydrogen-bonds from each dimer between the amino nitrogen atoms 
N(7A) and the sulfonamido hydrogen atom H(3A) to create a hydrogen-bonded sheet 




------- ---- --- - -------------- bill Ill 
LC  
Figure 2.11: A schematic diagram to represent the two dimensional hydrogen-bonded sheet of 
molecules of 5. The dimer units are represented by the squares in black with hydrogen-
bonds indicated by a dashed line and the ligand backbone by a solid line. The N(7A)-H --- 
O(1A) hydrogen-bonds lihking the units along the b axis are in blue and the N(3A)-H --- 
N(7A) hydrogen-bonds linking the chains along the c axis are marked in red. 
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2.4.1.2 N-(N-butyl-2-aminopropyl)4-methylbenzenesulfonamide (9) 
The other structure to exhibit a hydrogen-bonded dimeric motif was N-(2-












O(2AA) Ib 	 4\C(4A) S 
4 - 
C(6A) 	 05A) 
C(10A) 
Figure 2.12: The hydrogen-bonded dimer of N-(2-butylaminopropyl)-4-methylbenzenesulfonamide 
(9). 
Each molecule is involved in two types of hydrogen-bonding. Hydrogen-bonds 
between sulfonamido oxygen atoms and amino hydrogen atoms, [N(7A)-H---
O(1AJ1AA), 3.125(4) A; N-H-O, 144(3) 0] link two molecules of 9 to create a pseudo-
macrocycle. A second type of hydrogen-bond between an amino nitrogen atom 
acceptor site, N(7A), and a sulfonamido hydrogen donor atom, N(3A)-H link each of 
these ligands to two other molecules {N(3A)-H --- N(7A), 2.96 A, N-H-N, 167 0] (Figure 
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Figure 2.13: The hydrogen-bonded network of 9 cross-linking dimers along the c axis. 
A 
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2.4.1.3 N-(2-aminoethyl)-4-methylbenzenesulfonamide (1) 
There are two crystallographically independent molecules of 1, type A and type B, in 
the unit cell (Figure 2.14). Type A molecules, unlike type B, are folded due to an 
intra-molecular hydrogen-bond between the sulfonamido nitrogen atom and the amino 
hydrogen atom [N(6A)-H --- N(3A), 2.88 A; N-H-N, 950]. 
PC 
Figure 2.14: The two crystallographically independent molecules (Type A and Type B) of N-(2-
aminoethyl)4-methylbenzenesulfonamide 1, showing the atom labelling scheme. 
Molecule 1 has an extensive inter-molecular hydrogen-bonded structure. Type A 
molecules are linked together via type B molecules with hydrogen-bonds between the 
sulfonamido hydrogen atoms, H(3A) and H(3B) and amino nitrogen atoms N(6B) and 
N(6A) respectively to create a "parallel-stacked" AB chain orientated along the a axis 
(Figure 2.15). 
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Figure 2.15: The hydrogen-bonded chain of type A and type B molecules of! along the a axis. 
Type B molecules are also hydrogen-bonded to two other type A molecules via two 
sulfonamido oxygen atoms, O(1A) and O(1B), and two amino hydrogen atoms, 
H(6aB) and H(6aA), along the b axis to create a hydrogen-bonded sheet along the ab 
plane. Finally, type B molecules are also linked to each other in a hydrogen-bonded 
chain along the b axis via N(6B)-H(6bB) --- O(2B) hydrogen-bonds. This two 
dimensional hydrogen-bonded array is shown schematically in Figure 2.16. 
A 	 A 
B ----------------- B ------------------- - ------------------ 
 
B ----------------- --- ----------------- --- ------------------B 
Figure 2.16: The two dimensional hydrogen-bonded sheet of!. The dashed lines represent hydrogen-
bonds. 
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2.4.1.4 N-(N-benzyl-2-aminopropyl)-4-methylbenzenesulfonamide (7) 
A) 
Figure 2.18: The X-ray structure of N-(N-benzyl-2-aminopropyl)4-methylbenzenesulfonamide (7). 
Each molecule of 7 is linked to two other molecules with four hydrogen-bonds along 
the c axis to form a chain. Molecules are linked by hydrogen-bonds between the 
sulfonamido nitrogen atom N(3A) and the amino hydrogen atom N(7A)-H, [N(7A)-H-
--N(3A), 2.997(7) A; N-H-N, 158(11)'], and between the sulfonamido hydrogen atom 
N(3A)-H and the amino nitrogen atom N(7A), [N(3A)-H --- N(7A), 3.00 A; N-H-N, 
17001 as shown in Figure 2.18 below. 
H 	 H\ 
- --  
Bz 	
0S N----- 
p-CH3(C6H4) 	 Bz 	
(C6H4)H3C-p 
Figure 2.17: The 4-membered hydrogen-bonded ring linking molecules of 7 along the c axis. 
A feature of the secondary hydrogen-bonded structure of 7 is that the sulfonamido 
oxygens are not involved in any hydrogen-bonding. According to the rules of crystal 
engineering  the strongest hydrogen-bonds form first. This suggests that for 7 the 
combination of the amino hydrogen atom to sulfonamido nitrogen atom and the amino 
nitrogen atom to sulfonamido hydrogen atom bonds is stronger than any interaction 
involving the sulfonamido oxygen atoms. 
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2.4.1.5 N-(2-amino-phenyl)-4-methylbenzenesulfonamide (10) 
There are two molecules of 10 in the asymmetric unit, designated as A and B. Both 
have very similar intra-molecularly hydrogen-bonded structures and are shown in 
Figure 2.19. Both have two intra-molecular hydrogen-bonds, between a sulfonamido 
oxygen atom and an amino hydrogen atom [N(6)-H---O(1), 3.117(5) A and 3.179(4) 
A; N-H-O, 126(3)° and 125(5)° in molecules A and B respectively]. The amino 
hydrogen atom N(6)-H acts as a bifurcated hydrogen-bond donor also bonding to the 
sulfonamido nitrogen atom [N(6)-H---N(3), 2.797(5) A and 2.808(5)A; N-H-N, 
100(3)° and 102° in molecules A and B respectively]. 
C(12A) 




C(U) 	 CI1A) 




6A) S J 





C)13B) 	 C(16B) 	 C(8B) 
C(7B) 	OWID 
C(5B) 	N)3B) 	 C(1IB) 
0# - - _ - . 
O)2B) 
Figure 2.19: The structure of A and B molecules of [N-(2-aminophenyl)-4- 
methylbenzenesulfonamide] (10), showing atom labelling schemes. 
A 
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Type A molecules and type B molecules form individual hydrogen-bonded chains 
along the b axis. Linear chains of type A molecules are formed via two hydrogen-
bonds to two other molecules through the sulfonamido oxygen atom not involved in 
intra-molecular hydrogen-bonding, 0(2A), and the sulfonamido hydrogen atom, 
H(3A). Type B molecules form more complicated chains involving four inter-
molecular hydrogen-bonds to two molecules (Figure 2.20). The sulfonamido oxygen 
atom not involved in intra-molecular hydrogen-bonding, 0(2A), is bifurcated and 
hydrogen-bonds to the amino hydrogen atom of one molecule, H(B6A), and the 
sulfonamido hydrogen atom, H(3A), of a second molecule thus forming a chain. 
Figure 2.20: Hydrogen-bonded chain of type B molecules along the b axis in the structure of 10. The 
tolyl groups have been removed for clarity. 
2.4.2 Hydrogen-bonding in monosuffonamidodiamine ligands 
The length D ... A (A), where D is the oxygen or nitrogen atom of the hydrogen-bond 
donors and A the acceptor, and the angles D-H --- D (°) for all the hydrogen-bonding 
interactions in ligands 1, 5, 7, 9 and 10 are tabulated in Tables 2.3, 2.4 and 2.5. 
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Table 2.3: Intra-molecular hydrogen-bond lengths (A) and angles (°) of ligands 1 and 10. 
Ligand Interaction Hydrogen-bond Hydrogen-bond 
length / A angle / 
1A" N(A)-H---O(S) 2.88 95 10A  N(A)-H---O(S) 3.117(5) 126(3) 
N(A)-H---N(S) 2.797(5) 100(3) 
lOB" N(A)-H---O(S) 3.179(4) 125(3) 
N(A)-H---N(S) 2.808(5) 102(3) 
a  Ligands 1 and 10 have two crystallographically independent molecules, A and B, per asymmetric unit. Atoms 
labelled A are contained in an amino group. Atoms labelled S are contained in a sulfonamido group. 
Table 2.4: Hydrogen-bond lengths (A) and angles (°) in ligands 5 and 9 which form pseudo-
macrocyclic structures in the solid state. 
Ligand 	Interaction 	Number of 	Hydrogen-bond 	Hydrogen-bond 
interactions length / A angle / 
5 	N(A)-H---O(S) 	2 	 3.2610(17) 	 164.7(14) 
9 N(A)-H---O(S) 2 3.125(4) 143(3) 
Atoms labelled A are contained in an amino group. Atoms labelled S are contained in a sulfonamido group 
Table 2.5: Inter-molecular hydrogen-bond lengths (A) and angles (°) of ligands 1, 5, 7, 9 and 
10. 
Ligand Interaction Number of Hydrogen- Hydrogen- 
interactions bond length / bond angle / 
A 
1' 	molecule A N(A)---H-N(S) 1 2.83 172 
N(S)-H---N(A) 1 2.852(6) 170(3) 
O(.S) --- H-N(A) 1 3.11 155 
N(A)-H---O(S) 1 3.070(5) 151(3) 
molecule B N(S)-H---N(A) 1 2.83 172 
N(A)---H-N(S) 1 2.85 170 
N(A)-H---O(S) 1 3.111(5) 155(4) 
O(S)---H-N(A) 1 3.07 152 
N(A)-H---O(S) 2 3.169(4) 156(5) 
5 N(S)-H---N(A) 2 2.91 174 
N(A)-H---O(S) 2 3.1751(18) 134.9(14) 
7 N(S)-H---N(A) 2 2.997(7) 158(11) 
N(A)-H---N(S) 2 3.00 170 
9 N(S)-H---N(A) 2 2.96 167 
ba 	molecule A N(A)-H---O(S) 1 2.817(4) 172(4) 
O(S)---H-N(A) 1 2.81 172 
molecule B N(A)-H---O(S) 2 3.197(4) 144(5) 
N(S)-H---O(S) 2 2.945(4) 174(3) 
' These ligands have two crystallographically independent molecules A and B, per asymmetric unit. Atoms labelled 
A are contained in an amino group. Atoms labelled S are contained in a sulfonamido group. 
Each ligand is involved in between 4 and 6 hydrogen-bonding  interactions. The bond 
length and angles of inter-molecular hydrogen-bonding N(A)-H---O(S) interactions are 
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independent of whether or not the bond is involved in pseudo-macroe yclic ligand 
formation (mean values are 3.12 c.f. 3.05 A and 154 cf. 145 0). The lengths of the 
intra-molecular N(A)-H---O(S) bonds (mean 3.06 A) are very similar however the 
bond angles are smaller (mean 115 0) which is usually associated with a weaker bond 
due to the non-linear nature of the interaction. 
For N(A)-H---N(5) interactions a significantly smaller bond angle is also observed for 
intra-molecular interactions (mean 1010),  than for inter-molecular interactions (mean 
168°). However, the lengths are very similar, 2.81 and 2.93 A respectively. 
2.4.3 Monosulfonamidodiamine complexes 
2.4.3.1 Bis[N-(2-aminoethyl)-4-methylbenzenesulfonamidatojzinc(II) (12) 
The asymmetric unit of 12 contains two zinc complexes [Zn(1-H) 2] and two methanol 
molecules. The two complexes, referred to as complexes (1) and (2) below in the 
asymmetric unit have very similar geometries. The structure of the Zn(l) complex is 
shown in Figure 2.21. 
Figure 2.21: The X-ray structure of one of the two [Zn(1-H) 2] complexes (complex 1 containing 
Zn( 1)) in the asymmetric unit of bis[(N-(2-aminoethyl)-4-methylbenzene sulfonamidato)] 
zinc(II) (12). 
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In [Zn(1-H)2] the zinc atom is distorted from tetrahedral coordination geometry. The 
N(3)-Zn(1)-N(6) and N(3)-Zn(2)-N(6) chelate angles are significantly smaller, 
84.6(3)°, 84.9(3)0 and, 84.7(3)°, 85.3(3)° respectively, than 109.5 0 which is expected 
for a perfect tetrahedral complex. This can be attributed to the five-membered chelate 
ring which restricts the size of the bite distances, the distance between the two 
nitrogen atoms, which range from 2.69 to 2.72 A. The dihedral angle between the Zn, 
N(3A) and N(6A) planes and the Zn, N(3B) and N(6B) planes are 90.2 and 88.3° for 
the Zn(l) and Zn(2) complexes respectively. These values are close to 90° which 
would be observed for a perfectly terahedral system. The Zn-N( sulfonamido) bond 
lengths range from 1.949(8) to 1.975(8) A and are significantly shorter than the Zn-
N(amino) bonds which range from 2.035(7) to 2.059(7) A, suggesting that the anionic 
sulfonamidato nitrogen bonds more strongly than the amino nitrogen. 
No hydrogen-bonding is observed between the two chelated N-(2-aminoethyl)-4-
methylbenzenesulfonamidato ligands. The hydrogen-bond donors and acceptors of the 
ligands have been twisted out of any interaction range by the pseudo-tetrahedral 
geometry of the metal which forces the chelate units to be almost perpendicular to 
each other. There is, however, extensive hydrogen-bonding present within the lattice. 
The Zn(l) and Zn(2) complexes each form individual polymeric hydrogen-bonded 
chain along the a axis via three strong inter-molecular N-H --- O interactions between 
sulfonamidato oxygen atoms, O(1A), 0(2A) and O(lB), and amino hydrogen atoms, 
H(6aA), H(6aB) and H(6bB) in adjacent complexes. This is illustrated for the Zn( 1) 
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Figure 2.22: The hydrogen-bonded secondary structure of the Zn(l) complex along the a axis in the 
X-ray structure of [Zn(1-H) 2]. 
The number and nature of the inter-molecular hydrogen-bonds linking the Zn(2) 
complexes are the same as those linking the Zn( 1) complexes and only their lengths 
and angles differ, presumably due to the different orientations of the complexes. The 
chains of Zn( 1) and Zn(2) complexes alternate along the c axis and are bonded 
together by two similar hydrogen-bonded bridges via a methanol molecule between 
the bifurcated sulfonamidato oxygen atoms [0(2A) and 0(2C)] and the amino 
hydrogen atoms [H(6bA) and H(6aC)] of Zn( 1) and Zn(2) units respectively creating a 
two dimensional sheet. The atoms of Zn(l) complexes involved in forming these 
bridges are marked by arrows in Figure 2.22. The schematic diagram in Figure 2.23 
illustrates how the two chains of zinc complexes are linked together. 
WAI 




Zn2 Znl 	 Zn2 
a 	
-H--O-H--O= S \—N-H--- 
Me 
Figure 2.23: The two dimensional hydrogen-bonded sheet of 12. 
2.4.3.2: Bis[N-(2-aminoethyl)-4-methylbenzenesulfonamidatojnickel(II) (13) 
The asymmetric unit of 13 consists of half of the complex. The nickel(II) atom lies on 
an inversion centre and is coordinated by two amino and two sulfonamidato nitrogen 
atoms in a planar fashion with chelate, N(3)-Ni-N(6), angles of 85.97(13)°. This value 
is not far from the 900  expected for square-planar geometry. The smaller value of the 
angle than the ideal value may again be explained by the bite distance of 2.61 A which 
is restricted by the five-membered chelate ring. The sulfonamidato and amino 
nitrogen to nickel bond lengths are 1.909(3) and 1.918(3) A respectively. Unlike the 
analogous zinc complex [Zn(1-H) 2] both nitrogen atoms appear to bind to the metal 
centre with similar strength. 
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Figure 2.24: The X-ray structure of bis[N-(2-aminoethyl)-4-methylbenzenesulfonamidato]nickel(II) 
(13). 
Two intra-complex hydrogen-bonds between the sulfonamidato oxygen and amino 
hydrogen atoms [N(6A)-H --- O(1AA), 2.797(5) A; N-H-O, 123°] create a pseudo-
macrocyclic ligand. Extensive inter-molecular hydrogen-bonding is also present. 
The sulfonamidato oxygen and the amino hydrogen atoms involved in creating the 
pseudo-macrocycle are bifurcated and form N-H --- O interactions along the b axis with 
two adjacent complexes to create a one dimensional chain of molecules. Further 
hydrogen-bonded N(6A)-H --- O(2A) interactions between the sulfonamide oxygen and 
amino nitrogen atoms, not involved in the previous type of interaction, link the 
complex with four other complexes, two situated above and two below the chain of 
molecules to form a two dimensional hydrogen-bonded sheet in the bc plane. These 
hydrogen-bonding interactions are illustrated in Figure 2.25. 
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Figure 2.25: The secondary hydrogen-bonded structure of 13. The tolyl groups and hydrogen atoms 
not involved in hydrogen-bonding are omitted for clarity. 
2.4.3.3 Bis [N-(2-aminoethyl)-4-t-butylbenzenesulfonamidatoj copper(II) (16) 
The asymmetric unit of [Cu(2-H) 2] contains one complex (Figure 2.26), in which the 
copper(II) ion is slightly distorted from a planar geometry with a dihedral angle of 9.8° 
between the Cu(l), N(3A) and N(6A) plane and the Cu(l), N(3B) and N(6B) plane. 
The chelate angles are N(3A)-Cu-N(6A) 83.28(10)° and N(3B)-Cu-N(6B) 82.15(10)° 
which are smaller values than the 90° angle required for perfect square-planar 
coordination. These angles are less than in the analogous nickel complex (13) where a 
chelate angle of 86° is observed. This indicates the preference of d 8 nickel for a 
square-planar geometry because of the increase in ligand field stabilisation energy as 
the high energy dx 2-dy2  orbital is no longer occupied. The gain in ligand field 
stabilisation in d9 copper complexes is less, due to the extra electron, therefore the 
metal centre is less likely to push the geometry towards perfect square planar despite 
the bite distances of 2.64 and 2.62 A for the copper complex which are larger than the 
bite distance of 2.61 A in the nickel complex. The copper to sulfonamidato nitrogen 
bond lengths are 1.975(2) and 1.987(2) A and the copper to amino nitrogen bond 
lengths are 1.993(2) and 1.998(2) A. The difference in these bond lengths is not 
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significant and suggests that the sulfonamidato nitrogen atoms and the ammo nitrogen 
atoms are of approximately equal strength as coordinating atoms. 
Figure 2.26: X-ray structure of Bis[N-(2-aminoethyl)-4-tert-butylbenzenesulfonamidato]copper(1I) 
(16) showing intra-complex hydrogen-bonding. 
In an analogous way to the nickel complex (13) a head-to-tail arrangement of the 
ligands around the metal is observed and two intra-complex hydrogen-bonds between 
the sulfonamido oxygen and amino hydrogen atoms [N(6A)-H --- O(1B), 2.834(3) A; 
N-H-O, 138° and N(6A)-H---O(1B), 2.785(3) A; N-H-O, 120 01 create a pseudo-
macrocycle around the copper. This structure may be compared to the [Cu(5-H) 2] 
complex of the propane bridged ligands.' Two crystalline forms of [Cu(5-H) 2] were 
isolated' in which the copper(II) atom has either a highly distorted tetrahedral or 
highly distorted square-planar structure. The extra methylene unit in the backbone of 
ligand 5 cf. ligand 2, results in such a distortion of the complex geometry. There is no 
intra-molecular hydrogen-bonding in the two polymorphs of [Cu(5-H) 2] and it is 
thought' that extensive inter-molecular hydrogen-bonded networks are responsible for 
the unusual copper geometries. 
The secondary hydrogen-bonded structure of 16 consists of a chain of molecules along 
the a axis of the unit cell (Figure 2.27). Each centrosymmetric complex is linked to 
two other complexes via four hydrogen-bonds between amino hydrogen atoms and 
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sulfonamidato oxygen atoms [N(6B)-H --- O(2A), 2.970(3) A; N-H-O, 165°] and 
[N(6A)-H --- O(2B), 2.934(3) A; N-H-O, 164°]. 
Figure 2.27: Inter-molecular hydrogen-bonding in [Cu(2-H) 2] parallel to the a axis. The tolyl groups 
and hydrogen atoms not involved in hydrogen-bonding are omitted for clarity. 
The nickel(II) complex of ligand 1 and the copper(II) complex of ligand 2 are both 
planar with intra-molecular hydrogen-bonds between one of the sulfonamidato oxygen 
atoms and one of the amino hydrogen atoms creating a pseudo-macrocycle around the 
metal centres. In contrast, the zinc(II) complex has a distorted tetrahedral geometry 
and no intracomplex hydrogen-bonding. A CSD search (May 2001) showed that the 
metal to sulfonamidato nitrogen bond lengths for complexes 12, 13 and 16 were 
comparable to the lengths of similar complexes in the data base (CUN( sulfonamidato) 
1.922-2.003 A, Zn-N(su1fon jdato) 1.9251.969 A, NN(su1fonamidato) 1.9041.916 A). 
2.4.4 Hydrogen-bonding in sulfonamidodiamine complexes 
All hydrogen-bonding interactions for each sulfonamidodiamine complex are 
summarised in Tables 2.6 and 2.7. 
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Table 2.6: Details of intra-complex hydrogen-bonds which form a pseudo-macrocyclic ligand 
around the nickel(II) and copper(II) centres in complexes [Ni(1-H) 2](13) and [Cu(2-H) 2](16). 
Complex 	Interaction Number of 	Hydrogen-bond Hydrogen-bond 
interactions length / A angle / 
[Ni(1-H)2] 	N(A)-H---O(S) 2 	 2.797(5) 122 
[Cu(2-H) 2] N(A)-H---O(S) 1 2.834(3) 138 
N(A)-H---O(S) 1 	 2.785(3) 119 
Table 2.7: Details of inter-complex hydrogen-bonds in monosulfonamidodiamine complexes 
[Zn(1-H) 2] (12), [Ni(1-H) 2] (13) and [Cu(2-H) 2] (16). 
Complex 	Interaction 	Number of 	Hydrogen- 	Hydrogen- 
interactions bond length / 	bond angle / 
A 
[Zn(1-H)2 '2] 
Zn(1) complex N(A)-H---O(S) 2 3.031(11) 144 
N(A)-H---O(5) 2 3.012(10) 156 
N(A)-H---O(S) 2 2.939(11) 125 
N(A)-H---O(M) 1 3.003(12) 163 
O(S)---H-O(M) 1 2.792(11) 140 
Zn(2)complex N(A)-H---O(S) 2 3.057(11) 155 
N(A)-H---O(S) 2 3.168(11) 157 
N(A)-H---O(S) 2 2.939(11) 141 
N(A)-H---O(M) 1 3.003(12) 163 
O(S)---H-O(M) 1 2.792(11) 140 
[Ni(1-H)2] N(A)-H---O(S) 4 3.100(5) 143 
N(A)-H---O(S) 4 2.946(4) 156 
[Cu(2-H)2] N(A)-H---O(S) 2 2.970(3) 163 
N(A)-H---O(S) 2 2.934(3) 165 
[Cu(5H)2t] N(A)-H---O(S) 2 2.93 153 
FODSIA' N(A)-H---O(S) 2 3.16 140 
N(A)-H---O(S) 2 3.11 141 
N(A)-H---O(S) 2 2.89 151 
[Cu(5H)2 d] 
FODSIAO1' 
Cu(1) complex O(S)---H-N(A) 1 2.93 163 
O(Y---H-N(A) 1 3.04 172 
N(A)-H---O(S) 1 3.08 172 
N(A)-H---O(S) 1 2.98 173 
N(A)-H---O(S) 2 2.97 170 
N(A)-H---O(S) 2 3.09 172 
Cu(2) complex N(A)-H---O(S) 1 2.93 163 
N(A)-H---O(5) 1 3.04 172 
O(S)---H-N(A) 1 3.08 172 
O(S)---H-N(A) 1 2.98 173 
N(A)-H---O(S) 2 3.08 168 
N(A)-H---O(S) 2 2.90 170 
This structure has two ciystallographically independent metal complexes per asymmetric unit containing Zn(1) 
and Zn(2) . b  This complex exists in blue and green polymorphs. ' The blue polymorph has two ciystallographically 
independent complexes containing Cu(1) and Cu(2) per asymmetric unit. Atoms labelled A are contained in an 
amino group. Atoms labelled S are contained in a sulfonamido group. Atoms labelled M are contained in a 
methanol molecule. 
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Each complex is involved in between six and ten N(A)-H---O(S) hydrogen-bonding 
interactions. Intra-complex hydrogen-bonds have shorter lengths than inter-complex 
interactions but also have smaller bond angles, 2.80 and 3.01 A and 126 and 157° 
respectively. 
2.4.5 Hole sizes, bite distances and torsion angles. 
The "hole sizes" 7 in the free ligands, 5 and 9, which show pseudo-macrocyclic 
structures via inter-molecular hydrogen-bonding in a dimer were calculated from their 
solid state structures (Figure 2.28). The centroid (X) of the four nitrogen atoms of the 
pseudo-macrocycle was determined. Its mean distance (R m) from the four nitrogen 
atoms is termed the hole size. 
NI 	 N2 
R 1% /R2 
X 
%3 
N3 	 N4 
R 1 + R2 + R3 + R4 
4 
Figure 2.28: Calculation of the hole size of a hydrogen-bonded pseudo-macrocycle. 
Values are recorded in Table 2.8 below of the hole size in the dimeric units of ligands 
5 and 9 and in complexes 12, 13, 16, FODSIA (2 1) and FODSIA01 (22). 
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Table 2.8: The hole sizes of the pseudo-macrocyclic free ligands 5 and 9 and related metal(n) 
complexes. 
Structure Hole size I A 
5 3.14 
9 3.50 
[Zn(1.H)2a], (12) 2.00 
2.00 
[Ni(1-H)2], (13) 1.91 
[Cu(2-H)2], (16) 1.99 
[Cu(5-H)2]," FODSIA' (21) 1.98 
[Cu(5-H)2], FODSIA01 1 (22) 1.99 
1.99 
This structure has two crystallographically independent metal complexes per asymmetric unit 
containing Zn(1) and Zn(2). b  This complex exists in blue and green polymorphs (FODSIA 
and FODSIA01). ' The blue polymorph has two crystallographically independent complexes 
containing Cu( 1) and Cu(2) per asymmetric unit. 
A hydrogen-bonded dimeric pseudo-macrocyclic structure is not observed in the solid 
state of the two-carbon-bridged ligand (1) therefore we are unable to draw any 
conclusions here concerning the preorganisation of such ligands. However, two of the 
propane bridged ligands (5 and 9) show head-to-tail ligand dimerisation via hydrogen-
bonding. The hole size in 5 may be compared with that in three crystallographically 
independent [Cu(5-H)2] complexes.' The hole size of the preorgamsed dimer is over 1 
A (> 50%) larger than that in the copper complexes. If a similar hydrogen-bonded 
dimer were to be found in the organic phase prior to complexation it would be 
interesting to compare the structures of the free ligand and the complexed ligand to 
gain information on the conformational changes required for the ligands to coordinate 
to the metal centre. In particular, it is informative to see how the ligand "bites" (the 
distances between the two nitrogen donors) in the complexes compared with those of 
the donor atoms in the free ligands (Table 2.9). 
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Table 2.9: Bite distances (N amino Nsu Ifonamithto) in monosulfonamidodiamine ligands and their 
complexes. 
Ligand or Complex Bite distance / A 
molecule A 2.88 




ba 	 molecule A 2.80 
molecule B 2.81 
[Zn(1-H)2]" 	Zn(l) complex 2.72 
2.69 
Zn(2) complex 2.71 
2.70 





[Cu(5-H)2]' 	Cu( 1) complex 2.85 
FODSIA01' 2.82 
Cu(2) complex 2.81 
2.84 
This structure has two crystallographically independent ligands per asymmetric unit. 	b  This structure has two 
crystallographically independent metal complexes per asymmetric unit containing Zn(l) and Zn(2). C  This complex 
is centrosymmetric. 	d  This complex exists in blue and green polymorphs. 	e  The blue polymorph has two 
crystallographically independent complexes containing Cu(l) and Cu(2) per asymmetric unit. 
In each case the bite distance in the free ligand is greater than in the complex. 
However, the difference is usually less than 0.2 A, with exception of type molecule B 
of ligand 1 which has an extended configuration (Figure 2.14) and does not have an 
intra-molecular hydrogen-bonding interaction between the sulfonamido nitrogen and 
the amino hydrogen. The shorter bite distances observed in the copper complex 
[Cu(2-H)2] in comparison with [Cu(5-H) 2] may be explained by the shorter, two-
carbon backbone of ligand 2 which leads to the formation of a five membered chelate 
ring upon complexation. As the observed copper-nitrogen distances are very similar 
in [Cu(2-H) 2] and [Cu(5-H)2] and as the bite is constrained to be smaller in the five 
membered chelate ring in [Cu(2-H) 2] it is inevitable that the chelate angle N-Cu-N will 
be smaller (mean 82.7°) than in the six-membered chelate ring of [Cu(5-H) 2] (mean 
91.6°). 
To examine how the ligands change shape to reduce their bite distance and the hole 
size on complexation it is helpful to examine torsion angles in the chelate ring. A 
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torsion angle ('r) about a bond in a ring system is defined as the angle between the two 







Figure 2.29: Torsion angle c. 
The torsion angles in the ligand backbone of 1 and 7, in the inner great rings of the 
pseudo-macrocycles formed by ligands 5 and 9 and in the chelate rings of the metal 
complexes of ligands 1, 2 and 5 are listed in Tables 2.10 and 2.11. 
liH—NT•. 	N—SL i 	 e 
M\ M 	 0 
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Figure 2.30: Labelling for the torsion angles of ligands and complexes with a two or three carbon atom 
bridge between the nitrogen donors. 
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Table 2.10: Torsion angles in the free ligand 1 and in chelate rings and pseudo-macrocycles of 
its zinc and nickel complex and the copper complex of 2. 




[Ni(1-H) 21 [Cu(2-H)2] 
a 177.6 -167.2 
b 86.6 159.6 
C 59.7 	173.5 	49.9 -50.2 48.2 49.9 
d 100.4 96.4 171.5 -165.0 106.7 -169.2 
e -170.7 174.2 
1.5 53.6 
-25.0 -92.7 
h -177.6 -176.4 
-86.6 -172.6 
-47.3 45.0 -48.2 45.9 
k -147.1 158.3 106.7 159.9 
1 170.7 163.8 
M -1.5 29.0 
n 25.0 5.6 
This structure has two crystallographically independent molecules within the asymmetric unit (molecules A and 
B). b  This structure has two ciystallographically independent complexes in the asymmetric unit containing Zn(1) 
and Zn(2). 
The two conformers of 1 observed in the X-ray structure differ principally as a result 
of the torsion angle c about the central C-C bond which has trans configuration (174 °) 
in molecule B, leading to the extended conformation (Figure 2.14). Molecule A has a 
gauche configuration (torsion angle about c = 59.7°) providing an N---N bite (2.88 A) 
similar to that in the metal complexes. Formation of a chelate ring on complex 
formation is associated with a flattening of the bridge with torsion angles about c or j 
falling between 45 and 50° in the Ni(II) and Zn(II) complexes and the Cu(II) complex 
of the similar ligand 2. Whilst the chelate rings and the N 42 donor set are most nearly 
planar in the nickel complex, the sulfonamidato group is displaced further from the 
plane as revealed by the torsion angles about bonds d and k of 106.7° compared with 
values between 147 to 171° in the Cu(II) and Zn(II) complexes. The amino hydrogen 
atom in [Ni(1-H)2] is displaced to the same side of the coordination plane as the 
adjacent sulfonamidato oxygen atom (torsion angles b and c of 87°), presumably to 
allow formation of a favourable hydrogen-bonding interaction. A much "flatter" 
configuration is observed for the N-H bond in [Cu(2-H) 2] with torsion angles b and c 
of 160 and 173° respectively, again presumeably to optimise the N-H --- O=S 
hydrogen-bond because in this case the sulfonamidato group lies closer to the MN4 
coordinate plane (see above). Care needs to be taken not to over interpret results 
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based on parameters derived from the positions of hydrogen atoms because these are 
difficult to locate accurately in heavy atom structures. 
Table 2.11: Torsion angles in the free ligands 5, 7, 9 and the copper complex [Cu(5-H) 2]' 
Bond 5 7 9 [cu(5H)2Ia 







a -21.5 70.2 
b -58.5 67.3 
C -173.2 -179.5 174.2 -71.2 -63.0 -67.4 
d 64.2 -178.0 -176.9 62.0 53.3 61.0 
e 152.3 -152.7 -153.0 132.8 105.5 97.7 
45.5 43.1 
96.0 79.1 
h -102.9 5.5 
21.5 -70.2 
58.5 -67.3 
k 173.2 -174.2 -73.0 -69.3 -66.4 
64.2 176.9 64.2 62.0 56.4 
M 152.3 155.0 133.0 105.0 109.5 
n -45.5 -43.1 
o -96.0 
V 102.9 
This complex exists in blue and green polymorphs. b  The blue polymorph has two crystallographically 
independent [Cu(5-H) 2] complex units containing Cu(l) and Cu(2) per asymmetric unit. 
The gauche configuration about bonds c and d in the [Cu(5-H)2] complexes in 
comparison with the trans configuration about these bonds in ligands 5, 7 and 9 is 
associated with the formation of a chelate ring on complex formation. The free 
ligands each have an extended conformation in the solid state (Figures 2.9 (5), 2.12 (9) 
and 2.17 (7)). The configuration of ligands 5 and 9 does not appear to have been 
directed by the formation of a hydrogen-bonded macrocycle and the values of torsion 
angles about the two macrocycles are not similar 
2.4.6 Geometry of amido and sulfonamido nitrogens 
A number of studies may be found in the literature which investigate why the amido 
nitrogen is most commonly found to be planar in amides of carboxylic acids. The 
planarity of amides is associated with a resonance form in which, the lone pair of the 
nitrogen is also localised in the C-N bonding resulting in a partial N-C double bond, 
thus hindering rotation. 8 Figure 2.31 shows the two most important cannonical forms. 
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Figure 2.31: The resonance of the amides of carboxylic acids. 
It is thought that the biological importance of the amide group as part of the peptide 
bond is due in part to the rigid planarity of the amido nitrogen 9 which, coupled with 
hydrogen-bonding, provides proteins with the ability to form secondary and tertiary 
structures, e.g. "protein folding", which is fundamental to biological activity. 
Similar studies on sulfonamido systems can also be found. Planar sulfonamides have 
been reported however most tend to exhibit nitrogen pyramidalization' ° and thus, the 
energy barrier to rotation around the N-S bond is supposed to be less than the 
analogous N-C bond in amides. An ab initio comparative study of the electronic 
properties of amides of sulfonic and carboxylic acids' concluded that the conjugation 
over the —OC-N fragment in amides does not exist for the —0 25-N fragment in amides 
of sulfonic acids. It was therefore concluded" that there is no electronic analogy 
between amides and sulfonamides. 
2.4.7 Geometry of the sulfonamido nitrogen in monosulfonamidodiamine ligands 
The crystal structures obtained in this thesis of several sulfonamide ligands and their 
complexes allow us to look at the planarity of the sulfonamido nitrogen in relatively 
simple systems. Three parameters are used to evaluate the planarity of the 
sulfonamido nitrogen. The sum of the three angles around the nitrogen atom 0 is 3600 
when the unit is perfectly planar. The "out of plane angle" of the sulfur atom (the 
angle between the N-S bond and the bisector of the CNH or CNM angle) is zero when 
the unit is perfectly planar (Figure 2.32). 
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Figure 2.32: The out of plane angle (a) for the N-S bond is defined by the distance (a) of S from the 
HNC or MNC plane. 
The distance of the nitrogen atom from the plane defined by it's three bonded atoms is 
the simplest representation of the planarity of the sulfonamido nitrogen. These three 
parameters are given in Table 2.12. 
Table 2.12: Parameters defining the planarity of the sulfonamido nitrogen atoms in the 
monosulfonamido ligands and their metal complexes. 
Distance of N Sum of 3 angles Angle of S (°) 
Ligand or Complex from MCS or (°) around N, 0 from NCH/M 
HCS plane (A) plane, a 
1 ° molecule A 0.236 350.3 32.0 
molecule B 0.223 351.3 27.6 
5 0.194 343.6 39.9 
7 0.303 352.6 25.7 
9 0.271 344.9 37.9 
10" molecule B 0.143 355.5 20.5 
molecule A 0.194 350.3 31.4 
[Zn(1-H)2 1'] Zn(l) complex 0.245 353.5 23.1 
0.009 359.9 0.9 
Zn(2) complex 0.143 357.7 13.7 
0.069 359.5 6.6 
[Ni(1-H)21 0.301 350.0 28.8 
[Cu(2-H)2] 0.292 352.2 25.7 
0.017 360.0 1.6 
[Cu(5-H) 20] 	 0.013 360.0 2.1 
0.019 359.9 1.4 
[Cu(5H)2I'] 	Cu(1) complex 	0.199 355.7 21.8 
0.158 357.1 17.1 
Cu(2) complex 	0.236 353.7 25.7 
0.158 357.2 17.5 
These structures have two crystallographically independent molecules within the asymmetric unit (molecules A 
and B). ' This structure has two ciystallographically independent complexes in the asymmetric unit containing 
Zn(l) and Zn(2). This complex is centrosymmetric. d  This complex exists in blue and green polymorphs. The 
blue polymorph has two ciystallographically independent [Cu(5-H) 2] complex units containing Cu(l) and Cu(2) per 
asymmetric unit. 
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If a resonance effect occurs in sulfonamides we would expect to see a shortening in 
the S-N bond and a lengthening of the S=O bond as the nitrogen geometry moves 
towards planarity. These bond lengths are listed in Table 2.13. 
Table 2.13: S-N and S=O bond lengths of sulfonamido diamines and their complexes. 
Ligand or complex S0(1) / A S0(2) I A SO'i A S-N / A 
10 molecule A 1.424 1.432 1.428 1.614 
molecule B 1.446 1.435 1.441 1.593 
5 1.431 1.435 1.433 1.608 
7 1.433 1.442 1.438 1.604 
9 1.428 1.433 1.431 1.610 
10' molecule A 1.433 1.442 1.438 1.612 
molecule B 1.444 1.426 1.435 1.627 
[Zn(1H)2b] complex 1.456 1.450 1.453 1.563 
1.457 1.433 1.445 1.572 
complex 1.462 1.445 1.454 1.552 
1.437 1.453 1.445 1.572 
[Ni(1H)2d] 1.444 1.452 1.448 1.580 
[Cu(2-H)2] 1.442 1.447 1.445 1.585 
1.449 1.452 1.451 1.563 
[Cu(5-H)2"] 1.445 1.463 1.454 1.554 
1.445 1.456 1.451 1.572 
[Cu(5-H)2"] complex 1.448 1.450 1.449 1.560 
1.456 1.446 1.451 1.576 
complex 1.464 1.446 1.455 1.575 
1.454 1.446 1.450 1.553 
° These structures have two crystallographically independent molecules within the asymmetric unit (molecules A 
and B). "This structure has two ciystallographically independent complexes in the asymmetric unit containing 
Zn(l) and Zn(2). This complex is centrosymmetric. dThis  complex exists in blue and green polymorphs. e  The 
blue polymorph has two crystallographically independent [Cu(5-H)2] complex units containing Cu(l) and Cu(2) per 
asymmetric unit. f Mean. 
To analyse if there is a relationship between the parameters in Tables 2.12 and 2.13 
the correlation coefficients were calculated using Equation 2.3. 
Cov(X, Y) 
px,y = a 	
Eq 2.3 
The covariance of the two data sets (Cov(X 1')) is divided by the product of their 
standard deviations. The definition of the covariance is illustrated in Equation 2.4 
where i7j is the mean value of a set of values x or y. 
XC 
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Cov(X,Y) =-1_(Xi  —uj(y -.ç) 	Eq 2.4 
j=I 
The derivation of the standard deviations (/y)  of data sets x and y is shown in 
Equations 2.5 and 2.6. 
a 	 Eq2.5 
o 2=I(_)2 	 Eq 2.6 
The better the correlation between the two parameters the closer the coefficient is to 1 
and conversely if the parameters are unrelated the coefficient is zero. A positive 
coefficient is observed when one parameter increases as the other increases and for a 
negative coefficient one parameter increases as the other decreases. Results for 
sulfonamide ligands and complexes are shown in Tables 2.14 and 2.15 respectively. 
Table 2.14: The correlation coefficients of the parameters of nitrogen planarity in sulfonamide 
ligands 1, 5, 7, 9 and 10 with S=O and S-N bond length. 
X Y Correlation 
coefficient 
S-N length / A Average S=O length I A -0.49 
Distance of N from HCS plane / A Average S=O length / A -0.16 
Distance of N from HCS plane / A S-N bond length / A 0.31 
Sum of 3 angles around N, 0 Average S=O length / A 0.55 
Sum of 3 angles around N,0 S-N length / A -0.03 
Angle of S from NCH plane, a Average S=O length / A -0.65 
Angle of S from NCH plane, a S-N bond length / A 0.15 
Table 2.15: The correlation coefficients of the parameters of nitrogen planarity in sulfonamide 
complexes [Zn(1-H) 2], [Ni(1-H) 2], [Cu(2-H) 2] and [Cu(5-H) 2] with S=O and S-N bond length. 
X Y Correlation 
coefficient 
S-N length /A Average S=O length / A -0.51 
Distance of N from MCS plane / A Average S=O length / A -0.01 
Distance of N from MCS plane / A S-N bond length / A 0.36 
Sum of 3 angles around N, 0 Average S=0 length / A 0.05 
Sum of 3 angles around N, 0 S-N length / A -0.46 
Angle of S from NCM plane, a Average S=O length / A 0.05 
Angle of S from NCM plane, a S-N bond length / A 0.31 
The free ligands and the metal complexes show a reasonable correlation (-0.49 and 
-0.51) between the S-N and S=O bond lengths. There is very poor correlation between 
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the distance of N from the H/MCS plane and the S=O length (-0.16 and —0.01). Better 
correlation is shown between the distance of N from the MCS plane and the S-N 
length (0.36). However, for the free ligands the opposite correlation is observed (-
0.31). This is surprising as it is expected that the S-N bond would become shorter as 
the system became more planar due to electron delocalisation from the S=O bond over 
the S-N bond. For metal complexes there is a good correlation (-0.46) for 9 with the 
S-N length but not with the S=O length (403), in contrast for the free ligands a good 
correlation (0.55) is observed between 9 and the S=O length but not with the S-N 
length (0.05). Finally, there is good correlation between a and the S=O length for the 
free ligands (-0.65), whereas for complexes the correlation is close to zero (0.05) and a 
low correlation is observed in each case between a and the S-N length (0.15 and 0.31). 
2.4.8 Geometry of amides of carboxylic and sulfonic acids in the Cambridge 
Structural Database (CSD) 
The geometry of amides of sulfinic and carboxylic acids in the CSD (July 2001) were 
compared to the nitrogen atom geometry of sulfonamide ligands and complexes 
discussed in this chapter. The values of the sum of the three angles around the 
nitrogen atom, 0, for amides and their complexes are shown graphically in Figures 
2.34 and 2.35. These show that the geometry of the nitrogen atom in free amides of 
carboxylic acids is more likely to be planar (0 = 360') than the nitrogen atom in 
amides of sulfonic acids. 0 values for free sulfonamides are spread over a wider range 
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N 
NSIJU 	 NSU8A 
Figure 2.34: 9 values for amides of carboxylic acids and their complexes. (N = number of complexes 
and NSUM=O) 
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Figure 2.35: 9 values for amides of sulfonic acids and their complexes. (N = number of complexes and 
NSIJM =0) 
When the nitrogen atom is coordinated to a metal centre in amides of carboxylic acids 
the majority of 0 values are spread over a wider range (3563600) than for free amides. 
In contrast when the nitrogen atom of amides of sulfomc acids is coordinated to a 
metal centre the nitrogen atom is more likely to be planar than the nitrogen of a free 
sulfonamide and the majority of 0 values are in the range 3553600 (cf. 3403600  for 
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free sulfonamides). This was also observed for the monosulfonamidodiamine ligands 
discussed in this chapter. 
2.5 Equilibrium constants of monosulfonamidodiamines 
Values of log KLHTI,  log KML and log 13ML2  for ligands 1, 5 and 10 and their copper, 
nickel and zinc complexes were determined by Dr D. J. White. 12  The two stepwise 
deprotonation constants K, and K2 are shown in Figure 2.36 below. 
K1 
L + H 	- 	LH 
K2 
LH + H 	- 	LH 
Figure 2.36: Equilibria for ligand protonation and deprotonation. 
Log K is equal to the PKa value which measures the acidity of the protonated species. 
The results are given below in Table 2.16. 
Table 2.16: PKa values for ligands 1, 5 and 10. 
Ligand 	PKai 	pK02 
1 8.89 10.75 
5 	 9.49 	10.89 
10 3.17 9.83 
The pKa values of the sulfonamido groups in ligands 1 and 5 fall close to the usual 
value for sulfonamides (- 9) showing that the proton is lost relatively easily. The PK a 
of 10 is much lower, indicating the higher acidity of the proton. This is due to the 
electron withdrawing effect of the aromatic ring and delocalisation of anionic charge 
causing the N-H bond to be weaker. 
The formation constants KML and 13ML2  for these ligands with divalent copper, nickel 
and zinc are listed in Table 2.17. 
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KML 
	
LH + M2 	ML + H 
ML2 
2LH + M2 	ML2 + 2H 
Table 2.17: The formation constants log KML  and log BML2  of copper, nickel and zinc 
complexes of!, 5 and 10. 
Complex Log KML 	Log BML2 
[Cu(1-H)2] 10.40 19.42 




[Zn(5-H) 2'] 6.29 
[Cu(10-H) 21 
[Ni(10-H) 2] 9.49 	 14.36 
[Zn(10-H) 2] 9.75 14.70 
° Measurement of LogI3ML 2 was not possible due to precipitation of the complex. ' Measurement of either 
formation constant was not possible due to precipitation of the complex. 
2.5.1 Speciation of monosulfonamiamido diamines 
The protonation constants measured for ligands 1, 5 and 10 may be used to predict the 
species which will be present in solution at different pH values using the program 
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pH 
Figure 2.38: Calculated speciation distribution for ligand 1 as a function of pH for a 0.2 M 95% 
methanol solution. 
The diagram shows that the ligand exists as a monocation only below pH 3 and that 
the ligand is deprotonated only above pH 8. Between pH 3 and pH 8 the dominant 
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species is the neutral free ligand. A very similar distribution is observed for ligand 5. 
However, ligand 10 shows quite a different pattern (Figure 2.39). 
0.20 







Figure 2.39: The calculated speciation distribution for ligand 10 as a function of pH for a 0.2M 95% 
methanol solution. 
Only two species are predicted; below pH 5 most of the ligand is in the protonated 
form and above pH 5 the ligand is mostly present as its monoanion. These predictions 
suggest that ligand 10 would be the stronger complexing agent than 1 and 5 at neutral 
pH values 
2.5.2 Prediction of the selectivity of monosulfonamidodiamines 
If BML2  values for a series of metal ions are known for a ligand the Hyss2 program can 
be used to predict the selectivity of metal complexation. The equilibrium constants for 
the complexation of 1 with copper(II), nickel(II) and zinc(II) were used to generate the 
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Figure 2.40: The selectivity of! over Cu(II), Ni(IJ) and Zn(II) at a ligand concentration of I x 10 M 
and a metal concentration of 7 x 10 -4  M. 
The diagram plainly indicates the selectivity of 1 for copper. There is no visible plot 
of nickel or zinc complexation as the predicted concentrations of the nickel and zinc 
complexes formed are close to zero. A similar prediction was done for ligand 5, 
however only KML data are available for copper and zinc. As expected, selectivity for 
copper is predicted and concentrations of the Zn(5-H) 2 species are close to zero. For 
ligand 10 data are only available for the nickel and zinc ML and ML2 complexes. A 











Figure 2.41: The speciation plot for ligand 10 with Ni(II) and Zn(II). 
2.6 Solvent extraction 
To establish the strength of monosulfonamido ligands as metal extractants the 'S' 
curves for copper extraction of ligands 4 and 8 were determined. The metal selectivity 
of these ligands was also investigated. 
2.6.1 'S'-Curve determination 
'S' curve determination was important to assess the strength of simple 
monosulfonamido ligands. Due to the low solubility of metal complexes of ligands 1 
and 5, even in solvents such as chloroform, the S curves for copper were determined 
for their more soluble N-2-ethylhexyl analogues 4 and 8, (Figure 2.42). 
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Figure 2.43: The S curve of 4 and 8 with copper. The copper was gradually stripped from a 0.1 M 
solution of [Cu(L-H) 21 in dichloromethane using sulfuric acid. 
The pHy. value is the pH at which the ligand is half loaded with metal. 
Table 2.19: pHy, values of 4 and 8. 
Ligand 	 pH, value 
	
4 4.2 
8 	 6 
The pH./, values for ligands 4 and 8 are significantly higher than that of P50, <2.0 
indicating that monosulfonaniidodiamine ligands are much weaker extractants. 
Ligand 4 is a better extractant than ligand 8 and this is also illustrated in the following 
selectivity experiment. 
2.6.2 Selectivity of monosulfonamidodiamine ligands 
To establish the selectivities of the ethane - and propane - bridged sulfonamido 
extractants for divalent Co, Ni, Cu and Zn ions the more soluble ligands 4 and 8 were 
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Table 2.20: Selectivity of extraction of divalent metals shown by 0.1 M solutions of 4 and 8 in 
dichloromethane (DCM) after 1 hour contact at room temperature with an equal volume of an 
aqueous mixed metal(II) sulfate solution of 0.85 M of each of Co, Ni, Cu and Zn. 
Ligand 	M(I1) concentration in dichioromethane / ppm 
Co 	Ni 	Cu 	Zn 
4 	2.0 31.4 400 1.5 
8 9.4 	7.6 	70 	0.6 
Both extractants show a strong preference for copper. Neither gives 100% loading, 
(3177 ppm = 100% loading of copper). Ligand 4 is a stronger extractant than 8 which 
suggests that the ethyl bridge of ligand 4 is advantageous for metal complexation. 
This result is consistent with the stability constants (See Table 2.19) which showed 
that the 5-membered copper chelate is formed more readily than the 6-membered 
chelate. This may be rationalised from the solid state structures of the ligands. The 
ethane bridged ligand shows an N-H --- N intra-molecular hydrogen-bond and is 
therefore closer to the rigid arrangement required in the complex i.e. the greater the 
preorganisation of ligand leads to a more favourable AS. Also, the inter-donor 
repulsion energy term involved in bringing the Ntta.  donors close together is smaller 
for the more preorganised (ethane bridged) ligand, which would lead to a more 










Ligand 4 	Ligand 8 
Figure 2.44: The selectivity of 4 and 8 for cobalt(ll), nickel(II), copper(H) and zinc(II). 
Metal(H) selectivities of ligands 4 and 8 are Cu>Ni>Co=Zn and Cu>Co=Ni>Zn 
respectively (Figure 2.44). Extractant 4's selectivity is similar to that for the Irving-
Williams series. 14 However, we should not draw comparisons too closely as our 
species are 4-coordinate and not 6-coordinate. The main difference in selectivity 
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trends for the two extractants is the position of cobalt and nickel. The shorter 
backbone of 4 may result in preferential binding of nickel as a square planar geometry 
which will be more accessible than a tetrahedral geometry which a cobalt complex is 
likely to adopt. Following a similar argument for 8, the longer backbone may prefer a 
tetrahedral geometry of the nitrogen atoms and a planar N-M-N conformation may be 
less favourable. 
2.7 An electrochemical study of monosulfonamidodiamine complexes 
2.7.1 The stabilisation of metal(IH) centres by deprotonated amide groups 
0 	 0 
II II 
R-C-NHR 	 R-S-NHR 
0 
Figure 2.45: The amide and sulfonamide groups. 
The sulfonamide group can be compared to the amide group, (Figure 2.45). It is well 
known that amides are poor nucleophiles and therefore a poor coordinating atom. 15 
This is due to the delocalisation of the nitrogen lone pair electrons through orbital 
overlap with the carbonyl group. However, upon deprotonation of the amide the 
nitrogen becomes a much better donor. This type of behaviour is also observed for the 
sulfonamido group.' 5 
Some of the first evidence that deprotonated amide groups may stabilise Cu(III) and 
Ni(III) was the isolation of crystalline complexes of biuret K[M(NHCONHCONH) 2] 
where M = Cu(III) and Ni(III) by Bour and Steggerda.' 6 Ni(llI) complexes of 
macrocyclic tetra-aza ligands have been prepared and characterized in acetonitrile 
solution and as solids. 17,18,19  An example of such a ligand is shown in Figure 2.46. 
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H 
Figure 2.46: 5,5,7,12,12, 14-hexamethyl-( 1,4,8,11 -tetraaza-cyclotetradecane) 19 (A) which yields a 
Ni(III) complex. 
The Ni(III) complex of A is stable in the absence of oxygen and water. Ni(III) cyclam 
complexes are very unstable and decompose in aqueous solution .20 CU(HI) complexes 
of macro cyclic tetra-amines such as A have also been made in acetonitrile solution but 
the complexes are only stable on the time scale used in voltammetric measurements 
and undergo spontaneous reduction to Cu(II). In order to isolate samples work was 
done at 15 to 20°C. 19 Pulse radiolysis has also been used to generate transient 
Cu(III)-aquo and Cu(III)-amine complexes. 21 
2.7.2 Cu(HI) and Ni(llI) peptide complexes 
Margerum has carried out an extensive study of polypeptide ligand stabilisation of 
Ni(III) and Cu(III) centres. Oligopeptides were deprotonated upon complexation 
resulting in strong in-plane donor ligands which stabilise the M(III) oxidation state 
relative to M(II). It was found that the Cu(III)/Cu(II) couple decreases with an 
increase in the number of deprotonated amide groups per ligand. 22 
Margerum first reported that relatively long lived Cu(HI) peptide complexes could be 
formed in aqueous solution 23  and the similar Ni(III) peptide complexes were 
subsequently described . 24 The M(III) species (Figure 2.47) were formed by 
electrochemical or chemical oxidation of the relevant M(II) peptide complexes. 
The tetraglycrne ligand is involved in binding to the metal centre via three 
deprotonated amino peptide groups and one amine group. 
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Figure 2.47: Dianionic Ni(II) and Cu(II) complexes [Ni(B4H)] 2 and [Cu(B-4H)] 2  derived from 
tetraglycine (B). 
Evidence that metal and not ligand-based oxidation is involved in forming these 
complexes was provided by studies of EPR and uv-visible spectra. The M(III)/M(II) 
redox potentials for such peptide complexes are lower than other complexes as a result 
of the very strong electron donor properties of the tetra-anionic ligand (Table 2.20). 
Table 2.20: Comparison of M(III)/M(H) redox potentials for nickel and copper complexes of 
teraglycinate (B, see Figure 2.47) and the 14-membered N 4-macrocycle tetra-amine (A, see 
Figure 2.46). 
Electrochemical proccess 	 E°, V 
_______ 
[Ni"(B-4H)] -I- e 	[Ni11(B-4H)]2 	
0.79 
______ 




[Cu'11(B-4H)] + e 	__ [Cu '1(B-4H)]2 	
0.63 
 
______ 	 1.12 + 	
' [Cu"(A)] e4 
The lower electrode potential for the copper tetraglycine species with relation to the 
nickel species may be explained in terms of the ligand field stabilisation energies 
involved .25,26  The thermodynamic stability of the trivalent copper complex results 
from the ability of the peptide ligands to accommodate the square planar geometric 
preference of the d 8 complex with the consequent ligand field stabilisation energy. 
The oxidation of the Cu(II) centre from a d 9 configuration to a d 8 configuration is 
favourable for a square planar or tetragonal geometry which is observed for these 
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complexes as the high energy dx 2-dy2 orbital is no longer occupied in the d 8 low spin 
complex. 
2.7.3 Electrochemical studies of monosulfonamidodiamine complexes 
The oligopeptide complexes investigated by Margenim 2324 may be compared to the 
ethane-bridged monosulfonamidodiamine complexes which have been synthesised as 
part of this thesis. The ability of the sulfonamido group to stabilise metal oxidation in 
monosulfonamidodiamine complexes was investigated. Complexes of ligand 4 were 
used due to their higher solubility in DMF. 
The cyclic voltammograms of the cobalt and nickel complexes in the range 2 to —2V 
showed peaks for one oxidation process and one reduction process. Both were 
electrochemically irreversible, i.e. the electron transfer process is followed rapidly by 
a chemical reaction. The cyclic voltammogram for the copper complex showed these 
two waves plus an additional oxidation and reduction wave. Table 2.21 lists the peak 
redox potential of the oxidation and reduction processes for the complexes and the free 
ligand. Note that the free ligand also gave rise to an irreversible oxidation and 
reduction. 
Table 2.21: The oxidation and reduction potentials (V) of simple monosulfonaniidodiamine 
complexes of ligand 4. 
Molecule E oxidation (V) E reduction (V) 
[Co(II)(4-H) 2] +1.40 -0.95 
[Ni(II)(4-H) 2 ] +1.50 -0.90 
[Cu(II)(4-H)21 +1.45,+0.22 -0.95, -1.65 
4 +1.45 -0.9 
Cyclic voltammetry was performed at 25°C in dimethylformamide with a three-electrode system consisting of a 
platinum working electrode, a platinum auxiliary electrode, and a AgIAgCI reference electrode. 
A comparison of the values shown in Table 2.21 suggests that oxidation at Ca. +1.45V 
and reduction at Ca. —0.95V of the metal complexes is primarily ligand based because 
peaks are observed at very similar potentials in the free ligand. This leads us to 
conclude that sulfonamido ligands are unlikely to act in an analogous way to amide 
ligands in the stabilisation of a metal(III) centre and that the ligand is oxidised in 
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preference to the metal. Analysis of the decomposition products of the oligopeptide 
complexes investigated by Margerum found that oxidation of the ligand occurred at 
the methylene group and indeed this may be the case here. 27 The cyclic voltammogram 
for the copper complex is shown in Figure 2.48. 
-2.500-2.000-1.500 -1.000 -0.500 0 0.500 1.000 1.500 2.000 
V 
Figure 2.48: The cyclic voltammogram of[Cu(LI)(4-H) 2] in DMF / 0. 1M TBAI3F4 at 298 K. 
The ligand based oxidation and reduction peaks are found at points A and B and an 
additional oxidation and reduction process are found at point D and C. Oxidation peak 
D is a typical desorption peak 28  and may be ascribed to the oxidation of Cu(0) to 
Cu(II). This peak only appears if the applied potential is ramped beyond point C. 
Thus we conclude that the copper centre is reduced at potential C to copper metal 
which coats the working electrode and may be stripped off the electrode at potential D. 
Finally, no evidence that this class of ligands stabilises Cu(III), Ni(III) or Co(III) was 
found and it must be concluded that the deprotonated sulfonamido nitrogen does not 
have the same stabilising properties as peptide molecules. 
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2.8 Conclusions 
This chapter has shown that monosulfonamidodiamine ligands are relatively simple to 
make and are versatile complexing agents. The ligands show selectivity for copper, 
but those derived from aliphatic diamines are much weaker copper extractants than the 
commercial phenolic oximes. Those derived from aromatic 1, 2-diamines show higher 
stability constants for their copper(II) complexes but have low solubilities, limiting 
their usefulness as solvent extractants. Secondary hydrogen-bonding in the ligands 
produced the desired pseudo-macrocyclic ligand in some cases, but the high number of 
hydrogen-bond donor and acceptor sites in the ligands made prediction of the 
hydrogen-bonded secondary structure difficult. 
Chapter 3 deals with sulfonamide oxime ligands in which an oxime group is used to 
provide a single hydrogen-bond donor site with the intention of generating pseudo-
macrocyclic secondary structures more analogous to that in P50. 
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2.9 Experimental 
2.9.1 Instrumentation 
Melting points were determined with a Gallenkamp apparatus and are uncorrected. 
Elemental analysis was performed on a Perkin Elmer 2400 elemental analyser and a 
Carlo Erba 1108 Elemental analyser. IR spectra were obtained on a Perkin Elmer 
Paragon 1000 FT-IR spectrometer as potassium bromide discs or as thin films on NaC1 
plates. 'Hand ' 3C NMR spectra were run on Bruker WP200, AC250 and AVANCE 
DPX360 spectrometers. Chemical shifts (6) are reported in parts per million (ppm) 
relative to residual solvent protons as internal standards. Electron impact (El) mass 
spectra were obtained either on a Finnigan MAT4600 quadrapole spectrometer or on a 
Kratos MS50TC spectrometer. Fast atom bombardment (FAB) mass spectra were 
obtained on a Kratos MS50TC spectrometer in acetonitrile/3-nitrobenzyl 
alcohollthioglycerol matrices. Electrospray (ESI) mass spectra were obtained on a 
Thermoquest LCQ spectrometer in methanol. Inductively coupled plasma atomic 
emission spectroscopy (ICP-AES) analysis was performed on a Thermo Jarrell Ash 
Iris ICP-AES spectrometer. Potentiometric titrations were carried out in a sealed 
double jacket glass cell using a Metrohm 665 automated burette and a Corning 130 
digital pH meter fitted with a Phillips glass electrode and a calomel electrode. All 
measurements were fully automated. Titrations were performed at 25.0 ± 0.1 °C in 
constant ionic strength (I = 0. 1, [Et4N] [d041) 95% methanol solution under purified 
nitrogen. Solutions of ligand (ca. 1 x 10 mol dm 3) alone and in the presence of 0.3, 
0.8 and 1.5 equivalents of metal ion were titrated with 0.1 mol din. -3  Et4NOH 
respectively. Equilibrium constants were calculated from potentiometric data with the 
program MIINIQUAD. 29 Electrochemistry was carried out using a 0. 1M [TBA][BF 4] 
(TBA = tetrabutylammonium) inert electrolyte and voltammograms were generated 
using an AUTOLAB PGSTAT 20 instrument. 
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2.9.2 Solvent and reagent pretreatment 
Unless otherwise specified all reagents and solvents were obtained from commercial 
suppliers and were used as received. Solvents used for analytical purposes (NMR, 
MS, ICP) were of spectroscopic grade. 




1 was prepared by following the method of Kirsanov and Kirsanova. 2 A solution of 4-
methylbenzenesulfonyl chloride (86 g, 0.45 mol) in toluene (400 cm 3)  was added 
dropwise over 8 hours to a solution of 1,2-diaminoethane (81 g, 1.35 mol) in toluene 
(300 CM)  . The precipitate was isolated by filtration and washed with toluene (3 x 100 
cm3). The solid was digested with methanol (600 CM),  filtered and the solvent 
removed in vacuo to give a white solid which was recrystallised from water (1 dm 3) to 
yield a white crystalline product (50.91 g, 52%), mp 120-122°C (Found: C, 50.37; H, 
6.73; N, 12.84. Calc. for C 9H 14N202S: C, 50.45; H, 6.59; N, 13.07%). 5H  (CDC13 , 
200 MHz): 2.41 (s, 3 H, CH3), 2.85 (m, 2 H, CH2), 2.98 (m, 2 H, CH2), 7.29 (d, 2 H, J 
7.9, Ar CM, 7.75 (d, 2 H, J 8.3, Ar Cl]). öc (CDC13, 50 MHz): 21 (CH 3), 41 (CH2), 
45 (CH), 127 (2 C, Ar CH), 130 (2 C, Ar Cl]), 136 (Ar C), 143 (Ar Q. JR (KBr 
disc)/cm': 3362s, 3049m, 2952m, 2862m, 1597m, 1495w, 1471w, 1440w, 1316s, 





2 was prepared by an adaptation of the method of Kirsanov and Kirsanova. 2 A 
solution of 4-t-butylbenzenesulfonyl chloride (12 g, 0.05 mol) in toluene (100 cm) 
was added dropwise over 8 hours to a solution of 1,2-diaminoethane (9.34 g, 0.16 mol) 
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in toluene (100 cm3). The precipitate was isolated by filtration and washed with 
toluene (3 x 20 cm3). The product was recrystallised from toluene (250 cm 
3)  and 
washed with diethylether (3 x 20 cm 3). The white crystalline solid was dried in vacuo 
(5.39 g, 40%), decomposition temperature > 205°C (Found: C, 55.93; H, 7.89; N, 
11.03. Caic. For C12H20N202S: C, 56.22; H, 7.86; N, 10.93%). 6H  (CDC13, 250 
MHz): 1.29 (s, 9H, CH3), 2.76 (m, 2 H, CH2), 2.48 (m, 2 H, CH2), 3.02 (s, 2 H, NH2), 
7.47 (d, 2 H, J 7.5, Ar CH), 7.75 (d, 2 H, J 7.7, Ar CH). 8c (CDC1 3 , 63 MHz): 31 (3 C, 
CH3), 35 (Ar C), 41 (CH2), 45 (CH2), 126 (Ar CH), 127 (Ar CH), 137 (Ar C), 156 (Ar 
Q. IR data (KBrdisc)/cm': 2922s, 2677s, 1601s, 1511s, 1327m, 1161m. El MS, m/z 
256 (M, 20.0%). 
N-(N-benzyl-2-aminOethyl)-4-methylbenzenesulfonamide (3) 
CJ NH  N-LQ- 
Benzaldehyde (7.43 g, 0.07 mol) was added to a solution of N-(2-amino-ethyl)-4-
methylbenzenesulfonamide (2) (15 g, 0.07 mol) in ethanol (200 cm 3)  which was left to 
stir for one hour. A catalytic amount of anhydrous sodium tetraborate (0.2 g, 1 mmol) 
and sodium borohydride (10.59 g, 0.33 mol) were added and the solution was was 
stirred for one hour. Distilled water (100 cm 3)  was added, the methanol removed in 
vacuo, and the product extracted into dichloromethane (200 cm 
3)  which was washed 
with water (3 x 200 cm 3), dried over anhydrous magnesium sulfate and filtered. The 
solvent was removed in vacuo to yield a white precipitate which was recrystallised 
from ethanol (100 cm) to give a white crystalline solid (9.7 g, 46%), mp 78-80°C 
(Found: C, 63.11; H, 6.55; N, 9.16. Calc. for C 16H20N202S: C, 63.13; H, 6.62; N, 
9.20%). 5H  (CDC13, 360 MHz): 2.44 (s, 3 H, CH3), 2.73 (m, 2 H, CH2), 3.03 (m, 2 H, 
CH2), 3.67 (s, 2 H, CH2), 7.29 (m, 7 H, Ar CH), 7.76 (d, 2 H, J 8.3, Ar CH). 5c 
(CDC13 , 90 MHz): 22 (CH 3), 43 (CH2), 48(CH2), 53 (Cl-I2), 128 (2 C, Ar CH), 128 
(Ar CH), 129 (2 C, Ar CH), 129 (2 C, Ar CH), 130 (2 C, Ar CH), 137 (Ar C), 140 (Ar 
C), 144 (Ar Q. IR data (KBr disc)/cm -1 : 748m, 1162s, 1332s, 1598w, 2850m, 3060w, 
3450m. FAB MS, m/z 305 (MH,100%). 
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N-(N-2-ethylhexyl-2-aminoethyl)4-methylbenzenesulfonamide (4) 
NH 	N—U 
N-(2-aniinoethyl)-4-methylbenzenesulfonamide (0.26 g, 2 mmol) was added to a 
solution of 2-ethylhexanal (0.43 g, 2 mmol) in methanol (30 cm 3)  over molecular 
sieves and stirred for one hour. A catalytic quantity of anhydrous sodium tetraborate 
(0.2 g, 1 mmol) and sodium borohydride (0.15 g, 4 mmol) was then added and the 
mixture was stirred for a further hour. Dichloromethane (30 cm 3)  was then added and 
the solution was washed with water (3 x 30 cm. 3) and dried over anhydrous magnesium 
sulfate which was removed by filtration. The solvent was then removed in vacuo to 
give an opaque yellow oil. The oil was dissolved in the minimum quantity of 
methanol and filtered. The solvent was then removed in vacuo to leave a colourless 
oil (0.4 g, 88%), (Found: C, 62.32; H, 9.97; N, 8.55. Calc. for C 17H30N202S: C, 62.39; 
H, 9.47; N, 8.56). oH (CDC13, 360 MHz): 0.84 (t, 3 H, J 7.2, CH3), 0.92 (t, 3 H, J 7.0, 
Cl!3), 1.27 (m, 8 H, CH2), 2.35 (d, 2 H, J 5.6, CH2), 2.45 (s, 3 H, CH3), 2.69 (t, 2 H, J 
5.6, CH2), 3.00 (t, 2 H, J 5.6, CH2), 7.32 (d, 2 H, J 7.9, Ar Cl]), 7.78 (d, 2 H, J 8.3, Ar 
Cl]). 0c  (CDC13 63 MHz): 11 (CH 3), 14 (GEl3), 21 (CH3), 23 (CH2), 24 (Gil2), 29 
(GH2), 31 (GH2), 39 (CH), 42 (Gil2), 52 (GH2), 127 (2 C, Ar CH), 129 (2 C, Ar Gil), 
137 (Ar C), 143 (Ar Q. IR data (KBr disc)/cm': 661s, 815s, 1034m, 1094s, 1158s, 
1304s, 1458s, 1599m, 2873s, 2958s, 3286m. ESI MS, m/z 327 (MH, 100.0%) 
N-(3-aminopropyl)-4-methylbenzenesulfonamide (5) 
n — I--<:>—  
NH2 
5 was prepared by the method of Kirsanov and Kirsanova. 2 A solution of 4-
methylbenzenesulfonyl chloride (42.3 g, 0.23 mol) in toluene (250 cm 3)  was added 
dropwise over 8 hours to a solution of 1,3-diaminopropane (50 g, 0.66 mol) in toluene 
(200 cm3). The solution was stirred for a further 4 hours then the precipitate was 
isolated by filtration and washed with toluene (3 x 50 cm). The solid was digested 
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with methanol (300 cm) at room temperature and filtered. The solvent was removed 
in vacuo to give a white solid which was recrystallised from water (250 cm 3)  to yield a 
white crystalline solid (35.4 g, 69%), mp 115-117°C (Found: C, 52.21; H, 7.21; N, 
12.25. Caic. for C 10H 1 6N202S: C, 52.62; H, 7.06; N, 12.27). 5H (CDC13, 200 MHz): 
1.57 (tt, 2 H, J 6.2, CH2), 2.42 (s, 3 H, CH3), 2.78 (t, 2 H, J 6.1, CH2), 3.05 (t, 2 H, J 
6.2, CH2), 7.28 (d, 2 H, J 8.4, Ar CH), 7.73 (d, 2 H, J 8.3, Ar CH). 8c (CDC1 3 , 50 
MHz) 21 (CH3), 31 (CH2), 41 (CH2), 43 (CH2), 127 (2 C, Ar CH), 130 (2 C, Ar CH), 
137 (Ar C), 143 (Ar Q. JR data (KBr disc)/cm: 3063m, 2956m, 2919m, 2870m, 
1598m, 1495m, 1457w, 1437w, 1321s, 1 157s. FAB MS, m/z 229 (MH,100.0 %). 
N-(3-aminopropyl)4-t-butylbenzenesulfonamide (6) 
CNLQ 
6 was prepared by the adaptation of the method of Kirsanov and Kirsanova. 2 A 
solution of 4-t-butylbenzenesulfonyl chloride (12.10 g, 52 mmol) in toluene (100 cm 3) 
was added dropwise over 8 hours to a solution of 1,3-diaminopropane (11.49 g, 0.16 
mol) in toluene (100 cm 3). The resulting white solid was isolated by filtration, washed 
with toluene (3 x 20 cm3), recrystallised from water (200 cm 3) and washed with 
diethyl ether (3 x 20 cm 3)  to yield a white crystalline solid which was dried in vacuo 
(3.33 g, 24%), mp 226°C (Found: C, 50.37; H, 6.73; N, 12.84. Caic. for 
C 13H22N202S: C, 50.45; H, 6.59; N, 13.07%). E, (CDC1 3 , 200 MHz): 1.30 (s, 9 H, 
CH3), 1.59 (, 2 H, J 6.2, CH2), 2.80 (t, 2 H, J 6. 1, CH2), 3.07 (t, 2 H, J 6.3, CH2), 7.50 
(d, 2 H, J 8.8, Ar CH), 7.77 (d, 2 H, J 8.8, Ar CH). 8C (DMSO-d6, 63 MHz): 30 (CH2), 
31 (3 C, CH3), 35 (q), 38 (CH 2), 38 (CH2), 126 (2 C, Ar CH), 126 (2 C, Ar CH), 138 
(Ar C), 155 (Ar Q. JR data (KBr disc)/cm': 2961s, 1596m, 1542w, 1465m, 1329s, 
1156s. FAB MS, m/z 271 (M}i, 100.0%). 
110 
Chapter 2: Monosulfonamidodiamine ligancis 
N-(N-benzyl-3-aminopropyl)4-methylbenzenesutfonamide (7) 
1 	r'~) — I — NH HN 3-0 
Benzaldehyde (1.86 g, 18 mmol) was added to a solution of N-(3-aminopropyl)-4-
methylbenzenesulfonamide (4 g, 18 mmol) in ethanol (50 cm) which was left to stir 
for one hour. A catalytic amount of anhydrous sodium tetraborate (0.2 g, 1 mmol) and 
sodium borohydride (2.65 g, 70 mmol) were added and the solution was again stirred 
for one hour. Distilled water (100 cm  3)  was added, ethanol was removed in vacuo, 
and the solid was recrystallised from ethanol (100 cm  3)  to give a white crystalline 
solid (2.12 g, 38%), mp 82-84°C (Found: C, 63.93; H, 6.84; N, 8.76. Calc. for 
C 17H22N202S: C, 64.1; H, 6.96; N, 8.80%). E, (CDC1 3 , 200 MHz) 1.61 (U, 2 H, J 6.0, 
CH2), 2.40 (s, 3 H, Cl-I3), 2.65 (t, 2 H, J 5.9, CH2), 3.03 (t, 2 H, J 6.0, CH2), 3.69 (s, 2 
H, CH2), 7.27 (m, 7 H, Ar CH), 7.70 (d, 2 H, J 8.3, Ar CH). öc (CDCI 3 , 50 MHz) 21 
(CH3), 28 (CH2), 43 (CH2), 48 (CH2), 54 (CH2), 127 (2 C, Ar CH), 129 (2 C, Ar CH), 
137 (Ar C), 140 (Ar C), 143 (Ar C). JR data (KBr disc)/cm': 1156s, 1185w, 1326s, 
1454m, 1477m, 1497m, 1598m, 2832s, 2873w, 2933w, 2964w, 3059m, 3467w. FAB 
MS, m/z 319 (MH, 100%). 
N-(N-2-ethylhexyl-3-aminopropyl)4-methylbenzenesulfonamide (8) 
NH HN S--<7>- 
N-(3-aminopropyl)4-methylbenzenesulfonamide (2.81 g, 22 mmol) was added to a 
solution of 2-ethylhexanal (5 g, 22 mmol) in methanol (100 cm  3)  over molecular 
sieves. The solution was stirred for one hour. A catalytic quantity of anhydrous 
sodium tetraborate (0.2 g, 1 mmol) and sodium borohydride (0.15 g, 4 mmol) were 
added. The mixture was stirred overnight, filtered and the ethanol was removed in 
Hexane (150 cm  3)  was added and the solution was washed with water (3 x 150 
cm3) and dried over anhydrous magnesium sulfate. The hexane was removed in vacuo 
to yield a colourless oil (4.93 g, 66%), (Found: C, 63.54; H, 9.60; N, 8.24. Calc. for 
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C 18H32N202S: C, 63.49; H, 9.47; N, 8.22%). 8H (CDC1, 360 MHz): 0.90 (t, 3 H, J 
7.3, CH), 0.93 (t, 3 H, J 6.7, CH3), 1.62 (t, 2 H, J 5.5, CH2), 2.67 (t, 2 H, J 5.6, CH2), 
2.45 (s, 5 H, CH2, CH3), 3.08 (t, 2 H, J 5.7, CH2), 5.90 (m, 9 H, CH, 3 x CH2), 7.32 (d, 
2 H, J 8.1,2 H, Ar CR), 7.76 (d, 2 H, J 8. 1, Ar CH). 8 C (CDC13 , 90 MHz): 11 (CH), 
14 (CH3), 21 (CH3), 23 (CH2), 24 (CH2), 29 (CH2), 31 (cl-I2), 39 (CH), 42 (Gil2), 52 
(Gil2), 127 (2 C, Ar Gil), 129 (2 C, Ar Gil), 137 (Ar C), 143 (Ar Q. IR data (NaCl 
disc)/cm: 515s, 659s, 1036m, 1095s, 1164s, 1328s, 1458s, 1496m, 1599m, 2362w, 
2873s, 2928s, 3292m. ESI MS, mlz 341 (MH, 100.0%). 
N-(N-butyl-3-aminopropyl)4-methylbenzenesulfonamide (9) 
r—) j NH HN-S 
A solution of butanal (0.63 g, 8.76 mmol) in methanol (30 cm 3)  was added to a 
solution of N-(3.-aminopropyl)-4-methylbenzenesulfonamide) in methanol (30 cm 3) 
and was stirred for 12 hours. A catalytic amount of anhydrous sodium tetraborate (0.2 
g, 1 mmol) and sodium borohydride (1.33 g, 35 mmol) were added and the solution 
was stirred for one hour. Water (200 cm 3)  was added and the methanol was removed 
in vacuo. The resulting yellow oil was extracted into dichloromethane (2 x 100 cm 3 ). 
Removal of solvent from the organic phase in vacuo gave a yellow oil which was 
triturated with hexane (3 x 100 cm 3) and diethylether (3 x 5 cm) to yield a sticky 
white solid. This proved extremely difficult to purify. However a few crystals 
suitable for x-ray crystallography separated from the yellow oil on standing for 5 days. 
(CDCl, 250 MHz): 0.91 (t, 3 H, J 7. 1, CH3), 1.46 (m, 6 H, CH2), 2.41 (s, 3 H, 
CH3), 2.53 (t, 2 H, J 7.0, CH2), 2.68 (t, 2 H, J 5.8, 2 H, CH2), 3.05 (t, 2 H, J 5.9, CH2), 
7.29 (d, 2 H, J 8.0, Ar CH), 7.73 (d, 2 H, J 8.3, Ar Cl!). El MS, mlz 285 (MH, 
100.0%). 
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N-(2-aminophenyl)4-methylbenzenesulfonamide (10) 
P I H2N 	
11 (\7/ - 
10 was prepared by following the method of Cheng et al .3  A solution of 4-
methylbenzenesulfonyl chloride (4.3 g, 0.02 mol) in pyridine (50 cm) was added 
dropwise to a solution of 1,2-diaminobenzene (7.25 g, 0.07 mol) in pyridine (100 cm 3) 
over 8 hours. The mixture was quenched with hydrochloric acid (15% aq, 300 cm 3) 
and poured into ice (500 g). The resulting pink/brown solid was isolated by filtration, 
dried in vacuo and recrystallised from ethanol (100 cm 3)  to give a crystalline white 
solid (1.74 g, 28%), mp 135-136°C (Found: C, 59.38; H, 5.32; N, 10.52. CaIc. for 
C 13H 14N202S: C, 59.52; H, 5.38; N, 10.68%). 8H (CDC13 , 200 MHz): 2.41 (s, 1 H, 
CH3), 4.07 (s, 2 H, NH2), 5.93 (s, 1 H, NH), 6.42-6.54 (m, 2 H, Ar CH), 6.71-6.74 (dd, 
1 H, J 8.0, Ar Cl]), 7.00-7.07 (m, 1 H, Ar CH), 7.23-7.27 (m, 2 H, Ar CH), 7.59-7.63 
(m, 2 H, Ar CH). 8c  (CDC13 63 MHz): 21 (CH 3), 117 (Ar CH), 118 (Ar CH), 121 (Ar 
CH), 127 (Ar CH), 128 (Ar CH), 129 (Ar CH), 143 (Ar C), 144 (Ar Q. IR data (KBr 
disc)/cm': 3386m, 3209m, 1624s, 1464m, 1324s, 1151s, 726m. FAB MS. m/z 263 
(MH, 81.9%). 
N-(2-amino-phenyt)4-t-butyl benzene-sulfonamide (11) 
H$RNfQ 
11 was prepared by an adaptation of the method of Cheng et al.3 A solution of 4-t-
butylbenzenesulfonyl chloride (5.35 g, 23 mmol) in pyridine (50 cm 
3)  was added 
dropwise to a solution of 1, 2-diaminobenzene (7.25 g, 67 mmol) in pyridine (100 
cm 3)  over 8 hours. The mixture was quenched with hydrochloric acid (15% aq, 300 
cm3) and poured onto ice (500 g). The resulting pale brown precipitate was isolated 
by filtration, dried and recrystallised from ethanol (100 cm 3)  to give a crystalline white 
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solid (3.30 g, 47%), mp 135-136°C (Found: C, 63.25; H, 6.62; N, 9.18. Caic. for 
C 16H20N202S: C, 63.13; H, 6.62; N, 9.20 %). 8H (CDCI3, 200 MHz): 1.31 (s, 9 H, 
CH3), 4.02 (s, 2 H, NH2), 6.49-6.52 (m, 2 H, Ar CH), 6.69 (s, 1 H, NI]), 6.70-6.73 (m, 
1 H, Ar Cl]), 6.98-7.05 (m, 1 H, Ar Cl]), 7.44 (d, 2 H, J 8.8, Ar Cl]), 7.66 (d, 2 H, J 
8.8, Ar Cl]). öc (CDC13, 63 MHz): 31 (3C, CH3), 35 (q, C), 117 (Ar, CH), 118 (Ar, 
CH), 121 (Ar C), 126 (Ar, CH), 127 (Ar, CH), 128 (Ar, CH), 129 (Ar, CH), 136 (Ar 
C), 144 (Ar C), 157 (Ar Q. JR data (KBr disc)/cm: 3465m, 3387s, 2965s, 2869m, 
1625s, 1597s, 1464s, 1324s. FAB MS, m/z 305 (MH, 100.0%). 
2.9.4 Monosulfonamidodiamine complex synthesis 
BisIN-(2-aminoethyl)4-methylbenzenesulfonamidatoj zinc(II) (12) 
A solution of 1 (0.15 g, 0.7 mmol) and sodium hydroxide (0.7 mmol) in hot methanol 
(10 cm) was added to a solution of zinc(II) acetate dihydrate (77 mg, 0.35 mmol) also 
in methanol (10 cm3). The solution was left in a sealed vessel until the product 
separated as a white crystalline solid after 3 days which was collected by filtration, 
washed with methanol (3 x 5 cm) and dried in vacuo (0.14 g, 8 1%), (Found: C, 41.67; 
H, 4.89; N, 12.19. Calc. for C 18H26N404S2Zn: C, 41.58; H, 5.4; N, 11.50%). JR data 
(KBr disc)/cm-1 : 710w, 1599m, 1636w, 2858w, 2940w, 3346m. FAB MS, m/z 491 
(Mt, 66.2%). 
Bis [N-(2-aminoethyl)-4-methylbenzenesulfonamidato] nickel(I1) (13) 
The procedure described for 12 using nickel(II) acetate tetrahydrate yielded a beige 
crystalline solid (0.14 g, 83%), Crystals suitable for X-ray crystallography were obtained 
by the diffusion of toluene into a concentrated solution of 13 in dimethylformamide, 
(Found: C, 44.41; H, 4.87; N, 11.55. Caic. for C 18H26N4NiO4 S2 : C, 44.4; H, 5.4; N, 
11.50%). JR data (KBr disc)/cm': 1178m, 1148w, 1599m, 1654w, 3327m. FAB MS, m/z 
485 (M, 72.9%). 
Bis [N-(2-aminoethyl)-4-methylbenzenesulfonamidatolcobalt(II) (14) 
The procedure described for 12 using cobalt acetate tetrahydrate yielded a brown 
crystalline solid (0.08 g, 46%), (Found: C, 44.46; H, 5.40; N, 11.42. Caic. for 
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C 18H26N4Co02 S2 : C, 44.53; H, 5.40; N, 11.54%). JR (KBr disc)/cm': 1158m, 1372w, 
1583m, 1626m, 2966w, 292w, 3683w, 3289s, 3448m. FAB MS, m/z 486 (MH, 54.1%). 
Bis[N-(2-aminoethyl)4-methylbenzenesulfonamidatojcopper(I1) (15) 
A solution of 1 (0.15 g, 0.7 mmol) in hot methanol (10 cm) was added to copper 
acetate monohydrate (70 mg, 0.35 mmol) also in methanol (10 cm 3). The solution was 
left in a sealed vessel until the product separated as a purple crystalline solid overnight 
(0.13 g, 78%) (Found: C, 44.07; H, 5.18; N, 11.50. Cale. for C 18H26N4Cu04S2: C, 43.75; 
H, 5.30; N, 11.33%). JR data (KBr disc)/cm -1 : 710w 1178w 1348w 1603w 2946w 2819w 
3316s. ESI MS, m/z 490 (M, 82.5%). 
Bis [N-(2-aminoethyl)-4-t-butylbenzenesulfonamidatolcopper(II) (16) 
A solution of 2 (0.15 g, 0.58 mmol) in hot methanol (10 cm 3)  was added to a solution 
of copper(II) acetate monohydrate (58 mg, 0.29 mmol) also in methanol (10 cm 
3). 
The solution was left in a sealed vessel until the product separated as a purple 
crystalline solid overnight (0.12 g, 59%). Crystals suitable for X-ray diffraction were 
prepared by the diffusion of diethyl ether into a concentrated solution of 16 in methanol, 
(Found: C, 50.19; H, 6.75; N, 9.60. Cale. for C24H38N4Cu04S2: C, 50.02; H, 7.00; N, 
9.72%). JR (KBr disc)/cm -1 : 835m, 981m, 1129m, 1252s, 1655m, 1686m, 2986m, 3632m. 
ESI MS, m/z 574 (M, 65.0%). 
Bis [N-(N-2-ethylhexyl-2-aminoethylj-4-methylbenzenesulfonamidatolnickel(II) (17) 
A solution of 4 (0.15 g, 0.46 mmol) in hot methanol (10 cm 3)  was added to nickel(H) 
acetate tetrahydrate (57 mg, 0.23 mmol) in methanol (10 cm3) and the mixture was stirred 
for 30 minutes before the solvent was removed in vacuo to yield an orange oil which was 
triturated with hexane to give an orange solid which was dried in vacuo. (0.19 g, 45%), 
(Found: C, 57.53; H, 8.17; N, 7.79. Cale. for C 34H58N4NiO2 S2 : C, 57.46; H, 8.22; N, 
7.88%). JR data (KBr disc)/cm': 669s, 971m, 1137m, 1279m, 1466w, 2343m, 2361m, 
2929m, 3191m. FAB MS, m/z 709 (M, 77.8%). 
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Bis IN(N_2_ethyIhexy1_2-aminoethy11_4-methy1be11zenesu1fonamidato1coba1t(II) (18) 
Using cobalt(H) acetate tetrahydrate in the procedure described for 17 yielded a purple 
solid which was dried in vacuo. (0.13 g, 32%). JR data (KBr disc)/cm -1 : 668w, 1161w, 
1332w, 1412w, 1560s, 2361w, 2961w, 3464m. FAB MS. m/z 709 (MH, 96.0%), HRMS 
m/z caic. for 710.9322, found 710.3314. 
Bis (N_(N_2_ethylhexyl-2-aminoethyl]-4-methylbenzenesulfOflaflhidatOlCOpper(II) (19) 
Using copper(H) acetate monohydrate in the procedure described for 17 yielded a purple 
solid which was dried in vacuo. (0.22 g, 5 1%), (Found: C, 57.10; H, 8.14; N, 7.80. Caic. 
for C34H58N4Cu02 S2: C, 57.15; H, 8.18; N, 7.84%). IR data (KBr disc)/cm': 667s, 1136s, 
1274m, 1558s, 1685m, 2343m, 2362m, 2929m, 3447m. FAB MS, m/z 714 (MH, 10.1%). 
BisN_(2_aminopropy1)4-methy1benzenesu1fonamidatoJ cobalt(H) (20) 
A solution of 5 (0.15 g, 0.66 mmol) in hot methanol (10 cm 3)  was added to cobalt acetate 
tetrahydrate (82 mg, 0.33 mmol) in methanol (10 cm. 3). The solution was left sealed until 
the product separated as a purple crystalline solid after 3 days which was collected by 
filtration, washed with methanol (3 x 5 cm3) and dried in vacuo (61 mg, 36%), (Found: C, 
46.54; H, 6.13; N, 10.62. Calc. for C 20H30N4Co04 S2: C, 46.78; H, 5.89; N, 10.91%). JR 
data (KBr disc)/cm': 709w, 1134s, 1684w, 3332m, 2929w, 2878w, 2846w. ESI MS, m/z 
514 (M, 6.3%). 
Bis [N-(2-aminopropyl)-4-methylbenzenesulfonamidatolcoPper(ll) 
(blue polymorph 21)' 
A solution of 5 (0.15 g, 0.66 nimol) in hot methanol (10 cm 3)  was added to a solution of 
copper acetate monohydrate (66 mg, 0.35 mmol) also in methanol (10 cm 3). The solution 
was allowed to evaporate overnight to a volume of 10 cm  and yielded a blue crystalline 
solid which was collected by filtration, washed with methanol (3 x 5 cm3) and dried in 
vacuo (73 mg, 43%), (Found: C, 46.29; H, 5.62; N, 10.61. Caic. for C 20H30N4Cu02 S2 : C, 
46.33; H, 5.84; N, 10.81%). JR data (KBr disc)/cm': 1124s, 1195m, 1243s, 1274m, 
1324w, 1608m, 2922m, 3166m, 3270s. FAB MS, m/z 519 (MH, 62.0%). 
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Bis[N-(2-aminopropyl)4-methylbenzenesulfonamidato] copper(H) 
(green polymorph 22)' 
The procedure described for 20 using copper(II) acetate monohydrate yielded a green 
crystalline solid which was collected by filtration, washed with methanol (3 x 5 cm. 3 ) 
and dried in vacuo. (0.08 g, 47%), (Found: C, 46.12; H, 5.71; N, 10.79. Caic. for 
C20H30N4Cu02S2: C, 46.33; H, 5.84; N, 10.81%). IR data (KBr disc)/cm': 1028m, 
1324m, 1358m, 1446m, 1576s, 1080m, 1340m, 1384m, 1478w, 1606s, 2894m, 
3098m, 3179w. FAB MS, m/z 519 (Mt, 43.0%). 
Bis[N-(2-aminopropyl)4-methylbenzenesulfonamidatojzinc(fl) (23) 
The procedure described for 20 using zinc(II) acetate dihydrate yielded a white 
crystalline solid which was collected by filtration, washed with methanol (3 x 5 cm') and 
dried in vacuo (65 mg, 38%). (Found: C, 46.05; H, 5.42; N, 10.78. Calc. for 
C20H30N402S2Zn: C, 46.20; H, 5.82; N, 10.78%). JR data (KBr disc)/cm': 709w, 1173m, 
1590m, 1653w 2848w, 2884w, 2934w, 3340m. ESI MS, m/z 519 (M, 10.9%). 
Bis IN-(N-2-ethylhexyl-3-aminopropylll -4-methylbenzenesulfonamidatol copper(II) 
(24) 
A solution of 8 (0.15 g, 44 mmol) in hot methanol (10 cm 3)  was added to a solution of 
copper acetate monohydrate (44 mg, 0.22 mmol) also in methanol (10 cm 3). The solution 
was held at reflux for one hour and the solvent then removed in vacuo to yield a green oil 
(52 mg, 32%). JR data (CHC1 3)/cm 1 : 1173s, 1345s, 1683w, 2963m. ESI MS m/z 742 
(MH, 80.1%), HRMS m/z calc. for 743.5988, found 743.3561. 
Bis IN-(2-amino-phenyl)-4 methylbenzene-sulfonamidato]nickel(II) (25) 
A solution of 10 (0.15 g, 0.57 mmol) in hot methanol (10 cm) was added to a solution 
of nickel(II) acetate tetrahydrate (71 mg, 0.29 mmol) also in methanol (10 cm'). The 
solution was left in a sealed vessel for three days until the product separated as a pale 
green solid which was collected by filtration (0.15 g, 93%), (Found: C, 53.71; H, 4.36; N, 
9.61. Calc. for C26H26N4NiO2S2 : C, 53.63; H, 4.50; N, 9.62%). JR data (KBr disc)/cm': 
706w, 1163w, 1493s, 1599m, 3025w, 3448m. FAB MS. m/z 581 (ME[4 , 7.2%). 
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Bis[N-(2-amino-phenyl)4 methylbenzene-sulfonamidato] copper(II) (26) 
A solution of 10 (0.15 g, 0.58 mmol) in hot dimethylformamide (10 cm 3)  was added to a 
solution of copper acetate monohydrate (57 mg, 0.28 mmol) also in dimethylformamide 
(10 cm3). The solution was left sealed until product overnight until the product separated 
as a black crystalline solid which was collected by filtration, washed with 
dimethylformamide (3 x 5 cm3) and dried in vacuo. (0.15 g, 90%), (Found: C, 52.09; H, 
5.91; N, 12.35. Cale. for C 26H26N4Cu02 S2 : C, 52.19; H, 5.88; N, 12.17%). JR data (KBr 
disc)/cm': 707w, 1137m, 1390m, 1655s, 2927w, 3036w, 3448m. ESI MS m/z 587 (MH, 
100.0%). 
Bis IN-(2-amino-phenyI)-4 methylbenzene-sulfonamidatojzinc(II) (27) 
The procedure described for 25 using zinc(II) acetate dihydrate yielded a white crystalline 
solid which was collected by filtration, washed with methanol (3 x 5 cm3) and dried in 
vacuo (0.076g. 45%). (Found: C, 52.90; H, 4.46; N, 9.53. Cale. for C 26H30N402 S2Zn: C, 
53.11; H, 4.46; N, 9.53%). IR data (KBr disc)/cm': 707w, 1160w, 1197w, 1264s, 1306s, 
1542w, 1601m, 3035w, 3065w, 3259s, 3335s. FAB MS, m/z 589 (MH, 5.7%). 
2.9.5 Solvent extraction experiments from sulfate media 
S curve data 
50 cm  of 0. 1M Cu(H)L2 (L = 4 or 8) in dichloromethane was contacted with 50 cm  
deionised water in a tightly sealed, screw top, glass jar, equipped with a magnetic 
stirrer. The two-phase system was stirred at 600 r.p.m. and at room temperature for ½ 
h, after which time the pH of the aqueous phase was measured and a 1 cm  sample was 
taken from the organic phase and the aqueous phase. A small amount of concentrated 
H2SO4 was then added to the experiment which was stirred for a further '/2 h, the pH 
was again recorded and 1 cm  samples were taken from the organic and the aqueous 
phases. This procedure was repeated until the organic phase was yellow or colourless. 
The samples were diluted by a factor of 1:10 with water (aqueous samples) or white 
spirit (organic samples) and their copper content analysed by JCP-AES. The data 
collected were plotted as a graph of pH versus % copper in the organic phase using 
Microsoft Excel. 
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Selectivity data 
20 cm  of 0.1 M ligand solution (ligand = 4 or 8) were contacted with 20 cm  aqueous 
metal(II) sulfate solution (M = Co, Ni, Cu, Zn) and stirred for 1 h, after which time the 
two phases were separated by filtration. The samples were diluted by a factor of 1:10 
and their metal content analysed by ICP-AES. The data were plotted as bar charts 
using Microsoft Excel. 
2.9.6 X-ray crystallography 
Structures 1, 5, 7, 10, 12, 13 and 16 were determined by Andrew Parkin and structure 
9 was determined by Dr. Simon Parsons at the University of Edinburgh. In all cases 
data were collected at 220 K on a SMART or Stoe Stadi-4 diffractometer equipped 
with an Oxford Cryosystems low temperature device, using Cu-Kcx radiation for 13 
and Mo-Ka radiation for 1, 5, 7, 9, 10, 12 and 16. Reflections were scanned in o)--O 
mode. All structures were solved by direct methods (SHELXTL or S1R92 30 ' 31). All 
were completed by iterative cycles of least squares refinement against F2 and 
difference Fourier synthesis (SHELXTL 32). H-atoms were idealised, being placed 
using geometric or difference maps and treated by riding or refall methods. 
Sulfonamido nitrogen atoms were placed using difference maps. In all cases non-H 
atoms were modelled with final anisotropic displacement parameters and final 
refinement statistics are presented in Tables 2.22 (1, 5 and 7) 2.23 (9 and 10) and 2.24 
(12, 13 and 16). 
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Table 2.22: Crystallographic data for structures 1, 5 and 7. 
Structure 1 5 7 
Formula C9H 14N202 S C 10H 16N202S C 17H22N202S 
M 214.28 228.31 318.43 
Crystal system Monoclinic Monoclinic Orthorhombic 
Spacegroup Pn P2(1)/c Pna2(l) 
a/A 6.4295(17) 11.9460(8) 22.113 
b/A 	 7.0606(19) 	 7.8174(5) 	 8.4446(14) 
c/A -- 22.987(6) 13.1025(9) 8.9661(8) 
a.'0 90 90 90 
0/0 90.097(5) 108.5310(10) 90 
IWO 90 90 90 
U/A3 1043.5(5) 1160.16(13) 1674.3(4) 
Crystal size/mm 0.36 x 0.05 x 0.05 0.50 x 0.40 x 0.27 0.89 x 0.27 x 0.21 
D/gcm 1.364 1.307 1.263 
Z 4 4 4 
J1/mm' 0.287 0.262 0.202 
Scan type phi + omega phi + omega omega - theta 
9 Limits/' 1.77-26.44 1.80-26.40 2.58-24.96 
No. of unique data 3730 2371 1770 
No. data with 
[F>40(F)1 
3283 2002 1169 
No. parameters 278 200 182 
Ri 0.0378 0.0333 0.0564 
wR2 0.0795 0.0910 0.1094 
APmaxAPm,nIC A 3 0.290, -0.303 0.429,-0.299 0.259, -0.254 
Table 2.23: Crystallographic data for 9 and 10. 
Structure 	 9 	 10 
Formula C 14H24N202S 	C 13H 14N202 S 
M 	 284.41 262.32 
Crystal system Monoclinic Monoclinic 
Space group P21 Ic P2 (1) 
a/A 15.891(3) 11.245(8) 
b/A 6.5484(12) 6.100(5) 
C/A 15.549(3) 18.916(17) 
crio 90 90 
105.131(15) 98.50(8) 
7/0 90 90 
U/A3 1561.9(5) 1283.4(18) 
Crystal size/mm 0.70 x 0.43 x 0.19 0.86 x 0.51 x 0.35 
DIgcm' 1.209 1.358 
Z 4 4 
p1mm' 0.208 0.248 
Scan type omega - theta omega - theta 
0 Limits/' 2.66-24.93 2.63-25.05 
No. of unique data 2726 2503 
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No. parameters 	 183 414 
Ri 	 0.0526 0.0287 
wR2 0.1302 0.0773 
APmax , Apmide A 3 	0.255, -0.308 0.209, -0.241 
Table 2.24: Crystallographic data for structures 12, 13 and 16. 
Structure 	 12 	 13 	 16 
Formula C38H oN80 10S4Zn2 	C 18H26N4NiO4S2 	C24H38CuN404S2 
M 	 1047.92 	 485.26 	 574.24 
Crystal system Monoclinic Monoclinic Monoclinic 
Space group P2(1)/a P2(1)/c P2(1) 
a/A 11.784(6) 12.832(6) 6.2601(15) 
b/A 25.789(8) 6.912(3) 10.817(3) 
C/A 15.636(6) 12.253(5) 19.487(5) 
a10 90 90 90 
0/0 90.18(3) 108.68(3) 94.534(4) 
'(1° 90 90 90 
u/A3 4752(3) 1029.5(7) 1315.5(5) 
Crystal size/mm 0.62 x 0.10 x 0.08 0.47 x 0.16 x 0.10 0.40 x 0.30 x 0.03 
D/gcm' 1.465 1.565 1.450 
Z 4 2 2 
Wmm' 1.246 3.544 1.027 
Scan type omega - theta omega - theta phi + omega 
0Limits/° 1.30-23.52 3.64-60.01 1.05-26.40 
No. of unique data 5435 1476 5178 
No. data with 3754 1305 4554 
IF>4o(F)I 
No. parameters 565 134 316 
Ri 0.0535 0.0528 0.0311 
wR2 	 0.1408 	 0.1509 	 0.0648 
iPmaxAPmiri1e A 3 	0.380, -0.654 0.620, -0.626 0.604, -0.352 
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Chapter 3: Sulfonamido oxime ligands 
3.1 Introduction 
Sulfonamido oxime ligands were investigated due to their similarity to P50 type 
phenolic oxime metal extractants (see chapter 1). The ligands have two nitrogen 
donor atoms (sulfonamido and oximic) for coordination to a metal centre. The 
sulfonamido proton is acidic (pKa 9) and deprotonates on complexation to yield an 
anionic species, this also increases the nucleophilicity of the nitrogen donor atom. 
2:1 complex formation with a divalent metal ion produces a charge neutral species 
which is essential for solublility in organic solvents. The sulfonamido oxygen lone 
pairs could act as hydrogen-bond acceptor sites to the hydrogen-bond donor atom of 
the oxime function in a head-to-tail interaction to create a pseudo-macrocyclic ligand 
(Figure 3.1). 
Figure 3.1: Apseudo-macrocyclic sulfonamido oxime ligand coordinated to a metal centre. 
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3.2 Synthesis of simple monosulfonamido oxime ligands and their 
metal complexes 





R R R2 
28° methyl methyl H 
29a 'butyl methyl H 
30 propyl methyl H 
31 pentyl methyl H 
32" methyl methyl methyl 
33a methyl phenyl H 
Figure 3.2: The sulfonamido oxime ligands discussed in this chapter. a  Formula confirmed by X-ray 
crystallography. 
The complexes which have been isolated of the above ligands are given in Table 3.1. 
Table 3.1: Sulfonamido oxime complexes synthesised. 
Abbreviation Complex Colour 
34a [Cu(28-H)2] Brown 
35a [Cu(28-H) 2(28-2H)2 (MeOH)2 (MeO)21 Green 
36" [Ni(28-H) 2] Orange 
37 [Ni(28-H) 2] Purple 
38a [Ni2Na2(28-H)2(28-2H) 2(MeOH)4] Red 
39a [Ni4(OH)2(28-H) 2(28-2H)2(CH30H)4] Green 
40 [Ni(30-H) 2] Orange 
41 [Cu(33-H)2] Brown 
a  Formula confirmed by X-ray crystallography. 
3.2.1 Free Ligands 
Two ligands were initially synthesised, 1- { 2-[N-(4-methylbenzenesulfonamido)]-
phenyl} ethan- 1-one oxime (28) and 1- { 2-{N-(4-methylbenzenesulfonamido)]-
phenyl } (phenyl)methanone oxime (33) (Figure 3.3). 
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11 	 11 
--O-S-NH 





Figure 3.3: Ligands 28 and 33. 
The synthesis was achieved in two steps. The ammoketone was first converted to a 
sulfonamide by treatment with 4-methylbenzenesulfonyl chloride in pyridine which 
was then oximated in a 50:50, pyridine:ethanol medium (Figure 3.4). 




11-0- 1 e 
(ii) 
NHTS 	NOH e R 
Figure 3.4: The preparation of the sulfonamido oxime ligands 28 (R = methyl) and 33 (R = phenyl). 
(i) Pyridine, 298 K. (ii) 3 eq. NH 20H.HCI, 50:50, pyridine:ethanol, reflux for 4 hours. Ts 
= -S02(C6H4)CH3 . 
As observed for the sulfonamido diamine ligands in chapter 2, the solubility of the 
prototype ligands, whilst sufficient for defining the coordination properties, was too 
low to enable their colligative properties and their ability to act as solvent extractants 
to be studied. The preparation and study of more soluble derivatives is described in 
chapter 4. 
3.2.2 Metal complexes 
Metal complexes 34, 37, 40 and 41 were synthesised by treating two equivalents of 
the appropriate ligand with one equivalent of the appropriate divalent metal acetate 
(Equation 3.1) in methanol or ethanol.' 
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2LH + M(ll)(CH3COO)2 	[ML2] + 2CH3COOH 	Eq 3.1 
When this method failed to yield the desired complex one equivalent of base (B) was 
added to facilitate deprotonation of the ligand (Equation 3.2). Formation of the 
complexes 36, 38 and 39 required the addition of base; sodium, potassium or lithium 
hydroxide was used. 
2LH + 2B + M(U)(CH3COO)2 	[ML2] + 2[BH][CH3CO2 ] 	 Eq 3.2 
To study whether additional oxygen donors from the sulfonamido groups or from the 
oxime group can also be involved in complex formation, see Section 3.4.5, metal to 
ligand ratios of 1:1 were also tried. This resulted in the synthesis of 35. 
3.3 Characterisation of sulfonamido oxime ligands 
3.3.1 Nuclear magnetic resonance (NMR) spectroscopy 
Sulfonamido oxime ligands 28-33 may be easily characterised by proton nnir. The 
set of two doublets arising from the protons, c and d, on the 4-methylbenzene group 
which were easily assigned in the sulfonamido-diamine ligands (chapter 2) are 
usually hidden in the oxime ligands by other signals in the aromatic region. 
However, other peaks are readily assigned, e.g. in ligands 28-32 a peak for the 
methyl group at postion R' is observed between 1.95 and 2.38 ppm. 
To characterise 1- { 2-[N-(4-methylbenzenesulfonamido)]phenyl } ethan- 1-one oxime 
(28) (Figure 3.5) as an example. A peak for the p-methylbenzene group is observed 
at 2.03 ppm and peaks for protonsf (8.38 ppm) and m (10.85 ppm) are shifted to low 
field by the increasing electron withdrawing nature of the nitrogen and oxygen atoms 
respectively. The 1:1 ratio of the two methyl peaks (a and n) supported the 
characterisation and this was verified by the ratio of 3:8 between the methyl peak a 
and the aromatic region. ' 3C nmr is also useful to confirm structures. The two 
methyl carbon signals a and n at 21 and 12 ppm are easily identified as is the signal 
for the imino carbon, m, which is shifted downfield past the aromatic signals at 157 
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ppm. The remaining signals were assigned using DEPT techniques  and are listed in 






// 	\\ 	II OHm 
H3Ca Cb Ce—S—NHf 	N ''  
Cc=CdHd 0 Cg 	Cm 
HC 	
\ 	Ch ' • 'C!' 	CnH 3 
Ci.. 	Ck 
Cj 
label ' 3CNMR(ppm) 'H NMR (ppm) 
a 12 2.03 
b 125 
C 
1 127 7.054.65 




h and k 128,129 7.05-7.65 
iandj' 122,124 7.05-7.65 
M 157 10.85 
n 21 2.32 
Figure 3.5: 1- { 2-[N-(4-methylbenzenesulfonamido)]phenyl} ethan- 1-one oxime (28) 
including the labelling scheme used for nnir assignments. ' peaks for c, d, h, i, 
j and k all form a multiplet in the 'H nmr spectrum between 7.05 and 7.65 
ppm. 
3.3.2 Mass spectrometry and IR spectroscopy 
IR and mass spectrometry were used to support characterisation. JR confirming the 
presence of the sulfonamido group in the products. One strong band is expected in 
the 1370-1330 cm' region and another in the 1180-1160 cm -1 region for the -S0 2-N 
group. A weak peak is also expected for the C=N bond of the oxime group between 
1690 and 1640 cm'. This was sometimes difficult to identify due to the proximity of 
C=C peaks. Electron impact (El), fast atom bombardment (FAB) and electrospray 
ionisation mass spectrometry have all been used for analysis purposes. El and FAB 
gave the expected molecular ion and ES! spectra gave peaks of higher molecular 
weight, suggesting that assembly is occurring in solution, the latter will be discussed 
further in chapter 4. 
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3.3.3 X-ray crystallography 
Ligands 28, 29, 32 and 33 were also characterised by X-ray crystallography. This 
showed that the stereochemistry of the oxime is more commonly in an E 
configuration as ligands 28, 29, 32 and 33 were isolated in this form, however, ligand 
33 was also isolated in the Z configuration as a second polymorph. The bond lengths 
of the central components are similar for each ligand and are listed in Figure 3.6. 






Bond 28 29 32 
330 E isomer 33° Z isomer 
1.285(4) 1.280(5) 1.281(2) 1.294(5) 1.292(3) 
ii 1.484(4) 1.478(5) 1.485(2) 1.460(6) 1.488(3) 
iii 1.415(4) 1.407(5) 1.421(2) 1.409(6) 1.397(4) 
iv 1.421(4) 1.431(5) 1.410(2) 1.433(6) 1.428(3) 
V 1.614(2) 1.623(3) 1.6294(14) 1.632(4) 1.643(2) 
Figure 3.6: Bond lengths (A) for the central components of sulfonamido oxime ligands 28, 29, 32 and 
33. 
3.4 Solid state structures of sulfonamido oxime ligands and their 
complexes 
Sulfonamido oximes have significant numbers of hydrogen-bond donor and acceptor 





Figure 3.7: Hydrogen-bond donor (blue) and acceptor sites (red) of sulfonamido oximes. 
Ligands 28, 29, 30, 31 and 33 have eight hydrogen-bond acceptor sites, (three 
oxygen atoms, each with two lone pairs, and two nitrogen atoms) and two donor sites 
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(the oxime hydrogen atom and the sulfonamido hydrogen atom). Ligand 32 has the 
same number of acceptor sites but one less hydrogen-bond donor atom as the 
hydroxy hydrogen has been replaced with a methyl group. These numbers are 
greater than the one donor and the one acceptor site required for pseudo-macrocycle 
formation, but we assumed that these extra donors and acceptors would not interfere 
with ring formation. 
3.4.1 Free ligands 
3.4.1.1 1-12_[N-(4_methylbenzenesulfonamido)lphenyl}ethafl-1-Ofle oxime (28) 
The asymmetric unit of 28 is a single molecule which is related by a centre of 
symmetry to a second molecule • to form a hydrogen-bonded dimer via head-to-tail 
[O(8A)-H --- O(1A), 2.795(4) A; O-H-O, 159°] interactions between a sulfonamido 
oxygen atom and the hydrogen atom of the oxime (Figure 3.8). 
O(8A) 
• .c"4_ 	C(6A) AMA)  
	
N(7A)TC(5A 	






Figure 3.8: The dimeric hydrogen-bonded structure of 1 -{2-[N-(4-methylbenzenesulfonamido)]-
phenyl} ethan- 1-one oxime (28). 
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The hole size, as defined in chapter 2, of this pseudo-macrocycle is 2.94 A. The 
configuration of the oxime is E and a single intra-molecular hydrogen-bond [N-(3A)-
H --- N(7A), 2.595(3) A; N-H-N, 138'] between the sulfonamido hydrogen atom and the 
oximic nitrogen atom is observed. The six membered ring formed by this intra-
molecular hydrogen-bond is almost planar. The greatest torsion angle is 6.4° along the 
N---H hydrogen-bond. 
The sulfonamido nitrogen deviates slightly from planarity, bond angles for C-N-S, S-
N-H and H-N-C are 126.0, 114.7 and 114.3° respectively, 355° in total, and the 
nitrogen atom is found 0.166 A from the least squares plane. 
The benzene ring of the sulfonamido is tilted at an angle of 99.8° to the phenyl ring. 
Finally, the sulfur atom of the ligand is chiral due to one oxygen being involved in 
hydrogen-bonding. Since the molecules in the dimer pair are related by inversion 
symmetry one R enantiomer and one S enantiomer form the pseudo-macrocycle. 
3.4.1.2 1-{2_[N-(4_t_butylbenzenesulfonamido)]phenyl}ethan-1-one oxime (29) 
Molecule 29 has a very similar structure to 28. There is one molecule in the unit cell 
which forms two hydrogen-bonds with a second molecule which is generated by 
symmetry to form a dimer (Figure 3.9). In an analogous way to 28, hydrogen-bonds 
are formed between a sulfonamido oxygen atom and an oximic hydrogen atom 
[O(8AA)-H --- O(1A), 2.73(4) A; O-H-O, 146(5)0]. 
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C(21A) 	ç C(15A) 	
(1A) S(2A) 4q 
C(18A) 
C(19A) 
Figure 3.9: Hydrogen-bonded dimer of I -{2-[N-(4-t-butylbenzenesulfonamido)]phenyl}ethan- 1-one 
oxime (29). Hydrogen atoms not involved in hydrogen-bonding have been removed for 
clarity. 
An intra-molecular hydrogen-bond is again present between the sulfonamido 
hydrogen atom and the oximic nitrogen atom [N(3A)-H --- N(7A), 2.634(5) A; N-H-
N, 145(3)°]. The six membered ring formed by the intra-molecular hydrogen-bond 
deviates further from planarity than in 28. The largest torsion angle is along the N-H 
bond at 11.30,  this may be a result of the optimisation of the intra-molecular 
hydrogen-bonding interaction. 
The hole size of the hydrogen-bonded dimer is 2.91 A, slightly smaller than in 28 cf. 
2.94 A. The sulfonamido nitrogen atom of 29 is less planar than in 28. The sum of 
the angles around the nitrogen atom is 344.1°, and the nitrogen atom is found 0.278 
A from the SCH plane. Due to hydrogen-bonding the sulfur atom is again chiral 
with one R and one S isomer creating the pseudo-macrocycle. 
135 
Chapter 3: Sulfonamido oxime ligands 
3.4.1.3 1-12-[N-(4-methylbenzenesulfonamido)Iphenyl}ethan-1-one 0-
methyloxime (32) 
In 32 R2 is a methyl group and no longer a hydrogen atom. Removal of this 
hydrogen-bond donor atom prevented formation of a dimeric secondary hydrogen-
bonded structure. The asymmetric unit is shown in Figure 3.10. 
Figure 3.10: The X-ray structure of! -{2-[N-(4-methylbenzenesulfonamido)]phenyl}ethan-1-one 0-
methyloxime (32). 
Only intra-molecular hydrogen-bonding is observed between the sulfonamido 
hydrogen atom and the oximic nitrogen atom [N(3A)-H --- N(7A), 2.620(2) A; N-H-
N, 138.1(18)-l. The geometry of the sulfonamido nitrogen is close to planar and the 
sum of the angles around the nitrogen, is 354.1° and the nitrogen atom is found at 
0.172 A from the SCH plane. The six membered ring formed by the intra-molecular 
hydrogen-bond is not planar as in 28 and 29. This is probably due to the increased 
flexibility of 32 as it is not constrained by inter-molecular hydrogen-bonding. The 
only torsion angle close to zero is along the C(4A)-C(5A) bond at 1.70  where the two 
phenyl ring substituents are restricted by the aromatic bond. 
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3.4.1.4: 1(2[N(4methytbenzenesu1fonamido)1-pheflY1}(PheflY1)methaflOfle 
oxime (33) 
Two crystalline forms of 33 have been isolated. One polymorph form is the E 
isomer of the oxime and has a dimeric secondary hydrogen-bonded structure closely 
related to those of 28 and 29 (Figure 3.11). 
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Figure 3.11: The dimeric secondary hydrogen-bonded structure of the E isomer of 1-12-[N-(4- 
methylbenzenesulfonamido)]-phenyl) (phenyl)methanone oxime (33). Hydrogen atoms 
not involved in hydrogen bonding have been removed for clarity. 
The asymmetric unit consists of one molecule which is symmetry related to a second 
molecule to form a dimer via hydrogen-bonds between the sulfonamido oxygen atom 
and the oximic hydrogen atom [O(8A)-H --- O(2AA), 2.754(5) A; O-H-O, 15 1°]. The 
hole size of the dimer is 2.97 A. As observed for the structures of 28, 29 and 32 an 
intra-molecular hydrogen-bond between the sulfonamido hydrogen atom and the 
oximic nitrogen atom [N(3A)-H --- N(7A), 2.673(6) A; N-H-N, 141(5)0] forms a six 
membered ring. This ring is less planar than in 28 and 29 and the largest torsion 
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The Z isomer of the oxime forms a second polymorph and a different hydrogen-
bonded structure is observed. One molecule constitutes the asymmetric unit and 
instead of head-to-tail hydrogen-bonding, head-to-head and tail-to-tail hydrogen-
bonding is observed. Each ligand forms six inter-molecular hydrogen-bonds to two 
adjacent ligands leading to an infinite one-dimensional zigzag chain along the a axis, 
illustrated schematically in Figure 3.12. Two inter-molecular hydrogen-bonds 
between the sulfonamido hydrogen atom H(3A) and the sulfonamido oxygen atom 
O(1A) are observed [N(3A)-H---O(1A), 3.104(3) A; N-H-O, 156(2)°] and four 
interactions occur between the oxime moieties of the type [0(8A)-H---0(8AA), 
3.23 1(3) A; 0-11-0, 133(3)° and 0(8A)-H---N(7AA), 2.823(3) A; 0-H-N, 165(4)°]. 
Figure 3.12: The hydrogen-bonded oligomeric structure of the Z isomer of 33. 
Two intra-molecular hydrogen-bonds are present between the sulfonamido hydrogen 
atom and the oximic nitrogen atom [N(3A)-H --- N(7A), 3.22 A; N-H-N, 127 0] and a 
second interaction between the trifurcated sulfonamido hydrogen atom H(3A) and 
the hydroxy oxygen atom 0(8A) [N(3A)-H --- 0(8A), 2.915(4) A; N-H-0, 122(2)°] is 
possible because of the cis-stereochemistry of the oxime. The X-ray structure of the 
asymmetric unit of the Z isomer of 33 is shown in Figure 3.13. 
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Figure 3.13: The X-ray structure of the Z isomer of 33. 
The sulfonamido nitrogen atom deviates from planarity and the nitrogen atom is 
0.229 A from the least squares plane. Bond angles for C(4A)-N(3A)-S(2A), S(2A)-
N(3A)-H and H-N(3A)-C(4A) are 117.0, 110.4 and 117.0° respectively, 344.4° in 
total. 
One sulfonamido oxygen atom is involved in hydrogen-bonding and so the sulfur 
atom is chiral. Two symmetry related ligands are found in the unit cell, one is the R 
enantiomer and one the S enantiomer. 
The sulfonamido tolyl ring and the benzene ring a to the oximic carbon are not 
completely orthogonal to the central phenyl ring [122.3 and 109.1°], there is a 
dihedral angle between them of 28.7°. Weak it stacking interactions occur between 
the tolyl ring of the sulfonamido and the benzene ring a to the oxime (Figure 3.14). 
The distance between centroid of the two rings is 4.15 A in each case. 
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Figure 3.14: it stacking interactions in the oligomeric Z isomer of 33. 
3.4.2 Oxime stereochemistry 
The two stereoisomers of sulfonamido oxime ligands are shown in Figure 3.15. 
OH 









Figure 3.15: E and Z isomers of sulfonamido oxime ligands. 
There has been considerable study of the conformational isomers of oximes. It is 
thought that steric effects make the E isomer predominate and aromatic Z aldehyde 
oximes have been shown to rearrange to the trans E isomer by hydrogen ion 
catalysis. 3 Oximes in the Z conformation have even been found to convert 
spontaneously albeit very slowly in the solid state. 4 
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Results so far substantiate claims that the E isomer appears to predominate  as only 
one example of a sulfonamido oxime ligand (33) in the cis-conformation has been 
isolated when the group cx to the oxime is a bulky phenyl group. 
A factor which might explain why it is possible to crystallise the less stable isomer 
comes from consideration of the lattice energies of the two structures. The higher 
density of hydrogen-bonds present in the structure of the polymer may mean that its 
lattice energy is higher than that of the dimeric structure. Therefore the free energy 
loss in adopting the less favourable stereoisomer has been offset by the increase in 
the lattice energy. 
Each of the X-ray structures of metal complexes of sulfonamido oximes, which will 
be described in Sections 3.4.4 and 3.4.5, show that the oxime always exhibits E 
isomerism. This may be understood from the position of the hydroxy group in the 
two isomers. In the E isomer there is no obstruction to metal complexation, however 
in the Z isomer the hydroxy group precludes complexation. This has been observed 
in other ligand systems which include an oxime function, 5 e.g. only the E isomers of 
hydroxyoxime LIX reagents for metal extraction were found to be reactive towards 
copper. 
3.4.3 Hydrogen-bonding in sulfonamido oxime ligands 
Both the sulfonamido group and the oxime group have hydrogen-bond donor and 
acceptor functions. In molecules which contain either oxime or carboxyl functions 
such dual character often results in dimeric structures and functional groups from 
neighbouring molecules are linked with pairs of centrosymmetric hydrogen-bonds. 6 
This arrangement is also possible for molecules containing a sulfonamido group 
(Figure 3.16). 
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Figure 3.16: Centrosymmetric hydrogen-bonding of the sulfonamido group. 
There are 110 entries in the CSD (August 2001) for centrosymmetric hydrogen-
bonding in oximes (30% of all oxime entries) and 85 of sulfonamide molecules (17% 
of all sulfonamide entries). In molecules which incorporate both carboxylic and 
oxime groups, 6,7  head-to-tail interactions leading to a one dimensional chain structure 
are more commonly observed than the head-to-head, homologous binding, 
interactions which would lead to dimer formation. In fact only when bulky groups 
are incorporated into the ligands x to the oxime or carboxyl functions is a dimer 
including head-to-head interactions observed. In comparison, the preferred head-to-
tail interactions lead to a dimeric structure in sulfonamido oxime molecules involving 
only one and not two hydrogen-bonds. Homologous centrosymmetric binding of 
sulfonamido oximes as observed for 33(Z) leads to a one dimensional chain structure. 
The hydrogen-bonding interactions of sulfonamido oxime ligands are listed in Tables 
3.2 and 3.3. 
Table 3.2: The intra-molecular hydrogen-bond lengths (A) and angles (°) of ligands 28, 29, 
32 and 33. 
Ligand Interaction type Hydrogen-bond Hydrogen-bond 
length / A angle / 
28 N(Ox) --- H-N(S) 2.595(3) 138 
29 N(Ox) --- H-N(S) 2.634(5) 145(3) 
32 N(Ox) --- H-N(S) 2.620(2) 138.1(18) 
33" E isomer N(Ox) --- H-N(S) 2.673(6) 14 1(5) 
33°Zisomer N(Ox) --- H-N(S) 3.22 127 
N(Ox) --- H-N(S) 2.915(4) 122(2) 
° Molecule 33 has been isolated as two polymorphs, the stereochemistry of the oxime is either E or Z. Atoms 
labelled Ox are contained in an oxime group. Atoms labelled S are contained in a sulfonamido group. 
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Table 3.3: The inter-molecular hydrogen-bond lengths (A) and angles (°) of ligands 28, 29, 
and 33. 
Ligand Interaction type Number of Hydrogen-bond Hydrogen-bond 
interactions length I A angle / 
28a O(Ox)-H --- O(S) 2 2.795(4) 159 
290 O(Ox)-H --- O(S) 2 2.743(4) 146(5) 
33abE isomer O(Ox)-H --- O(S) 2 2.754(5) 151 
O(S)---H-N(S) 2 3.104(3) 156(2) 
33b Zisomer N(Ox) --- H-O(Ox) 2 2.823(3) 165(4) 
O(Ox)-H --- O(Ox) 2 3.23 1(3) 133(3) 
° Inter-molecular hydrogen-bonding in these molecules forms a pseudo-macrocyclic ligand structure. b Molecule 
33 has been isolated as two polymorphs, the stereochemistry of the oxime is either E or Z. 
The intra-molcular hydrogen-bonds of sulfonamido oxime ligands have similar 
lengths and angles. The small angles (122 .4146 . 00) are probably due to the rigidity 
of the ligand backbone. The inter-molecular hydrogen-bonds of 28, 29 and the E 
isomer of 33 are also very similar and are longer (mean 2.76 A) in comparison with 
the intra-molecular hydrogen-bonds (mean 2.63 A). The inter-molecular hydrogen-
bonds of the Z isomer of 33 are even longer (mean 3.05 A). 
3.4.4 Sulfonamido oxime IML 2I complexes 
It is thought that the increased strength and selectivity of P50 over other similar 
phenolic oximes is due to the two intra-complex hydrogen-bonds which create a 
pseudo-macrocycle around the metal centre. It was hoped that the coordination 
chemistry of sulfonamido oxime ligands with divalent metal ions would be similar to 
phenolic oxime, P50 type, ligands and that a hydrogen-bonded pseudo-macrocyclic 
ligand would be formed on complexation via the oxime hydrogen-bond donor atom 
and the sulfonamido oxygen acceptor sites. The proposed size of the pseudo-chelate 
ring formed by intra-complex hydrogen-bonding for sulfonamido oxime systems is 
seven membered in comparison with the five membered pseudo-chelate ring of 
phenolic oximes (Figure 3.17). 
143 
Chapter 3: Sulfonamido oxime ligands 
R 0-H*.-  j\ 
R— ($< Q. N=< 
H-0 R 
H--OR 
, R 0 S_ 
e  I I 
0-, \ 
R0--H 
Figure 3.17: Pseudo-macrocyclic ligand formation on complexation with divalent metal ions for 
phenolic oxime complexes and sulfonamido oxime complexes. 
3.4.4.1 Bis I1{2LN4methy1benzenesu1fonamidato)1PhenY1}ethafl-1-0h1e oximej 
copper(il) (34) 
When two equivalents of 28 was reacted with one equivalent of copper acetate in 
methanol a brown complex (34) was obtained. The X-ray structure of 34 is shown in 
Figure 3.18. 
Figure 3.18: The X-ray structure of bis[ 1 -{2-[N_(4-methylbenzenesulfonamidato)]phenyl}ethafl- 1-
one oxime]copper(II) (34). 
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The copper(II) atom has slightly distorted planar coordination geometry, the dihedral 
angle between the plane defined by the N(3A)-Cu-N(7A) chelate and the N(3B)-Cu-
N(7B) chelate is 5.9° and the sum of the chelate angles is 360.1°. The copper to 
sulfonamido nitrogen bond lengths are at 1.947(3) and 1.952(3) A and the copper to 
oximic nitrogen lengths are at 2.035(3) and 2.043(3) A. The N(3)-Cu-N(7) bond 
angles are 85.46(1 1) and 88.95(l1)°. The hole size of 34 is 1.99 A, a smaller value 
than that observed for the free ligand cf. 2.94 A. 
The ligand arrangement around the copper(II) atom is similar to the solid state 
hydrogen-bonded structure of the free ligand (Figure 3.8) and intra-complex 
hydrogen-bonding between the sulfonamidato oxygen atom to the oximic hydrogen 
atom [O(8)-H---O(1), 2.725(4) and 2.706(4) A; O-H-O, both at 164°] creates a pseudo-
macrocycle around the copper. The hydrogen-bond length is slightly longer than in the 
free ligand however the bonds are more linear cf. [O(8)-H---O(2), 2.80 A; O-H-O, 1590]. 
The sums of the angles around the sulfonamido nitrogen are 353.5 and 351.6 0 . In each 
case the nitrogen atom is less planar than for the free ligand cf. (355.0°). This may be 
due to the constraints required for nitrogen coordination to the copper atom. The 
chirality of both ligands at the sulfur is R and the configuration of the oxime is E in both 
cases. 
3.4.4.2 Bis[1_{2_IN_(4_methylbenzenesulfonamidato)lphenyl}ethafl-1-Ofle oximeJ 
nickel(II) (36) 
When two equivalents of 28 and one equivalent of nickel acetate were combined in 
methanol and two equivalents of potassium hydroxide were added an orange 
complex was obtained with a nickel: ligand ratio of 1:2 (Figure 3.19). 
145 
Chapter 3: Sulfonamido oxime ligands 
Figure 3.19: The X-ray structure of bis[ 1 -{ 2_[N-(4_methylbenzenesulfonamidatO)]pheflYl }ethan- 1-
one oxime] nickel(II) (36). 
The asymmetric unit consists of half of the complex and the whole complex is generated 
through an inversion centre. The nickel(II) ion has square planar geometry. The N(3)-
Ni(l)-N(7) angle is 89.78(l 1)' and the bond lengths are at Ni(l)-N(7A) 1.881(3) A and 
Ni(l)-N(3A) 1.903(3) A. The sulfonamido nitrogen is less planar than in the free ligand 
and the sum of the angles about the nitrogen atom in 36 is 348.8°. 
The hydrogen-bonding in the nickel complex differs from that in copper complex 34 and 
intra-complex hydrogen-bonds between the hydroxy hydrogen atom and the 
sulfonamidato nitrogen atom [0(8A)-H---N(3A), 2.704(4) A; 0-H-N, 131 0] .  This may 
be a result of the preference of nickel(H) for perfect planar geometry, or the difference in 
the central radii of the planar Ni(II) and Cu(II) ions. The 14-membered pseudo-
macrocyclic structure in the nickel complex 36 closely resembles that in the Cu-
complexes of the phenolic oxime reagents used in copper recovery. The sulfOnamidato 
group has been pushed away from the N 42 plane and the closest sulfonamidato oxygen 
atom is 3.11 A from the hydroxy hydrogen atom. In order for a sulfonamidato oxygen 
atom to interact with the hydroxy hydrogen atom a deviation of the metal geometry away 
from planarity such as in the copper complex which has a dihedral angle of 5.9° between 
the chelate planes may be required. 
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3.4.5 Sulfonamido oxime cluster complexes 
At the beginning of this project it was hoped that the coordination chemistry of 
sulfonamido oxime ligands would be similar to P50 type phenolic oxime molecules. 
The complexation studies in section 3.4.4 have shown that these ligands can complex 
divalent metal ions to form ML 2 complexes. However, the complexation behaviour 
of 28 with copper(II) and nickel(II) varies with reaction conditions as the 
deprotonated oximic oxygen atom and the sulfonamido oxygen atoms are also able to 
coordinate to metal centres formating polynuclear species. The atoms available for 




 3.20: The donor atoms of sulfonamido oxime ligands. 
3.4.5.1 ICu4(28_H)2(28-2H)2(CH30H)2(CH30)21 (35) 
When 28 and copper acetate were combined in a 1:1 ratio in methanol a green 
crystalline solid was isolated with the formula [Cu4(28-H) 2(28-
2H)2(CH30H)2(CH30)2] (35). The asymmetric unit consists of half of the 
tetranuclear species. There are two chemically different copper coordination spheres 
in 35, type one (Cu(l)) and type two (Cu(2)). Each copper has a five-coordinate 
geometry and forms a distorted square based prismatic structure. Two ligands are 
singly deprotonated at the sulfonamido nitrogen atom and act as bidentate ligands 
(type B ligands) and two ligands are doubly deprotonated, at the sulfonamido 
nitrogen atom and the hydroxy oxygen atom and act as tetradentate ligands (type A 
ligands). Two methanol molecules complete the coordination sphere of the Cu( 1) 
atom and two methoxide groups balance the charge to give a neutral species. 
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Figure 3.21: X-ray structure of the copper cluster [Cu 4(28-H) 2(28-2H)2(CH30H)2(CH30)21 (35). 
Type one copper(II) atoms are coordinated by two nitrogen atoms and a sulfonamido 
oxygen atom of a type A ligand [Cu(1)-N(3A) at 1.904(2) A, Cu(l)-N(7A) at 1.958(2) 
A and Cu(1)-0(2A) at 2.2766(19) A, a methanol molecule [Cu(1)-O(IM) at 2.244(2) Aj 
and a bridging methoxide oxygen atom [Cu(l)-0(8A) at 1.8760(18) A] completes the 
coordination sphere. 
Type two copper(II) atoms are coordinated by the two nitrogen atoms of a type B ligand 
[Cu(2)-N(3B) at 1.952(2) and Cu(2)-N(7B) at 2.010(2) A] and two deprotonated oximic 
oxygens of the type A ligands [Cu(2)-0(8A) 2.54 and 1.9759(19) A]. The coordination 
sphere is completed by the oxygen atom of a bridging methoxide group [Cu(2)-0(2M) at 
1.9199(18) A] toaCu(l) atom. 
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The deprotonated oximic oxygen atoms of type A ligands act as hydrogen-bond acceptor 
sites to the adjacent oximic hydrogens of type B ligands [O(8B)-H --- O(8A), 2.61 A; 0-
H-0, 155°]. Two further hydrogen-bonds between a sulfonamido oxygen atom of a type 
B ligand and a methanolic hydrogen atom are observed [O(1B) --- H-O(1M), 2.63(3) A; 
O-H-O, 163(4)°] 
Weak it stacking interactions between the phenyl rings of the ligands occur (Figure 
3.22). The distance between the centroid of the two phenyl rings is 3.957 A and the 
angle between the planes of the two aromatic rings is 13.30. 
Figure 3.22: it stacking in 35. The distance between the two phenyl rings is 3.98 A. 
The one to one, ligand to metal ratio in 35 is important from a metal extraction 
perspective. If this tetranuclear species were formed instead of a ML2 complex on 
extraction of copper from an aqueous phase into an organic phase and the metal 
could also be stripped back out of the complex this would mean that the efficiency of 
28 as an extractant would increase two fold. This is unlikely as analogues of the 
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methanol and groups incorporated into the cluster to complete the copper 
coordination spheres and balance the overall charge would not be present in the 
hydrocarbon solvents used for metal extraction. 
The binding of the sulfonamido oxygen atoms to copper and the formation of a four 
membered ring by the coordination of the sulfonamido nitrogen N(3A) and oxygen 
0(2A) to the same copper centre are unusual. The angles of this ring are at 67.2 to 
102.4°. 
3.4.5.2 INi2Na2(28-H)2(28-211)2(CH30H)41 (38) 
A red heterometallic cluster complex (38) was formed when two equivalents of 
sodium hydroxide were added to two equivalents of 28 and one equivalent of nickel 
acetate. The X-ray structure of this cluster is shown in Figure 3.23. 
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Figure 3.23: The X-ray structure of the nickel and sodium cluster (38). 
The two halves of this cluster are related by an inversion centre lying between the 
sodium atoms. The entire complex is achieved via inversion of this fragment. The 
cluster consists of two tetracoordinate nickel(II) ions, two hexacoordinate sodium 
ions, two singly deprotonated (type B) molecules of 28, two doubly deprotonated 
(type A) molecules of 28 and four methanol molecules. Each is a 
[NiNa(C 15H15N2S03)(C15H14N2S03) (CH30H)21 moiety linked to the other half via 
hydrogen-bonding to methanol molecules and interactions to the two sodium ions. 
This can be seen schematically below in Figure 3.24. 
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Figure 3.24: A schematic diagram of half of the nickel cluster. Oxygen is bonded to sodium ions 
(1) and (1A). u Oxygen is bonded to sodium (1). Oxygen is bonded to sodium (1A). 
The nickel(II) atom is coordinated by two molecules of 28 in a distorted planar 
fashion with the N(3B)-Ni-N(7B) and N(3A)-Ni-N(7A) chelate angles at 86.7(2) and 
86.4(2)° respectively. The nickel to sulfonamido nitrogen bond lengths are 1.883(5) and 
1.900(5) A and the nickel to oximic nitrogen bond lengths are 1.876(5) and 1.9 10(5) A. 
The sum of the angles around the nickel is 361.40  and the dihedral angle between the 
chelate planes is 15.40 . 
The oximic hydrogen atom of type B ligands forms two hydrogen-bonding interactions 
to the deprotonated oxime of a type A ligand via bifurcated [O(8B)-H --- 0(8A), 2.495(8) 
A; 0-H-0, 1530]  and [0(8B)-H --- N(7A), 2.88 A; 0-H-N, 117] interactions. The 
oxygen atom of the deprotonated oxime group 0(8A) and the uncoordinated 
sulfonamido oxygen 0( 1A) form strong inter-molecular interactions with two methanol 
molecules coordinated to the two sodium ions, [0(1M)-H---0(8A), 2.780(7) A; 0-H-0, 
168°; 0(2M)-H---0(1A), 2.887(7) A; 0-H-0, 149°] 
The coordination sphere of the sodium atom consists of two methanolic oxygen atoms, 
[Na(1)-0(lM) at 2.3 12(5) A and Na(1)-0(2M) at 2.403(6) A], and four sulfonamido 
oxygen atoms, [Na(1)-0 at 2.34 1(5), 2.419(4), 2.485(5) and 2.485(5) A] complete the 
sphere to form an octahedral six coordinate geometry. The geometry of the sodium ions 
and the hydrogen-bonding described above can be seen in Figure 3.25. 
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Figure 3.25: X-ray structure of the nickel cluster (38) showing the coordination sphere of the sodium 
ion and all hydrogen-bonding interactions. The sulfonamido aromatic rings and 
hydrogen atoms not involved in hydrogen bonding have been removed for clarity. 
3.4.5.3 INi4(28-H)2(28-2H)2(OH)2(MeOH)51 (39) 
Complex 39 consists of four nickel(II) ions (Ni(1-4)), four molecules of 28, two of 
which are singly deprotonated (ligands B and D) and two which are doubly 
deprotonated (ligand A and C), two hydroxy groups and five methanol groups. The 
X-ray structure can be seen in Figure 3.26. 
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Figure 3.26: The X-ray structure of 39. The aromatic sulfonamido group and hydrogen atoms not 
involved in hydrogen bonding have been removed for clarity. 
The core of the nickel cluster consists of four six coordinate nickel(H) ions linked in 
a fused butterfly shape by two hydroxy oxygen atoms, 0(124) and 0(123), and the 
deprotonated oximic functions of ligands A and C (N(7C), 0(8C) and N(7A), 
0(8A)). Ni(1) and Ni(2) are capped by a methanolic oxygen atom 0(12) (Figure 
3.27). 
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Figure 3.27: The coordination spheres of the four nickel(II) ions in the core of complex 39. 
The asymmetric unit of 39 consists of one whole cluster molecule and there are six 
hydrogen-bonds in the cluster. The coordination spheres of Ni(l)-Ni(4) are 













- 	 O(8C) 
Figure 3.28: A schematic diagram of the coordination spheres of Ni(l) and Ni(2). Ni(l) is 
coordinated by the two nitrogen atoms of ligand A and the oxygen atom of a methanol 
group [Ni(l)-N(3A) at 2.073(18) A; Ni(l)-N(7A) at 1.978(17) A and Ni(l)-0(1) at 
2.094(16) A]. It is bridged to Ni(2) by one methanol group and two hydroxide groups 
[Ni(l)-0(12) at 2.248(18) A; Ni(l)-0(123) at 2.060(15) A and Ni(l)-0(124) at 
2.037(16) A]. Ni(2) has a similar coordination sphere, but with slightly different bond 
lengths. 
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Figure 3.29: A schematic diagram of the coordination spheres of Ni(3) and Ni(4). Bond is part of 
the deprotonated oxime group of ligand A. ' Bond is part of the deprotonated oxime 
group of ligand C. Ni(3) is coordinated to two nitrogen atoms of ligand B and the 
oxygen atom of a methanol group [Ni(3)-N(3B) at 2.155(18) A; Ni(3)-N(7B) at 2.04(2) 
A and Ni(3)-0(3) at 2.117(18) Al. Ni(3) is linked to Ni(4) by the deprotonated 
hydroxide oxygen atoms of ligands A and C which act as bridging atoms [Ni(3)-0(8A) 
at 2.117(15) A and Ni(3)-0(8C) at 2.117(14) A]. 
3.4.6 Coordination sites of sulfonamido oxime ligands 
The oxime function is more common than the sulfonamido group in transition metal 
complexes, it has only one atom (N) available for coordination to a metal centre in 
contrast with the sulfonamido group which has a possible three donor sites (N and 2 
x 0). There are 1066 entries in the Cambridge Structural Database (CSD), (July 
2001), of an oximic nitrogen coordinating to a transition metal centre in contrast with 
268 entries of transition metal complexes exhibiting coordination of the sulfonamido 
group through the nitrogen atom and 87 entries of coordination through an oxygen 
atom. 
These 87 complexes in the CSD include 21 metal centres. The most common types 
of complex are tin (15 entries), sodium (14 entries) and silver and titanium (11 
entries each). There are only 11 examples where the sulfonamido group binds 
through the sulfonamido nitrogen atom and an oxygen atom to the same metal centre 
in an analogous manner to the coordination of 28 in complex 35 (Figure 3.30), ten 
titanium complexes and one vanadium complex. Therefore, to date, the coordination 
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Figure 3.30: Coordination of the sulfonamido group by a chelating mode via the nitrogen and one 
oxygen atom. 
Sulfonyl moieties are known to serve as electron donors capable of forming adducts 
with metal cations in either an intra- or inter-molecular fashion. 8 In sulfonamido-
titanium chemistry it has been suggested that coordination of the sulfonamido 
oxygen atoms to Ti(IV) is due to the poor donor character of the amide substituted 
with the strongly electron withdrawing —S0 2Ar group. 9 The inductive effect of this 
group decreases the degree of it donation from the filled nitrogen Pz  orbital to an 
empty titanium d orbital. It has also been reported that the hapticity of bis-
sulfonamido ligands is highly dependent on crystal packing forces in titanium 
chemistry. 10 Depending on whether N-2-(4-methylbenzenesulfonylamino 
cyclohexyl)-4-methylbenzene -sulfonamido) (Figure 3.31) is resolved or a racemic 
mixture prior to complexation to Ti(IV) the coordination of either one or two 
sulfonamido oxygens to the titanium centre. 10 
SO2ToI 
(::~ ' N / Ti \M 
SO2T0I 
Figure 3.31: Bis[ 1, 2-Di(4-methylbenzenesulfonamidato)cyclohexane)] bis [dimethyaminato] 
titanium(IV). Tol = C61-14CH3 . 
In rare earth metal disulfonamido complexes the interaction of the sulfonamido 
oxygen with the metal centre is stronger than in titanium complexes, and 
delocalisation of charge is observed. 8 This may be explained by the model in Figure 
3.32. Delocalisation of charge may be occurring in complex 35 as the SO bond 
lengths in type A ligands (where one sulfonamido oxygen atom is coordinated to the 
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copper centre) are 1.436(2) and 1.4664(19) A in comparison with 1.446(2) and 
1.440(2) A in type B ligands (which do not coordinate to the metal centre through a 
sulfonamido oxygen atom). However the differences in bond lengths here are not 
large enough to be called significant. The S-N length is also shorter (1.593(2) A) in 
type A ligands in comparison with 1.600(2) A in type B ligands. 
.. 
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Figure 3.32: Charge delocalisation model of the i 2-coordinating sulfonamido group.' 
3.4.7 Hydrogen-bonding in sulfonamido oxime complexes 
The hydrogen-bond lengths (A) and angles (°) of sulfonamido oxime ML2 complexes 
and cluster complexes are listed in Tables 3.4 and 3.5 respectively. 
Table 3.4: The bond lengths (A) and angles (°) of intra-complex hydrogen-bonds in ML2 
complexes 34 and 36. 
Complex 	Interaction type 	Hydrogen-bond length I A 	Hydrogen-bond angle / 
Cu(28-H)2 (34) O(S)---H-O(Ox) 2.725(4) 	 164 
O(Ox)-H --- O(S) 	 2.706(4) 164 
Ni(28-H)2 (36)' 	N(5')---H-O(Ox) 2.704(4) 	 131 
O(Ox)-H --- N(S) 2.70 131 
Complex 36 is centrosymmetric. Atoms labelled Ox are contained in an oxime group. Atoms labelled S are 
contained in a sulfonamido group 
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Table 3.5: The bond lengths (A) and angles (°) of intra-complex hydrogen-bonds in 
sulfonamido oxime cluster complexes 35, 38 and 39. 
Complex Interaction type Number of Hydrogen-bond Hydrogen-bond 
interactions length / A angle / 
355 O(S)---H-O(M) 2 2.653(3) 163(4) 
O(Ox) --- H-O(Ox) 2 2.61 155 
38"  O(S)---H-O(M) 2 2.89 149 
O(Ox) --- H-O(M) 2 2.780(7) 168 
O(Ox) --- H-O(Ox) 2 2.495(8) 153 
N(Ox)---H-O(Ox) 2 2.87(7) 117 
39 O(H)-H---O(S) 1 2.95(2) 128 
O(H)-H---O(S) 1 2.91(2) 129 
O(I1)-H --- O(S) 1 2.91(2) 126 
O(H)-H---O(S) 1 3.06(2) 125 
O(Ox) --- H-O(Ox) 1 2.71(2) 139 
O(Ox') --- H-O(Ox) 1 2.70(2) 123 
'Complex 35 is centrosymmetric and half the molecule consists of a Cu 2(28-H)(28-2H)(MeOH)(MeO) fragment. 
b  Complex 38 is centrosymmetric and half the molecule consists of a NiNa(28-H)(28-2H)(MeOH) 2 fragment. 
Atoms labelled Ox are contained in an oxime group. Atoms labelled S are contained in a sulfonamido group. 
Atoms labelled M are contained in a methanol group. Atoms labelled H are contained in a hydroxy group. 
There are seven different kinds of hydrogen-bond listed in Tables 3.4 and 3.5. Of the 
total 22 interactions only two are between the sulfonamido oxygen and oximic 
hydrogen atoms. The oximic hydrogen atom is involved in over half of the total 
hydrogen-bonding interactions (12), the strongest of which are with another oximic 
oxygen atom (mean length 2.61 A). 
All the hydrogen bonds fall between 2.45-3.06 A and most angles are greater than 
140°. The two exceptions are in the nickel complexes 36 and 39. In 36 the small 
angle (13 P)could be a product of the constrained planar N4 2 donor set of the nickel 
geometry. The data from complex 39 however, should not be over interpreted due to 
the poor R factor of the structure (17%). 
3.4.8 Hole size, bite distances and torsion angles 
One of the aims of this thesis was to look at the importance of the hydrogen-bonded 
pseudo-macrocycle around a metal centre. Even if the hydrogen-bonded ligand 
template exists in solution it would be improbable that this could be doubly 
deprotonated due to the close proximity of the anionic nitrogen atoms. Nevertheless, 
it is still helpful to compare the hole sizes of free ligands and ML2 complexes. The 
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hole sizes (calculated as the mean distance from the nitrogen atoms to the centroid of 
the four donor atom) are given with the bite distances (the distance between the two 
nitrogen donor atoms) in Table 3.6. 
Table 3.6: The hole size and bite distances of sulfonamido oxime ligands and complexes. 
Ligand or complex Hole size / A Bite distance / A 
28 2.94 2.60 
29 2.91 2.63 
32 2.62 
33' E isomer 2.97 2.67 
330 Z isomer 3.22 




36c 1.89 2.67 






Ligand 33 has been isolated as two different polymorphs. In one the oxime has E stereochemistiy and in the 
other Z stereochemistry. b Complex 35 is centrosymmetric and half the molecule consists of a Cu 2(28-H)(28-
2H)(MeOH)(MeO) fragment. Complex 36 is centrosymmetric. d Complex 38 is centrosymmetric and half the 
molecule consists of a NiNa(28-H)(28-2H)(MeOH)2 fragment. 
The hole sizes of ligands 28, 29 and the E isomer of ligand 33 are all 1 A larger than 
in the copper and nickel complexes (34 and 36 respectively), this behaviour was also 
observed for monosulfonamidodiamine ligands (section 2.4.5). The bite distance of 
ligands 28, 29, 32 and the E isomer of 33 are very similar and fall in the range 2.60-
2.67 A. The Z isomer of 33 has a larger bite (3.22 A) but it is known that Z isomers 
of oximes do not coordinate to metal centres, 5 and therefore this distance is of little 
relevance to an assessment of the preorgamsation of the ligands. With the exception 
of 38 all the bites are larger in the complexes than in the free ligand and fall between 
2.67 and 2.80 A. To accommodate these changes in hole size and bite distance on 
complexation a change in the conformation of the ligand backbone must occur. To 
investigate this the torsion angles about the inner great ring of the pseudo-
macrocycle are listed in Tables 3.7, 3.8 and 3.9. 
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Figure 3.33: Labelling of the torsion angles around the inner great ring of sulfonamido oxime 
pseudo-macrocylic ligands. 
Table 3.7: Torsion angles (°) for sulfonamido oxime ligands 28, 29, 32 and 33. 
Bond 
28 	 29 
Ligand 
32b 33" E isomer 	33" Z isomer 
a -86.1 -23.3 4.7 
b 161.6 	 163.1 -177.6 165.8 	 179.9 
c 179.8 177.8 179.8 -177.4 0.6 
d -3.0 	 1.3 1.1 19.7 	 -64.7 
e 0 1.2 1.7 -2.8 1.7 
-153.9 	 128.1 -153.1 119.6 	-117.1 
172.3 -178.1 -169.2 
h 93.3 	 -138.1 -121.9 
140.6 169.1 -166.8 
86.1 	 23.3 -47 
k -161.6 -163.1 -165.8 
1 -179.8 	-177.8 177.4 
M 3.0 -1.3 -19.7 
n 0 	 -1.2 2.8 
o 153.9 -128.1 -119.6 
p -172.3 	 178.1 169.2 
-93.3 138.1 121.9 
r -140.6 	-169.1 - 	 166.8 
o  Ligand 33 has been isolated as two different polymorphs. In one the oxime has E stereochemistry and in the 
other Z stereochemistry. b Free ligand 32 does not form a pseudo-macrocyclic dimer (see 3.4.1.3). 
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Table 3.8: Torsion angles (°) for sulfonamido oxime ML 2 complexes 34 and 36. 
a  Complex 




b -163.4 168.9 
C 179.2 -179.4 
d -29.2 -28.5 






k -162.7 -168.9 
1 -179.2 179.4 
M -28.8 28.5 
n 1.5 -2.1 









b 158.7 174.4 175.8 	- -166.6 - 162.9 
C 178.2 179.6 -177.8 176.9 -179.1 -176.1 179.3 -176.9 
d -16.3 -29.1 34.4 -25.8 	44.6 -26.7 37.4 -29.9 
e 10.6 1.7 -0.7 3.0 -11.2 -6.3 -7.6 2.5 
f -169.2 -106.5 148.2 -98.4 	160.4 -158.0 160.6 -157.8 
"Complex 35 is centrosymmetric and half the molecule consists of a Cu 2(28-H)(28-2H)(MeOH)(MeO) fragment. 
b Complex 38 is centrosymmetric and half the molecule consists of a NiNa(28-H)(28-2H)(MeOH)2 fragment. 
Torsion angle c (0.6°) confirms the stereochemistry of the Z isomer of 33. In all 
other structures c falls in the range 176.1-179.8°. The values of d, e, m and n in the 
complexes are greater than those in the comparable ligands 28, 29 and 32. This twist 
around the ligand backbone will increase the bite distance on complexation. 
Twisting the imine bonds (torsion angles c and 0 would not significantly increase the 
N • N bite and accordingly no significant changes to these torsion angles was 
observed on complex formation. In general the value of the torsion angles about the 
amino bond (f and o) for the cluster complexes 35, 38 and 39 are similar to those in 
the free ligands. However for complexes 34 and 36f and o are smaller indicating a 
larger twist from planarity. This may be attributed to the displacement of the 
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sulfonamido group to approach the oxime function of the adjacent ligand to 
maximise the intra-complex hydrogen-bond between the sulfonamido and oxime 
functions in a 7-membered chelate ring of a pseudo-macrocyclic ligand around the 
metal centre. 
3.4.9 Geometry of the sulfonamido nitrogen 
A study similar to that described for monosulfonamido ligands (chapter 2, section 
2.4.4.2) into the planarity of the sulfonamido nitrogen of sulfonamido oxime ligands 
was undertaken. Two angles, 0 and cx were measured (8 is as the sum of the angles 
S-N-HIM, HIM-N-C and C-N-S and cc is the angle of the sulfur atom from the plane 
defined by the nitrogen, carbon and hydrogen or metal atoms) and the distance of the 
nitrogen from the plane of the carbon, sulfur and hydrogen or metal atoms was 
measured. The results are given in Tables 3.10 and 3.11. 
Table 3.10: Values of the parameters 0, cc and the distance of the nitrogen atom from the 
HCS plane to show the planarity of the sulfonamido nitrogen atom in sulfonamido oxime 
ligands. 
Ligand 	Distance of N from HCS 	Sum of 3 angles, 0, 	Angle of S, a, from 
plane / A 	 around N / 	 NCH plane / 
28 	 0.166 355.0 21.2 
29 0.278 	 344.1 	- 	 36.4 
32 	 0.172 354.1 23.4 
33aEisomer 	 0.229 	 344.4 	 43.0 
33aZisomer 0.229 349.1 - 32.5 
' Ligand 33 has been isolated as two different polymorphs. In one the oxime has E stereochemistry and in the 
other Z stereochemistry 
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Table 3.11: Values of the parameters 9, a and the distance of the nitrogen atom from the 
MCS plane to show the planarity of the sulfonamido nitrogen atom in sulfonamido oxime 
complexes. 
Complex Distance of N from MCS Sum of 3 angles, 0, Angle of 5, cc, from 
plane / A around N ° NCM plane / 
34 0.242 353.5 25.2 
0.276 351.6 28.6 
35a 0.020 360.0 2.4 
0.266 352.2 28.2 
0.321 348.8 33.3 
38c 0.186 356.2 18.5 
0.291 350.6 29.7 
39 0.191 356.0 19.1 
0.229 354.3 22.9 
0.182 356.4 18.1 
0.189 356.0 19.7 
O  Complex 35 is centrosymmetric and half the molecule consists of a Cu 2(28-H)(28-2H)(MeOH)(MeO) fragment. 
b Complex 36 is centrosymmetric. 0 Complex 38 is centrosymmetric and half the molecule consists of a NiNa(28-
H)(28-2H)(MeOH)2 fragment. 
In contrast to the behaviour of monosulfonamidodiamine ligands on complexation 
(chapter 2), the sulfonamido nitrogen atom of ligand 28 becomes less planar on 
complexation. As discussed in chapter 2, if the planarity of the amide is associated 
with a delocalisation of electronic density in the N-S0 unit then we might expect 
there to be a connection between the planarity of the nitrogen and the lengths of the 
sulfur to oxygen and sulfur to nitrogen bonds. S0 and S-N bond lengths are 
recorded in Tables 3.12 and 3.13. The correlation coefficients between bondlengths 
and parameters defining the planarity of the sulfonamido nitrogen atom (see also 
section 2.4.4.2) are recorded in Tables 3.14 and 3.15. 
Table 3.12: S=O and S-N lengths for sulfonamido oxime ligands. 
Ligand s=o(i) I A S=0(2) / A Average S=O 
Length /A 
S-N bond! A 
28 1.445 1.426 1.436 1.614 
29 1.438 1.431 1.435 1.625 
32 1.432 1.428 1.43 1.629 
33°Eisomer 1.425 1.440 1.433 1.631 
330 Zisomer 1.434 1.428 1.431 1.643 
Ligand 33 has been isolated as two different polymorphs. In one the oxime has E stereochemistry and in the 
other Z stereochemistry. 
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Table 3.13: 5=0 and S-N lengths of sulfonamido oxime complexes. 
Complex S0(l) / A S=0(2) / A Average S=O S-N bond / A 
Length /A 
34 1.434 1.428 1.431 1.643 
1.451 1.433 1.442 1.594 
350 1.436 1.466 1.451 1.593 
1.446 1.440 1.443 1.600 









39 	1.420 1.495 1.458 1.569 
1.418 1.421 1.420 1.567 
1.441 1.443 1.442 1.598 
1.408 1.460 1.434 1.587 
' Complex 35 is centrosymmetric and half the molecule consists of a Cu 2(28-H)(28-2H)(MeOH)(MeO) fragment. 
"Complex 36 is centrosymmetric. C Complex 38 is centrosymmetric and half the molecule consists of a NiNa(28-
H)(28-2H)(MeOH) 2 fragment. 
Table 3.14: The correlation coefficients of the parameters of nitrogen planarity in 
sulfonamido oxime ligands 28, 29, 32 and 33 with S=O and S-N bond lengths. 
X Y Correlation 
coefficient 
S-N length / A Average S=O length / A -0.76 
Distance of N from HCS plane / A Average S0 length / A 0.17 
Distance of N from HCS plane / A S-N bond length / A -0.14 
Sum of 3 angles around N, 0 Average S=O length / A 0.01 
Sum of 3 angles around N, 0. S-N length / A 0.36 
Angle of S from NCH plane, a Average S0 length / A -0.36 
Angle of S from NCH plane, a S-N bond length / A 0.45 
Table 3.15: The correlation coefficients of the parameters of nitrogen planarity in 
sulfonamidooxime complexes 34, 35, 36, 38 and 39 with S=O and S-N bond lengths. 
X 	- Y Correlation 
coefficient 
S-N length / A Average S0 length / A -0.12 
Distance of N from MCS plane / A Average S=O length / A -0.28 
Distance of N from MCS plane / A S-N bond length / A 0.20 
Sum of 3 angles around N, 0 Average S=0 length / A -0.28 
Sum of 3 angles around N, 0 S-N length / A 0.37 
Angle of S from NCM plane, a 
Angle of S from NCM plane, a 
Average S=O length / A 
S-N bond length / A 
-0.47 
0.39 
Only one strong correlation (-0.76) is observed for sulfonamido oxime ligands with 
the S=O and the S-N lengths whereas analysis of the same data for sulfonamido 
oxime complexes shows poor correlation (-0.12). Correlation of the parameters of 
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nitrogen planarity with the S=O length is also weak and all values are less than 0.28. 
The complexes show the expected correlation (negative or positive values) however, 
the ligands show an opposite correlation to what is expected. Stronger correlation is 
observed with the S-N length and the parameters of nitrogen planarity and values fall 
above 0.36, the coefficients for the ligands and the complexes are similar. 
3.5 A study of the solution properties of 34 and 35 
Ratios of 1:1 and 1:2 of copper(II) acetate and 1-12-[N-(4-methylbenzene 
sulfonamido)]phenyl}ethan-l-one oxime (28) in methanol both produced green 
solutions however a green tetranuclear species 35 was isolated from the 1:1 mixture 
and a brown ML2  complex 34 was isolated from the 1:2 mixture. When complexes 
34 and 35 were dissolved in methanol solution they each yielded a green solution, 
however, in chloroform a brown and a green solution were achieved. The solution 
structures of these species were investigated. 
Vapour pressure osmometry (vpo) of the complexes in chloroform solution indicate 
that 34 retains its structure and that 35 exists as a larger aggregate. The average 
masses of the species in solution are in Table 3.16. 
Table 3.16: Vpo measurements for 34 and 35 in chloroform solution at 25°C. n = measured 
osmolality/calculated osmolality. 
Complex 	Calculated osmolality 	Average mass in 	 n 
(mmol) 	 solution 
34 	 20.16 678 	 1.02  
35 18.54 	 1954 1.23 
However, analysis by electrospray ionisation mass spectrometry of methanolic 
solution of 34 and 35 produce identical spectra. Both spectra have a strong peak at 
691.9 (Cu(28-H)2Na) and a smaller peak at 754.8 (Cu2(28-H)2Na). 
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Electron paramagnetic resonance (epr) was employed to try to define the copper 
coordination sphere of complexes 34 and 35 in chloroform solution. The spectra are 
plotted in Figure 3.33. 
22 
Figure 3.33: The EPR spectra of 34 and 35 in chloroform. 
The profile of 34 (g x gy#gz) in chloroform is characteristic of a Jahn-Teller-distorted 
tetragonal copper(II) coordination environment. The irregular slope of the gj region 
of 35 possibly indicates the presence of more than one type of Cu(H) coordination 
environment in solution consistent with the two types of centre observed in the 
tetranuclear complex. 
3.6 Equilibrium constants 
The pKa i (Equation 3.4) value of 9.81 for 28 was determined by Dr D. J. White." 
This value is comparable to the pKa, values for monosulfonamidodiamine ligands 1 
and 5 in chapter 2, cf. 8.89 and 9.49. 
K 1 
LH + H 	- 	 LH 	 Eq 3.4 
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Figure 3.32: Calculated speciation distribution for ligand 28 as a function of pH for a 0.2 M solution 
in 95% methanol solution at 25°C. 
The diagram shows that below pH 5 the ligand exists as a monocation and above this 
pH as the neutral free ligand. 
3.7 Conclusion 
The secondary hydrogen-bonded structures of the sulfonamido oxime free ligands 
have proved to be much more predictable than for monosulfonamido diamine ligands 
(chapter 2) and depend on the stereochemistry of the oxime function. The predicted 
sulfonamido oxygen atom to oximic hydrogen atom interaction does occur for the 
copper complex 35. However the nickel complex 36 showed than an interaction 
between the oximic hydrogen atom and the sulfonamido nitrogen atom is also 
favourable. 
The sulfonamido oxime ligands are relatively simple to make and have proved to 
have an interesting coordination chemistry. For a ligand to be suitable for solvent 
extraction it must form labile complexes because the metal must also be stripped 
back out of the complex and it is important that the coordination chemistry of a 
ligand is known and that simple complexes are formed. Simple mononuclear 2:1 
complexation was predicted for sulfonamido oxime ligands. However, three 
complexes of 1-1 2-[N-(4-methylbenzenesulfonamido)]phenyl } ethan- 1-one oxime 
(28) have been isolated which show that these ligands can form clusters. Formation 
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of polynuclear complexes using doubly deprotonated ligands increases metal loading 




Melting points were determined with a Gallenkamp apparatus and are uncorrected. 
Elemental analysis was performed on a Perkin Elmer 2400 elemental analyser or a 
Carlo Erba 1108 Elemental analyser. JR spectra were obtained on a Perkin Elmer 
Paragon 1000 FT-JR spectrometer as potassium bromide discs. 'H and ' 3C NMR 
spectra were run on Bruker WP200, AC250 and AVANCE DPX360 spectrometers. 
Chemicals shifts () are reported in parts per million (ppm) relative to residual 
solvent protons as internal standards. Electron impact (El) mass spectra were 
obtained either on a Finnigan MAT4600 quadrapole spectrometer or on a Kratos 
MS50TC spectrometer. Fast atom bombardment (FAB) mass spectra were obtained 
on a Kratos MS50TC spectrometer in acetonitrile/3-nitrobenzyl alcohollthioglycerol 
matrices. Electrospray ionisation (ES!) mass spectra were obtained on a Thermoquest 
LCQ spectrometer. Inductively coupled plasma atomic emission spectroscopy (ICP-
AES) analysis was performed on a Thermo Jarrell Ash Iris ICP-AES spectrometer 
Potentiometric titrations were carried out in a sealed double jacket glass cell using a 
Metrohm 665 automated burette and a Corning 130 digital pH meter fitted with a 
Phillips glass electrode and a calomel electrode. All measurements were fully 
automated. Titrations were performed at 25.0 ± 0.1 °C in constant ionic strength (I = 
0.1, [EtN][ClO]) 95% methanol solution under purified nitrogen. Solutions of 
ligand (ca. 1 x 10-3 mol.dm 3) alone and in the presence of 0.3, 0.8 and 1.5 
equivalents of metal ion were titrated with 0.1 mol.dm 3 Et4NOH respectively. 
Equilibrium constants were calculated from potentiometric data with the program 
MINIQUAD.' 2  X-band EPR data for chloroform solutions were recorded on an X-
band Brucker ER200D SCR spectrometer. 
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3.8.2 Solvent and reagent Pretreatment 
All reagents and solvents were commercially available (Acros or Aldrich) and were 
used as received. Solvents used for analytical purposes (NMR, MS, ICP) were of 
spectroscopic grade. 





A solution of 1-(2-amino-phenyl)-ethanone (15 g, 0.11 mol) in pyridine (50 cm3) was 
added dropwise to a solution of 4-methylbenzenesulfonyl chloride (25 g, 0.13 mol) 
also in pyridine (50 cm). The solution was stirred overnight after which time a 
white precipitate had formed. Full precipitation was achieved through the addition of 
diethylether (8 cm 3). The solid was isolated by filtration and washed with diethyl 
ether (3 x 20 CM)  . The product was recrystallised from ethanol (300 cm 
3)  to give a 
crystalline solid (17.68 g, 55%), mp 147-149°C (Found: C, 62.34; H, 5.23; N, 4.85. 
Caic. for C 15H 15NO3S: C, 61.79; H, 5.06; N, 4.65%). 81 (CDC1 3 , 200 MHz) 2.35 (s, 
3 H, CH3), 2.55 (s, 3 H, CH3), 7.4 (m, 8 H, Ar Cl]). 8c (CDC13 , 90 MHz): 22 (Cl-I3), 
29 (Cl-I3), 119 (Ar CH), 122 (Ar C), 123 (Ar CH), 128 (2C, Ar CH), 130 (2 C, Ar 
CH), 132 (Ar CH), 135 (Ar CH), 137 (Ar C), 140 (Ar C), 144 (Ar C), 203 (C=O). IR 
data (KBr disc)/cm': 3086m, 3054m, 3036m, 1652s, 1506w, 1359s, 1165s. El MS, 
m/z 289 (M, 37%). 
170 




A solution of 1-(2-ammo-phenyl)-ethanone (9.06 g, 67 mmol) in pyridine (20 cm 3) 
was added dropwise to a solution. of 4-t-butylbenzenesulfonyl chloride (5.35 g, 23 
mmol) also in pyridine (50 cm3) and the solution was stirred overnight. The solvent 
was then removed in vacuo leaving an orange solid which was recrystallised from 
ethanol (50 cm3) and washed with water (3 x 10 cm 
3)  to give a yellow crystalline 
solid (5.32 g, 70%), mp 124-126°C (Found: C, 64.98; H, 6.46; N, 4.17. Calc. for 
C 18H21NO3S: C, 65.23; H, 6.39; N, 4.23%). 8 H (CDC 13 , 250 MHz) 1.27 (s, 9 H, 
CH3), 2.53 (s, 3 H, CH3), 7.06 (m, 1 H, Ar CH), 7.44 (m, 3 H, Ar CH), 7.73 (m, 4 H, 
Ar Cl]), 11.45 (s, 1 H NH). öc (CDC1 3 , 63 MHz): 28 (CH3), 31 (3 C, Cl-I3), 35 (C'), 
119 (Ar CH), 122 (Ar C), 122 (Ar Gil), 126 (Ar CH), 127 (Ar CH), 132 (Ar CH), 
135 (Ar CH), 136 (Ar C), 140 (Ar C), 157 (Ar C), 202 (-00). IR data (KBr 
disc)/cm': 2964m, 2874m, 1648s, 1593m, 1578m, 1467w, 1498m, 1341s, 1162s, 
707s. El MS, m/z 331 (Mt, 38.4%). 
1{2[N-(4-propy1benzenesu1fonamido)1pheny1}ethafl-1-one 
0 
A solution of 1-(2-amino-phenyl)-ethanone (6.2 g, 46 mmol) in pyridine (30 cm 
3) 
was added dropwise to a solution of 4-propylbenzenesulfonyl chloride (10 g, 46 
mmol) also in pyridine (20 cm3). The solution was stirred overnight after which time 
a white precipitate had formed. Full precipitation was achieved through the addition 
of diethyl ether (8 cm 3). The solid was isolated by filtration and washed with diethyl 
ether (3 x 20 cm 3). The product was recrystallised from ethanol (75 cm 
3)  to give a 
crystalline solid (4.56 g, 3 1%), mp 112-114°C (Found: C, 64.53; H, 5.90; N, 4.36. 
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Cale. for C 17H 19NO3S: C, 64.33; H, 6.03; N, 4.41%). 8H (CDCI 3 , 250 MHz): 2.18 (t, 
3 H, J 7.3, CH3), 1.56 (m, 2 H, CH2), 2.53 (s, 3 H, CH3), 2.56 (m, 2 H, CH2), 7.35 
(m, 8 H, Ar Cl]), 11.43 (s, N-R). 8 C (CDCI3, 63 MHz): 13 (CH3), 23 (CH2), 28 
(CH3), 38 (CH2), 119 (Ar CH), 122 (Ar C), 122 (Ar CH), 127 (2 C, Ar CH), 129 (2 
C, Ar CH), 132 (Ar CH), 135 (Ar CH), 137 (Ar C), 139 (Ar C), 148 (Ar C), 202 
(C0). JR data (KBr disc)/cm': 668m, 1162m, 1254m, 1456m, 1648m, 2342s, 
2361s, 3649m. FAB MS: m/z 318 (MH, 54.2%). 
1-12- [N-(4-pentylbenzenesulfonamido)I phenyl)ethan-1 -one 
11 
A solution of 1-(2-amino-phenyl)-ethanone (3.93 g, 29 mmol) in pyridine (50 cm 3) 
was added dropwise to a solution of 4-n-pentyl benzene sulfonyl chloride (7.18 g, 29 
mmol) also in pyridine (50 cm 3). The solution was stirred overnight after which time 
a small amount of white precipitate had formed. Full precipitation was achieved 
through the addition of water (8 cm 3). The solid was isolated by filtration and 
washed with water (3 x 20 cm 3) and hexane (3 x 20 cm 3). The product was 
recrystallised from hexane (300 cm 3)  to give a crystalline solid (4.82 g, 48%), mp 90-
92 oc (Found: C, 65.91; H, 6.73; N, 3.97. Calc. for C 19H23NO3 S: C, 66.06; Fl, 6.71; 
N,4.05%). 8H (CDC1 3 , 360 MHz) 0.90 (m, 3 H, CH3), 1.32 (m, 4 H, CH2), 1.61 (m, 
2 H, CH2), 2.59 (s, 3 H, CH3), 2.64 (m, 5 H, CH2), 7.10 (m, 1 H, Ar Cl), 7.27 (m, 2 
H, Ar Cl]), 7.49 (m, 1 H, Ar Cl]), 7.73 (d, 2 H, J 8.4, Ar Cl), 7.80 (m, 2 H, Ar CH), 
11.47 (s, C0). öc (CDC1 3 , 90 MHz) 14 CH3), 23 (CH2), 29 (CH3), 31 (CH2), 32 
(CH2), 36 (CH2), 120 (Ar CH), 122 (Ar C), 123 (Ar CH), 128 (2 C, Ar CH), 129 (2 
C, Ar CH), 132 (Ar CH), 135 (Ar CH), 137 (Ar C), 140 (Ar C), 149 (Ar C), 203 
(CO). JR data (KBr disc)/cm - 1 : 680m, 760m, 931m, 1 162s, 1342m, 1496m, 1648s, 
2346w, 2867m, 2947m. FAB MS, mlz 346 (MH, 62.8%) 
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A solution of (2-amino-phenyl)-phenyl-methanOfle (21.89 g, 0.11 mol) in pyridine 
(45 cm) was added dropwise to a solution of 4-methylbenzene sulfonyl chloride 
(24.98 g, 0.131 mol) in pyridine (15 cm) over 8 hours. Complete precipitation of 
the product was achieved by pouring the solution over an ice water mixture (500 
cm3). The precipitate was then isolated by filtration and dried in vacuo. The product 
was recrystallised from ethanol (250 cm 
3)  to give a yellow crystalline solid (26.39 g, 
67%), mp 126-127°C (Found: C, 68.19; H, 4.81; N, 4.04. Calc. for C 20H 17NO3S: C, 
68.36; H, 4.88; N, 3.99). 811 (CDCI3 250 MHz): 2.21 (s, 3 H, CH3), 7.40 (m, 13 H, Ar 
CH), 9.97 (s, 2 H, NB). 8c (CDCI3, 63 MHz): 21 (CH 3), 124 (Ar CH), 124.0 (Ar 
CH), 127 (Ar C), 128 (2 C, Ar CH), 129 (2 C, Ar CH), 130 (2 C Ar CH), 130 (2 C, 
Ar CH), 133 (Ar CH), 134 (Ar CH), 134 (Ar CH), 136 (Ar CH), 138 (Ar C), 139 (Ar 
C), 144 (Ar C), 198 (-C=O). IR data (KBr disc)/cm': 3246s, 3054w, 1968w, 1918w, 
1649s, 1636s, 1596m, 1578w, 1395s, 1167s, 724s. El MS, m/z 351 (M, 70.3%). 
3.8.4 Synthesis of sulfonamide oximes 
112[N-(4-methylbenzenesulfonamido)Jpheflyl}ethafl-1-Ofle oxime (28) 
11 
--O-S-NH NOH 
Hydroxylamine hydrochloride (7.15 g, 0.10 mol) was added to a solution of 1-{2-[N-
(4-methylbenzenesulfonamido)]phenyl} ethan- 1-one (10 g, 28 mmol) in a 50:50 
pyridine: ethanol solution (350 cm 3). This was heated at reflux for 4 hours and then 
cooled. The solvent was removed in vacuo to give a yellow oil. The oil was 
triturated with water (200 cm) to produce a white solid which was isolated by 
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filtration. This solid was dried in vacuo then recrystallised from toluene (50 cm) to 
give a white crystalline product (8.93 g, 84%), mp 149-150°C (Found: C, 58.92; H, 
5.51; N, 9.37. Caic. for C 15H 16N203S: C, 59.39; H, 5.32; N, 9.23%). 8H(CDC13, 200 
MHz): 2.03 (s, 3 H, CH3), 2.32 (s, 3 H, CH3), 7.27 (m, 5 H, Ar CH), 7.62 (m, 3 H, Ar 
CH), 8.38 (s, NH), 10.85 (s, OFT). 6c  (CDC13, 50 MHz) 12 (GEl3), 21 (CH3), 122 (Ar 
CU), 124 (Ar CH), 125 (Ar C), 127 (2 C, Ar CU), 128 (Ar CH), 129 (2 C, Ar CH), 
129 (Ar CH), 136 (Ar C), 136 (Ar C) 143 (Ar C), 157 (C=N-OH). JR data (KBr 
disc)/cm: 3423s, 2923m, 1654w, 1622s, 1576m, 1366m, 1329s, 1152s. El MS, mlz 
304 (M, 47.0%). 




Hydroxylamine hydrochloride (3.49 g, 0.05 mol) was added to a solution of 1-{2-[N-
(4tbutylbenzenesu1fonamido)]pheny1 } ethan- 1-one (5 g, 15 mmol) in a 50:50 
pyridine:ethanol solution (150 ern 3). This was heated at reflux for 4 hours and then 
cooled. The solvent was removed in vacuo to give a yellow oil which was triturated 
with water (200 cm3) hours to yield a white solid which was recrystallised from 
toluene (50 cm) to give a white crystalline product (3.88 g, 74%), mp 192-193°C 
(Found: C, 62.32; H, 6.32; N, 8.02. Caic. for C 18H22N203S: C, 62.40; H, 6.40; N, 
8.09%). 8H (CDC13, 250 MHz): 1.26 (s, 9 H, CH3), 1.95 (s, 3 H, CH3), 7.06-7.67 (m, 
8 H, Ar CH), 8.39 (s, 1 H, NH), 10.76 (s, 1 H, OR). 8C (CDC13 , 63 MHz): 12 (GH3), 
31 (3 C, CH3), 35 (C), 122 (Ar CU), 124 (ArCH), 125 (C-NOH), 127 (Ar CU), 128 
(ArCH), 129(ArCH), 135 (ArC). IR(KBrdisc)/cm':764m, 1013m, 1162s, 
1329s, 1496m, 1593w, 2362w, 2870w, 2966m, 5387s. El MS, m/z 346 (M, 44.8%). 
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1_12-(N_(4-propylbenzenesulfonamido)Ipheflyl}ethafl-1-Ofle oxime (30) 
NOH 
Hydroxylamine hydrochloride (2.7 g, 38 mmol) was added to a solution of 1-12-[N-
(4-propylbenzenesulfonamido)]phenyl } ethan- 1-one (4 g, 13 nmiol) in a 50:50 
pyridine: ethanol solution (150 cm 3). This was heated at reflux for 4 hours and then 
cooled. The solvent was removed in vacuo to give a white oil. The oil solidified 
over 72 hours to give a white solid which was washed with water (3.57g, 85%), mp 
118-119°C (Found: C, 61.47; H, 5.85; N, 8.34. Calc. for C 37H20N203S: C, 61.42; H, 
6.06; N, 8.43%). 8H (CDC1 3 , 200 MHz): 0.88 (t, 3 H, J 7.3, CH3), 157 (s, 2 H, J 7.5, 
CH2), 2.01 (s, 3 H, CH3), 2.55 (t, 2 H, J 7.6, CH2), 7.12-7.33 (m, 5 H, Ar CH), 7.61 
(m, 3 H, Ar CH), 8.41 (s, 1 H, NB), 10.83 (s, 1 H, N-OR). 8 C (CDC1 3, 90 MHz): 13 
(CH3), 14 (CH3), 25 (CH2), 38 (CH2), 123 (Ar CH), 125 (Ar CH), 128 (2 C, Ar CH), 
129 (Ar CH), 129 (2 C, Ar CH), 130 (Ar CH), 136 (Ar C), 137 (Ar C), 149 (Ar C), 
157 (Ar Q. IR data (KBr disc)/cm': 756m, 1012m, 1092m, 1155s, 1330s, 1498m, 
1635w, 2876m, 2933m, 3391s. FAB MS: m/z 333 (MH, 100.0%). 
1_{2[N_(4penty1benzenesu1fonamido)1pheny1}ethafl-1-Ofle oxime (31) 
NOH 
11 
Hydroxyamine hydrochloride (0.37 g, 5 mmol) was added to a solution of 1-{2-[N-
(4-pentylbenzenesulfonamido)]phenyl}ethan-l-one (0.62 g, 2 minol) in a 50:50 
pyridine: ethanol solution (30 cm 3). This was heated at reflux for 4 hours and then 
cooled. The solvent was removed in vacuo to give a colourless oil. The oil was 
triturated with water (5 cm, 3) and subsequently with hexane (5 cm3) to yield a white 
solid which was recrystallised from diethylether and hexane (20 cm. 3) and dried in 
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vacuo, (0.55g, 85%), mp 82-84° C (Found: C, 63.43; H, 6.75; N, 7.79. Caic. for 
C 19H24N203S: C, 63.31; H, 6.71; N, 7.77%). 8H (CDCI3, 360 MHz): 0.90 (m, 3 H, 
CH3), 1.31 (m, 4 H, CH2), 1.59 (m, 2 H, CH2), 2.07 (s, CH3), 2.62 (m, 2 H, CH2), 
7.13 (t, 1 H, J 6.9, Ar CH), 7.22 (d, 2 H, J 8.4, Ar CH), 7.31 (m, Ar CH), 7.36 (m, 1 
H, Ar CH), 7.65 (m, 3 H, Ar CH). 8C (CDCI 3, 90 MHz): 13 (CH3), 14 (CH3), 23 
(CH2), 31 (CH2), 32 (CH2), 36 (CH 2), 123 (Ar CH), 125 (Ar CH), 126 (q, Ar C), 127 
(2 C, ArCH), 128 (Ar CH), 129 (2 C, Ar CH), 130 (Ar CH), 136 (Ar C), 137 (Ar C), 
149 (Ar C), 158 (>C=NOH). IR data (KBr disc)/cm: 659m, 1157s, 1332m, 1505m, 
1628w, 2362w, 2859m, 2926m, 3401s. FAB MS, m/z 361 (MH, 100.0%). 




Hydroxylamine hydrochloride (1.95 g, 23 mmol) was added to a solution 1-{2-[N-(4-
methylbenzenesulfonamido)]phenyl}ethan-l-one (2.02 g, 6.9 mmol) in a 50:50 
pyridine: ethanol solution (60 cm 3). This was heated at reflux for 4 hours and then 
cooled. The solvent was removed in vacuo to give a white solid. The solid was 
washed with water (3 x 10 cm 3) and dried in vacuo. This was then recrystallised 
from toluene (20 cm 3)  to give a yellow crystalline product (1.19 g, 54%), mp 122-
124°C (Found: C, 60.40; H, 5.59; N, 8.69. Caic. for C 16H 1 8N203S: C, 60.36; H, 
5.70; N, 8.80%). SH (CDC13 , 200 MHz): 2.03 (s, 3 H, CH3), 2.38 (s, 3 H, CH3), 4.09 
(s, 3 H, OCH3), 7.23 (m, 5 H, Ar CH), 7.64 (m, 3 H, Ar CH), 10.79 (s, 1 H, NB). öc 
(CDC13, 50 MHz): 14 (CH 3), 22 (Cl-I3), 63 (OCH3), 122 (Ar CH), 124 (Ar CH), 125 
(Ar C), 128 (2 C, Ar CH), 129 (Ar CH), 130 (2 C, Ar CH), 136 (Ar C), 137 (Ar C), 
144 (Ar C), 156 (Ar Q. IR data (KBr disc)/cm': 660s. 754s, 918s, 1052s, 1159s, 
1293m, 1605m, 2364w, 2818m, 2936m, 2978m. FAB MS, m/z 319 (M}[, 100.0%). 
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Hydroxylamine hydrochloride (6.49 g, 93 mmol) was added to a solution of 1-{2-[N-
(4methylbenzenesulfonamido)]-pheflYl}(PheflYl)methan0fle oxime (10 g, 28 mmol 
in a 50:50 pyridine: ethanol solution (350 cm3). This was heated at reflux for 4 hours 
and then cooled. The solvent was removed in vacuo to give a yellow oil which was 
triturated with water (3 x 200 cm 3)  to yield a white solid which was recrystallised 
from toluene (50 cm 3)  to give a white crystalline product (3.55 g, 34%), mp 160°C 
(Found: C, 65.73; H, 4.93; N, 7.73. CaIc. for C 20H18N203S: C, 65.55; H, 4.95; N, 
7.64 %). Two isomers of 6 were detected by 'H nmr. & (CDC1 3 , 200 MHz): Major 
isomer, 2.20 (s, 3 H, CH3), 7.45 (m, 15 H, Ar CH), 10.60 (s, 1 H, N-Oil), Minor 
isomer: 2.36 (s, 3 H, CH3), 6.88-8.03 (m, 15 H, Ar Cl), 9.95 (s, 1 H, N-Oil). 
Signals for the major isomer only were detected by 13C nmr. c  (CDC13 50 MHz): 21 
(CH3), 125 (Ar CH), 126 (Ar CH), 127 (Ar C), 127 (2 C, Ar CH), 128 (2 C, Ar CH), 
128 (2 C, Ar CFI), 129 (Ar CH), 129(2 C, Ar CH), 130 (Ar CH), 130 (Ar CH), 135 
(Ar C), 135 (Ar C), 136 (Ar C), 143 (Ar C), 157 (C=N-OH). IR (KBr disc)/cm': 
3276s, 1654w, 1600w, 1578w, 1492m, 1343m, 1169s. El MS, mlz 366 (M, 
100.0%). 
3.8.5 Synthesis of sulfonamido oxime complexes 
Bis I1_{2_LN(4_methy1benzenesu1fonamidat0)1PhenY1}ethan 10h1e oxime] 
copper(II) (34) 
A solution of 28 (0.15 g, 0.49 mmol) in hot methanol (10 cm) was added to a solution of 
copper acetate monohydrate (49 mg, 0.25 mmol) also in methanol (10 cm 
3).  The 
solution was sealed until the product separated overnight as a brown crystalline solid 
which was collected by filtration, washed with methanol (3 x 5 cm) and dried in vacuo 
(0.12 g, 75%), (Found: C, 53.77; H, 4.63; N, 8.72. Calc. for C 30H30N4Cu06S2 : C, 53.60; 
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H, 4.49; N, 8.33%). IR data (KBr disc)/cm-1 : 708m, 1153m, 1367w, 1596m, 3423m. 
FAB MS m/z 672 (MIfF,  18.0%). 
Cu4(C15H16N2S03)2(C I5H I5N2SO3)2(CH30H)2(CH30)2 (35) 
A solution of 28 (0.15 g, 0.49 mmol) in hot methanol (10 cm 
3)  was added to a solution 
of copper acetate monohydrate (98 mg, 0.49 mmol) also in methanol (10 cm). The 
solution was sealed until the product separated overnight as a green crystalline solid 
which was collected by filtration, washed with methanol (3 x 5 cm3) and dried in vacuo 
(0.19 g, 95%). (Found: C,48.31; H, 4.67; N, 6.91. CaIc. for: CH 76N8Cu4016S2 C, 
48.29; H, 4.56; N, 7.04 %). IR data (KBr disc)/cm': 1355w, 1446s, 1602s, 3375s, 3477s. 
ESI MS m/z 367 ([Cu(C 15H 16N203S)], 19.7%), 670 ([Cu(C15H15N203S)21 +, 12.6%). 
Bis [1_{2.IN(4_methylbenzenesu1fonamidat0)1PheflY1Iet 11an_1_011e 
oximeJnickel(II) (orange, 36) 
A solution of 28 (0.15 g, 0.49 mmol) and potassium hydroxide (0.49 mmol) in hot 
methanol (10 cm3) was added to a solution of nickel acetate tetrahydrate (61 mg, 0.25 
mmol) also in methanol (10 CM)  . The solution was sealed until the product separated 
after 3 days as an orange crystalline solid which was collected by filtration, washed with 
methanol (3 x 5 cm3) and dried in vacuo (0.13 g, 38%). (Found: C, 53.74; H, 4.28; N, 
8.14. Calc. for C 30H30N4NiO6S2: C, 54.23; H, 4.55; N, 8.43%). IR data (KBr disc)/cm': 
706w, 115 Is, 1490m, 1560m, 3048w, 3423w. ESIMS m/z 663 (M, 100.0%). 
BisI1{2_IN(4methylbenzenesulfonamidatO)1 phenyl) ethafl-l-one 
oximelnickel(II) (purple, 37) 
A solution of 28 (0.15 g, 0.49 mmol) in hot ethanol (10 cm 3)  was added to a solution of 
nickel acetate tetrahydrate (61 mg, 0.25 mmol) also in ethanol (10 cm). The solution 
was sealed until the product separated after 3 days as a purple solid which was collected 
by filtration, washed with ethanol (3 x 5 cm3) and dried in vacuo (0.06 g, 37%), (Found: 
C, 54.21; H, 4.23; N, 8.74. Calc. for C 30H30N4NiO6S2: C, 54.23; H, 4.55; N, 8.43%). IR 
data (KBr disc)/cm1 : 708m, 1133s, 1369w, 1597m, 1654w, 2871m, 2923m, 3422m. 
FAB MS m/z 664 ([Ni(C 15H15N203S)21, 34.0%). 
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N12Na2(C 15H1 6N2SO3)2(C15HI5N2SO3)2(CH30II)2(CH30)2 (38) 
A solution of 28 (0.15 g, 0.49 mmol) and sodium hydroxide (0.49 mmol) in hot 
methanol (10 cm3) was added to a solution of nickel acetate tetrahydrate (61 mg, 0.25 
mmol) also in methanol (10 cm 3). The solution was sealed until the product separated 
after 3 days as red crystalline solid which was collected by filtration, washed with 
methanol (3 x 5 cm) and dried in vacuo (84 mg, 45%). (Found: C, 51.03; H, 5.04; N, 
7.33. Calc. for CH 76N8Na2Ni2O 1 6S4: C, 51.08; H, 4.96; N, 7.45%). JR data (KBr 
disc)/cm: 1438m, 1560m, 1654m, 3448w. ESI MS m/z 666 ([Ni(C 15H 15N203S)21, 
41.2%),1460 ([Ni2(C 15H1 6N2S03)2(C 15H 15N2S03)2(CH3OH)2 (CH3O)2], 66.0%). 
Ni4(1-H)2(1-2H)2(OH)2(MeO)5 (39) 
A solution of 28 (0.15 g, 0.49 mmol) and lithium hydroxide (0.49 mmol) in hot methanol 
(10 cm) was added to a solution of nickel acetate tetrahydrate (61 mg, 0.25 mmol) also 
in methanol (10 cm). The solution was sealed until product was observed. An orange 
crystalline solid was initially observed, however after 7 days a small number of green 
crystals were isolated (8 mg, 8%). Due to the small number of crystals formed 
microanalysis was not possible. JR data (KBr disc)/cm': 668m, 1087m, 1127m, 1235m, 
1561w, 1655m, 2344s, 2363s, 3435s, 3856m. ESI MS m/z 1452 (Ni4(C 15H15N2S03)2 
(C 1 5H 14N2SO3)2(OH)2(MeOH)3, 43.0%), m/z 1484 (Ni1(C 1 5H 15N2503)2 (C 15H 14N2S03)2 
(OH)2(MeOH)4, 15.2%) m/z 1516 (Ni4(C 1 5H15N2S03)2(C1 5H 14N2S03)2(011)2 
(MeOH)5 , 7.6%). 
Bis I1{2_IN(4_propy1benzenesu1fonamidato)]PheflY1}etha 11-1-01 oximel 
nickel(I1) (40) 
A solution of 30 (0.15 g, 0.45 mmol) and potassium hydroxide (0.49 mmol) in hot 
methanol (10 cm 3) was added to a solution of nickel acetate tetrahydrate (56 mg, 0.22 
mmol) also in methanol (10 cm 3). The solution was sealed until the product separated 
after 3 days as an orange crystalline solid which was collected by filtration, washed with 
methanol (3 x 5 cm3) and dried in vacuo (39 mg, 25%). (Found: C, 56.56; H, 5.38; N, 
7.76. Calc. for C34H38N4NiO6S2: C, 56.52; H, 5.30; N, 7.75%). JR data (KBr disc)/cm': 
1150s, 1309s, 1456m, 1636w, 2871m, 2931m, 2960m, 3042m. FAB MS m/z 665 (M, 
16.0%). 
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Bis[2[N(4methylbenzenesu1fonamidatO)]-PheflYl}(PhenY1)methafl0ne oximel 
copper(H) (41) 
A solution of 33 (0.15 g, 0.41 mmol) in hot methanol (10 cm 3)  was added to a 
solution of copper acetate monohydrate (41 mg, 0.21 mmol) also in methanol (10 
cm3). The solution was sealed until the product separated overnight as a brown 
crystalline solid which was collected by filtration, washed with methanol (3 x 5 cm) 
and dried in vacuo (0.11 g, 67%), (Found: C, 60.61; H, 4.43; N, 6.89. Caic. for 
C40H36N4Cu06S4: C, 60.48; H, 4.31; N, 7.05%). IR data (KBr disc)/cm': 668m, 
1089s, 1167s, 1281m, 1328m, 1490m, 1597m, 3059m, 3275m, 3394m. ESI MS m/z 
794 (MW, 67.0%). 
3.8.6 X-ray crystallography 
Structures 28, 33E, 34 and 38 were determined by Dr. Simon Parsons and 29, 32, 
33Z, 36 and 39 were determined by Andrew Parkin at the University of Edinburgh. 
In all cases data were collected at 220 K on a SMART or Stoe Stadi-4 diffractometer 
equipped with an Oxford Cryosystems low temperature device, using Cu-Ku 
radiation for 28, and Mo-Ku radiation for 29, 32, 33E, 33Z, 34, 35, 36, 38 and 39. 
Reflections were scanned in 0)-B mode. Structures 28, 29, 32, 33Z, 34, 35, and 39 
were solved by direct methods (SHELXTL' 3) and 36, 38 and 33E by Patterson 
methods (DIRDIF' 4). All were completed by iterative cycles of least squares 
refinement against F2 and difference Fourier synthesis (SHELXTL). H-atoms were 
idealised, being placed using geometric or difference maps and treated by riding or 
refall methods. All sulfonamido hydrogen atoms were placed using difference maps. 
In all cases non-H atoms were modelled with final anisotropic displacement 
parameters and final refinement statistics are presented in Tables 3.17 (28, 29, 32), 
3.18 (33E and Z), 3.19 (34-36) and 3.20 (38 and 39). 
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Table 3.17: Crystallographic data for structures 28, 29 and 32. 
Structure 28 29 32 
Formula C 15H 16N203 S C 18H22N203S C 16H 18N203 S 
M 304.36 346.44 318.38 
Crystal system Monoclinic Monoclinic Monoclinic 
Space group P21 In P2(1)/c P2(1)/n 
a/A 8.2135(13) 10.2876(18) 11.332(2) 
b/A 8.2717(12) 15.182(3) 8.4432(14) 
c/A 21.717(3) 11.844(3) 16.599(3) 
1.110 90 90 90 
94.061(9) 107.341(19) 100.381(15) 
11/0 90 90 90 
u/A3 1471.7(4) 1765.9(6) 1562.1(5) 
Crystal size/mm 0.36 x 0.12 x 0.12 0.27 x 0.27 x 0.23 0.86 x 0.54 x 0.43 
D/gcm' 1.374 1.303 1.354 
Z 4 4 4 
jilmm' 2.062 0.201 0.221 
Scan type omega - theta omega - theta omega-2theta 
0Limits/° 4.08-60.13 2.67-25.06 2.72-25.00 
No. of unique data 2172 3117 2735 
No. data with IF>4c5(F)1 1788 1851 2361 
No. parameters 195 273 272 
RI 0.0452 0.0547 0.0304 
wR2 0.1255 0.1302 0.0826 
Pmx4Pmin/e A 3 0.245, -0.358 0.350, -0.259 
0.221, -0.259 
Table 3.18 : Crystallographic data for structures 33(E) and 33(Z). 
Structure 33(E) 33(Z) 
Formula C20H 18N203 S C20H 18N203 S 
M 366.42 366.42 
Crystal system Monoclinic Triclinic 
Space group P21 / c P - 1 
a/A 9.7368(16) 8.083(6) 
b/A 11.865(2) 9.772(7) 
c/A 16.242(3) 11.885(8) 
a? 90 72.46(5) 
101.523(17) 85.18(4) 
7/0 90 80.29(6) 
u/A3 1838.5(6) 881.8(11) 
Crystal size/mm 0.51 x 0.19 x 0.16 	 0.47 x 0.23 x 0.23 
D/gcm' 1.324 1.380 
Z 4 2 
Wmm' 0.198 0.206 
Scan type omega-theta omega-theta 
OLimits/° 2.56-25.09 2.56-25.11 
No. of unique data 3267 3134 
No. data with IF>4cT(F)1 1712 2577 
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No. parameters 	 242 308 
RI 	 0.0677 0.0391 
wR2 0.1609 0.0918 
.pmax4Pmin1e A-3 	 0.249, -0.261 0.244, -0.355 
Table 3.19 : Crystallographic data for structures 34-36. 
Structure 34 35 36 
Formula C30H30CuN406S2 C64H72Cu4N80I6S4 C30H30N4NiO6S2 
M 670.24 1591.70 665.41 
Crystal system Monoclinic Triclinic Triclinic 
Space group P21/n P-i P-i 
a/A 12.2008(14) 8.8883(4) 8.4754(15) 
b/A 15.258(2) 14.4574(7) 8.5995(15) 
c/A 17.329(2) 14.7591(5) 11.0123(19) 
OVO 90 62.487(3) 95.134(3) 
108.704 82.793(3) 92.934(3) 
IWO 90 85.357(2) 114.367(2) 
U/A3 3055.6(6) 1668.22(12) 724.8(2) 
Crystal size/mm 0.54 x 0.19 x 0.12 0.15 x 0.10x0i0 0.34 x 0.15 x 0.08 
D/gcm' 1.457 1.584 1.525 
Z 4 1 1 
p/mm' 0.901 1.457 0.865 
Scan type omega + theta phi + omega Phi + omega 
e Limits/° 2.67-25.00 2.31-30.49 1.87-26.43 
No. of unique data 5330 9467 2919 
No. data with IF>4a(F)1 4032 5640 2191 
No. parameters 394 448 199 
Ri 0.0437 0.0479 0.0565 
wR2 0.1059 0.1153 0.1288 
APmax4Pminle A 3 
 0.412, -0.339 0.616,-0.742 1.655,-1.045 
Table 3.20 Crystallographic data for structures 38 and 39. 
Structure 38 39 
Formula CH74N8Na2Ni2O 16S4 C69H98N8N4023 S4 
M 1502.95 1770.63 
Crystal system Triclinic Monoclinic 
Space group P-i P2 (1)/n 
a/A 10.236(6) 13.572(4) 
b/A 14.096(8) 27.576(7) 
C/A 14.395(8) 21.439(6) 
61.883(19) 90 
0/0 73.43(3) 95.890(6) 
73.26(3) 90 
U/A3 1726.6(17) 7981(4) 
Crystal size/mm 0.54 x 0.27 x 0.23 0.28 x 0.07 x 0.04 
D/g cm' 1.445 1.474 
Z 1 4 
p/mm' 0.751 1.111 
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Scan type omega-theta phi + omega 
0 Limits/* 2.78-25.09 1.21-21.16 
No. of unique data 6127 8520 
No. data with IF>4a(F)I 3881 5371 
No. parameters 441 443 
Ri 0.0759 0.1785 
wR2 0.1950 0.3613 
APmnxAPmin/e A 3 0.888, -1.421 1.128, -0.902 
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4.1 Introduction 
The X-ray crystal structures of monosulfonamidodiamine ligands and sulfonamido 
oxime ligands and some of their metal complexes discussed in chapters 2 and 3 have 
provided very valuable insight into the secondary hydrogen-bonded structures of 
such ligands. It was the aim of this thesis to look at the importance of a head-to-tail 
hydrogen-bonded pseudo-macrocycle around a metal centre. It was also proposed to 
examine the importance of the self association of the free ligand in solution prior to 
complexation and establish whether a preorganised structure aids complexation. In 
certain cases a pseudo-macrocyclic ligand secondary structure was observed in the 
solid state and although such preorganisation of the ligand was not observed 
exclusively this does not rule out such interactions in solution. It was therefore 
considered important to investigate the solution structures of sulfonamido ligands. 
4.2 Improving ligand solubility 
In order to investigate the self assembly properties of monosulfonamidodiamine 
ligands and their strength and selectivity when used as metal extractants the ligands 
had to be soluble in a range of solvents. The very low solubility of the sulfonamido 
diamine and sulfonamido oxime ligands in organic solvents is thought to be due to 
the polar sulfonyl, amino and oxime groups and also to the extensive inter-molecular 
hydrogen-bonding networks which exist in the solid state. In order to increase ligand 
solubility in non-polar solvents either the number of hydrogen-bond donors or 
acceptors, marked in Figure 4. 1, could be reduced by replacing the sulfonamido 
groups in A and B by the sulfinamido groups in C and D, or a bulky hydrocarbon 
group could be introduced into the molecule at R, R 2 or R3 . 
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S NH 	NOW 







R -NH 	NOW 
-0-0 H 	
ó R3 
C 	 U 
Figure 4.1: Hydrogen-bond donor (blue), and acceptor atoms (red), in monosulfonamidodiamine (A) 
and sulfonamido oxime (B) ligands, and their sulfinamide analogous (C) and (D). 
4.2.1 Reducing the number of hydrogen-bond donors and acceptors 
4.2.1.1 An introduction to sulfinamides 
One approach to reduce the number of hydrogen-bond donors and acceptors would 
be to replace sulfonamido groups with sulfinamido groups (see Figure 4.1). It was 
hoped that this would encourage the formation of more selectively hydrogen-bonded 
structures and thus, inter-complex hydrogen-bonding may be reduced or even 
prevented leading to an improved solubility. Another reason for attempting the 
syntheses of such novel sulfmamide ligands was that the coordination chemistry of 
sulfmamides has been very little explored. Only three papers were found containing 
such studies. 1,2,3 The most recent paper describes a high yield route to nitrogen 
bonded sulfinamide complexes using the starting material [(NH 3)5Co03 SCF3] 
(CF3 SO3)2 and the sulfmamide ligand NH2SOCH3.' It was found that the use of 
weakly coordinating solvents led to complexes in which the sulfmamide was 
coordinated to cobalt through the oxygen atom. In order to produce high yields of N 
bonded complexes (Equation 4.1) dry dipolar aprotic solvents and sterically 
hindered, non-coordinating bases had to be used. Uv-vis and 'H nmr spectroscopy 
were used to characterise the complexes formed. 
[(NH3)5Co03 SCF3](CF3S03)2 + NH2SOCH3 	[(NH3)5C0NH2S0CH3](CF3S03)3 Eq 4.1 
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Two earlier studies in the same laboratory were published in 1985 •2,3  In one paper2 
the ligands C6H5NHSOCH(CH3)2 (I), C 6H5NHSOCH2COO'Bu (II) and 
C6H 1  ,NHSOCH2COO'Bu (Ill) were complexed to zinc halides in an attempt to 
model the active site of zinc metalloproteins. The stoichiometry of the complexes 
was determined as one zinc to two ligands by nmr titration and was confirmed using 
atomic absorption spectroscopy. It was found that only the sulfmamido oxygen not 
the carboxyl groups in II and Ill are involved in binding to the zinc and that the 
complexes are tetrahedral with a 2L : ZnX2 stoichiometry. A continuation  of this 
study used ligands of type (II), with a substituent, X, on the aromatic ring 
XC6H4NHSOCH2COO tBu where X is o-NH2 (IV), o-OH (V), rn-OH (VI) or p-OH 
(VII). 'H nmr titrations were again used to determine complex stoichiometry and the 
Zn to L ratios were proved to be 1:1, 1:1, 2:1 and 1:2 for the complexes of ligands IV 
to VII respectively. JR techniques were again used to formulate the coordination 
spheres of the complexes. 
The preparation of sulfmamides is well documented in the literature. They are used 
as versatile synthetic intermediates, 4  for example in the preparation of racemic and 
chiral sulfinic acid esters via the reaction of sulfinamides with alcohols. 5 They are 
also an important class of compounds due to their biological activity, 6 the 
sulfmamide group may be used to replace the amide bond in peptide transition state 
analogues, as potential peptidase inhibitors or as substrates for the development of 
catalytic antibodies. 7,8 
Several methods for sulfmamide preparation are published including the use of 
Grignard reagents, 9 ' 10  azides," and the sulfmation of amines with sulfmic acids in the 
presence of activating reagents such as diphenylphosphorochloridate.' 2  However, 
the majority of papers treat an amine with the relevant sulfinyl chloride, in an 
anhydrous diethylether medium at 0°C.' 3" 4" 5 '5  The latter method was chosen in this 
project. 
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Sulfinyl chlorides are not available commercially due to their instability at room 
temperature. Their synthesis has been widely explored due to their extensive use in 
the preparation of racemic and optically active sulfmyl derivatives such as sulfinates, 
thiosulfinates, sulfmamides and sulfoxides. 16  The original preparation was based on 
the solvolysis of organosulfur trichioride using a hydroxylic solvent such as water 
(Equation 4.2))6 
RSC13 + H20 	RSOC1 + 2HC1 	Eq 4.2 
Problems associated with this method such as the isolation of the labile organosulfur 
trichiorides and the large quantity of HC1 produced led to further work by Douglass 
et al. ' 7" 8" 9 From 1958 Douglass developed what became the most common 
procedure of sulfinyl chloride preparation, oxidative chlorination of sulfenyl 
derivatives (disulfides) in the presence of acetic acid (Equation 4.3) and subsequently 
in the presence of acetic anhydride (Equation 4.4). 
17,18,19 In Equation 4.3 the 
isolation of the organosulfur trichioride is avoided and it is assumed that it is formed 
as an intermediate in the reaction. The second reaction, in Equation 4.4, avoids both 
these problems as no hydrogen chloride gas is formed. 
RSSR + 2CH3COOH + 3d 2 	01 2HC1 + 2CH3COC1 + 2RSOC1 	Eq 4.3 
RSSR + 2(CH3CO)20 + 3d 2 	 2RSOCI + 4CH3COCI 	Eq 4.4 
In 1978 an important modification was reported by Schenk and Muller 2° in which 
chlorine was replaced by sulfuryl chloride. In this thesis sulfinyl chloride precursors 
were prepared from the related thiols by reaction with sulfuryl chloride in acetic acid 
at low temperature (Equation 45)21 
RSH + 2S02C12 + CH3COOH 	RSOC1 + CH3COC1 + 2S02 + 2HC1 	Eq 4.5 
This method generates sulfmyl chlorides in quantitative yields from both aliphatic 
and aromatic thiols whereas the success of the other methods mentioned depends on 
the nature of the R groups. Taking the starting materials, in the ratios close to those 
required by Equation 4.5, leads only to a sulfmyl derivative and avoids any possible 
sulfonamide formation. The thiol starting materials are either commercially 
available or can be easily synthesised. 
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Since only low boiling by-products are formed in the reaction (Equation 4.5) the 
sulfmyl chlorides are easily obtained in high purity. Alkanesulfinyl chlorides can be 
distilled to give a final pure product. However, aromatic sulfinyl chlorides should 
not be distilled due to the danger of explosion. 22  This was first reported by Douglass 
et a122  after the attempted distillation of p-toluenesulfinyl chloride. Alkanesulfinyl 
chlorides should also not be stored in sealed containers at room temperature. 
23 
Sulfinyl chlorides can disproportionate to the sulfonyl chloride and the sulfenyl 
chloride. The subsequent self condensation of alkanesulfenyl chloride generates 
hydrogen chloride gas, among a variety of products, and thus high pressure can 
develop within the container which can lead to an explosion. 
4.2.1.2 Sulfinamide target molecules 
The sulfinyl chlorides prepared using the method of Yoon et a!21 were 2-methyl-l-





42 	 43 
Figure 4.2: 2-methyl-i -propanesulfinyl chloride (42) and 4-methylbenzenesulfinyl chloride (43). 







Figure 4.3: Sulfinamide target ligands. R = -CH 2CH(CH3)2 or —C61-14CH3 . 
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4.2.1.3 Attempted synthesis of monosulfinamido diamine ligands. 
The method of Raiford et al  13  was initially followed for the sulfmamide preparation 
due to the large number of sulfinamides which this paper includes. Reaction of a 
range of aryl amines were reported of which o-chloroaniline (Figure 4.4) is one 
example. 13  The method involves the treatment of a solution of two equivalents of 
amine dissolved in three volumes of dry diethylether with 1.25 portions of sulfmyl 
chloride in two volumes of dry diethylether, with continuous agitation at 0 °C (Figure 
44) • 1 3 
NH2 
C1 	 0 
11 
2eq. 6 I.25 eq. ___Q_S_CI 0 S11NHNOH (i) 	 eCH3 
Figure 4.4: The method of sulfinamide preparation of Raiford et al.  13  (i) Et20, 0°C. 
The extra equivalent of the amine is used as a base to mop up the HC1 produced. The 
use of a second equivalent of the amine is also quoted in a paper by van der Marel 
and Liskamp. 7  When one equivalent of the amine is replaced by pyridine or 
diisopropylethylamine lower yields resulted. 7 
Following this procedure exactly with 1 ,2-diaminoethane and 2-methyl-1-
propanesulfmyl chloride (Figure 4.5), yielded a mixture of monosubstituted and 




11 	 (I) 
2eq. 	 + 	I.25. H2N 	 + 
0 
11 	H 
S 1-1 N __~N-_S —Y 
H 	 11 
0 
44 
Figure 4.5: The reaction of 1 ,2-diaminoethane and 2-methyl-1-propanesulfinyl chloride. (i) Et 20, 
0°C. 
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Isolation of the symmetrical disubstituted sulfinamide was achieved. However, it did 
not prove possible to isolate the monosubstituted species. A modification of the 
sulfmyl chloride to amine ratio from 1.25:2, to 3:1 used by Kirsanov et a124 to 
produce monosubstituted sulfonamidodiamines failed to produce a monosubstituted 
product. Also, attempts made to replace one mole of the amine with triethylamine or 
Hunig's base (N,N,diisopropylethylamine) in the attempted synthesis of 
monosulfinamidodiamine ligands yielded only an intractable oil. 
As monosubstitution did not prove possible for 1 ,2-diaminoethane it was decided to 
use N-acyl- 1 ,2-diaminoethane as a starting material on the grounds that the acyl 
group should make the substituted nitrogen less nucleophilic, encouraging formation 
of the monosulfinamido product. However, the acyl group failed to have the desired 
effect and 1 H nmr analysis of the product indicated that a mixture of both mono- and 
di-substituted products were present (Figure 4.6). 
	
11 	H 	11 
S _ll_cH3 
11 







N 	 11 




Figure 4.6: The attempted synthesis of N[2(2methyl-propane-1-suIfiny1amiflO)-ethY1]-aCetamide 
(I) resulted in a mixture of products I, II and M. (I) Et20, 0°C. 
A di-amino starting material with only one amino hydrogen available for substitution 
was then prepared. The N-acyl- 1 ,2-diaminoethane used previously was treated with 
phthalic acid anhydride to form the phthalimide, 45 (Figure 4.7). 
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Figure 4.7: Protection of the NH 2  group of the N-acyl-1, 2-diaminoethane. (i) n-butyl acetate, 5 hr. 
reflux. 
Phthalimide 45 failed to react with the sulfinyl chloride. This result was surprising as 
N-acylated sulfonamido systems have been reported to stabilise the sulfinamide 
group.8 
The reaction of 1 ,2-diaminoethane was also tried with 4-methylbenzenesulfmyl 
chloride, but again only a disubstituted product (46) could be isolated. There was 
very little evidence for the presence of a monosubstituted species. Due to the 
difficulties encountered in the attempted synthesis of a monosubstituted 
diaminoalkane ligand the investigation into sulfinamido derivatives of simple 
diamino ligands was abandoned. 
4.2.1.4 Attempted syntheses of sulfinamide oxime ligands 
The reaction of one equivalent of 2-methyl-i -propanesulfmyl chloride with one 
equivalent of 1 -(2-aminophenyl)ethanone in diethylether in the presence of one 
equivalent of triethylamine (Figure 4.8) yielded an intractable brown oil. 
	
NH2 	0 	 NN 	0 
(I) 
J'~'Io ci + U U 
Figure 4.8: The failed reaction of one equivalent of 2-methyl-i -propanesulfinyl chloride with one 
equivalent of 1 -(2-aminophenyl)ethanone. (i) Et 20, 0°C, 1 eq. Net3 . 
The sulfmamide preparation of Raiford et al  13  was then applied, using 4-
methylbenzenesulfinyl chloride. This resulted in successful synthesis of, 47. 
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2 eq. 	 + 1.25 eq. ___<()>__ —c 
47 
Figure 4.9: Synthesis of 1 {2-[N-(4methylbenzenesulfinamido)]phenYl}ethafl- 1-one (47) (i) Et 20, 
0°C. 
One equivalent of 1-(2-amino-phenyl)-ethanone may be replaced with either 
triethylamine or potassium carbonate, however this did reduce the yield and purity of 
the product. 
Oximation of the ketone group was attempted using the same method used for 











Figure 4.10: The attempted oximation of I -{2-[N-(4-methylbenzenesulfinamido)]phenyl} ethan- 1-
one, (47) results in the formation of 1 -(2-ammophenyl)ethan- 1-one oxime (48). (i) 
50:50 pyridine:ethanol, 4 hr. reflux. 
The order of sulfmylation and oximation was then reversed but the reaction of 1-(2-
aminophenyl)ethanone (48) with 4-methylbenzenesulfinyl chloride (Figure 4.11) 
failed to give the desired material. So too did the comparable methoxy oxime 49. 
One of the problems associated with carrying out the reaction of 49 was its low 
solubility in diethylether. 
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NI-i2 	NOR 	 11 
(i) 	
NOR 
2 	 + 1.25 eq. 	 4_ci 
48 R=H 
49 R=CH3 
Figure 4.11: The attempted reaction of 1 -(2-amino-phenyl)-ethanone (48) and with 1 -(2-amino-
phenyl)ethan-1 -one 0-methyl-oxime (49) with 4-methylbenzenesulfinyl chloride. (i) 
Et20, 0°C. 
The attempted syntheses of the sulfmamide oxime target molecule was stopped at 
this point as the ketosulfmamide 47 had proved to be unstable at ambient 
temperature, even under a nitrogen atmosphere. Even if the preparation of the target 
oximes had been achieved is is very likely that these would also be unstable. 
Consequently, it would have been very difficult to study their coordination chemistry 
or the hydrogen-bonded secondary structure of the molecules. The propensity of 
sulfinamides to hydrolyse 
25,26  in the presence of acid or base would also have caused 
problems, making it very difficult to assess the "strength" of sulfinamide extractants 
by determining "S-curves" [plots of% loading against pH, see section 2.6.1]. 
4.2.2 Ligand solubilisation by the introduction of a lipophilic group 
As the attempted reduction of the number of hydrogen-bond acceptor sites by the 
replacement of the sulfonamido group by a sulfmamide group proved unsuccessful a 
second option to increase ligand solubility by the introduction of a lipophilic group 
was pursued. 
4.2.2.1 The introduction of a lipophiic group into monosulfonamidodiamine 
ligands 
The first approach was to modify R, the group at position 4 on the benzenesulfonyl 
ring. Selected sulfonyl chlorides which have larger R groups than methyl are 
commercially available and p-t-butylbenzenesulfonyl chloride was used to prepare 
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2. However the solubility of the resulting ligand was very little different from the 
methyl analogue (Figure 4.12). 
11 IS, 3 	 + 	
0)
H2N jj—C)—<— 	0 
2 
Figure 4.12: Synthesis of N-(2-aminoethyl)4-t-butylbenzenesulfoflamide (2). (i) Toluene, 25°C. 
The second approach was to replace one amino hydrogen on the unsulfonated 
nitrogen atom via imination27 and reduction (Figure 4.13). 
0)
Ts-N ' 	NH2 
+ 	R5CHO 
H 





















Figure 4.13: N-alkylation of the mono sulfonamidodiamines via imine formation and reduction of the 
derivatives formed. (I) Ethanol, 25°C. (ii) XS NaBH 4, catalytic quantity of NaB 407 . 
Ts = -SO2C6H4CH3. 0  Experimental details of these ligands may be found in 
experimental section 2.10.3. 
The N-propyl (50) and N-butyl (9) derivatives proved very difficult to purify as they 
are oily solids which cannot be recrystallised. The N-benzyl derivatives 3 and 7 are 
crystalline solids but have only marginally greater solubility than the unsubstituted 
compounds 1 and 5. Fortunately the addition of the 2-ethylhexyl group, afforded 
pure products 4 and 8 and also increased the ligand solubility dramatically affording 
ligands which were soluble in non polar solvents. 
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4.2.2.2 The introduction of a lipophiic group into sulfonamido oxime ligands 
Ligands synthesised using commercially available benzenesulfonyl chlorides with 
large alkyl groups in the para position are listed in Figure 4.14. 
NOH 
R
f J J JL 
Ligand R R' 
28 methyl methyl 
29 t-butyl methyl 
30 n-propyl methyl 
31 n-pentyl methyl 
33 methyl phenyl 
Figure 4.14: Sulfonamido oxime ligands synthesised using commercially available sulfonyl 
chlorides. 
Ligands 29-31 have increased solubilty over the methyl analogue, 28. However, they 
are still insoluble in non polar solvents such as hexane. 
4.2.3 Synthesis of sulfonyl chlorides 
As the commercially available benzenesulfonyl chlorides did not afford sulfonamido 
oxime ligands of the required solubility the preparation of a sulfonyl chloride with a 
more lipophilic hydrocarbon group was attempted. Sulfonyl chlorides can be 
synthesised by a variety of routes. 28 
There are three types of reaction: C-S(VI) bond formation 
oxidation 
formation from other S(VI) containing compounds. 
Formation of carbon to hexavalent sulfur bonds. Aryl sulfonyl chlorides may be 
prepared by reaction of chlorosulfonic acids with aromatic compounds which are 
activated toward electrophilic attack (Equation 4 . 6) . 29  Low temperatures are 
necessary to avoid di- and tn- sulfonation of the aromatic ring. 
ArH + C1S03H 	r  ArS02C1 	Eq 4.6 
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The analogous reactions of aliphatic compounds give lower yields. 30 
Aromatic diazonium salts on treatment with sulfur dioxide in the presence of 
copper(II) chloride (Equation 4.7) give arylsulfonyl chlorides. 3 ' 
ArN2 Cl 
s02 
ArSOCl + N2 	Eq 4.7 
CuCl2 
Sulfur dioxide also reacts with aliphatic compounds with the addition of chlorine 
(Equation 4.8) under conditions which permit formation of radicals. 
32 However, a 
mixture of compounds is achieved. 
so2 
RH 	RS0C1 	Eq 4.8 
Cl2 
Sulfuryl chloride may be used to prepare both aromatic and aliphatic sulfonyl 
chlorides. Aromatic hydrocarbons are treated in the presence of A1C1 3 (Equation 
4.9). Ring chlorination may also occur. 33 
s02c12 
ArH 	ArSOCl 	 Eq 4.9 
AIC13 
For aliphatic halide molecules, high yields of alkylsulfonyl chlorides are claimed 
when they are converted into alkyllithium or Grignard reagents (Equation 4.10) and 
subsequently treated with sulfuryl chloride. 34,35 
Mg 	 S02C12 
RC1 	- RMgX 	RSOCl 	Eq 4.10 
The following reactions lead to sulfonyl chlorides via oxidation. Alkane sulfenyl 
chlorides may be oxidised using nitric acid to give the sulfonyl chloride in high yield 
(Equation 4 . 1l) . 36 
RSC1 HNO3 
	
RSOCl 	Eq 4.11 
Alternatively arene sulfmic acids and their alkali metal salts may be oxidised using 
chlorine or copper halides, in water or aqueous acetic acid (Equation 4.12). 
However, ring chlorination may occur. 37,38 
ArS02H or ArS02 	
ox 	
ArSOCl + H2 	Eq 4.12 
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Alkylsulfmate salts, obtained by the reaction of sulfur dioxide with either 
alkyllithiums or Grignard reagents are converted into sulfonyl chlorides upon 
reaction with sulfuryl chloride (Equation 4.13) . 39 A mixture of thionyl chloride and 
DMF may also be used .40 
RS02Li S02Cl2r RS02CI 	Eq 4.13 
A classical method is by the oxidation of thiols or disulfides with chlorine in the 
presence of water, acetic acid or nitric acid (Equation 4.14) 
.4142 
RSH orRSSR_
Cl2  RS02C1 	Eq 4.14 
Aromatic and aliphatic sulfonyl chlorides may be prepared by oxidation of a 
thiocarbamic ester, after Newman-Kwart rearrangement (Equation 4.15)
43  or by 
treatment of S-alkyl isothiouronium salts with aqueous chlorine (Equation 4.1 
44 
S 	 0 
II  	II 	Ox ArO—CNR2 	ArS—CNR2 __ ArSOCl Eq 4.15 
NH2 
alkyl— S - 5cr 
NH2 
Cl2 
aIkylSOCl Eq 4.16 
There is some risk of explosion when salts are directly chlorinated 
45  and a safer 
method involves the reduction of the salt to the thiol prior to chlorination. 46 
The oxidation of sulfides, sulfoxides and sulfones to give sulfonyl chlorides is also 
possible. However, forcing conditions may be required .47,48,49 
Finally sulfonyl chlorides may be prepared from other S(VI) containing 
compounds, mostcommonly from sulfonic acids and their salts. When PC1 5 is used 
side reactions may occur as it is a strong chlorinating agent (Equation 4.17). 50 
RS03H or RS03 	
PCL5 RS02X 	Eq 4.17 
POd 3  may also be used as the chlorinating agent where fewer side reactions occur. 
51 
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4.2.3.1 2-Ethyihexylsulfonyl chloride 
It was hoped that the 2-ethyihexyl group, used to solubilise 
monosulfonamidodiamines via N-substitution, would improve the solubility of 
sulfonamido oximes and the synthesis of 2-ethyihexylsulfonyl chloride (51) was 
attempted (Figure 4.15). 
Figure 4.15: 2-Ethyihexylsulfonyl chloride (51) 
It was decided to prepare the 2-ethylhexane sulfonate salt which would then be 
chlorinated. The Strecker 52 method to prepare the sodium salt of 2-ethythexane 
sulfomc acid from 1 -bromo-2-ethylhexane proved unsuccessful (Figure 4.16). 
Br 	 K 	Na* 
- 
Figure 4.16: Attempted preparation of 2-ethyihexyl sodium sulfonate by the Strecker synthesis. (i) 
Na2SO3 , H20, reflux. 
The failure of this reaction was probably due to the insolubility of 2-ethyihexyl 
bromide in water. However, the reaction did not succeed even when a 3:1 
water:ethanol medium was used. It has been reported that poor yields are obtained in 
the preparation of sulfonate salts from alkyl halides with chains containing more than 
five carbon atoms 53,54  via the Hemilian method in which the sodium sulfate is 
replaced by ammonium sulfate. 
Due to the limited commercial availability of alkyl sulfonic acids Ziegler et al 
developed a route to alkylsulfonyl chlorides via the chlorination of thiols prepared 
from alkylisothiouronium salts. 46 Alkylisothiouronium salts may be easily obtained 
from the reaction of alkylhalides with thiourea (Figure 4.17).46 
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B 	
NH2 
r  Br C 
II 
Nil2 
Figure 4.17: Synthesis of 2-ethyihexylisothiouronium bromide. (i) NH 2CSNH2 , EtOH, 12 hr. reflux. 
Alkylisothiouronium salts may be directly chlorinated, but this can be hazardous due 
to the explosive nitrogen trichloride which can be produced. 55  Ziegler avoided this 
problem by the reducing of the alkylisothiouromum salt to a thiol prior to 










Figure 4.18: The preparation of 2-ethyihexylsulfonyl chloride (51) based on the method of Ziegler. 46 
(i) H20, NaOH. (ii) ice, CH3COOH, C12( g). 
The desired sulfonyl chloride was obtained in good yield, 54%, and purified by 
distillation. Reaction with 1 -(2-aminophenyl)ethanone produced the sulfonamide 1-
{ 2-[N-(2-ethylhexanesulfonamido)]phenYl} ethan- 1-one. This intermediate could not 
be isolated in a pure form and was used crude in the oximation reaction to yield the 
target molecule as an impure yellow oil (Figure 4.19). 
Figure 4.19: 1- {2[N_(2_ethy1hexanesulfonamido)]phenYl}ethafl- 1-one oxime. 
1- { 2-[N-(2-ethythexanesulfonamido)]PheflYl } ethan- 1-one oxime proved very 
difficult to purify and also discoloured from pale yellow to red overnight suggesting 
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that the compound was unstable. For these reasons it was decided to investigate the 
synthesis of aromatic sulfonyl chlorides which were known to afford stable 
sulfonamido oxime products. 
4.2.3.2 Synthesis of aryl sulfonyl chlorides 
The development of a convenient method for the synthesis of aryl sulfonyl chlorides 
with a chosen length of alkyl chain at the para position to the sulfonyl group was 
attempted. The first step was to attach an appropriate alkyl group to a benzene ring. 
The well known Friedel Crafts alkylation reaction is known to produce a mixture of 
products. 56  A recent publication by Taylor et a157 covers the addition of 
organolithium reagents to styrene to produce pure alkylbenzene derivatives of higher 
yield than analogous reported Friedel Craft reactions. This procedure was followed. 
The first target molecule was tetradecylbenzene (52). Dodecyllithium was prepared 
and then added to a solution of styrene (Figure 4.20). 
(I)
Q____ CH3-(CH2) 11 -Br + BuLi 	 CH3-(CH2) 13-Li 	 (CH2)13CH3 
52 
Figure 4.20: The synthesis of tetradecylbenzene (52). (i) Et 20, -78°C, N2 . (ii) Styrene, -25°C. 
Addition of the sulfonyl chloride group was achieved using chlorosulfomc acid 
(Figure 4.2l).58 
+ CIS03H 	 CI-ll___(j__(CH2)i3CH3 + 
53 
Figure 4.21: The preparation of 4-tetradecylbenzenesulfonyl chloride (53). (i) Chloroform, 25°C. 
The chloride was purified using Kugelrohr techniques before it was reacted with 1-
(2-amino-phenyl)-ethanone to produce 1 -{2-[N-(4-tetradecylbenzenesulfonamido)] 
phenyl }ethan-l-one. This could not be isolated as a pure form and the crude product 
was oximated to produce the target molecule 1 -{2-[N-(4-tetradecylbenzene 
sulfonamido)]phenyl }ethan- 1-one oxime (Figure 4.22). 
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11 
H3C(H2C)13 _C~_ S-NH NOH 11 
Figure 4.22: 1 -{2-[N-(4-tetradecylbenzenesulfonamido)]pheflYI}ethan- I -one oxime. 
Again the sulfonamido oxime proved extremely difficult to purify. The boiling point 
of the molecule was too high for purification by distillation and chromatography 
techniques proved unsuccessful. 
Preparation of the n-octyl analogue, 1- {2-[N-(4-octylbenzenesulfonamido)]phenyl } 
ethan-l-one oxime (54) was then attempted (Figure 4.23). 
54 
Figure 4.23: Target molecule 1 -{2-[N-(4-octylbenzenesulfonamido)]phenyl} ethan- 1-one oxime (54). 
Commercially available sodium 4-octylsulfonate was used as the precursor. Alkyl 
sulfonate salts may be chlorinated by a variety of methods (see 4.2.2.3). Phosphoryl 
59 chloride was chosen to yield 4-octylbenzenesulfonyl chloride (55) (Figure 4.24). 
+ Pod 3 
(I) 
55 
Figure 4.24: Synthesis of 4-octylbenzenesulfonyl chloride (55). (i) 170°C, 1 hr. (ii) Dichloroethane, 
30 mm. reflux. 
A clean product was obtained and used without purification in the reaction with 1-(2-
aminophenyl)ethanone to produce the sulfonamido intermediate 1-12-[N-(4-
octylbenzenesulfonamido)]phenyl 
} 
ethan- 1-one (56). Oximation of 56 yielded target 
molecule 54. Again, however, the product proved very difficult to purify. 
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At this stage the situation was reviewed. It was apparent that ligands with 
sufficiently large alkyl substituents to ensure solubility in hexane and related 
hydrocarbons could not be obtained readily in a purity which would make colligative 
property measurement reliable. Consequently it was decided to investigate 
association phenomena in solution in other types of solvent. The pure ligand 31 was 




Figure 4.25: 1- {2-[N-(4-pentylbenzenesulfonamido)]PheflYl }ethan- 1-one oxime (31) 
4.3 Investigation of ligand association in solution. 
There are several ways in which association of molecules in solution may be 
explored. The methods below allowed a study of the behaviour of both 
monosulfonamidodiamine and sulfonamido oxime ligands. 
4.3.1 Electrospray ionisation mass spectrometry 
Electrospray ionisation spectrometry has emerged as a very useful technique 
60 which 
allows detection of supramolecular species which are held together only by non 
covalent interactions. 6 ' The sensitivity of the technique allows analysis of very 
dilute samples, the mild nature of the ionisation process also minimises 
fragmentation of the parent species and even allows the analysis of ionic transition-
metal complexes which often undergo reduction during the ionisation. 62  Due to it's 
ability to produce multiply-charged species it can be applied to the characterisation 
of very high molecular weight compounds. 63 
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4.3.2 Vapour pressure osmometry 
The association of molecules in solution causes the vapour pressure to increase. By 
measuring this change using "vapour pressure osmometry" the average mass of the 
species in solution may be determined indicating the degree of aggregation. The 
technique may be used simply to find the average mass in solution or if, several 
readings at different concentrations and at different temperatures are taken, both 
equilibrium constants and thermodynamic information may be achieved. Vapour 
pressure osmometry (VPO) has been used to study the solution structure of 
commercial metal extractants. 64 '65  A knowledge of the processes taking place in 
solution and the stoichiometry of the extracted species is very important in solvent 
extraction processes in order to define optimal conditions for the unit operations of 
separation and concentration. 64 For example, VPO was used to establish whether 









R 	S \ 
/ 
III 
Figure 4.26: The commercial reagents cyanex 272 (I), 302 (II) and 301 (III). 
It was found that while I and Ill exist as dimers, II is a monomer presumably due to 
the poor hydrogen-bond donor and acceptor properties of the thiol and 
thiophosphoryl groups. The solution behaviour of additives used in solvent 
extraction have also been studied by VPO. 66  Vapour pressure osmometry may also 
be applied to study molecules of biological importance such as cholesterol 67 and 
inorganic materials. 68 
4.3.3 NMR spectroscopy 
Variable concentration and variable temperature proton nmr have been widely used 
to look at the association of species in solution. 
69,70,71,72 The technique has been used 
to study a variety of systems such as cyclodextrins 69 or more drug molecules and 
nucleotides. 70 A proton involved in hydrogen-bonding will exhibit a downfield shift 
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due to deshielding by the hydrogen-bond acceptor and proton nnir may be applied to 
systems where two or more species are present in addition to studying the self 
association of molecules. 7 ' Two dimensional correlation spectroscopy and nuclear 
Overhauser effect spectroscopy may also be used to study interactions based on the 
combination of it stacking and hydrogen-bonding e.g. in model systems for 
nucleotides. 72 
4.3.4 Infrared spectroscopy 
Infrared spectroscopy is also a useful tool to study the association of molecules, both 
in the solid state and in solution. A shift in a peak in an JR spectrum with a change 
in concentration or the addition of a second species to the solution indicates a change 
in the strength of the bond which can be interpreted in terms of the atoms being 
involved in more or less hydrogen-bonding interactions. Most studies reported have 
used organic solutions, 73,74  usually carbon tetrachloride, as a convenient medium 
however the technique may also be applied to study molecules in such solvents as 
supercritical carbon dioxide. 75 
4.4 Solution studies of monosulfonamidodiamine ligands 
4.4.1 ESI spectra of monosulfonamidodiamines 
ESI spectra were recorded using 1 x 106  M samples of ligands 1, 5, 4 and 8 in 
methanol (Figures 4.27-4.30). 
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215.1 	 ..fl  11 
Figure 4.27: ES! spectrum of a 1 x 10-6M methanolic solution of (N-(2-amino-ethyl)-4- 
methylbenzenesulfonamide) (1). 
456.8 	 I\ 
Figure 4.28: ES! spectrum of a 1 x 1016 M methanolic solution N-(3-aminopropyl)4-methylbenzene-
sulfonamide (5). 
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NH HN—S 






Figure 4.30: ES! spectrum of a 1 x 10-6  M methanolic N-(N-2-ethylhexyl-3-aminopropyl)4-
methylbenzenesulfonamide (8). 
Each spectrum displays peaks for a monomer and a dimer species in solution. These 
results are encouraging, however at best they are qualitative. Although the 
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concentration of the initial ligand solution was known, molecular ions are produced 
by evaporation of the solvent until the droplets are reduced in size (Figure 4.31) to 
the point at which desolvation may be aided by repulsive Coulombic forces 
overcoming the cohesive forces of the droplet. 
76 Therefore the concentration of 
ligand is much higher prior to detection and it must be remembered that such dimer 
peaks may be a product of the ESI technique only. 
evaporation 
( MH+
MH+ 	 ( MH+ 
Figure 4.31: Reduction in droplet size using the ES! technique. 
4.4.2 VPO of monosulfonamidodiamine ligands 
Preliminary VPO studies on ligands 1, 5 and 10 were carried out in chloroform due 
to their limited solubility in other solvents (Figure 4.32). These preliminary studies 
were carried out to confirm that VPO could be used to follow association 
phenomenon before undertaking the preparation of ligands with solubility in a range 
of organic solvents. Results for all VPO measurements in this chapter are tabulated 
in Appendix I. 
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Figure 4.32: The aggregation number (n), determined by VPO as a function of concentration for 
ligands (N-(2-aminoethyl)-4-methylbenzenesulfoflamide) • (1), N-(3-aminopropyl)-4-
methylbenzenesulfonamide d (5), and N-(2-aminophenyl)-4-methylbenzene-
sulfonamide A (10). [n is determined by the division of the experimentally determined 
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At a concentration of 20 mmolal the aggregation number of each species is very 
similar. As the concentration increases the value of n also increases indicating more 
aggregation in solution. Aggregation of ligand 1 increases with concentration 
slightly more rapidly than 5 or 10. 
Measurement of monosulfonamido diamines in solvents of different polarity was 
made possible by the introduction of a 2-ethyihexane group into ligands 1 and 5 
(Figure 4.33). 
NH HN NH HN—S--O- 11 
Figure 4.33: Monosulfonamidodiamino ligands N_(N2ethy1hexyl-2-aminoethyl)-4-methYlbenZene 
sulfonamide (4) and 
(8). 
Measurements were made in cyclohexane, toluene, chloroform, acetone and 
acetonitnie (dielectric constants are 2.0, 2.4, 4.8, 20.7 and 37.5 respectively77). It 
was expected that as the dielectric constant of the solvent increased a lower ligand-
aggregation would be observed, however it must be remembered that this is not 
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Figure 4.34: The aggregation number (n),determined by VPO, of N-(N-2-ethylhexyl-2-aminoethyl)-
4-methylbenzenesulfonamide (4) in cyclohexane N, toluene ., acetone s, chloroform 
A and acetonitrile x. 
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Figure 4.35: The aggregation number (n),determined by VPO, of N-(N-2-ethylhexyl-3-
aminopropyl)-4-methylbenzenesulfonamide (8) in cyclohexane U, toluene •, acetone•, 
chloroform A and acetonitrile x. 
The highest aggregation numbers for both 4 and 8 are observed in cyclohexane 
solution. Ligand 4 shows the expected trend in aggregation with solvent at high 
concentration and significantly higher aggregation numbers are observed for the non 
polar cyclohexane and toluene solutions. However at low concentration it is 
surprising to see more aggregation in acetone and acetomtrile over chloroform 
considering their much higher dielectric constants. Ligand 8 shows a different 
picture and aggregation cannot be explained by a change in dielectric constant. The 
lower aggregation in toluene than acetone found for 8 has been observed before at 
Edinburgh with 2-hydroxyphenyl oxime ligands. 78 
4.4.3 Proton nmr of monosulfonamidodiamine ligands 
Analysis of the behaviour of monosulfonamidodiamines in solution by proton nmr 
did not prove possible because the peak for the amino protons is not observed in 
chloroform-d1 or toluene-d8  and only a very broad peak is observed in acetonitrile-d3. 
The position of amino hydrogen atoms is unpredictable as it depends on the extent to 
which the hydrogen atoms are involved in hydrogen-bonding. 79 
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4.4.4 IR of monosulfonamidodiamine ligands 
IR spectra of ligands 4 and 8 were recorded at a concentration of 5 x 101  M in 
dimethylsulfoxide, acetonitrile, acetone, chloroform, toluene and cyclohexane. The 
wave numbers of the N-H peak were recorded and are listed in Table 4.1. 
Table 4.1: Amino peaks (cm) for 0.5 M solutions of ligands 4 and 8 in different solvents, 
a 
In some solvents the amino peak was not clearly observed for 8. 
Solvent & 	DMSO Acetonitrile 	Acetone 	Chloroform Toluene Cyclohexane 
dielectric 
constant 	45.0 	37.5 	20.7 	4.8 	2.4 	2.0 
4 	3317.9 	3278.4 	3268.8 	3287.1 	3283.2 	3280.0 
3271.6 	- 	 3288.0 	3290.9 
As the amino proton becomes more involved in hydrogen-bonding the N-H bond is 
expected to become weaker and will be seen at lower v in the IR spectrum. As the 
dielectric constant of a solvent is reduced it is expected that more inter-ligand 
hydrogen-bonding will be observed. For 4 this appears to be the case as moving 
from left to right along the table energy associated with the wave number for the N-H 
stretch decreases. The high degree of hydrogen-bonding in these solvents may be 
attributed to the solvents themselves being involved in hydrogen-bonding with the 
amino group. Trends are less clear for 8 because the N-H stretching band could not 
be observed in several solvents. 
4.5 Solution studies of sulfonamido oxime ligands 
4.5.1 ESI spectra of sulfonamido oxime ligands 
ESI spectra were recorded using 1 x 106  M samples of ligands 28, 33 and 32 in 
methanol (Figures 4.36-4.38). 
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I—' 
rnl 
Figure 4.36: ESI spectrum of a 1 x 10 M methanolic solution of 1-{2-[N-(4-methyl- 
benzenesulfonamido)]phenyl}ethan- 1-one oxime (28). 
0 0 
%5— NH N 
im 
Figure 4.37: ESI spectrum of a 1 x lO M methanolic solution of 1-{2-[N-(4-methylben.zene-
sulfonamido)]phenyl}(phenyl)methaflOne oxime (33). 
754.6 
215 




Figure 4.38: ESI spectrum of a 1 x 10-6M methanolic solution of l-{2-[N-(4-methyl-
benzenesulfonamido)]phenYl}ethafll -one 0 methyl oxime (32) 
ES! spectra of sulfonamido oxime ligands show evidence for the formation of a 
dimer species. It is interesting to note that a peak for a species with a mass slightly 
higher than the value expected for a dimer is observed for 32. These results are again 
consistent with the formation of associated species but given the nature of the 
technique do not prove that such behaviour occurs in solvents and under conditions 
of use which relate to extraction. 
4.5.2 VPO of sulfonamido oxime ligands 
Only sulfonamido oxime ligands 28 and 33 were studied using VPO. Due to their 
limited solubility results were recorded at only three different osmolatilities in 
chloroform solution, (Figure 4.39). 
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Figure 4.38: The aggregation number (n), [where n is the average mass determined in solution 
divided by the relative molecular mass of the molecule] determined by VPO for 1-{2-
[N-(4-methylbenzenesulfonamido)]phenyl} ethan- 1-one oxime (28) 0 and 1 -1 2-[N-(4- 
methylbenzenesulfonamido)]phenyl)(phenyl)methanone  oxime (33). in chloroform. 
Ligand 33 is shown to have a higher aggregation number than 28. This may be due 
to the second (Z) isomer of 33 which is also present in solution (Figure 4.40). 
OH 









Figure 4.40: E and Z isomers of 33. 
In 28 the oxime has E configuration and the X-ray structures of each sulfonamido 
oxime ligand of this configuration show only hydrogen-bonded dimerisation in the 
solid state (chapter 3). However, for 33 the X-ray structure of a Z isomer was also 
obtained and here the oxime is involved in a hydrogen-bonded oligomeric secondary 
structure. If this is also occuring in solution a higher value of n would be expected 
for 33 in comparison with 28. 
4.5.3 Proton nmr of sulfonamido oxime ligands 
4.5.3.1 Preliminary studies 
A preliminary nmr study on sulfonamido oxime ligands was undertaken using l-{2- 
[N-(4-methylbenzenesulfonamido)]phenyl} ethan- 1-one oxime (28) and 1-{2-[N-(4- 
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methylbenzenesulfonamido)phenyll }(phenyl)methanone oxime (33) in chloroform. 
[All data for the nmr experiments in this chapter may be found in Appendix II.] 
Peaks for the oxiniic proton and the sulfonamido proton were easily identified and 
spectra were recorded at different concentrations (Figure 4.41). Spectra were also 
run on ligand 32 in which the hydroxy oxime group has been replaced by a methoxy 
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Figure 4.41: Change 	in chemical shift of the 	oximic proton 	of 1-12-[N-(4- 
methylben.zenesulfonamido)] phenyl }ethan-1 -one oxime (28) N and 1-12-[N-(4- 
methylbenzenesulfonamido)phenyl] }(phenyl)methanone oxime (33) • in chloroform. 
The data plotted in Figure 4.41 for 1{2[N(4methylbenzenesu1fonamido)]Pheflyl} 
(phenyl)methanone oxime (33) are for the predominant E isomer. Because pure 
samples of the  and Z isomers of 33 were not available no further studies of 33 were 
done as the other isomer present could lead to complex association behaviour. 
It was expected that the chemical shifts of protons involved in hydrogen-bonding 
would move to higher field with increasing temperature, indicating that they are less 
involved in hydrogen-bonding. This was shown to be the case for 1-{2-[N-(4-
methylbenzenesulfonamido)]phenyl } ethan- 1-one oxime (28) (Figure 4.42). 
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Figure 4.42: The change in chemical shift of the oximic proton A and the sulfonamido proton 0 of 
1 {2_[N-(4-methy1benzenesuIfonamidO)] phenyl}ethan- 1-one oxime (28) with 
temperature of a 70 mM chloroform solution. 
4.5.3.2 Determination of equilibrium constants for the association of 
sulfonamido oxime ligands 
Following the success of these preliminary experiments, more comprehensive studies 
on the behaviour of 1- { 2[N-(4-methylbenzenesulfonamido)]phenYl }ethan- 1-one 
oxime (28) in chloroform and of 1-{2-[N-(4-pentylbenzenesulfonamidO)] 
phenyl } ethan- 1-one oxime (31) in deuterated chloroform, toluene and acetonitnle 
were carried out. The plot in Figure 4.43 shows the very similar behaviours in 
chloroform solution of ligand 28 and its more soluble analogue 31. 
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Figure 4.43: Chemical shifts of 1 {2{N(4_methylbenzenesulfonamido)]PheflYl}ethanl -one oxime 
(28) U, and of 1 -{2-[N-(4-pentylbenzenesulfonamido)]PheflYl} ethan- 1-one oxime (31) 
•, in chloroform at 297K. 
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Figure 4.44: The effect of temperature on the chemical shift of the oxime proton of l-{2-[N-(4-
pentyl-benzenesulfonamido)]phenYl }ethan- 1-one oxime (31) in chloroform, acetonitrile 
and toluene at 297K •, 307K N, and 317K A. 
Figure 4.44 clearly indicates that the chemical shift of the oximic proton is very 
dependent on the nature of the solvent. The signals in toluene are at lower field than 
those for solutions of identical concentration and at the same temperature in CDC13 
indicating that more hydrogen-bonding is taking place. The higher values for the 
chemical shifts of the oximic proton in acetonitrile solution can be attributed to the 
involvement of the solvent molecules in hydrogen-bonding to the oximic proton. 
This would also explain the very small changes in chemical shift of the oximic 
proton with concentration. The chemical shift of the sulfonamido proton also 
changes with solvent, concentration and temperature. 
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Figure 4.45: The effect of temperature on the chemical shift of the sulfonamido proton of 1 -{2-[N-
(4-pentylbenzenesulfonamido)]pheflYl}ethan-1 -one oxime (31) in chloroform and 
toluene at 297K •, 307K A,and 317K U. 
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X-ray crystallography studies of sulfonamido oxime ligands (section 3.4) showed 
that the sulfonamido NH of ligands 28, 29 and 33 is involved in intra-molecular 
hydrogen-bonding. The solution structure of these ligands may not be the same as 
the solid state structure. However, if this intra-molecular hydrogen-bond is present 
in solution it should become stronger upon the association of the ligands by 
hydrogen-bonding thus changing the chemical shift of the proton. This would be a 
result of the oximic nitrogen becoming more electronegative due to the hydrogen-
bonding interaction of the oximic proton and of the sulfonamido proton becoming 
more electropositive due to the inductive effect of a hydrogen-bond on the 
sulfonamido oxygen atom. 
Figure 4.46 shows that the data for ligand 31 in chloroform at 297K may be fitted to 
two different models. 80  In one, a monomer-dimer equilibrium is assumed and in the 
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Figure 4.46: Curve fits for dimerisation equilibrium and N-merisation equilibrium of nmr data for 31 
in chlororform 0 at 297K. 
In order to determine which type of equilibrium applies in our systems, a study of the 
concentration dependence of nmr signals of (31) should be carried out. This was not 
possible due to the limited solubility of this ligand. From the ESI spectra which 
indicate the presence of dimer species and from VPO measurements for 28 and 33 
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which suggest that aggregation numbers do not exceed 2 it was assumed that the 
equilibria are monomer-dimer for 28 and 31. Similar problems in the identification 
of equilibrium systems by nmr have been previously reported by others, e.g. 
Neumann who used 19F nmr to investigate the aggregation behaviour of acid red 266 
dye in aqueous solution. 81 
Nmr data were used to calculate the equilibrium constant (K) (Equation 4.18) for the 
self association of these ligands using the programme WinEQNMR. 82 
K 
2L - 	- L2 	Eq4.18 
Equilibrium constants calculated for ligands 28 in chloroform-d, and 31 in 
chloroform-dl and toluene-d8 are given in Table 4.2. The data collected for 31 in 
acetonitrile solution could not be fitted by the programme WiuEQNMR to calculate 
the association constants. This may be due to the very small changes in chemical 
shift observed with concentration which indicate that very little association of 
molecules of 31 is taking place in acetomtrile. 
Table 4.2: The equilibrium constant (K) for the dimerisation of 1-12-[N-(4- 
methylbenzenesulfonamido)] phenyl }ethan- 1-one oxime (28) in chloroform-d i and 1 -{ 2-[N- 
(4pentylbenzenesulfonamido)]pheflYl}ethan-l-Ofle oxime (31) in chloroform-di and 
toluene-dg at 297, 307 and 317K. 
Ligand Solvent K at 297K K at 307K K at 317K 
28 Chloroform-d1 5.3±0.5 4.7±0.5 3.7±0.3 
31 Chloroform-d 1 4.2 ± 0.4 3.8 ± 0.5 3.3 ± 0.5 
31 Toluene-d8 7.8 ±0.4 6.4±0.4 5.1 ±0.5 
The observed equilibrium constants show that a higher level of aggregation of 
sulfonamido oxime ligands is observed in the less polar toluene solution. The 
pentyl-substituted ligand 31 shows a smaller degree of association than the methyl-
substituted ligand 28 in chloroform solution. 
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4.5.3.3 Thermodynamic data for the association of sulfonamido oxime ligands 
When similar data are collected at different temperatures AG may be calculated at 
each temperature from the equilibrium constant K (Equation 4.19) and AH and AS 
may be determined using Equation 4.20. 
AG=—RT1nK 	 Eq4.19 
AG = AN - TAS 	 Eq 4.20 
Table 4.3: Thermodynamic data for the dimerisation of 1-{2-[N-(4-
methylbenzenesulfonamido)] phenyl}ethan-l-one oxime (28) in chloroform at 298K and for 
the climerisation of 1 -{2-[N-(4-pentylbenzenesulfonamidO)]pheflYl }ethan- 1-one oxime (31) 
in chloroform and toluene at 298K. 
Ligand Solvent AG kJ mol' AlT kJ mol' AS J mol'K' 
28 Chloroform-d 1 -4.2 ± 2.9 -14.5 ± 2.9 -34.7 ± 9.4 
31 Chloroform-d 1 -6.1 ±2.1 -9.7±2.1 -20.7 ±6.8 
31 Toluene-d8 -5.1 ±3.3 -21.0± 3.3 -53.3±10.6 
As might be anticipated for a reaction where bonds are formed the AH values are 
negative indicating an exothermic proccess. The negative sign of AG indicates that 
the association of sulfonamido oxime molecules is a favourable proccess and the loss 
in entropy of the systems is attributed to the organisation of the ligands by hydrogen-
bonding. The dielectric constant of chloroform (4.8) is roughly twice the value of 
toluene (2.4), this shows strong negative correlation with the magnitude of the 
equilibrium constants of dimerisation of 31 at different temperatures which are 
approximately double in toluene. This illustrates the effect of solvent polarity on 
hydrogen-bonding. 
4.5.4.4 Speciation of sulfonamido oxime ligands 
The working concentration of P50, Avecia's copper extractant, depends on the pH 
and the amount of copper in the aqueous feed and can range between 0.2-0.45 M. 83 
Using the computer package 'HySS2' 84 and the equilibrium constants determined for 
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ligand concentrations for may be predicted. The percentage of dimer and monomer 
present relative to the total molar concentration of the ligand as the monomer are 
shown in Figures 4.47, 4.48 and 4.49. 
Concentration (M) 
Figure 4.47: The variation in the % of dimer and monomer of ligand 28 in chloroform with ligand 
concentration. 
Concentration (M) 
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Figure 4.49: The variation in the % of dimer and monomer of ligand 31 in toluene with ligand 
concentration. 
Figures 4.47, 4.48 and 4.49 show the similar behaviour of 28 and 31. The gradient of 
the curve showing the % of dimer depends on the different equilibrium constants. In 
each case, at concentrations above 0.5 M the ligand exists almost completely as a 
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Figure 4.50: The predicted % of ligand dimerisation for ligands 28 (—) and 31 (—) in chloroform and 
ligand 31 (--) in toluene. 
4.6 Conclusions 
This chapter has ruled out the use of sulfinamido molecules to replace sulfonamido 
ligands as extractants on practical grounds. They have proved to be unstable and 
their preparations are difficult. In general terms the sulfonamido-ligands have low 
solubilities in non-polar solvents and this may limit their usefulness in any 
commercial application. The solubility of the monosulfonamidodiamine ligands was 
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improved by the introduction of a 2-ethyihexyl group and the solubility of 
sulfonamido oxime ligand 28 was enhanced by the use of 4-pentylbenzenesulfonyl 
chloride as the sulfonatmg component. Studies of the more soluble oxime ligands 
indicate that dimerisation to give pre-organised dimer set may occur in a similar 
manner to that proposed for the commercial oxime extractants for copper. However, 
the equilibrium constants for these dimerisation processes, as measured by nmr 
experiments, are relatively small and the importance of preorganisation in enhancing 
the "strength" of extractants in metal-recovery processes is not clear. Ligand-ligand 
association is also revealed in the studies on the monosulfonamidodiamine ligands 
but it has not proved possible to estimate the equilibrium constants for these 
processes because the signals associated with the N-H groups cannot be assigned in 
their proton nnir spectra. The following chapter expands the original aim to look at 
the development of ligands to form ternary complexes in an extraction process using 
the information on hydrogen-bonding gathered in chapters 2, 3 and 4. 
4.7 Experimental 
4.7.1 Instrumentation 
Melting points were determined with a Gallenkamp apparatus and are uncorrected. 
Elemental analysis was performed on a Perkin Elmer 2400 elemental analyser and a 
Carlo Erba 1108 Elemental analyser. IR spectra were obtained on a Perkin Elmer 
Paragon 1000 FT-JR spectrometer as potassium bromide discs or as thin films on 
NaCl plates. 'Hand ' 3 C NMR spectra were run on Bruker WP200, AC250 and 
AVANCE DPX360 spectrometers. Chemicals shifts () are reported in parts per 
million (ppm) relative to residual solvent protons as internal standards. Electron 
impact (El) mass spectra were obtained either on a Finnigan MAT4600 quadrapole 
spectrometer or on a Kratos MS50TC spectrometer. Fast atom bombardment (FAB) 
mass spectra were obtained on a Kratos MS50TC spectrometer in acetonitrile/3-
nitrobenzyl alcohollthioglycerol matrices. Electrospray ionisation (ESI) mass spectra 
were obtained on a Thermoquest LCQ spectrometer. Inductively coupled plasma 
atomic emission spectroscopy (ICP-AES) analysis was performed on a Thermo 
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Jarrell Ash Iris ICP-AES spectrometer. Vapour pressure osmometry (VPO) 
measurements were performed on a Wescor 5500 apparatus. 
4.7.2 Solvent and reagent pretreatment 
All reagents and solvents were commercially available (Acros or Aldrich) and were 
used as received. Solvents used for analytical purposes (NMR, MS, ICP, VPO, IR) 
were of spectroscopic grade. 
4.7.3 Synthesis of sulfinyl chlorides 
2-Methyl-propane-1-sulfinyl chloride (42) 
) o 
s. cI 
42 was prepared by the method of Yoon et a121 . A well stirred mixture of 2-methyl-1 
-propanethiol (45.1 g, 0.5 mol) and acetic acid (30.0 g, 0.5 mol) was cooled to -40°C. 
Sulfuryl chloride (141.8 g, 1.05 mol) was added dropwise over a period of 30 
minutes. Gas evolution was observed during the addition of the first quarter of the 
sulfuryl chloride, and the colour changed to yellow. Stirring was continued for 30 
minutes at -40°C, and the mixture was then allowed to reach room temperature over 
a period of 2h. Gas evolution commenced again and the colour changed to red. The 
mixture was warmed at 30°C until gas evolution ceased (-4h), while the pale yellow 
colour of the sulfmyl chloride appeared. Acetyl chloride was distilled off under 
vacuum to leave the crude sulfinyl chloride. The product was purified by distillation 
at 20 mm Hg, bp 94-98°C (55.15 g, 78%), (Found: C, 34.29; H, 6.43. Caic. for 
C4H9C1OS: C, 34.16; H, 6.45%). E,H (CDC1 3 , 200 MHz): 1.09 (d, 6 H, J 8.3, CH3), 
2.29 (m, 1 H, CH), 3.29 (m, 2 H, CH2). Sc (CDC13 , 50 MHz): 21 (CH3), 22 (CH3), 
25 (Gil), 74 (GH2). IR data (NaCl plate)/cm': 722w, 1147s, 1371m, 1387w, 1400w, 
1466m, 2875w, 2932w, 2964s. 
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4-Methylbenzenesulfinyl chloride (43)21 
0  11  
Using 4-methylbenzenethiol (62.11 g, 0.5 moles) in the procedure described for 42 
yielded 43 (58.46 g, 67%). This was charcterised by nmr and JR spectroscopy and 
was not purified before use due to the risk of explosion. 22 6H (CDC13, 360 MHz): 
2.49 (s, 3 H, CH3), 7.43 (d, 2 H, J 8.0, Ar Cl]), 7.80 (d, 2 H, J 8.3, Ar Cl]). öc 
(CDCI3 , 90 MHz): 22 (CH3), 124 (2 C, Ar CH), 131 (2 C, Ar CH). JR data (NaC1 
plate)/cm- I : 810w, 1161m, 1377s. 





( \  
0 
n-Butyl acetate (200 cm 3)  was added to phthalic acid anhydride (5.26 g, 36 mmol) 
and N-acetylethylenedianiine (3.3 g, 32mmol). The mixture was heated at reflux for 
five hours and then left to cool. The resulting yellow solid was collected by filtration 
and recrystallised from ethanol (50 cm 3) to yield a white crystalline solid, (5.08 g, 
68%), mp 184°C (Found: C, 62.18; H, 5.00; N, 11.94. Calc. for C 1 2H12N203: C, 
62.06; H, 5.21; N, 12.06%). S (CDC1 3 , 200 MHz) 1.90 (s, 3 H, CH3), 3.46-3.54 (m, 
2 H, CH2), 3.81-3.86 (m, 2 H, CH2), 6.09 (s, NH). 8c (CDCI3, 63 MHz) 23 (CH3), 37 
(CH2), 39 (CH2), 123 (2 C, Ar CH), 132 (2 C, Ar C), 134 (2 C, Ar CH), 168 (C=O), 
170 (2 C, C=O). JR data (KBr disc)/cm': 714w, 1027w, 1159w, 1400m, 1382m, 
1657s, 1705s, 2361w, 3286m, 3461w. FAB MS, m/z 233 (MH, 100.0%) 
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1, 2-Di(2-methylpropane-1-sulfinylamino)ethane (44) 
çSNH HNS) 
A solution of 2-methylpropane-1-sulfmyl chloride (5 g, 0.036 mol) in dry 
diethylether (50 cm  3)  was added dropwise to a solution of 1 ,2-diaminoethane (12.8 g, 
0.21 mol) in diethylether (150 cm 3) at —10°C over a period of two hours. A white 
precipitate and a yellow oil are observed. The diethylether was then removed in 
vacuo and tetrahydrofuran (100 cm  3)  was added. The tetrahydrofuran was then 
decanted, filtered and the solvent removed in vacuo to yield a white powder. 
Analysis proved this to be a disustituted product (44) (1.11 g, 23%), mp 109-111 °C 
(Found: C, 44.57; H, 8.55; N, 10.45. Caic. for C 10H24N202S2: C, 44.74; H, 9.01; N, 
10.44%). 8H  (CDC13, 200 MHz): 1.04 (d, 6 H, J 6.6, CH3), 2.06 (m, 2 H, Cl]), 2.63 
(m, 2 H, CH2), 3.31 (m, 4 H, C112), 4.83 (m, 2 H, NI]). 8c (CDC13 , 50 MHz): 21 (2 
C, CH3), 22 (2 C, CH 3), 24 (2 C, CH), 44 (2 C, CH 2), 63 (2 C, CH2). IR data (KBr 
disc)/cm - 1 : 1035s, 1078m, 1509m, 2960m, 3218m, 3434w. FAB MS, m/z 269 (MH, 
100.0%) 
1, 2-Di(4-methylbenzene-1-sulfinylamiflO)ethafle (46) 
—0-11 	sil—<7~— 
A solution of 4-methylbenzenesulfinyl chloride (5 g, 29 mmol) in dry diethylether 
(50 cm) was added dropwise to a solution of 1,2-diaminoethane (5.16 g, 86 mmol) 
in diethylether (150 cm 3) at —10°C over a period of two hours. A white precipitate 
and a yellow oil are observed. The diethylether was then removed in vacuo and 
tetrahydrofuran (100 cm  3)  was added. The tetrahydrofuran was then decanted, 
filtered and the solvent removed in vacuo to yield a white powder. Analysis proved 
this to be the disubstituted product (1.32 g, 27%), mp 104-106°C (Found: C, 56.74; 
H, 5.69; N, 8.31. Caic. for C 16H20N202S2: C, 57.11; H, 5.99; N, 8.33%). (CDCI3 , 
360 MHz): 2.43 (s, 6 H, CH3), 3.02 (m, 4 H, CH2), 7.31 (d, 4 H, J 7.9, Ar Cl]), 7.58 
(d, 4 H, J 8.3, Ar Cl]). Sc (CDC1 3 , 91 MHz): 22 (2 C, CH3), 41 (CH2), 42 (CH2), 126 
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(4C, Ar CH), 130 (4 C, Ar CH), 141 (2 C, Ar C), 142 (2 C, Ar Q. IR data (KBr 
disc)/cm': 1047s, 1087m, 1490w, 2872m, 2918m, 31965s, 3448w. FAB MS, m/z 
337 (MW, 58.6%). 
1{2_IN(4methy1benzenesu1finamidO)Jphefly1}ethan-1-Ofle (47) 
/JNH 0 
A solution of 4-methylbenzenesulfmyl chloride (0.32 g, 1.8 mmol) in dry 
diethylether (10 cm 3)  was added dropwise to a solution of 1-(2-amino-phenyl)- 
ethatione  (0.5 g, 3.7 mmol)in dry diethylether (10 cm 3). The mixture was then stirred 
for one hour. At the end of this time a yellow precipitate had formed and this was 
isolated by filtration. The yellow precipitate was washed with water (3 x 5 cm 3) to 
yield a white powder. (0.56 g, 55%). 8H  (CDC13, 360 MHz): 2.45 (s, 3 H, CH3), 2.61 
(s, 3 H, CH2), 7.03 (t, 1 H, J 7. 1, Ar Cl]), 7.37 (d, 2 H, J 8.5, Ar Cl]), 7.50 (t, 1 H, J 
7.8, Ar Cl]), 7.65 (d, 1 H, J 8.4, Ar Cl]), 7.71 (d, 2 H, J 8.2, Ar Cl]), 7.87 (d, 1 H, J 
8.0, Ar Cl]), 10.88 (NI]). 8 c (CDC13 , 91 MHz): 22 (CH 3), 29 (CH3), 117 (Ar CH), 
121 (Ar CH), 122 (Ar C), 126 (2 C, Ar CH), 130 (2 C, Ar CH), 133 (Ar CH), 135 
(Ar CH), 141 (Ar C), 142 (Ar C), 145 (Ar C), 202 (C=O). IR data (KBr disc)/cm: 
1054m, 1070m, 1363s, 1488s, 1618m, 1648s, 2797m, 3435m. FAB MS, m/z 274 
(MH, 41.8%) 
4.7.5 Introduction of a lipophilic group into monosulfonamidodiamines 
N(N-propy1-3-aminopropy1)4-methY1beflZeneSU1fOflamide (50) 
NH HN-S 
A solution of propanal (1.53 g, 26.3 mmol) in methanol (30 cm 3) was added to a 
solution of N-(3-aminopropyl)-4-methylbenzenesulfonamide) (4 g, 17.5 mmol) in 
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methanol (30 cm. 3 ) and was stirred for 12 hours. A catalytic amount of anhydrous 
sodium tetraborate (0.2 g, 1 mmol) and sodium borohydride (2.65 g, 70 mmol) were 
added and the solution was stirred for one hour. Water (200 cm 3)  was added and the 
methanol was removed in vacuo. The resulting yellow oil was extracted into 
dichloromethane (2 x 100 CM)  . Removal of solvent from the organic phase in vacuo 
gave a yellow oil which was triturated with hexane (3 x 100 cm) and diethylether (3 
5 cm3 ) to yield a sticky white solid (2.61 g, 55%). This proved difficult to purify. 
6H (CDC1 3 , 200 MHz): 0.84 (t, 3 H, J 7.2, CH3), 1.48 (m, 4 H, CH2), 2.36 (s, 3 H, 
CH3), 2.41 (t, 2 H, J 7.0, CH2), 2.57 (t, 2 H, J 5.9, CH2), 2.96 (t, 2 H, J 5.0, CH2), 
7.23 (d, 2 H, J 8.5, Ar Cl]), 7.67 (d, 2 H, J 8.3, Ar CH). FAB MS, mlz 271 (MH, 
100.0%). 
4.7.6 Synthesis of alkyl sulfonyl chlorides 
2-Ethyihexanesulfonyl chloride (51) 
11 
51 was prepared by an adaptation of the method of Zeigler and Sprague. 
46  1 -Bromo-
2-ethylhexane (38.63 g, 0.2 mol) and thiourea (15.22 g, 0.2 mol) in 50 cm  of ethanol 
were refluxed overnight. The ethanol was then removed in vacuo to leave a white 
solid. The crude isothiouronium salt was dissolved in 250 cm  warm water and 40% 
sodium hydroxide was added until no more cloudiness developed. The crude 2-
ethyhexane thiol was separated, washed with water, and dissolved in 50 cm 3 of acetic 
acid. About 25 g of crushed ice was added to the solution and the mixture was 
saturated with chlorine at 0-15°C. The oily product was extracted with diethylether. 
The extract was washed with 5% sodium bisulfite solution (100 
CM)  , and water (2 x 
100 cm 3)  then and dried over magnesium sulfate. The extract was filtered and the 
diethylether evaporated. A yellow liquid was obtained by distillation at 0.75 mm Hg, 
bp 92-96°C (14.89 g, 35%). 8H (CDC13, 360 MHz): 0.95 (m, 6 H, CH3), 1.36 (m, 4 
H, CH2), 160 (m, 4 H, CH2), 2124 (m, 1 H, Cl]), 3.71 (d, 2 H, J 6.0, CH2). 6c 
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(CDC13 , 90 MHz): 11 (CH3), 14 (GEl3), 23 (CH2), 26 (CH2), 29 (CH2), 32 (CH2), 37 
(CH), 70 (CH2). FAB MS, m/z (MH, 21.6%). 
4.7.7 Synthesis of alkyl-substituted arylsulfonyl chlorides 
Tetradecylbenzene (52) 
0- (CF'2)13CH3 
52 was prepared by an adaptation of the method of Wei et al. 
57 1 -bromododecane (5 
g, 20 mmol) in dry diethylether (20 cm 3)  was cooled to -78°C in an acetone/dry ice 
bath. Butyllithium (20 mmol) was then added and the mixture was allowed to stir for 
30 minutes. A solution of styrene (1.9 g, 18 mmol) in dry diethylether (20 cm) was 
then cooled to -25°C using an o-xylene/dry ice bath. The dodecyllithium solution 
was then added to the styrene solution via a canula, care was taken to maintain the 
temperature below -25°C. A colour change was then observed to deep orange. The 
solution was left to stir at -25°C for two hours. Methanol (1 cm 3) was then added 
and the solution became an opaque white. The mixture was allowed to stir for 10 
minutes before it was washed with water (3 x 50 cm 3). The ethereal solution was 
then dried over anhydrous magnesium sulfate. The colourless oil was then purified 
by kugelrohr (3.20 g, 58%), (Found: C, 86.84; H, 12.97. Cale. for C 20H34 C, 87.51; 
H, 12.48%). 6H (CDC13, 360 MHz): 0.86 (t, 3 H, J 6.9, CH3), 1.28 (m, 26 H, CH2), 
7.20 (m, 5 H, Ar CH). 8c (CDC13, 91 MHz): 14 (GIl3), 14 (CH2), 23 (CH2), 23 
(CH2), 28 (GIl2), 28 (GIl2), 30 (CH2), 30 (CH2), 30 (GIl2), 30 (CH2), 32 (CH2), 33 
(CH2), 37 (CH), 47 (CH2), 126 (Ar CH), 128 (2 C, Ar CH), 129 (2 C, Ar CH), 147 
(Ar Q. JR data (KBr disc)/cm': 1603w, 2854s, 2924s, 3027m. 
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4-Tetradecylbenzenesulfonyl chloride (53) 
--<:~--(CH2)13CH3 c_ If 
53 was prepared by the adaptation of the method of Buckel et al.58 To a solution of 
tetradecylbenzene (2.5 g, 9 mmol) in chloroform (30 cm  3),  chlorosulfomc acid (3.18 
g, 27 mmol) was added and the mixture was stirred at room temperature for 20 hours. 
The solution was then poured on ice, and the aqueous layer was then extracted with 
dichloromethane (2 x 50 cm 3). The combined extracts were washed with water (100 
cm3), a 10% aqueous solution of NaHCO3 (100 cm 3) and water (2 x 100 cm 3) before 
being treated with activated charcoal and dried over anhydrous MgSO4. The residue 
was purified by kugelrohr (3.00 g, 89%). 8 H (CDC13 , 360 MHz): 0.90 (m, 3 H, CH3), 
1.27 (m, 26 H, CH3), 7.40 (d, 2 H, J 8.5, Ar Cl]), 7.98 (d, 2 H, J 8.6, Ar Cl]). öc 
(CDC13 , 91 MHz): 14.4 (CH 3), 15 (CH2), 23 (CH 2), 23 (CH2), 28 (C112), 28 (CH2), 30 
(CH2), 30 (CH2), 30 (CH2), 32 (CH2), 32 (CH2), 37 (CF1), 37 (CH2), 49 (CH2), 128 
(2 C, Ar CH), 129 (2 C, Ar CH), 142 (Ar C), 156 (Ar Q. JR data (neat, NaC1 
plate)/cm': 1083m, 1175m, 1306w, 1381m, 2854s, 2926s. 





4-Octylbenzenesulfonyl chloride was prepared by the adaptation of the method of 
Yamaguchi et al.59  A mixture of sodium 4-octylsulfonate (6.14 g, 21 mmol) and 
phosphoryl chloride (4.83 g, 32 mmol) was stirred at 170°C for two hours. The 
mixture was cooled to 60°C before dichloromethane (100 cm  3)  was added and the 
solution was heated at reflux for 30 minutes. The solution was then cooled and 
poured into water (100 cm  3),  the sulfonyl chloride was then extracted with 
chloroform, washed with aqueous sodium chloride solution (2 x 100 cm 3) and dried 
with anhydrous magnesium sulfate (5.56 g, 92%). 8H (CDC1 3 , 360 MHz): 0.92 (t, 3 
H, J 6.7, CH3), 1.33 (m, 10 H, CH2), 1.69 (t, 2 H, J 7.3, CH2), 2.76 (t, 2 H, J 7.7, 
CH2), 7.44 (d, 2 H, J 8.5, Ar Cl]), 7.98 (d, 2 H, J 8.5, Ar Cl]). 6c  (CDC13 , 90 MHz): 
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14 (CH3), 23 (GH2), 30 (CH2), 30 (CH2), 31 (CH2), 32 (cl-I2), 37 (CH2), 54 (CH2), 
128 (2 C, Ar CH), 130 (2 C, Ar CH), 142 (Ar C), 152 (Ar Q. IR data (NaCl plate, 
neat)/cm': 1175m, 1379m, 2856s, 2927s. FAB MS, m/z 289 (MIr, 28.6%) 
1_12(N_(4octy1benzenesu1fonamidO)IPheflY1}ethan-1-0ne (56) 
H3C(H2C)7___. D_ 0 . 
A solution of 1-(2-amino-phenyl)-ethanone (2.11 g, 15.6 mmol) in pyridine (30 cm 3) 
was added dropwise to a solution of 4-octylbenzenesulfonyl chloride (4.5 g, 15.6 
mmol) in pyridine (30 cm) at 0°C over one hour. The mixture was then allowed to 
stir overnight. The pyridine was then removed in vacuo to produce a pink oil. 
Hexane (100 cm 3)  was then added to give a pink solid which was recrystallised from 
hexane (150 cm 3)  to yield a white crystalline solid (2 g, 3 5%), mp 63-64°C %), 
(Found: C, 68.19; H, 7.60; N, 3.60. Caic. for C 22H29NO3S C, 68.18; H, 7.54; N, 
3.61%). oH (CDC13 , 360 MHz): 0.90 (t, 3 H, J 6.8, CH3), 1.28 (s, 10 H, CH2), 1.59 
(m, 2 H, CH2), 2.58 (s, 3 H, CH3), 2.63 (t, 2 H, J 7.8, CR)),  7.09 (t, 1 H, J 7.0, Ar 
CH), 7.26 (d, 2 H, J 8.3, Ar CH), 7.48 (t, 1 H, J 7.2, Ar CH), 7.73 (d, 1 H, J 7.8, Ar 
CH), 7.77 (d, 2 H, J 8.3, Ar CH), 7.82 (d, 1 H, J 8.0, Ar CH). 5c  (CDC13, 90 MHz): 
14 (Cl-I3), 23 (CH2), 29 (Cl-I 3), 30 (2 C, CH2), 30 (CH2), 32 (CH2), 32 (CH2), 36 
(CH2), 120 (Ar CH), 123 (Ar C), 123 (Ar CH), 128 (2 C, Ar CH), 129 (2 C, Ar CH), 
132 (Ar CH), 135 (Ar CH), 137 (Ar C), 141 (Ar C), 149 (Ar C), 203 (C=O). IR data 
(KBr disc)/cm': 760m, 1162s, 1226m, 1342m, 1498m, 1648s, 2928s. FAB MS, m/z 
388 (MH, 100.0%), HRMS m/z caic. for 388.5511, found 388.1952. 
1_2_N(4_octy1benzenesuIfonamido)IPheflY1}etha11_1_0fle oxime (54) 
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Hydroxyamine hydrochloride (1.08 g, 16 mmol) was added to a solution of 1-{2-[N-
(4-octylbenzenesulfonamido)]phenyl}ethan- 1-one (2 g, 5.2 mmol) in a 50:50 
pyridine: ethanol solution (30 cm 3). This was heated at reflux for 4 hours and then 
cooled. The mixture was poured into water (100 cm 3),  the product was then 
extracted into diethylether (2 x 50 cm 3) and washed with water (6 x 100 cm3). The 
ethereal solution was then dried over anhydrous magnesium sulfate, filtered and the 
diethylether removed in vacuo to yield a yellow oil (1.77 g, 85%). 8H (CDC13 , 360 
MHz): 0.90 (s, 3 1-1, Cl-I3), 1.29 (m, 10 H, CH2), 1.51 (m, 2 H, CH2), 2.11 (s, 3 H, 
Cl-!3), 2.63 (m, 2 H, CH2), 1.51 (m, 2 H, CH2), 2.11 (s, 3 H, CH3), 2.63 (m, 2 H, 
CH2), 7.25 (m, 6 H, Ar Cl]), 7.60 (d, J 8.4, 2 H, Ar Cl]). öc (CDC13, 90 M}Iz): 13 
(CH3), 15 (Cl-I3), 23 (CH2), 30 (CU2), 30 (CU2), 31 (CU2), 32 (CH2), 32 (CU2), 36 
(CU2), 122 (Ar CH), 126 (Ar CH), 128 (2 C, Ar CU), 129 (2 C, Ar CU), 136 (Ar C), 
137 (Ar C), 137 (Ar CU), 137 (Ar C), 137 (Ar C), 149 (Ar C), 150 (Ar CU), 157 
(C=NOH). JR data (nujol, NaCl plate)/cm': 1159w, 1377m, 1625w, 3392w. FAB 
MS, m/z 403 (MJ{F  71.3%). 
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5.1 Introduction 
Chapters 2 and 3 dealt with ligand systems in which a hydrogen-bond donor atom 
and a hydrogen-bond acceptor site were built into one ligand system. Pseudo-
macrocyclic ligand formation of these ligands occured through a head-to-tail 
arrangement of the ligands. Progression from such ML 2 systems led to the attempted 
development of ML 1 L2 complexes in which one ligand (L') contains two acceptor 
sites and the second ligand (L) contains two donor sites. Such a system could also 
be applied to tridentate ligand systems to create ligands which form a pseudo-cage 
structure. A schematic representation of such 4-coordinate and 6-coordinate ML 1 L2 











Figure 5.1: Target ML 1 L2  systems where X are the donor atoms, A are the hydrogen-bond acceptor 
sites and D are the hydrogen-bond donor sites. 
Such systems could be very versatile as metal extractants because different 
hydrogen-bond donor and acceptor ligand types could be combined to tune the 
properties of the systems to bind selectively to one target metal. 
Bis- and tris-sulfonamido ligands (L') were synthesised. The two oxygen atoms of 
each sulfonamide group provide hydrogen-bond acceptor sites. The sulfonamido 
nitrogen atoms should be relatively easily deprotonated to give di- or tn-anionic 
ligands [L'-2H] 2 or [L'-3H] 3 . Simple, di- or tn- amines were envisaged as the 
complementary (L 2) ligands because of their N-H hydrogen-bond donor groups. 
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5.2 Bidentate bis-sulfonamidodiamine ligand systems 
5.2.1 Synthesis of bis-sulfonamidodiamine ligands 
The generic form of the disulfonamidodiamine ligands synthesised is shown in 
Figure 5.2. 
S N N-3-0 
R 
57 
58 	 1 ,2-trans-cyclohexane 
59 o-phenylene 
Figure 5.2: The generic form of a disulfonamidodiamine ligand, and ligands synthesised in this work. 
57 and 58 were readily prepared by the addition of two equivalents of 4-
methylbenzenesulfonyl chloride in toluene to one equivalent of the relevant diamine 
in toluene (Figure 5.3). 
H2N NH2 + 	2TsCI 	
(i) 	
TsHN NHTS 	+ 2HCI 
Figure 5.3: The synthesis of ligands 57 (R = -(CH2)2-) and 58 (R = 1,2-C 6H 10). (i) toluene, 25°C. 
59, was prepared following the method of Cheng et al. 1 The same reagent 
stoichiometries were used but pyridine was used as the solvent instead of toluene. 
5.2.2 Characterisation of bis-sulfonamidodiamine ligands 
5.2.2.1 NMR spectroscopy 
The characteristic resonances in the aromatic region, used to identify the 
monosulfonamido diamine ligands, shown by p-alkylarylsulfonamides were again 
useful for the identification of bis-sulfonamidodiamine ligands. The four aromatic 
protons fall into two magnetically equivalent sets in c and d (Figure 5.4) which have 
sufficiently different chemical shifts to give rise to two doublets, observed between 
7.2 and 7.7 ppm depending on the exact structure, and with a coupling constant 3JHH 
of typically 8 Hz. The d protons were shifted to lower field with respect to the c 
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protons due to the deshielding effect of the sulfonyl group. The 4-methylbenzene 
groups also give rise to a further characteristic singlet at around 2.4 ppm for the 
methyl group. 
As an example, 1 ,2-di(4-methylbenzenesulfonamido)ethane (57), shows a further 
multiplet at 2.70 ppm assigned to the methylene hydrogens of the ethane linkage 
group (Figure 5.4). ' 3C NMR is also useful in confirming the structures. 
Assignments for 1 ,2-di(4-methylbenzenesulfonamido)ethane (57) are given in Figure 
5.4. The methyl signal of the p-methylbenzene group is usually found around 20 
ppm and two equivalent sets of four aromatic C-H groups are found around 130 ppm. 
The remaining signals are easily assigned using DEPT techniques. 2 
He Nd Hd He 
Cc—Cd 0 	H2Cf—ICH2 	 Cd=C0 
H 3Ca—Cb Ce—S—NH HN—S—Ce Cb—aCH3 




Hd Hd He 
' 3C NMR (ppm) 'H NMR (ppm) 
a 21 2.38 
b 143 
C 127 7.38 
d 130 7.61 
a 143 
42 2.70 
Figure 5.4: NIvIR assignments for 1, 2-di(4-methylbenzenesulfonamido)ethafle (57). 
5.2.2.2 Mass spectrometry, IR spectroscopy and micro-analysis 
IR and mass spectrometry were routinely used for characterisation. One strong band 
was found in the 1370-1330 cm -1 region and another in the 1180-1160 cm' region 
for the -S02-N group. Of the mass spectrometry techniques available (El, FAB and 
ES!) fast atom bombardment has been used primarily for analysis purposes. The 
composition of each compound was supported by elemental analysis. 
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5.2.2.3 X-ray crystallography 
Ligands 57, 58, and 59 were all characterised by X-ray crystallography. The bond 
lengths of the central components of each ligand are listed in Figure 5.5. 
Fv 	11 -Pi., 11 	11 - iqi iv' 101 
ToI—S--1--NH 	HN—S—ToI 	ToI—S--1—NH 	HNLSToI 	ToI—S--1—NH 	HN—S—ToI 
II II II II II II 
0 	 0 	 0 	 0 	 0 	 0 
57 	 58 	 59 
Bond 	57" 	 58a 	 59 
1.622(3) 1.6113(19) 1.621(3) 
ii 	1.467(5) 1.465(3) 1.414(5) 
iii 1.509(7) 1.531(4) 1.414(5) 
iv 	1.467(5) 1.465(3) 1.429(5) 
V 	 1.622(3) 1.6113(19) 1.624(3) 
° Molecules 57 and 58 are centrosymmetric. 
Figure 5.5: Bond lengths (A) for the central components of bis-sulfonamidodiamine ligands 57, 58, 
and 59. 
The S-N lengths are similar in each case. The C-N lengths in 57 and 58 are similar 
however they are shorter in 59 due to the delocalisation of the it electrons over the C-
N bond. The C-C length in 59 is also shorter due to the aromatic nature of the bond. 
5.2.3 Solid state structures of bis-sulfonamidodiamine ligands 
5.2.3.1 1, 2-Di(4-methylbenzenesulfonamido)ethane (57) 
The asymmetric unit of 57 consists of half of the molecule, the whole molecule is 
generated by a centre of symmetry (Figure 5.6). 
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ck (1 A) 	 cl6A ) 
C(7AA) 	
C(9AA) 	 C 
C(4A)






Figure 5.6: The X-ray structure 1, 2-di(4-methylbenzenesulfonamido)ethane (57). 
There is no intra-molecular hydrogen-bonding in 57, however molecules are linked 
along the b axis by four hydrogen-bonds between the sulfonamido oxygen atom 
(O(1A)) and the sulfonamido hydrogen atoms (H(3A)), [N(3A)-H --- O(1A), 2.958(4) 
A; N-H-O, 165(4) 0] (Figure 5.7). 
Figure 5.7: The hydrogen-bonded chain of molecules of 57 along the b axis. 
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5.2.3.2 1, 2-Di(4-methylbenzenesulfonamido)cyclohexane (58) 
The asymmetric unit of 58 consists of half of the molecule and the whole molecule is 
generated by a C2 axis passing through the cyclohexane ring (Figure 5.8). 
CO Id 
O(2A) 
Figure 5.8: The X-ray structure 1, 2-di(4-methylbenzenesulfonamido)cyclohexane (58). 
The secondary hydrogen-bonded structure is very similar to 57 and the sulfonamido 
groups assemble across inversion centres to form a chain along the c axis. In total, 
there are four hydrogen-bonds per molecule involving the sulfonamido oxygen 
(0(2A)) and hydrogen atom (H(3A)), [N(3A)-H --- O(2A), 2.956(2) A; N-H-O, 
172(2)°] (Figure 5.9). 
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Figure 5.9: Inter-molecular hydrogen-bonded chain of molecules of 58 along the c axis. 
5.2.3.3 1,2-Di(4-methylbenzenesulfonamido)benzene (59) 
The asymmetric unit of 59 is shown in Figure 5.10. There are two intra-molecular 
hydrogen-bonds per molecule. Similar hydrogen-bonds were observed for the 
monosubstituted molecule (10) discussed in section 2.4.1.5. One sulfonamido 
hydrogen atom (H(3A)) is bifurcated and forms hydrogen-bonds with the 
sulfonamido nitrogen atom (N(3B))and the sulfonamido oxygen atom (0(2B)) of the 
second sulfonamido group [N(3A)-H --- N(3B), 2.809(4) A; N-H-N, 101(3)°] and 
[N(3A)-H --- O(2B), 2.877(4) A; N-H-O, 134(4)°] respectively. 
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Figure 5.10: The asymmetric unit of 1, 2-di(4-methylbenzenesulfonamido)benzene (59). 
Molecules of 59 are linked along the c axis by two inter-molecular hydrogen-bonds 
between the sulfonamido hydrogen atom (H(3B)) not involved in intra-molecular 
hydrogen-bonding and a sulfonamido oxygen atom (0(2A)) [N(3A)-H --- O(2A), 
2.975(4) A; N-H-O, 170(5) 0] (Figure 5.11). 
Figure 5.11: The hydrogen-bonded chain of molecules of 59 along the c axis. 
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5.2.4 Hydrogen-bonding in bis-sulfonamidodiamine ligands 
The intra- and inter-molecular hydrogen-bonding interactions in bis-
sulfonamidodiamine ligands are summarised in Tables 5.1 and 5.2. 
Table 5.1: The intra-molecular hydrogen-bond lengths (A) and angles (°) of bis-
sulfonamido ligand 59. 
Ligand 	- Interaction type 	Hydrogen-bond 	Hydrogen-bond 
length I A angle / 
59 	N(S)-H---O(S) 	2.809(4) 	 101(3) 
	
N(S)-H---N(S) 2.877(4) 134(4) 
Atoms labelled S are contained in a sulfonamido group. 
Table 5.2: The inter-molecular hydrogen-bond lengths (A) and angles (°) of bis-sulfonamido 
ligands 57, 58 and 59. 
Ligand Interaction type Number of Hydrogen-bond Hydrogen-bond 
interactions length / A angle I 
57 N(S-H --- O(S) 4 2.958(4) 165(4) 
58 N(S)-H---O(S) 4 2.956(2) 172(2) 
59 N(S)-H---O(S) 2 2.975(4) 170(5) 
Atoms labelled S are contained in a sulfonamido group. 
The average intra-molecular hydrogen-bond length (2.85 A) is shorter than the mean 
inter-molecular length (2.96 A). However, the inter-molecular bonds are closer to 
linearity (mean bond angle 168°) than the intra-molecular bonds (mean bond angle 
= 118°). 
5.2.5 Attempted formation of transition metal complexes of bis-
sulfonamidodiamine ligands 
The reaction of equimolar mixtures of bis-sulfonamido ligands 57-59 and a diamine 
with an identical hydrocarbon backbone with metal(H) acetate salts in methanolic 
solution did not generate metal complexes containing deprotonated sulfonamides. 
Colour changes for the reaction of copper, nickel and cobalt acetates were consistent 
with the formation of diamine complexes. The complexation of 57 with copper(II) 
and N,N'-dibutyl- 1 ,2-diaminoethane or N,N'-dibenzyl- 1 ,2-diaminoethane was also 
tried in addition to reaction mixtures where pyridine or 1 ,2-diaminoethane were used 
as the amine and the solvent. However, the only product of these reactions identified 
was the tris( 1 ,2-diaminoethane)copper(II) complex with two acetate counteramons. 
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5.3 Tridentate tris-sulfonamidotriamino ligand systems 
5.3.1 Synthesis of tridentate tris-sulfonamidotriamine ligands 









61 	 62 
Figure 5.12: Target ligands tris-[2-(4-methylbenzenesulfonyamido)ethyl]amine (60), cis-cis-1,3,5- 
tris-(4-methylbenzenesulfonamido)cyclohexane (61) and N,N',N'-tris-(4-methylbenzene 
sulfonyl)-2-aminomethyl-2-methylpropafle- 1,3-diamine (62). Ts = -S0 2C6H4CH3. 
The tn-amine precursor of 60 is commercially available and the method of Chen et 
a!3 was used to synthesise 60 according to the scheme in Figure 5.13. 4-
Methylbenzenesulfonyl chloride in diethylether was added dropwise to tris-(2-
aminoethyl)amine and sodium hydroxide in water. This led to the formation of 60 in 
good yield (79%). 
NH2 	 NHTs 
TsHN H2N 	
(I) 
N, 	 + 3TsCI 	 + 3HCI 
NH2 	 NHTs 
Figure 5.13: The synthesis of tris-(2-(4-methylbenzenesulfonamido)ethyl)amifle (60). 	(i) 1. 
Diethylether, 2. NaOH, H 20. 
The cis-cis-1, 3, 5-tniaminocyclohexane required for the synthesis of 61 was not 
commercially available and was prepared by the method of Bowen et a!4 (Figure 
5.14). 
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Figure 5.14: The synthesis of the hydrobromide salt of cis- cis-1,3,5-triaminocyclohexane (64) via 
cyclohexane- 1 ,3,5-tricarboxylic acid tris-(benzoxy-amide) (63). (i) 1. Benzene, NEt 3 , 
diphenylphosphorylazide. 2. Benzyl alcohol, 18 hour reflux. (ii) 1. 30% v/w HBr in 
acetic acid, stir for 3 hours. 2. Ethanol. 
The tris-sulfonamide 61 was prepared by the reaction of 4-methylbenzenesulfonyl 
chloride with 64 using a similar method  for the synthesis of 60. 
The preparation of the triamine precursor of ligand 62 was attempted by the route 











Figure 5.15: The synthesis of 1,1,1 -tris(aminomethyl)ethane (67). (i) 3 eq. 4-methylsulfonyl 
chloride, pyridine, 0°C. (ii) Sodium azide, ethylene glycol, 16 hours at 135°C. (iii) 
Ethanol, H2, PdC, 3.4 atm. 
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1,1,1 -Tris(hydroxymethyl) ethane was reacted with 4-methylbenzenesulfonyl 
chloride to yield 1,1,1 -tris(benzenesulfonyloxymethyl)ethane (65) which was 
subsequently treated with sodium azide to yield 1,1,1 -tris(azidomethyl)ethane (66).6 
The third step, involving the reduction of 66 using lithium aluminium hydride, 6 
proved to be difficult and resulted in low yields. Reduction of the azide by 
hydrogenation  proved to be a much simpler and quicker route to 67 and resulted in 
higher yields. 
The ti-is-sulfonamide 62 was prepared by the reaction of 4-methylbenzenesulfonyl 
chloride with 67 using the method of Crank and Eastwood. 9 Conditions were again 
similar to those used for the synthesis of 60 and 61. 
Aliphatic azides are known to be potentially explosive and other routes to 67 and 62, 
avoiding azide formation, were explored. None of the experiments mentioned below 
proved successful. However it may be useful to others to note that such routes were 
tried. Figure 5.16 shows the attempted displacement of methylsulfonate groups from 
68 or bromide groups from 69, by sodium amide. Reaction of 68 failed and 'H nmr 
analysis of the product formed upon reaction of 69 suggested the formation of a 
polymeric material. 
(I H ) i  NH2 
X 	 NH2 
Figure 5.16: Attempted synthesis of salt of 67 by the displacement of X by sodium amide. 
X = -OS02CH3 (68) or Br (69). (i) Na, NH3(i qu id). 
The direct synthesis of 62 by the nucleophilic substitution of a methylsulfonate group 
by a 4-methylbenzenesulfonamide group was also tried (Figure 5.17). However, 
experiments where 4-methylbenzenesulfonamide was generated in situ using sodium 
methoxide or butyllithium and where it was first prepared using sodium all proved 
unsuccessful. 
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r 	)X 	+ 3TSNH 	 I 	jHTs +  3 CH3S02 
NHTs NHTs 
Figure 5.17: The reaction of 2-methyl-i ,3-bis(methylsulfoyloxy)-2-(methylsulfonylOXy-methYl)-
propane (68) with 4-methylbenzenesulfonamide. X = -OS0 2CH3 . 
5.3.2 Characterisation of tris-sulfonamidotriamine ligands 
5.3.2.1 NMR spectroscopy 
Characterisation was accomplished using nmr assignments for the sulfonamido units 
as outlined in 5.2.2.1. 
Each of the tns-sulfonamido ligands have significantly different backbones and the 
'H and ' 3C nmr assignments for each ligand are listed in Figure 5.18. In ligand 60, 
two additional multiplet signals are observed for the methylene groups at 2.42 and 
2.86 ppm. The protons of methylene groups fare shifted further downfield than in 
group g due to the electron withdrawing sulfonyl group. 
The hydrogen atoms of the cyclohexyl ring in 61 are in three different environments. 
Atoms h and i are different as they are positioned trans to either another proton or a 
sulfonamido group. Although signals h and i are multiplets, and the coupling 
constants cannot be measured for the splitting pattern, the signals may be assigned 
due to the width of the signal. Protons h and i are coupled resulting in a large 
geminal coupling. Each proton would also be coupled to protonf, in h this results in 
a large axial-axial coupling and in i a smaller axial-equatorial coupling is observed. 
Therefore it is expected that a broader signal is observed for h than for i. 
A singlet for the methylene groups of 62 is observed at 2.58 ppm and for the methyl 
group h at 0.77 ppm. 
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' 3C NMR spectra were readily assigned. The methyl signal of the 4-methylbenzene 
group is usually found at 20 ppm.and two equivalent sets of six aromatic C-H groups 
are found around 130 ppm. The remaining signals are easily assigned using DEPT 
techniques. 2 











4 r NHTs 
TsHN 	
NI-ifs I 	 NI-Irs 
NI-ITS 	 Hh 
60 	 61 	 62 
Nd 	NC 
o 	Cd- Cc 
II 
T 	—S—Ce 	Cb—CH 3a 
o 	Cc 
Hd 	Hc 
a b c d a f 9 	h 
60 	'Hnmr 2.38 - 7.25 7.76 - 2.86 2.42 - 	 - 
13Cnmr 22 137 128 130 144 55 41 	- 	 - 
61 	'Hnmr 2.42 - 7.35 7.58 - 2.97 - 	 0.88 1.50 
13Cnmr 22 140 127 130 143 49 41 - 	- 
62 	'H nmr 2.40 - 7.41 7.66 - 2.58 - 	 0.77 - 
13Cnmr 22 138 127 131 144 48 - 	 19 	- 
Figure 5.18: 'Hand ' 3C nmr assignments for 60, 61 and 62. 
5.3.2.2 Mass spectrometry, JR spectroscopy, X-ray crystallography and micro-
analysis 
IR and mass spectrometry were routinely used for characterisation. JR spectroscopy 
confirmed the presence of the sulfonamide group in the products. One strong band 
was expected in the 1370-1330 cm - 1 region and another in the 1180-1160 cm - 1 region 
for the -S02-N group. Of the mass spectrometry techniques available (El, FAB and 
ESI) fast atom bombardment has been used primarily for analysis. Each ligand was 
analysed by X-ray crystallography and the composition of the bulk sample was 
determined by elemental analysis to support the structure. 
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5.3.3 Solid state structures of tris-sulfonamidotriamine ligands 
5.3.3.1 Tris-(2-(4-methylbenzenesulfonamido)ethyl)amifle (60) 
There are two crystallographically independent molecules of 60 in the asymmetric 
unit, type 1 and type 2, (Figure 5.19). Each shows extensive intra-molecular 
hydrogen-bonding. Type 1 molecules (containing arms A, B and C) have two 
interactions from the bifurcated sulfonamido hydrogen atom of arm A to the central 
nitrogen atom and to a sulfonamido oxygen atom of arm C [N(3A)-H --- N(1), 
2.849(4) A; N-H-N, 110(4)°; N(3A)-H --- O(1C), 3.187(4) A; N-H-O, 129(4) 0] and 
one interaction from the sulfonamido hydrogen atom of arm B to the sulfonamido 
nitrogen atom of arm C [N(3B)-H --- N(3C), 3.321(5) A; N-H-N, 155(5)°]. There are 
four intra-molecular interactions in type 2 molecules (containing arms D, E and F). 
The bifurcated sulfonamido hydrogen atom of arm E bonds to the bifurcated 
sulfonamido oxygen of arm F and to the central nitrogen atom [N(3E)-H --- O(2F), 
2.956(4) A; N-H-O, 163(5)0 ; N(3E)-H --- N(2), 2.91 A; N-H-N, 102 0]. The 
sulfonamido hydrogen atom of arm D is also bifurcated and forms interactions with 
the bifuracted sulfonamido oxygen atom of arm F and the central nitrogen atom 
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Figure 5.19: The two crystallographically independent molecules, type 1 and type 2, of tris-(2-(4-
methylbenzenesulfonamido)ethyl)amine (60) in the unit cell. 
Extensive inter-molecular hydrogen-bonding is also observed in 60. 	Each 
crystallographically independent molecule forms separate hydrogen-bonded chains. 
Type 1 molecules are linked to two other molecules via two hydrogen-bonds 
between the sulfonamido hydrogen atom of arm C and a sulfonamido oxygen atom 
of arm A [N(3C)-H --- O(2A), 2.793(4) A; N-H-N, 154(5)°] (Figure 5.20). Very 
similar interactions between the sulfonamido hydrogen atom of arm F and a 
sulfonamido oxygen atom of arm E link type 2 molecules [N(3F)-H --- O(1E), 
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Figure 5.20: Hydrogen-bonded chain of type 1 molecules of 60 along the a axis. 
5.3.3.2 Ciscis_1,3,5,tris-(4-methy1benzenesu1fOflaflhidO)-CYC1OheXafle (61) 
There are two crystallographically independent molecules of 61 in the asymmetric 
unit (Figure 5.21). 
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Figure 5.21: The X-ray structures of the two crystallographically independent molecules, type 1 and 
type 2, of Cis-cis- 1 ,3,5-tris(4-methylbenzenesulfonylamino)-cycloheXafle (61). 
There are no intra-molecular hydrogen-bonding interactions, however there are 
extensive inter-molecular interactions. Type 1 molecules (containing arms A, B and 
C) and type 2 molecules (containing arms D, E and F) form separate parallel-stacked 
chains along the b axis. Molecules are linked by three hydrogen-bonding 
interactions to form stacks, pairs of adjacent stacks are linked by further hydrogen-
bonding. Stacks of type 1 molecules are linked by a hydrogen-bond from a 
sulfonamido oxygen of arm C to the sulfonamido hydrogen atom of arm B [N(3B)-
H --- O(1C), 2.977(4) A; N-H-O, 175(3)°] and by hydrogen-bonds, via an ethanol 
molecule, between a sulfonamido oxygen of arm A and the sulfonamido hydrogen of 
arm A of the second molecule [O(1Sl)-H---O(1A), 2.67(5) A; O-H-O, 1620, N(3A)- 
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Figure 5.22: Type 1 molecules linked by hydrogen-bonding to form a stack. 
Pairs of parallel stacks of type 1 molecules are linked by diagonal hydrogen-bonding 
interactions between a sulfonamido oxygen atom and the sulfonamido hydrogen 
atom of arm C of each molecule [N(3C)-H --- O(2C), 2.894(4) A; N-H-O, 160(4) 0} 
(Figure 5.23). 
Figure 5.23: Hydrogen-bonding between the stacks of type 1 molecules. 
Type two ligands form a similar hydrogen-bonded parallel stacked structure to type 
one molecules with slightly different hydrogen-bond lengths and angles. 
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5.3.3.3 N,N 1 ,N"-tris-(4-methylbenzenesulfonyl)-2-aminomethyl-2-
methylpropane-1, 3-diamine (62) 
The asymmetric unit of 62 is shown in Figure 5.24. There is only one intra-
molecular hydrogen-bond between the sulfonamido nitrogen atom of arm B and the 





D  1.ç,C(4B) S(2B) 
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C(128) 
Figure 5.24: The asymmetric unit ofN,N',N"-tris-(4-methylbenzenesulfonyl)-2-aminomethyl-2-
methyipropane- 1, 3-diamine (62). 
Molecules of 62 are linked by pairs of hydrogen-bonds formed across inversion 
centres by the sulfonamido groups of arms B and C along the c axis to form a chain 
[N(3C)-H --- O(1B), 2.924(4) A; N-H-O; 172(3)°, N(3B)-H --- O(1C), 2.913(4) A; N-
H-O, 159(4)°] (Figure 5.25). 
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Figure 5.25: Hydrogen-bonding of the sulfonamido groups of arms B and C of 62 across inversion 
centres to form a chain along the c axis. 
5.3.4 Hydrogen-bonding in tris-sulfonamidotriamine ligands 
The intra- and inter-molecular hydrogen-bonding interactions in the tris-sulfonamido 
ligands are summarised in Tables 5.3 and 5.4. 
Table 5.3: The intra-molecular hydrogen-bond lengths ( A) and angles (°) of tris-
sulfonamido ligands 60, 61 and 62. 
Ligand 	 Interaction type Hydrogen-bond Hydrogen-bond 
length / A angle I 
600 	Molecule 1 	N(S)-H---O(S) 3.187(4) 129(4) 
N(S)-H---N(S) 3.31(5) 155(5) 
N(S)-H---N(A) 2.849(4) 110(4) 
Molecule 2 	N(S)-H---O(S) 2.956(4) 163(5) 
N(S)-H---O(S) 3.306(5) 170(5) 
N(S)-H---N(A) 2.91 102 
N(S)-H---N(A) 2.90 100 
62 	 N(S)-H---N(S) 2.985(4) 108(3) 
' Ligand 60 has two crystallographically independent molecules in the asymmetric unit. Atoms labelled S are 
contained in a sulfonamido group. Atoms labelled A are tertiary amino nitrogen atoms. 
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Table 5.4: The inter-molecular hydrogen-bond lengths (A) and angles (°) of tris-
sulfonamido ligands 60, 61 and 62. 
Ligand 	 Interaction type 	Number of 	Hydrogen- 	Hydrogen- 
interactions 
	
bond length / bond angle I 
A 
60' 	Molecule 1 	N(S)-H...-O(S) 	2 	2.793(4) 	154(5) 
Molecule 2 N(S)-H---O(S) 2 2.900(5) 165(5) 
61° 	Molecule 1 	N(S).H --- O(S) 	2 	2.894(4) 	160(4) 
N(S)-H---O(S) 1 2.977(4) 175(3) 
O(E)-H---O(S) 	1 	 2.67(5) 	162 
N(S)-H---O(E) 1 2.813(5) 170(5) 
Molecule 2 	N(S)-H.--O(S) 	2 	2.898(4) 	165(3) 
N(S)-H---O(S) 1 2.899(4) 177(4) 
O(E)-H-.-O(S) 	1 	2.867(5) 	162 
N(S)-H---O(E) 1 2.813(5) 170(5) 
62 	 N(S)-H---O(S) 	1 	2.924(4) 	172(3) 
N(S)-H---O(S) 1 2.913(4) 159(4) 
Ligands 60 and 61 have two crystal lographically independent molecules in the unit cell. Atoms labelled S are 
part of a sulfonamido group. Atoms labelled E are contained in an ethanol molecule. 
In the tris-sulfonamidotriamine ligand 60 inter-molecular hydrogen-bonds (mean 
length and angle, 2.85 A, 159°) appear to be stronger than intra-molecular 
interactions (mean length and angle, 3.06 A, 133°). In molecule 62 intra- and inter-
molecular interactions have similar mean lengths of 2.90 and 2.92 A respectively. 
However the bond angles of the inter-molecular interactions (mean = 166°) are 
closer to linearity than the intra-molecular interactions (mean = 108°). The inter-
molecular interactions of 61 have very similar values to those in molecules 60 and 
62. As a result of the rigidity of the backbone of ligand 61 no intra-molecular 
hydrogen-bonds are observed. 
5.3.5 Coordination chemistry of tris-sulfonamidotriamine ligands 
5.3.5.1 Attempted formation of transition metal complexes of tris-
sulfonamidotriamine ligands 
Formation of metal complexes of the trifurcated tns-sulfonamido ligands proved 
more difficult than expected. Zinc, copper, cobalt and nickel(H) acetates or 
tetrafluoroborates were added to methanolic or acetonitrile solutions of ligands 60, 
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61 or 62 and sodium methoxide or potassium hydroxide was added in a 3:1 base to 
ligand ratio in an attempt to deprotonate each sulfonamido nitrogen atom. In most 
cases colour changes were observed however a solid material was not always 
isolated. Good analyses were obtained only for copper (70) and nickel (71) 
complexes of t ris [2(4methylbenzenesulfonamido)ethyl]amifle (60). 
Characterisation of products of complexation reactions of Cis-cis- 1 ,3,5-tris-(4-
methylbenzenesulfonamido)cyclohexane (61) and N,N',N"-tris-(4-methylbenzene 
sulfonyl)-2-aminomethyl-2-methyl propane-1, 3-diamine (62) did not prove possible. 
Attempts to form ternary complexes of the tripodal ligands in a one to one ratio with 
a triamine of an identical hydrocarbon backbone in methanol proved unsuccessful, 
using acetate and tetrafluoroborate transition metal(H) salts and sodium methoxide or 
potassium hydroxide as a base. Colour changes were consistent with formation of 
triamino complexes with copper, cobalt and nickel acetates and no evidence for a 
ternary sulfonamido-amino complex was observed. 
5.3.5.2 	N,N',N",N ... (Tris_(2_(4_methylbenzeneSUlfOflYlamiflatO)ethYl)aminatol 
copper(H) potassium(I) (70) 
The asymmetric unit of N,N',N",N ... [tris(2(4methylbenzenesulfonylamine)-ethyl)-
amine]copper(II) potassium(I) (70) comprises of one complex and one molecule of 
tetrahydrofuran (Figure 5.26). The copper has trigonal bypyramidal geometry and is 
coordinated to all four nitrogen atoms of ligand 60 and a water molecule. All three 
sulfonamido nitrogen atoms are deprotonated and a potassium cation balances the 
charge on the monoamomc complex. Lengths of bonds from the copper to the 
sulfonamidato nitrogen atoms are 2.052(3), 2.057(2) and 2.114(2) A, the lengths of 
bonds to the central nitrogen atom and to the coordinated water molecule are 
2.04 1(2) A and 2.000(2) A respectively. The potassium ion forms close contact 
interactions with three sulfonamido oxygen atoms, in the range of 2.65-2.84 A. 
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Figure 5.26: X-ray structure of N,N,N',N  ... [tris(2(4.methylbenzenesulfonyIamiflatO)ethy1)am1fle] 
copper(II) potassium(I) (70). 
There is no extensive inter-complex hydrogen-bonding between sulfonamido units. 
However, there are three intra-complex hydrogen-bonds. There is a bifurcated 
hydrogen-bond involving a hydrogen atom of the water molecule and the nitrogen 
atom (N(3B)) and an oxygen atom (0(1B)) of arm B of the ligand [0(1W)-H---
N(3B), 3.03 A; 0-H-N, 108°; 0(1W)-H---0(1B), 2.665(3) A; 0-H-0, 167(4) 0] and 
one interaction between the other hydrogen atom of the water molecule and an 
oxygen atom of arm C of the ligand [0(1W)H---0(2C), 2.694(3) A; 0-H-0 154(2)°]. 
These hydrogen-bonds are illustrated in Figure 5.26. 
5.3.6 Attempted methylation of tris_12-(4-methylbenzenesulfonylamino) 
ethylJ amine (60) 
The X-ray structure of complex 70 showed that all four nitrogen atoms of ligand 60 
can coordinate to the metal centre to form a monoaniomc complex. This results in 
the encapsulation of the metal centre by the ligand rather thanfac-coordination of the 
three sulfonamido nitrogen atoms which is required for the formation of a pseudo- 
0(1A) 
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cage complex using a second tridentate hydrogen-bonding amine ligand (Figure 5.1). 
Methylation of the capping tertiary nitrogen atom to give ligand I (Figure 5.27) 
would dramatically change the ligating properties of this ligand type. 
Me 
NHTs TsHN 	 I 
Figure 5.27: Methylated tris-[2-(4-methylbenzenesulfonylamino) ethyi]amine. 
There is no longer a lone pair on the capping nitrogen atom to interact with metal 
centres. The incorporation of the methyl unit will result in an exo-configuration with 
the methyl located away from the sulfonamido-metal bonds. This would promote the 
desired fac-octahedral arrangement of the three deprotonated sulfonamido groups. 
Another potentially useful feature of I in it's deprotonated form is that it would form 
neutral complexes with divalent metal ions, the quaternary ammonium centre 
providing the equivalent of the potassium ion in 70. There are many literature 
examples of the methylation of similar tertiary amines. 10" 1 However, only one 
example of the methylation of a tertiary nitrogen attached to three ethylamine groups 
was found in the literature and this was a cryptand.' 2 Three different methylating 
agents were tried, methyl iodide, dimethyl sulfate and trimethyloxomum 
tetrafluoroborate. The first two reagents failed to give any product and the latter 
reagent resulted only in the protonation of the nitrogen atom. It is thought that the 
difficulty in methylating this species may be due to the hydrogen-bonding 
interactions of the lone pair of central nitrogen (see Figure 5.19). 
5.3.7 Nitrogen geometry of bis- and tris-sulfonamide ligands 
The planarity of the sulfonamido nitrogen atom of bis- and tris-sulfonamido ligands 
and complex 70 were investigated in a similar manner to that described for the 
monosulfonamido ligands (chapter 2, section 2.4.4.2) by the measurement of 0 (the 
sum of the angles S-N-HIM, HIM-N-C and C-N-S) and a (the angle of the S-N bond 
from the plane defined by the nitrogen, carbon and hydrogen or metal atoms). The 
distance of the nitrogen atom from the plane defined by the carbon, sulfur and 
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hydrogen or metal atoms to which it is bonded. The results are given in Tables 5.5, 
5.6 and 5.7. 
Table 5.4: Values of the parameters 0, a and the distance of the nitrogen atom from the HCS 
plane to define the planarity of the sulfonamide nitrogen atom in bis-sulfonamidodiamine 
ligands 57, 58 and 59. 
Ligand Distance of N from HCS Sum of 3 angles, 0, Angle of S, a, from 
plane / A around N / NCH plane / 
570 0.274 343.4 40.3 
0.274 343.4 40.4 
580 0.224 349.6 31.9 
0.224 349.6 31.9 
59 0.221 348.6 32.1 
0.202 351.1 28.0 
0  Ligands 57 and 58 are centrosymmetric. 
Table 5.6: Values of the parameters 9, a and the distance of the nitrogen atom from the HCS 
plane to define the planarity of the sulfonamide nitrogen atom in tris-sulfonamidodiamine 
ligands 60, 61 and 62. 
Ligand Distance of N from Sum of 3 angles, 9, Angle of S, a, from 
HCS plane / A around N / NCH plane / 0 
600 	Molecule 1 0.273 345.2 37.1 
0.311 340.4 42.5 
0.285 343.8 41.0 
Molecule  0.311 341.6 41.2 
0.298 343.2 40.3 
0.198 352.3 27.9 
61 0 	Molecule 1 0.228 350.9 29.1 
0.313 340.1 42.8 
0.239 347.1 33.8 
Molecule 2 0.255 346.5 35.2 
0.142 356.3 19.0 
0.244 346.7 34.4  
62 	 0.181 	 353.7 	 25.2 
	
0.255 347.6 33.8 
0.167 	 354.5 	 23.7 
a Ligands 60 and 61 have two independent molecules in the asymmetric unit. 
Table 5.7: Values of the parameters 9, a and the distance of the nitrogen atom from the 
MCS plane to define the planarity of the sulfonamide nitrogen atom in complex 70. 
Complex 	Distance of N from 	Sum of 3 angles, 0, 	Angle of 5, a, from 
MCS plane / A around N / 0 	 NCM plane / 
70 	 0.394 	 343.5 	 36.9 
0.231 354.3 21.4 
0.081 	 359.3 	 7.6 
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In most cases in chapter 2 the sulfonamido nitrogen becomes more planar following 
the complexation of the ligand, this is also observed here on the complexation of 
ligand 60. As discussed in chapters 2 and 3, if the planarity of the amide is 
associated with a delocatisation of electron density in the N-S=O unit then we might 
expect there to be a connection between the planarity of the nitrogen and the lengths 
of the sulfur to oxygen and sulfur to nitrogen bonds. S=O and S-N bond lengths are 
recorded in Tables 5.8 and 5.9. The correlation coefficients between bondlengths 
and parameters defining the planarity of the sulfonamido nitrogen atom (see also 
section 2.4.4.2) are recorded in Tables 5.10 and 5.11. 
Table 5.8: S=O and S-N lengths of bis-sulfonanudodiamine ligands. a Ligands 57 and 58 
are centrosymmetric. 
Ligand S=O( 1) / A S=0(2) / A Average S=O S-N bond / A 
Length / A 
570 1.435 1.427 1.431 1.622 
1.435 1.427 1.431 1.622 
58a 1.428 1.434 1.431 1.611 
1.428 1.434 1.431 1.611 
59 	1.426 	- 	1.433 	 1.430 	 1.621 
	
1.425 1.440 1.433 1.625 
Table 5.9: S=O and S-N lengths of tris-sulfonamidotriamine ligands. a Ligands 60 and 61 
have two crystallographically independent molecules in the unit cell. 
Complex S=O(1) / A S0(2) I A Average S0 S-N bond / A 
Length I A 
600 	Molecule 1 1.424 1.434 1.429 1.617 
1.431 1.426 1.429 1.616 
1.426 1.424 1.425 1.630 
Molecule 2 1.433 1.434 1.434 1.626 
1.436 1.427 1.432 1.623 
1.427 1.436 1.432 1.625 
61' 	Molecule 1 1.432 1.438 1.435 1.598 
1.433 1.425 1.429 1.619 
1.432 1.442 1.437 1.603 
Molecule 2 1.429 1.431 1.430 1.619 
1.431 1.431 1.431 1.593 
1.438 1.433 1.436 1.611 
62 	 1.433 	1.430 	1.432 	 1.609 
1.438 1.424 1.431 1.612 
1.452 	1.427 	1.440 	 1.607 
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Table 5.10: The correlation coefficients of the parameters of nitrogen planarity in bis-
sulfonamido ligands 57, 58 and 59 with their SO and S-N bond lengths. 
X Y Correlation 
coefficient 
S-N length / A Average S=O length / A 0.35 
Distance of N from HCS plane / A Average S=O length / A -0.36 
Distance of N from HCS plane I A S-N bond length / A 0.36 
Sum of 3 angles around N, 0 Average S0 length / A -0.41 
Sum of 3 angles around N, 0. S-N length / A 0.20 
Angle of S from NCH plane, a Average S=O length / A -0.33 
Angle of S from NCH plane, a S-N bond length / A 0.21 
Table 5.11: The correlation coefficients of the parameters of nitrogen planarity in tris-
sulfonamido ligands 60, 61 and 62 with S0 and S-N bond lengths. 
X Y Correlation 
coefficient 
S-N length / A Average S0 length / A -0.49 
Distance of N from MCS plane / A Average S0 length / A -0.44 
Distance of N from MCS plane / A S-N bond length / A 0.43 
Sum of 3 angles around N, 0 Average S=O length / A -0.46 
Sum of 3 angles around N, 0 S-N length / A 0.66 
Angle of S from NCM plane, a Average S=O length I A -0.64 
Angle of S from NCM plane, a S-N bond length I A 0.70 
In the bis-sulfonamidodiamine ligands there is no correlation between the S-N and 
S=O lengths to suggest that nitrogen geometry is linked to a resonance effect, 
whereas in tns-sulfonamidotriamine ligands the expected negative correlation is 
observed (449). Bis- and tris-sulfonamido ligands show correlations of the same 
sign in each of the six remaining cases, however the correlation is always stronger 
for tris-sulfonamido ligands. For a and the distance of N from the HCS plane the 
expected correlations with S-N and S=O are observed, however 0 values show 
opposite correlations to those expected. 
5.4 Conclusion 
Bidentate and tridentate sulfonamido ligands have been successfully synthesised. 
However, in the limited studies of the formation of complexes with divalent 
transition metal ions carried out to date their application in the development of 
ternary complexes using ligands capable of forming pseudo-macrocycle or cage 
structures did not prove successful. This may be a result of the more favourable 
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formation of a simple ammo complex [M(L2)2] 2 over the ternary [M(L' -2H)L 2] or 
[M(L'-3H)L2] -  complexes. In the case of the bulky tridentate ligands it is also 




Melting points were determined with a Gallenkamp apparatus and are uncorrected. 
Elemental analysis was performed on a Perkin Elmer 2400 or a Carlo Erba 1108 
elemental analyser. IR spectra for solid materials were obtained as potassium 
bromide discs and for liquid materials as neat samples using sodium chloride plates 
on a Perkin Elmer Paragon 1000 FT-IR spectrometer. 'H and ' 3C NMR spectra were 
run on Bruker WP200, AC250 and AVANCE DPX360 spectrometers. Chemical 
shifts (ö) are reported in parts per million (ppm) relative to residual solvent protons 
as internal standards. Electron impact (El) mass spectra were obtained either on a 
Finnigan MAT4600 quadrapole spectrometer or on a Kratos MS50TC spectrometer. 
Fast atom bombardment (FAB) mass spectra were obtained on a Kratos MS50TC 
spectrometer in acetonitrile/3-nitrobenzyl alcohol/thioglycerol matrices. Electrospray 
ionisation (ESI) mass spectra were obtained on a Thermoquest LCQ spectrometer. 
5.5.2 Solvent and reagent pretreatment 
All reagents and solvents were commercially available (Acros or Aldrich) and were 
used as received. Solvents used for analytical purposes (NMR, MS) were of 
spectroscopic grade. 
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5.5.3 Synthesis of bis-sulfonamidodiamine ligands 
1, 2-Di(4-methylbenzenesulfonamido)ethane (57) 
-0-1- [-\ -FO-- NH 	HN 
A solution of 1,2-diaminoethane (20 g, 0.33 mol) in toluene (100 cm 3)  was added 
dropwise over one hour to a solution of 4-methylbenzenesulfonyl chloride (126.89 g, 
0.67 mol) in toluene (500 cm 3). A white precipitate was formed which was isolated 
by filtration and washed with methanol (3 x 50 cm 3). The powder was then 
recrystallised from ethanol (250 cm 3) to give a white crystalline solid (27.77 g, 23%), 
mp 160-162°C (Found: C, 52.27; H, 5.50; N 7.64. Caic. for C 16H20N204 S2 : C, 52.15; 
H, 5.47; N, 7.60%). oH (DMSO-d6, 200 MHz): 2.38 (s, 6 H, CH3), 2.70 (m, 4 H, 
CH2), 7.38 (d, 4 H, J 8.5, Ar CH), 7.61 (d, 4 H, J 8.1, Ar CH): 0c  (DMSO-d6, 50 
MHz): 21 (2 C, CH3), 42 (2 C, Gil2), 127 (4 C, Ar CH), 130 (4 C, Ar CH), 137 (2 C, 
Ar C), 143 (2 C, Ar C). JR data (KBr disc)/cm': 1156s, 1334s, 1496m, 1506w, 
1559w, 1597m, 2886w, 2940w, 3288s. FAB MS, m!z 369 (MH, 11.9%). 
Trans-1, 2-di(4-methylbenzenesulfonamido)cyclohexane (58) 
A solution of 4-methylbenzenesulfonyl chloride (15.25 g, 0.08 mol) in pyridine (50 
cm 3)  was added dropwise over 8 hours to a solution of 1,2-diaminocyclohexane (4.57 
g, 0.04 mol) in pyridine (50 cm3). The solvent was removed in vacuo to give a 
yellow oil which was triturated with water (3 x 200 cm 3)  for 24 hours to produce a 
white solid which was isolated by filtration. The product was dried in vacuo and 
recrystallised from ethanol (50 cm) to give a white crystalline solid (6.6 g, 39%), mp 
179-180°C (Found: C, 56.73; H, 6.23; N, 6.53. Caic. for C20H26N204S2: C, 56.85; H, 
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6.20; N, 6.53%). 8H (DMSO-d6 , 250 MHz) 1.05 (m, 4 H, CH2), 1.44 (m, 4 H, CH2), 
2.37 (s, 6 H, CH3), 2.87 (s, 2 H, NH), 7.34 (d, 4 H, J 7.3, Ar CH), 7.65 (d, 4 H, J 7.7, 
Ar CH). 6c  (DMSO-d6, 63 MHz) 21 (2 C, CH3), 22 (2 C, CH), 29 (2 C, CH 2), 54 (2 
C,CH2),127(4C,ArCH),130(4C,ArCH),139(2C,ArC),143(2C,ArC),IR 
data (KBr disc)/cm: 1170m, 1333m, 2859m, 2928m, 3064w, 3268s. FAB MS, mlz 
423 (M, 7.5%). 
1, 2-Di(4-methylbenzenesulfonamido)benzene (59) 
11 5? 11 
-0-11 	ri--o- 
N2-(4-methylbenzenesulfonylamino-cyclohexyl)-4-methY1bCnZefleSU1fOflamide was 
prepared by the method of Cheng et al.' A solution of benzene- 1 ,2-diamine (10 g, 
92 mmol) in pyridine (125 cm 3)  was added dropwise overnight to a solution of 4-
methylbenzenesulfonyl chloride (52.89 g, 0.28 mol) in pyridine (125 cm 3). The 
solution was then neutralised using 15% HC1(aq) (350 cm 3)  giving a cream precipitate 
which was isolated by filtration which was washed with water (250 cm 3) and diethyl 
ether (2 x 20 cm. 3) and dried in vacuo. The powder was then recrystallised from 
ethanol (150 cm 3)  to yield a white crystalline solid (39.30 g, 39%), mp 184-186°C 
(Found: C, 57.44; H, 4.67; N, 6.49. Caic. for C 20H20N204S2: C, 57.67; H, 4.83; N, 
6.74%). S, (DMSO-d6, 250 MHz): 2.38 (s, 6 H, CH3), 6.98 (m, 4 H, Ar CH), 7.20 
(d, 4 H, J 8.0, Ar CH), 7.56 (d, 4 H, J 8.3, Ar CH). 8c (DMSO-d6, 50 MHz): 22 (2 C, 
CH3), 124 (2 C, Ar CH), 127 (2 C, Ar CH), 128 (4 C, Ar CH), 131 (2 C, Ar C), 131 
(4 C, Ar CH), 137 (2 C, Ar C),145 (2 C, Ar Q. IR data (KBr disc)/cm': 1147s, 
1164s, 1326s, 1498m, 1596w, 2923w, 3318m, 3374. FAB MS, mlz 417 (MH, 
83.7%). 
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5.5.4 Synthesis of tris-sulfonamidotriamine ligands 
Tris-12-(toluene4-sulfonamido)ethylj amine (60) 
Tris-[2-(toluene-4-sulfonamido)ethyl]amifle was prepared by the method of Chen et 
al .3  4-Methylbenzenesulfonyl chloride (100 g, 0.52 mol) in diethylether (300 cm) 
was added dropwise to tris(2-aminoethyl)amine (25.2 g, 0.17 mol) dissolved in water 
(350 cm) containing sodium hydroxide (29.1 g, 0.52 mol) with vigorous stirring at 
room temperature. Stirring was continued for two hours after the addition and the 
reaction mixture was then allowed to stand for twelve hours. The product which 
separated out was collected by filtration, washed with water and recrystallised from 
methanol (100 cm 3)  to yield a white crystalline solid (81.76 g, 79%), mp 116-118°C 
(Found: C, 53.31; H, 5.98; N, 9.16. Caic. for C27H36N406S3: C, 53.27; H, 5.96; N, 
9.20%). oH (CDC13, 200 MHz): 2.38 (s, 9H, CH3), 2.42 (m, 6 H, CH2), 2.86 (m, 6 H, 
CH2), 7.25 (d, 6 H, J 7.9, Ar Cl]), 7.76 (d, 6 H, J 8.3 , Ar Cl]). 0c (CDC1 3, 90 MHz): 
22 (3C, CH3), 41 (3 C, CH2), 55 (3 C, CH 2), 128 (6 C, Ar CH), 130 (6 C, Ar CH), 
137 (3 C, Ar C), 144 (3 C, Ar Q. IR data (KBr disc)/cm': 670m, 839m, 963m, 
1179s, 1191m, 1359m, 1600w, 2924w, 2964w, 3457w. FAB MS, m/z 583 (MH, 
100.0%). 




Cis-cis-1,3,5, tris-(4-methylbenzenesulfonylamino)-cyclohexane was prepared by the 
method of Stetter et al. 5 4-Methylbenzenesulfonyl chloride (16.96 g, 8.9 x 102  mol) 
in diethylether (100 cm) was added dropwise to cis-cis-cyclohexane- 1 ,3,5-triamino-
trihydrobromide (11.03 g, 30 mmol) dissolved in water (150 cm 3)  containing sodium 
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hydroxide (5 g, 89 mmol) with vigorous stirring at room temperature. Stirring was 
continued for two hours after the addition and the reaction mixture was then allowed 
to stand for twelve hours. A white solid was collected by filtration and dissolved in 
dichloromethane (100 cm 3),  the organic phase was then washed with 10% NaHCO3 
aqueous solution (100 cm3) and water (2 x 100 cm 3). The organic phase was dried 
over anhydrous magnesium sulfate and the dichloromethane was removed in vacuo 
to yield a white material. This was recrystallised from ethanol (300 cm 3)  to yield a 
white crystalline solid (4.4g, 23%), mp 210-212°C (Found: C, 54.88; H, 5.63; N, 
6.97. Cale. for C 27H33N30653: C, 54.80; H, 5.62; N, 7.10%). ö (DMSO-d6, 360 
MHz): 0.88 (m, 3 H, CH2), 1.50 (m, 3 H, CH2), 2.42 (9 H, s, CH3), 2.97 (m, 3 H, 
CH), 7.35 (d, 6 H, J 8.1, Ar CH), 7.58 (d, 6 H, J 8.1, Ar CH). Sc (DMSO-d6, 90 
MHz): 22 (3 C, GEl 3), 41 (3 C, CH2), 49 (3 C, CH), 127 (6 C, Ar CH), 130 (6 C, Ar 
CU), 140 (3 C, Ar C), 143 (3 C, Ar Q. IR data (KBr disc)/cm': 1091m, 1159s, 
1316m, 1438m, 3258m. FAB MS, m/z 592 (MH, 26.6%). 
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N,N',N"tri(4methylbenzenesulfOflyl)-2-am1flOmethYl-2-methYlPr0Pane 1 ,3-diamine 
was prepared by the method of Crank and Eastwood. 9 4-Methylbenzenesulfonyl 
chloride (15.76 g, 83 mmol) in diethylether (300 cm 
3)  was added dropwise to a 
solution of 2-aminomethyl-2-methyl-propane- 1,3-diamine (3.23 g, 28 mmol) in 
water (150 cm 3)  with vigorous stirring. The mixture was allowed to stir for one and 
a half hours and then left to stand overnight. The diethylether was then removed in 
vacuo and the water was decanted to leave a thick white oil. This was triturated with 
a hexane and diethylether mixture to yield a white solid. Recrystallisation from 
ethanol (350 cm 3)  yielded a white crystalline material (5.44 g, 34%), mp 220-222°C 
(Found: C, 53.92; H, 5.37; N, 6.99. Calc. for C26H33N306S3: C, 53.86; H, 5.74; N, 
7.25%). 8H  (CDCI3 , 360 MHz): 0.77 (s, 3 H, CH3), 2.40 (s, 9 H, CH3), 2.58 (s, 6 H, 
CH2), 7.41 (d, 6 H, J 8. 1, Ar Cl]), 7.66 (d, 6 H, J 8.3, Ar Cl]). 8 c (CDC13, 90 MHz): 
19 (GIl3), 22 (3 C, GIl3), 48 (3 C, CH2), 127 (6 C, Ar CH), 131 (6 C, Ar CH), 138 (3 
C, Ar C), 144 (3 C, Ar C). JR data (KBr disc)/cm': 664s, 819m, 1093m, 1156s, 
1318,1434m, 2923w, 3285m. FAB MS, m/z 580 (MH, 19.4%). 
Cis-cis-cyclohexane-1,3,5-tricarboxyliC acid tris-(benzoxyamide) (63) 
C6H5H2COHNOC ZT7.CONHOCHCH 
C6H5H2COHNOC 
Cis-cis-cyclohexane-1,3,5-tricarboxylic acid tris-(benzoxyamide) was prepared by 
the method of Bowen et al.4 Cis-cis-1,3,5-cyclohexanetricarboxylic acid (8.97 g, 41 
mmol) was washed into a one litre round bottom flask with benzene (300 cm') and 
triethylamine (17.5 cm3 , 0.12 mol) was added followed by diphenyiphosphorylazide 
(34.65 g, 0.13 mol). The mixture was stirred for one hour and 30 minutes to allow 
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all the solid to dissolve before being held at reflux for 30 minutes before benzyl 
alcohol (14.92 g, 0.14 mol) was added. The mixture was then refluxed for a further 
18 hours after which time it was cooled to room temperature and the white powder 
product isolated by vacuum filtration and washed with cold benzene (3 x 10 cm 3)  and 
dried in vacuo (12.2 g, 56%), mp 218-220°C. 614  (CDC13 , 200 MHz): 1.08 (m, 3 H, 
CH2), 1.90 (m, 3 H, CH2), 3.41 (m, 3 H, Cl]), 5.02 (s, 6 H, CH2), 7.37 (m, 15 H, Ar 
CH). 6c  (CDC13, 63 MHz): 43 (3 C, CH 2), 48 (3 C, CH), 66 (3 C, CH 2), 128 (6 C, Ar 
CH), 129 (6 C, Ar CH), 138 (3 C, Ar CH), 156 (3 C, Ar Q. IR data (KBr disc)/cm: 
1124s, 1227s, 1285s, 1542s, 1686s, 2949w, 3033w, 3313s. ESI MS, m/z 532 (MH, 
100.0%). 
Cis-cis-cyclohexane-1, 3, 5-triamino-trihydrobromide (64) 
H2N
—Z 	NH2 .3F[Br 
H2N 
Cyclohexane-1,3,5-triamino-trihydrobromide was prepared by the method of Bowen 
et al.4  30% v/w hydrogen bromide in acetic acid (100 cm 
3)  was added to 
cyclohexane-1,3,5-tricarboxylic acid tris-(benzoxyamide) (63) (8.3 g, 1.56 x 10 2 
mol) and the mixture was stirred for three hours during which time effervescence of 
carbon dioxide was observed. Ethanol (100 cm 3)  was then added and the mixture 
was stirred for a further 30 minutes. A white solid was then isolated by filtration, 
(3.5 g, 60%). 6H  (D20, 200 MHz): 1.62 (q, 3 H, J 12.2, axial Cl]), 2.44 (d, 3 H, J 
11.2, equatorial Cl]), 3.49 (U, 3 H, J 12.2, J 3.6, CH-NH2). 6c  (DMSO-d6, 90MHz): 
34 (3 C, CH2), 46 (3 C, CH). IR data (KBr disc)/cm: 1210m, 1406m, 1476s, 
1588m, 2995s. FAB MS, m/z 131 (C 6N3H 1 6, 100.0%). 
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2-methyl- 1,3 bis(toluene4sulfonyloxy)-2-(toluene-4-sulfOflYlOXYmethY1)PrOPane 
was prepared by the method of Stetter and B6ckmann. 7 4-Methylbenzenesulfonyl 
chloride (65.5 g, 0.83 mol) in pyridine (100 cm) was added dropwise to a solution of 
1,1,1, tris(hydroxymethyl) ethane (33.2 g, 0.28 mol) in pyridine (120 cm 3) at 0°C. 
The temperature was maintained at 0°C for one hour and then stirred at ambient 
temperature for 24 hours. The solvent was removed in vacuo and the residue was 
dissolved in chloroform (200 cm 3). This organic solution was washed with water (3 
x 200 cm3), 6M sulfuric acid (200 cm 3) and water (3 x 200 cm 3). The chloroform 
layer was then dried over anhydrous magnesium sulfate, filtered and the solvent 
removed in vacuo. The resulting yellow oil was added to diethylether to obtain a 
white solid (117.9 g, 73%), mp 104-106°C (Found: C, 54.15; H, 5.20. Calc. for 
C26H3009S3: C, 53.59; H, 5.15%). & (CDC13 , 200 MHz): 0.88 (s, CH3), 2.45 (s, 9 H, 
CH3), 3.74 (s, 6 H, CH2), 7.35 (d, 6 H, J 8.0, Ar CR), 7.70 (d, 6 H, J 8.3 , Ar Cl]). 8 c  
(CDC13, 63 MHz): 16 (Gil3), 22 (3 C, CH3), 39 (C), 70 (3 C, CH2), 128 (6 C, Ar Gil), 
130 (6 C, Ar CH), 132 (3 C, Ar C), 145 (3 C, Ar Q. IR data (KBr disc)/cm': 670m, 
839m, 963m, 1179s, 1191m, 1359m, 1600w, 2924w, 2964w, 3457w. FAB MS, m/z 
583 (MH, 100.0%). 




1,1,1-Tris (azidomethyl) ethane was prepared by the method of Fleischer et al.6 A 
mixture of 65 (50 g, 88 mmol) and NaN3 (30 g, 0.47 mol) in diethylene glycol (200 
cm 3)  was stirred under nitrogen and maintained at 135°C for 16 hours. After cooling, 
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the mixture was poured into water (400 cm. 3) and extracted into diethylether (3 x 150 
cm3). The diethylether was subsequently washed with water (3 x 150 cm). The 
ethereal solution was dried over MgSO4 then treated with activated charcoal and 
upon evaporation gave an almost colourless oil (12.89 g, 75%). oH (CDC13 , 360 
MHz) 1.02 (s, CH3), 3.30 (s, 6H, CH2). 0c  (CDC13, 90 MHz): 0 19 (Gil 3) 41 (C), 56 
(3C, CH2). JR data (neat, NaCl plate)/cm: 2102(s). 
2-Aminomethyl-2-methyl-propane-1,3-diamifle (67) 
rN NH2 
2-Aminomethyl-2-methyl-propane-1,3-diamifle was prepared by the method of 
Zompa and Anselme. 8 1,1,1-Tris(azidomethyl) ethane (11.54 g, 59 rnmol) in ethanol 
(200 cm3) and PdC (1 g) were placed in a Pyrex hydrogenating chamber. The 
mixture was hydrogenated at 3.4 atmospheres for 6 hours. The atmosphere was 
purged and recharged with hydrogen twice during this period. The mixture was then 
filtered through glass fibre filter paper, and the ethanol was then removed in vacuo to 
yield a yellow oil (5.4 g, 78%). The triamine was used with no further purification. 
0H (CDC13 , 200 MHz): 0.76 (s, 3 H, CH3), 2.54 (s, 6 H, CH2). Oc  (CDC13, 90 MHz): 
19 (CH3), 40 (C), 47 (3 C, CH 2). IR data (neat, NaCl plate)/cm': 2867m, 2917m, 





2-Methyl-i ,3-bis(methylsulfoyloxy)-2-(methylsulfonyloxy-methyl)-propane 	was 
prepared by the method of Latour et al. 13  Methanesulfonyl chloride (11.86 g, 100 
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mmol) in dry pyridine (25 cm 3)  was added dropwise at 0°C under nitrogen to a 
stirred solution of 1,1,1 -tris(hydroxymethyl)ethane (3.84 g, 32 nimol) in a pyridine 
and chloroform mixture (50:50, 50cm3). The mixture was maintained at 0°C for 14 
hours then the solvent was then removed in vacuo. Dichioromethane (100 cm 3) was 
then added and the solution was washed with water (3 x 100 cm). The organic layer 
was then separated and dried over anhydrous magnesium sulfate and the solvent 
removed in vacuo to give a white solid. Recrystallisation from ethanol (50 cm 3) 
yielded a white crystalline solid (11.34 g, 62%), mp 79-80°C (Found: C, 27.12; H, 
4.82. Calc. for C 8H 1809S3: C, 27.11; H, 5.12%). &i (DMSO-d6, 360 MHz): 1.07 (s, 3 
H, CH3), 3.26 (s, 9 H, CH3), 4.17 (s, 6 H, CH2). 8c (DMSO-d6, 63 MHz): 4 (CH3), 25 
(3 C, CH3), 28 (C), 59 (3 C, CH2). LR data (KBr disc)/cm': 855s, 981s, 1002s, 






1,3-Dibromo-2-bromomethyl-2-methyl-propane was prepared by the method of 
Kasowski and Bailer. 14  Sodium bromide was added to a solution of 2-methyl-1,3- 
bis-(toluene-4-sulfonyloxy)-2-(toluene-4-sulfonyloxy-methyl)-propane in diethylene 
glycol (250 cm3). The mixture was heated at 140°C for 12 hours under nitrogen. 
The resulting mixture was allowed to cool to 90°C before ice was added to cool the 
mixture to room temperature. The mixture was extracted with dichioromethane (3 x 
150 CM)  . The organic layer was separated and washed with water (3 x 300 cm 
3), 
dried over anhydrous magnesium sulfate, filtered and the dichloromethane was then 
removed in vacuo to yield a brown liquid. This was distilled at 73°C under 0.53 mm 
Hg to yield a colourless liquid (30.5 g, 49%), (Found: C, 19.47; H, 3.03. Calc. for 
C5H9Br3 : C, 19.44; H, 2.94%). 6H (CDC1 3, 250 MHz): 1.23 (s, 3 H, CL!3), 3.44 (s, 6 
H, CH2). 8c (CDC13, 63 MHz): 2.07 (CH3), 38.8 (3 C, CH 2), 39.4 (C). lIP, data (KBr 
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disc)/cm': 664m, 851m, 1246m, 1269s, 1377m, 1459s, 2833w, 2934m, 2971s, 
3584w. FAB MS, m/z 307 (MH, 23.3%). 
5.5.5 Complexes of tris-sulfonamidotriamine ligands 
N,N',N' ',N' ' ' [Tris-(2-(4-methylbenzenesulfonylaminato)-ethYl)-amiflel copper(II) 
potassium(I) (70) 
A solution of 60 (0.15 g, 0.25 mmol) and sodium hydroxide (0.75 mmol) in hot 
methanol (10 cm 3)  was added to a solution of copper(H) acetate monohydrate (83 
mg, 0.25 mmol) also in methanol (10 cm3). The solution was left in a sealed vessel 
until the product separated as a green solid after 3 days which was collected by 
filtration, washed with methanol (3 x 5 cm. 3) and dried in vacuo (9 mg, 45%). 
Crystals suitable for X-ray crystallography were grown from a concentrated solution 
of 70 in tetrahydrofuran layered with isoproylether (Found: C, 46.39; H, 5.25; N, 
7.13. Calc. for C 31 H43N4Cu K 08 S3 : C, 46.63; H, 5.43; N, 7.02%). IR data (KBr 




The procedure described for 70 using nickel(II) acetate tetrahydrate yielded a green 
crystalline solid (57 mg, 30%), (Found: C, 45.01; H, 4.71; N, 7.29. Calc. for 
C27H35N4NiO7S3: C, 44.63; H, 5.22; N, 7.43%). IR data (KBr disc)/cm': 1078m, 
1132s, 1249s, 2862w, 3503m. FAB MS, m/z 706 (([Ni(L-3H)]K, 5.5%). 
5.5.6 X-ray crystallography 
Structures 57, 58 and 60 were determined by Dr. Simon Parsons and structures 59, 
61, 62 and 70 were determined by Andrew Parkin at the University of Edinburgh. In 
all cases data were collected at 220 K on a SMART or Stoe Stadi-4 diffractometer 
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equipped with an Oxford Cryosystems low temperature device, using Cu-Ka 
radiation for 59 and 60, and Mo-Kct radiation for 57, 58, 61, 62 and 70. Reflections 
were scanned in o-8 mode. Structures 58-62 were solved by direct methods 
(SHELXTL or S1R92 15 " 6) and 57 by Patterson methods (DIRDIF' 7). All were 
completed by iterative cycles of least squares refinement against F2 and difference 
Fourier synthesis (SHELXTL). H-atoms were idealised, being placed using 
geometric or difference maps and treated by riding or refall methods. All 
sulfonamido hydrogen atoms were placed using difference maps. In all cases non-H 
atoms were modelled with final anisotropic displacement parameters and final 
refinement statistics are presented in Tables 5.12 (57-59), 5.13 (60-62) and 5.14 (70). 
Table 5.12 : Crystallographic data for structures 57, 58 and 59. 
Structure 	 57 	 58 	 59 
Formula C 161-120N204S2 	C20H26N204S2 	C201-120N204S2 
M 	 368.46 422.55 416.50 
Crystal system -Monoclinic Orthorhombic Monoclinic 
Space group P211c Pcca Pccn 
a/A 5.7761(14) 19.580(5) 36.994(7) 
bIA 8.0862(13) 8.5379(15) 8.371(2) 
c/A 18.328(3) 12.765(2) 12.9947(18) 
aI° 90 - 	 90 90 
97.97 90 90 
90 90 90 
u/A3 847.8(3) 2134.0(7) 4024.2(13) 
Crystal size/mm 0.08 x 0.12 x 0.49 x 0.27 x 0.27 0.62 x 0.38 x 0.32 
0.62 
D/gcni' 1.443 1.315 1.375 
Z 2 4 8 
u/mm' 	 0.337 	 0.277 2.647 
Scan type omega-2theta omega - theta omega - theta 
o Limits/0  2.76-25.02 3.05-25.09 4.78-59.93 
No. of unique data 1480 1900 2941 
No. data with IF>4a(F)1 1032 1321 2302 
No. parameters 114 132 322 
Ri 0.0559 0.0424 0.0536 
wR2 	 - 	 0.1230 	 0.1046 	 0.1390 
.pmax4Pmin/e A 3 	 0.236, -0.318 0.274,-0.365 0.417, -0.458 
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Table 5.13: Crystallographic data for structures 60, 61 and 62. 
Structure 60 61 62 
Formula C27H36N406S3 C29H39N307S3 C26H33N306S3 
M 608.78 637.81 579.73 
Crystal system Orthorhombic Monoclinic Orthorhombic 
Space group P212121 P2(1)/n Pna2(1) 
a/A 13.0269(11) 28.6768(18) 15.5276(11) 
b/A 13.13 14(13) 6.3737(4) 11.7498(8) 
C/A 35.332(6) 35.806(2) 15.7691(11) 
a/C 90 90 90 
DI° 90 102.8730(10) 90 
90 90 90 
u/A3 6043 .9(13) 6380.1(7) 2877.0(3) 
Crystal size/mm 0.62 x 0.42 x 0.21 0.36 x 0.24 x 0.05 0.40 x 0.17 x 0.13 
DIgcm' 1.338 1.328 1.338 
Z 8 8 4 
iilmnf' 2.631 0.281 0.302 
Scan type omega - theta phi + omega phi + omega 
0 Limits/* 3.59-70.19 0.83-26.40 2.16-26.38 
No. of unique data 6035 12996 2947 
No. data with IF>4a(F)1 5482 10825 2781 
No. parameters 746 791 359 
RI 0.0381 0.0813 0.0359 
wR2 	 0.0972 	 0.1915 	 0.0888 
.Prnax, ip min/e A 3 	 0.243, -0.432 0.866, -0.496 0.359,-0.225 
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Table 5.14: Crystallographic data for structure 70. 
Structure 	 70 
Formula C3 1 H43CuKN4O8S3 
M 	 798.51 
Crystal system 	- Monoclinic 








Crystal size/mm 0.37 x 0.1 x 0.1 
Ddg cm' 1.492 
Z 2 
plmm' 0.962 
Scan type phi + omega 
o Limits/* 4.13-26.36 
No. of unique data 6437 
No. data with IF>4a(F)1 5899 
No. parameters 441 
Ri _0.031 
wR2 	 0.0703 
LPmpx, Pm i n1e A 3 	 0.571, -0.437 
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6.1 Introduction 
In Chapters 2 and 3 ligand systems following a similar design to P50 type phenolic 
oxime ligands (see Chapter 1) were explored. The promising results of these studies 
led to some preliminary work on the development of dinucleating sulfonamido oxime 
ligands. The aim of this work was to progress from ML2 systems to M 2L2 systems 
(Figure 6.1) with the same emphasis on hydrogen-bonded pseudo-macroe ycle 
formation. Such ligands would encapsulate two metal centres, thus increasing the 
power of L as a metal extractant by 100%. 
A _1Th




Figure 6.1: M2L2  dinuclear systems where X are the donor atoms, A are the hydrogen-bond acceptor 
sites and D are the hydrogen-bond donor sites. 
Figure 6.1 shows two five coordinate metal centres with trigonal pyramidal geometry 
coordinated by two penta-dentate ligands. The attempted synthesis of such structures 
is discussed in this chapter. 
6.2 Synthesis of dinucleating sulfonamido oxime ligands 
Such ligands required five coordinating atoms, one hydrogen-bond donor atom and 
one acceptor site. Ligand design had to allow some flexibility to successfully 
encapsulate two metal centres however care had to be taken that chelate ring sizes 
would not be too large. The target ligand system is shown in Figure 6.2 and 
incorporates aspects of the sulfonamidodiamine and sulfonamido oxime ligands 
discussed in Chapters 2 and 3. 
289 
Chapter 6: Dinucleating sulfonamido oxime ligands 
73 R(U112)2- 
72 R 
Figure 6.2: Target ligands 72 and 73. 
It was envisaged that the phenolic oxygen atom and the sulfonamido nitrogen atom 
would deprotonate on complexation resulting in a diamomc ligand and thus 
coordination of two ligands to two divalent metal ions would result in a neutral 
species. 
The phenolic head group was chosen as dinuclear zmc(ll), nickel(II) and copper(II) 
complexes with similar N 20 donor sets are known. "2'3 Fenton et al have developed 
a variety of dinucleatmg ligands, which form complexes with ligand to metal ratios 
of 1:1 or 1:2 depending on the substituents on the two nitrogen atoms, to model the 
active sites of some bimetallic biosites. 4 
The synthesis of 72 and 73 requires four steps (Figure 6.3). The triol precursor is 
commercially available, this was converted to 75 by the method of Lambert et a15 via 
selective oxididation to give 74, followed by the chlorination of the aliphatic alcohol. 
The reaction of 75 with either N(Nbenzyl3aminoprOPYl)-4-methYlbeII2efle 
sulfonamide (7) or zenesu1f0nIm1de (3) yielded 
76 and 77 respectively. Finally 76 and 77 were oximated to produce ligands 72 and 73. 
Potassium hydrogen carbonate was necessary in step (iii) to avoid the formation of the 
hydrochloride salt of starting material 3 or 7 and in step (iv) to improve the yield. 
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(I)  
All 




(iv) 	 if 
TsNR-NBz 	OH 	NOH 
72/73 
11 
TsNR-NAz OH 	0 
76/77 
Figure 6.3: Synthesis of dinucleating sulfonamido oxime ligands 6-hydroxy-3-methyl-5 {2, 6-diaza-2-
benzyl-6[N-(4-methylbenzenesulfonyl)]hex-1 -yl}benzaldehyde oxime 	(72) and 6- 
hydroxy-3-methyl-5 {2,5-diaza-2-benzyl-5[N-(4-methylbeazenesulfonyl)]pent- l-yl } 
benzaldehyde oxime (73). (i) Mn02, toluene. (ii) SOC1 2, CH202. (iii) BzHN-R-NHTs 
{R = -(CH 2)3- (7), = -(CH2)2- (3)), K2CO3, dimethylformamide. (iv) NH20H.HCI, 
K2CO3, EtOH. 
6.3 Characterisation of dinucleating sulfonamido oxime ligands 
6.3.1 NMR spectroscopy 
The 'H and the ' 3C nmr spectra of ligands 72 and 73 may be easily interpreted. In 
each case the two doublets at roughly 7.3 and 7.7 ppm identify the p-
methylbenzenesulfonamido moiety of these ligands. The peaks of the two methyl 
groups at approximately 2.3 and 2.4 ppm with intensities in the ratio of 1:1 indicate 
that the correct product has been formed. A more detailed discussion of the spectra 
of 72 (Figure 6.4) follows. 
The two doublets arising from the two chemically equivalent pairs of protons c and d 
are at 7.25 and 7.70 ppm respectively. The signal for the d protons is shifted to 
lower field due to the electron withdrawing nature of the sulfonyl group. The two 
peaks for the methyl groups are assigned as 2.25 (a) and 2.14 (r), following a 
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comparison of the spectrum with that of the starting precursor (7). The methylene 
protons f, g and h are at 2.88, 1.64 and 2.43 ppm. The central unit (g) is shielded 
from the electron withdrawing amino and sulfonamido groups and may therefore be 
assigned to the signal found at the lowest ppm value. The sulfonamido group is 
more electron withdrawing than the amino group and therefore the protons of 
methylene group f are found at lower field to those of group h. The remaining 
methylene groups i and s are singlets at 3.59 and 3.41 ppm, these values were 
assigned as the aromatic ring attached to methylene unit i has two electron 
withdrawing groups attached, therefore the signal for i was expected at lower field. 
Finally, the two aromatic protons o and q were identified and assigned as 6.95 and 
7.01 ppm. The aromatic protons u, v and w of the benzyl group form a multiplet at 
7.20 ppm. Signals for the oximic proton, the sulfonamido proton and the alcoholic 
proton were not observed. 
The ' 3C nmr spectrum may be used to support the previous characterization. The 
two signals for the methyl groups are be easily identified at high field (21 and 22 
ppm). The signals for methylene units, aromatic CH, quaternary carbons and the 
signal for the oximic carbon are all present in the correct numbers. The signals were 
assigned using the same rationale used for the 'H spectrum and DEPT techniques. 6 
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Signal 'H nmr ' 3C nmr Signal 'H nmr 
3C nmr 
a 2.25 21 1 143 
b - 118 m 151 
C 7.25 130 o 6.95 129 
d 7.70 130 p 125 
e 129 q 7.01 33 
2.88 53 r 2.41 22 
1.64 26 s 3.41 56 
h 2.43 43 t 138 
3.59 59 u 7.20 129 
139 v 7.20 127 
k 154 w 7.20 128 
Figure 6.4: 'H and ' 3C nmr assignments for ligand 72. 
6.3.2 IR spectroscopy and mass spectrometry 
IR and mass spectrometry have been routinely used for characterisation. IR 
spectroscopy was used to confirm the presence of the sulfonamide group by one 
strong band in the 1370-1330 cm -1 region and another in the 1180-1160 cm' region 
for the -S02-N group. A weak peak was expected for the C=N bond of the oxime 
group between 1690 and 1640 cm-1 . Of the mass spectrometry techniques available 
(El, FAB and ESI) fast atom bombardment has been used primarily for analysis 
purposes. 
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6.4 Complexation study of ligands 72 and 73 
Complexation of ligands 72 and 73 were attempted in methanol solution in 1:2 and 
2:2 ligand to metal(II) acetate ratios with the required amount of sodium hydroxide 
added as a base. 
6.4.1 Complexation of 72 
A 1:2 mixture of copper(II) acetate and 72 gave green crystals which upon analysis 
by X-ray diffraction proved this material to be a 1:2 complex. A bright green 
powder (79) from the reaction of nickel(II) acetate with 72 again in a 1:2 ratio. 
Reaction with both zinc and cobalt salts proved unsuccessful. 
6.4.2 Complexation of 73 
Two visually different products were isolated from the reaction with copper. A 
brown/yellow precipitate (80) was isolated from the 1:2 mixture and a pale green 
precipitate (81) from the 2:2 mixture. Microanalysis proved 80 to be a 1:2 complex 
however the only evidence for 81 as a 2:2 ligand:metal complex was from ESI MS 
where a peak for [Cu2(73-H)21 + at 1059 of intensity 39.2% was observed, however a 
peak for a 1:2 complex at 996 of intensity 52.7% was also observed. The reaction of 
nickel(II) acetate with 73 in the two different ratios produced a bright green solid 
(82) from the 1:2 mixture and a pale green solid from the 2:2 mixture. It did not 
prove possible to characterise the latter product however good evidence for a 
complex with a metal to ligand ratio of 1:2 was obtained for 82 from ES! MS, 
[Ni(73-H)2 1 m/z 991 100.0%. 
No products were isolated from the 1:2 mixtures of cobalt or zinc to 73. However a 
2:2 mixture with cobalt yielded a dark brown solid (83), peaks in the ESI spectrum 
were present for both complex type, [CO 2(73-H)2] m/z 1047, 23.2% and [Co(73-
H)2] m/z 525, 33.4%. A yellow precipitate was isolated from a 2:2 mixture with 
zinc and 73 (84) and evidence for a 2:2 complex was also found from analysis by 
ES! MS, [Zn2(73-H) 2] m/z 1093, 58.7%. 
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Good microanalysis was only obtained for complexes 78 and 79. This may have 
been a result of the unreliability of the apparatus at the time or a result of a mixture 
of products being formed. Due to time limitations the materials were not purified 
further. 
6.5 Solid state structures of dinucleating sulfonamido oxime ligands 
6.5.1: 6-Hydroxy-3-methyl-512, 6-diaza-2-benzyl-6 IN-(4-methylbenzene 
sulfonyl)Ihex-1-yl} benzaldehyde (76) 
The X-ray structure of the intermediate sulfonamido molecule 76 is shown in Figure 
6.5. 
Figure 6.5: The X-ray structure of 76. 
The value of e (the sum of the three angles around the nitrogen atom) is 348.7°, and 
the value of cc (the angle of the S-N bond from the plane defined by the sulfonamido 
nitrogen and hydrogen atoms and the adjacent carbon atom) is 0.229A. There is no 
inter-molecular hydrogen-bonding in 76 however, there are four intra-molecular 
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bonds. The phenolic hydrogen atom (H(10A)) is bifurcated and forms interactions 
with the carbonyl oxygen atom (0(12A)) and sulfonamido oxygen atom (0(2B)) 
[0(1OA)-H --- 0(12A), 2.6407(17) A; 0-H-0, 141.6(18)°; 0(1OA)-H --- 0(2B), 
2.9913(18) A; 0-H-0, 110 01. The sulfonamido hydrogen atom H(3A) is also 
bifurcated and forms interactions with the tertiary nitrogen atom N(7A) and the 
phenolic oxygen atom 0(1OA) [N(3A)-H --- N(7A), 3.13 A; N-H-N, 124 0, N(3A)-H--
-0(10A), 2.8748(18) A; 0-H-N, 151.6(16) 0]. 
6.5.2 Bis(6-hydroxy-3-methyl-5{2, 6-diaza-2_benzy1-6N-(4-methy1benzene 
sulfonyl)I hex-1-yl}benzaldehyde oximato)copper(II) (78) 
Complexation of 72 with copper(II) acetate in a 2:1 ratio yields complex 78 (Figure 
6.6). The ligand is monodeprotonated and binds to one metal centre with a ligand to 
metal ratio of 2:1. The asymmetric unit consists of half of the complex. The copper 
atom has a planar geometry with bond lengths to the deprotonated phenolic oxygen 
atom and the oximic nitrogen atom of 1.8936(11) and 1.9499(13) A respectively and 
a N-Cu-N chelate angle of 92.3°. The values of 0 and a for the sulfonamido group 
of 72 are 350.4° and 0.21 A respectively. The sulfonamido nitrogen is not involved 
in binding to the metal centre and it's geometry is very similar to the sulfonamido 
nitrogen in molecule 76. 
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-C.1 
Figure 6.6: X-ray structure of 6-Hydroxy-3-methyl-5 { 2, 6-diaza-2-benzyl-6[N-(4-methylbenzene 
sulfonyl)]hex- 1 -yI}benzaldehyde oximate copper(II) (78). 
The inner great ring of the pseudo-macrocycle which is formed around the copper 
centre is very similar to that of P50 (see Chapter 1) and is formed via hydrogen-
bonding interactions between the oximic hydrogen atoms and the deprotonated 
phenolic oxygen atoms [0(12A)-H --- 0(1OA), 2.615 A; 0-H-0, 141°]. There are 
four other hydrogen-bonds per complex, each sulfonamido hydrogen atom is 
bifurcated and forms interactions with the deprotonated phenolic oxygen atom and 
the tertiary amino nitrogen atom [N(3A)-H---0(1OA), 3.08 A; N-11-0, 1370 , N(3A)-
H --- N(7A), 3.06 A; N-H-N, 129°]. 
Two of the three types of hydrogen bond in complex 78, are similar to those 
observed in molecule 76. The interaction between the sulfonamido proton H(3A) 
and the deprotonated oximic oxygen atom 0(1OA) is longer and less linear in 
complex 78 than in molecule 76 however the interaction between the bifurcated 
sulfonamido proton H(3A) and the amino nitrogen N(7A) is similar in both length 
and linearity. These changes are a result of a change in conformation of the ligand 
upon complexation. The sulfonamidodiamine arm of the ligand does not change its 
shape significantly, however it has been pushed further from the central coordinating 
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oxygen atom resulting in the elongation of the O(1OA) --- H-N(3A) bond. The 
hydrogen-bonds involved in the formation of the pseudo-macrocyclic ring are both 
shorter and more linear than the other two interactions, the optimisation of these 
interactions may have been achieved as a result of the planar nature of the N4 2 donor 
set. 
6.6 Conclusion 
Two potentially dinucleating ligands have been successfully synthesised and 
preliminary complexation studies undertaken. The simple coordination mode of 78 
to one copper centre to give a pseudo-macrocyclic structure shows how favourable 
this arrangement is. No crystals of X-ray quality were grown of materials believed to 
contain 2:2, ligand:metal complexes however encouraging information was achieved 
by ES! MS analysis. 
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6.7 Experimental 
6.7.1 Instrumentation 
Melting points were determined with a Gallenkamp apparatus and are uncorrected. 
Elemental analysis was performed on a Perkin Elmer 2400 elemental analyser and a 
Carlo Erba 1108 Elemental analyser. JR spectra were obtained on a Perkin Elmer 
Paragon 1000 FT-JR spectrometer as potassium bromide discs. 'H and ' 3C NMR 
spectra were run on Bruker WP200, AC250 and AVANCE DPX360 spectrometers. 
Chemicals shifts () are reported in parts per million (ppm) relative to residual 
solvent protons as internal standards. Electron impact (El) mass spectra were 
obtained either on a Finnigan MAT4600 quadrapole spectrometer or on a Kratos 
MS50TC spectrometer. Fast atom bombardment (FAB) mass spectra were obtained 
on a Kratos MS50TC spectrometer in acetonitrile/3-nitrobenzyl alcohollthioglycerol 
matrices. Electrospray ionisation (ESI) mass spectra were obtained on a Thermoquest 
LCQ spectrometer. 
6.7.2 Solvent and reagent pretreatment 
All reagents and solvents were commercially available (Acros or Aldrich) and were 
used as received. Solvents used for analytical purposes (NMR, MS) were of 
spectroscopic grade. 
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6.7.3 Ligand syntheses 
6-Hydroxy-3-methyl-512, 6_diaza_2benzy16N-(4methy1benzenesu1fOnY1)IheX- 
1-yl}benzaldehyde oxime (72) 
Ethanol (50 cm3) was added to 6-hydroxy-3-methyl-5 { 2, 6-diaza-2-benzyl-6[N-(4-
methylbenzenesulfonyl)]hex- l-yl }benzaldehyde (76) (0.44 g, 0.97 mmol), 
hydroxylamine hydrochloride (0.20 g, 2.9 mmol) and potassium carbonate (0.4 g, 2.9 
mol). The mixture was heated at reflux for one hour. The solution was cooled and 
subsequently filtered and the ethanol was then removed in vacuo to yield a yellow 
oil. The oil was dissolved in dichioromethane (50 cm3) and the solution was washed 
with water (3 x 50 cm) and dried over anhydrous magnesium sulfate. The solution 
was then filtered before the dichioromethane was removed in vacuo to yield a second 
yellow oil. This was triturated with hexane to yield a yellow powder (0.71g, 86%), 
mp 116-118°C. oH (CDC13 , 200 MHz): 1.64 (t, 2 H, J 5.3, CH2), 2.25 (s, 3 H, CH3), 
2.41 (s, 3 H, CH3), 2.43 (t, 2 H, J 6. 1, CH2), 2.88 (t, 2 H, J 5.7, CH2), 3.41 (s, 2 H, 
CH2), 3.59 (s, 2 H, CH2), 6.95 (s, 1 H, Ar CH), 7.01 (s, 1 H, Ar CH), 7.20 (m, 5 H, 
Ar CH), 7.25 (d, 2 H, J 7.9, Ar CH), 7.70 (2 H, d, J 8.3, Ar CH), 8.24 (s, 1 H, Ar 
CH). 0c  (CDC13, 90 MHz): 21 (CH3), 22 (CH3), 26 (CH 2), 43 (CH2), 53 (CH2), 56 
(CH2) 59 (CH2), 118 (Ar C), 125 (Ar C), 127 (2 C, Ar CH), 128 (Ar CH), 129 (2 C, 
Ar CH), 129 (Ar C), 130 (2 C Ar CH), 130 (2 C, Ar CH), 133 (Ar CH), 138 (Ar C), 
139 (Ar C), 143 (Ar C), 151 (C=N-OH), 154 (Ar Q. JR data (KBr disc)/cm: 668m, 
1093m, 1153s, 1319s, 1459s, 1599w, 1655w, 2950m, 3360s. FAB MS, m/z 482 
(MH, 92.8%). HRMS m/z calc. for MH 482.6239, found 482.2156. 
300 
Chapter 6: Dinucleatmg sulfonamido oxime ligands 
6-Hydroxy-3-methyl-512, 5-diaza-2-benzyl-51N-(4-methylbenzenesulfonyl)] pent- 
1-yI}benzaldehyde oxime (73) 
-Q--(
N' 
6-Hydroxy-3-methyl-5 {2,5-diaza-2-benzyl-5 [N-(4-methylbenzenesulfonyl)]pent- 1-
yl}benzaldehyde (77) (0.56 g, 1.2 mmol), hydroxylamine hydrochloride (0.26 g, 3.7 
mmol) and potassium carbonate (0.51 g, 3.7 mmol) were added to ethanol (50 cm 3). 
The mixture was heated at reflux for one hour. The solution was cooled and then 
filtered. The ethanol was then removed in vacuo to yield a yellow oil. 
Dichloromethane (50 cm 3)  was added and the solution was washed with water (3 
50 cm3) and dried over anhydrous magnesium sulfate. The solution was then filtered 
before the dichioromethane was removed in vacuo to yield a second yellow oil. This 
was triturated with hexane to yield a yellow powder (0.52 g, 89%), mp 129-13 1. 8H 
(CDC13, 200 MHz): 2.28 (s, 3 H, CH3), 2.38 (s, 3 H, CH3), 2.59 (t, 2 H, J 5.6, CH2), 
2.95 (t, 2 H, J 5.5, CH2), 3.51 (s, 2 H, CH2), 3.58 (s, 2 H, CH2), 6.94 (d, 2 H, J 9.3, 
Ar CH), 7.18 (m, 7 H, Ar CH), 7.67 (d, 2 H, J 8.3, Ar CH). öc (CDC13, 90 MHz): 
20 (CH3), 22 (CH3), 41 CH2), 52 (CH2), 55 (CH2), 55 (CH), 58 (CH2), 118 (Ar C), 
125 (Ar C), 128 (2 C, Ar CH), 129 (2 C, Ar CH), 130 (2 C, Ar CH), 130 (2 C, Ar 
CH), 130 (Ar CH), 133 (Ar CH), 140 (Ar C), 138 (Ar C), 144 (Ar C), 152 (Ar CH), 
154 (Ar Q. IR data (KBr disc)/cm': 1160s, 1326m, 1654m, 2924m, 3432s. FAB 
MS, m/z 468 (MH, 24.5%). HRMS m/z calc. for (MH) 468.597, found 468.195. 
2-(Hydroxymethyl)-6-carbaldehyde4-methylphenol (74) 
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2(Hydroxymethy1)-6-carbaldehyde-4-methylPhef101 was prepared by the method of 
Lambert et al.5 2,6-Bis(hydroxymethyl)-4-methylphenol (15 g, 89 mmol) and 
manganese dioxide (19.3 g, 0.22 mol) were stirred in toluene (3 dm 3) at room 
temperature for 4 days. The Mn02 was filtered off, and evaporation of toluene gave 
a brown powder. Recrystallisation from toluene (50 cm 3) afforded a white powder 
(7.5 g, 5 1%), mp 71-73°C (Found: C, 65.15; H, 5.82. Calc. for C 9H 1003 : C, 65.05; 
H, 6.07%). ö (CDC1 3 , 360 MHz) 2.37 (s, 3 H, CH3), 2.55 (s, -Oil), 4.76 (s, 2 H, 
CH2), 7.32 (s, 1 H, Ar Cl]), 7.43 (s, 1 H, Ar Cl), 9.88 (s, 1 H, -CHO), 11.20 (s, 1 H, 
Ar-Oil). 8c  (CDC1 3, 90 MHz) 21 (CH3), 129 (Ar C), 130 (Ar C), 133 (Ar CH), 137 
(Ar CH), 158 (Ar C), 197 (C=O). JR data (KBr disc)/cm: 1435m, 1648s, 2925m, 
3379m. El MS, m/z 166 (MH, 5 6,3%). 
2-(Chloromethyl)-6-carbaldehyde-4-methylphef101 (75) 
CI 	OH 	0 
2-(Chloromethyl)-6-carbaldehyde-4-methylpheflol was prepared by the method of 
Lambert et al.5 Thionyl chloride (4 cm3 , 55 mmol) in dichloromethane (6 cm 
3)  was 
added dropwise a solution of 2-(hydroxymethyl)-6-carbaldehyde-4-methylphef101 
(74) (3.05 g, 18 mmol) suspended in dichioromethane (6 cm 
3)  to yield a clear bright 
yellow solution. The mixture was stirred for 1 hour and the solvent and SOC1 2 were 
removed in vacuo. The residue was recrystallised from hexane/dichioromethane to 
yield a white crystalline solid (2.17 g, 64%), mp 92-94° C. 8H (CDC1 3 , 360 MHz): 
2.39 (s, 3 H, CH3), 4.70 (s, 2 H, CH2), 7.38 (s, 1 H, Ar Cl]), 7.50 (s, 1 H, Ar Cl]), 
9.90 (s, 1 H, -COH), 11.29 (s, 1 H, -Oil). 8c (CDCI3, 90 MHz): 21 (CH 3), 40 (CH2), 
121 (Ar C), 126 (Ar C), 130 (Ar C), 134 (Ar CH), 139 (Ar CH), 158 (Ar C), 197 
(>C0). JR data (KBr disc)/cm: 3186m, 2853m, 1644s, 1601m, 1472m, 1303m, 
1257m, 1208m, 704m. El MS, m/z 184 (M, 36.5%). HRMS m/z caic. for (M) 
184.6196, found 184.0291. 
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6-Hydroxy-3-methyl-512, 6-diaza-2-benzyl-6[N-(4-methylbenzenesulfonyt)lheX- 
1-yI}benzaldehyde (76) 
HJ 'l NI-IBz 	OH 	0 
4-Methyl-N-(2-benzylamino-propyl)-benzenesulfonamide (1.72 g, 5.4 mmol) in 
dimethylformamide (25 ern 3) was added dropwise to a mixture of K2CO3 and 2-
(chloromethyl)-6-carbaldehyde-4-methylphenol (1 g, 5.4 mmol) in 
dimethylformamide (25 cm 3 ). The mixture was stirred for 48 hours before H20 (50 
cm 3)  was added. The product was extracted into dichloromethane (3 x 70 cm. 3) and 
the extracts were combined and then washed with water (5 x 200 cm. 3), dried over 
MgSO4 and filtered. The solvent was removed in vacuo to yield a yellow oily solid 
which was triturated with a mixture of iso-propyl ether and iso-propyl alcohol to 
produce a yellow solid. This was recrystallised from ethanol (50 cm 3)  to give a 
yellow crystalline material (0.66 g, 26%), mp 105-107°C (Found: C, 67.08; H, 6.59; 
N, 6.13. Caic. for C26H30N204S: C, 67.13; H, 6.51; N, 6.19%). 8H  (CDC13 , 360 
MHz): 1.72 (m, 2 H, CH2), 2.35 (s, 3 H, CH3), 2.44 (s, 3 H, CH3), 2.53 (t, 2 H, J 6.3, 
CH2), 2.97 (t, 2 H, J 6.2, CH2), 3.55 (s, 2 H, CH2), 3.66 (s, 2 H, CH2), 7.31 (m, 9 H, 
Ar CH), 7.70 (d, 2 H, J 8.1, Ar CH), 10.06 (s, 1 H, H-C=O). 8c (CDC13, 90 MHz): 
21 (Gil3), 22 (CH3), 26 (Gil2), 43 (Gil2), 52 (Gil2), 54 (CH2), 59 (Gil2), 122 (Ar C), 
126 (Ar C), 127 (2 C, Ar Gil), 128 (Ar Gil), 129 (Ar C), 129 (2 C, Ar Gil), 130 (2 C, 
Ar Gil), 130 (2 C, Ar CH), 132 (Ar Gil), 138 (Ar C), 138 (Ar C), 143 (Ar C), 159 
(Ar C), 195 (>CO). IR data (KBr disc)/cm -1 : 3450w, 3252s, 2948m, 2925m, 
2837m, 2815m, 1653s, 1325m, 1266m, 1158s, 1091m, 735m. FAB MS, m/z 667 
(MW, 67.2%). 
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6-Hydroxy-3-methyl-52, 5diaza2_benzy15N-(4-methytbenzenesu1fony1)Ipeflt- 
1-yl}benzaldehyde (77) 
11 	1xII NBz 	OH 	0 
-0-11 H 
4-Methyl-N-(2-benzylamino-ethyl)-benzenesulfoflamide (1.16 g, 5.4 mmol) in 
dimethylformamide (25 cm) was added dropwise to a mixture of K2CO3 (0.75 g, 5.4 
mmol) and 2-(chloromethyl)-6-carbaldehyde-4-methylphenol (1 g, 5.4 mmol) in 
dimethylformamide (25 cm3). The mixture was stirred for 48 hours before it was 
added to 50 cm  H20. The product was extracted into dichloromethane (3 x 70 cm 3). 
The dichioromethane extracts were then combined and washed with water (5 x 100 
cm3), dried over M9SO4 and filtered. The solvent was removed in vacuo to yield a 
yellow oil which was triturated with a mixture of hexane and diethylether to yield a 
pale yellow solid (0.56 g, 23%), mp 102-104°C. 8H (CDC1 3 , 360 MHz): 2.37 (s, 3 
H, Cl!3), 2.42 (s, 3 H, CH3), 2.59 (m, 2 H, CH2), 3.01 (m, 2 H, CH2), 3.53 (s, 2 H, 
CH2), 3.58 (s, 2 H, CH2), 5.29 (s, 1 H, NH), 7.27 (m, 9 H, Ar Cu), 7.66 (d, 2 H, J 
8. 1, Ar CH), 9.95 (s, 1 H, H-C=O), 11.27 (s, 1 H, -OH). 8c (CDC13, 90 MHz): 21 
(CH3), 23 (CH3), 41 (CH 2), 53 (Cl-I2), 53 (CH2), 59 (CF1), 121 (Ar C), 127 (Ar C), 
128 (2 C, Ar CH), 128 (Ar CH), 129 (2 C, Ar CH), 129 (2 C, Ar CH), 130 (2 C, Ar 
CH), 133 (Ar CH), 137 (Ar C), 139 (Ar C), 139 (Ar CH), 144 (Ar C), 158 (q, Ar 
CH), 196 (C=O). IR data (KBr disc)/cm: 1159s, 1326s, 1647s, 2828w, 2916w, 
3028w, 3248s. FAB MS, m/z 453 (MH, 100.0%). HRMS m/z calc. for (MH) 
452.5744, found 453.18621. 
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6.7.4 Metal complexes 
Bis(6-Hydroxy-3-methyl-5{2, 6-diaza-2-benzyl-6 [N-(4-methylbenzenesulfonyl)] 
hex-1-yl}benzaldehyde oximato)copper(ll) (78) 
A solution of 72 (0.07 g, 0.15 mmol) in hot methanol (10 cm 
3)  was added to 
copper(II) acetate monohydrate (14.5 mg, 0.08 mmol) in methanol (10 cm 3) and the 
mixture was stirred for 30 minutes. The solution was left sealed until the product 
separated as a green crystalline solid after 3 days which was collected by filtration, 
washed with methanol (3 x 5 cm 3) and dried in vacuo (45 mg, 5 5%), (Found: C, 
61.01; H, 6.45; N, 8.44. Calc. for C 52H60N6Cu08S2: C, 60.95; H, 5.90; N, 8.20%). 
IR data (KBr disc)/cm': 1139m, 1262m, 1412w, 2929m, 3191m. FAB MS, m/z 
1023 ([Cu(L-H)2]H, 38.8%). 
Bis(6-Hydroxy-3-methyl-512,6-diaza-2-beflzyl-61N-(4-
methylbenzenesulfonyl)Jhex-1-yI}benzaldehyde oximato)nickel(II) (79) 
Using nickel(II) acetate tetrahydrate in the procedure described for 78 yielded a green 
solid which was dried in vacuo (20 mg, 26%), (Found: C, 61.45; H, 5.92; N, 8.23. Calc. 
for C 52H60N6Cu08S2: C, 61.18; H, 5.63; N, 8.20%). hR data (KBr disc)/cm -1 : 1136s, 
1279m, 2929m, 3447m. ESI MS, m/z 1019 ([Ni(L-H)21H, 10.1%). 
Cu(ll)(73-H)2 (80) 
A solution of 73 (0.07 g, 0.15 mmol) in hot methanol (10 cm 
3)  was added to copper(ll) 
acetate monohydrate (15 mg, 0.08 mmol) in methanol (10 cm. 3) and the mixture was 
stirred for 30 minutes. The solution was left sealed until the product separated as a 
brown/yellow solid after 3 days which was collected by filtration, washed with methanol 
(3 x 5 cm3) and dried in vacuo (20 mg, 27%) (Found: C, 60.25; H, 5.66; N, 843. Calc. 
for C50H56N6Cu08S2: C, 59.64; H, 5.66; N, 8.43%). IR data (KBr disc)/cm': 1 159s, 
1324m, 2907m, 3518m. ESI MS, m/z 996 ([Cu(L-H) 2]E[4 , 100.0%). 
Cu2(I1)(73-2H)2 (81) 
A solution of 73 (0.07 g, 0.15 mmol) in hot methanol (10 cm 3)  was added to copper(II) 
acetate monohydrate (30 mg, 0.15 mmol) in methanol (10 cm 3) and the mixture was 
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stirred for 30. The solution was left sealed until the product separated as a pale green 
solid after 3 days which was collected by filtration, washed with methanol (3 x 5 cm. 3) 
and dried in vacuo (15 mg, 19%) ES! MS, m/z 996 [Cu(L-H)2]H, 52.3%, mlz 1059 
[Cu2(L-2H)2]H, 39.2%. 
Bis(6-Hydroxy-3-methyl-5{2,5-diaza-2-beflZyl-5 IN-(4-methylbenzenesulfonyl)J 
pent-1-yI}benzaldehyde oximato)nickel(II) (82) 
Using nickel(II) acetate tetrahydrate in the procedure described for 80 yielded a bright 
green solid which was dried in vacuo (8 mg, 11%). ES! MS, m/z 991 ([Ni(L-H) 21, 
100.0%). 
CO2(II)(73-2H)2 (83) 
Using cobalt(II) acetate tetrahydrate in the procedure described for 81 yielded a dark 
brown solid which was dried in vacuo (8 mg, 11%). ES! MS, m/z 525 [Co(L-H) 2], 
33.4%, m/z 1047 [CO2(L-2H)2], 23.2%. 
Zn2(II)(73-21[)2 (84) 
Using zinc(II) acetate dihydrate in the procedure described for 81 yielded a yellow 
solid which was dried in vacuo (8 mg, 11%). ES! MS m/z 1093 [Zn2(L-2H) 2]Na, 
58.7%. 
6.7.5 X-Ray Crystallography 
Structures were determined by Andrew Parkin at the University of Edinburgh. In all 
cases data were collected at 220 K on a SMART diffractometer equipped with an 
Oxford Cryosystems low temperature device, using Mo-Kcx radiation. Reflections 
were scanned in u-0 mode. Structures 76 and 78 were solved by direct methods 
SHELXS-97 and S1R92 respectively. All were completed by iterative cycles of least 
squares refinement against F2 and difference Fourier synthesis (SHELXTL). H-
atoms were idealised, being placed using difference maps and treated by riding or 
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refall methods. In all cases non-H atoms were modelled with final amsotropic 
displacement parameters and final refinement statistics are presented in Table 6.1. 
Table 6.1: Crystallographic data for structures 76 and 78. 
Structure 	 76 	 78 
Formula C26H30N204S 	C52HCuN608 S2 
M 	 466.58 1024.72 
Crystal system Monoclinic Triclinic 
Space group P2(1)/c P-i 
alA 9.5809(9) 7.5641(10) 
b/A 15.7180(14) 12.7392(16) 
cIA 16.0848(14) 13.3729(17) 
cr]0 90 79.513(2) 
0/0 104.249(2) 85.6 18(2) 
IWO 90 78.047(2) 
U/A3 2347.7(4) 1238.6(3) 
Crystal size/mm 0.38 x 0.28 x 0.10 0.30 x 0.27 x 0.08 
D/mgm 3 1.320 1.374 
Z 4 1 
iJmm' 0.174 0.586 
Scan type phi + omega phi + omega 
0 Limits/' 1.84-26.40 1.55-26.40 
No. of unique data 4775 4974 
No. data with tF>4a(F)I 3506 4185 
No. parameters 418 433 
RI 0.0354 0.0314 
wR2 	 0.0826 	 0.0837 
Prnax, APmin/e A 3 	 0.215, -0.385 0.390, -0.337 
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Chapter 7: Conclusions 
The class of sulfonamido ligands used to mimic the hydrogen-bonding effects shown 
by the commercial phenolic oxime extractants for copper have proved to have very 
rich coordination chemistry. Several solid state structures of free ligands and their 
complexes were obtained which in addition to solution studies of the ligands lead us 
to believe that self-association via hydrogen-bonding occurs in certain solvents. 
Investigation of "the role of hydrogen-bonding of sulfonamido ligands on their 
ability to act as metal extractants" led us to carry out research in two further areas, 
the use of ternary sulfonamido systems as metal extractants and the development of 
binucleating ligands to increase the metal:ligand ratio to 2:2. 
Monosulfonamidodiamine ligands proved to be relatively simple to make and are 
versatile complexing agents. Two to one ligand:metal complexes were formed 
exclusively and X-ray crystal structures of two complexes displayed hydrogen-
bonded pseudo-macrocyclic ligand arrangements around the nickel and copper 
centres analogous to copper complexes of phenolic oximes. Extraction experiments 
proved that the ligands show high selectivity for copper. However the ligands are 
much weaker copper extractants than the commercial phenolic oximes. 
Synthesis of sulfonamido oxime ligands, which are closer in design to phenolic 
oximes, proved to be straight forward. However, preparation of pure ligands with 
high solubility in solvents of low polarity such as toluene proved more difficult. 
These sulfonamide oxime ligands were found to have very rich coordination 
chemistry as a result of the additional potential donor atoms which can coordinate to 
the metal centres. Two to one ligand:metal complexes analogous to those of 
phenolic oximes were isolated. It is also possible to isolate polynuclear complexes. 
In each of these clusters methanol or methoxide were coordinated. If such ligands 
were to be used as solvent extractants the working medium would not be methanol 
but a hydrocarbon solvent. Under these conditions it is likely that only 2:1 
ligand:metal complexes would be observed. 
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Solution studies of both monosulfonamidodiamine and sulfonamido oxime ligands 
indicate that aggregation in solution is occurring, but it has not been possible to 
assign structures to these aggregates. It was therefore difficult to assess the 
importance of preorgamsation in enhancing the "strength" of extractants. Although 
the difference in number of the hydrogen-bond donor and acceptor sites in both 
ligand types is not large (monosulfonamidodiamine ligands have one additional 
acceptor site and sulfonamide oxime ligands have one extra donor site) a much larger 
variety of secondary structures dependant on hydrogen bonding is observed for the 
former. The prediction of the hydrogen-bonded secondary structure of 
monosulfonamidodiamine ligands proved extremely difficult. Secondary structures 
of sulfonamido oximes proved to be much more predictable and dependent on the 
E/Z stereochemistry of the oxime function. Individual dimer units were formed 
which may be a result of their more rigid backbone. 
The strategy of forming ternary complexes by assembly of a bis- or tris-hydrogen-
bond donor ligand with a bis- or tris-hydrogen-bond acceptor ligand around a metal 
cation did not prove successful. This approach is likely to be less successful for the 
development of selective metal-recovery reagents because the formation of binary 
complexes may arise. 
Whilst it proved possible (Chapter 6) to synthesise potentially dinucleating ligands 
which could undergo head-to-tail hydrogen-bonding via sulfonamido and oxime 
units, it was not possible to characterise solid state samples of 2:2 copper complexes 
in the complexation studies to date. A 2:1 complex with copper was shown to have 
the same 14-membered inner great ring as in the commercial phenolic oxime 
complexes, providing further evidence for how readily this structural motif is found. 
This approach to enhancing the copper-transfer efficiency by using pseudo-
macrocyclic assemblies which incorporate bridging donor atoms has great potential, 
but the intrinsically low solubility of the sulfonamido group means that larger 
solubilising functional groups will have to be introduced into the ligand, reducing the 
benefit of the lower ligand-to-metal mass ratios used in transport. 
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The structural analyses undertaken have shown that sulfonamide ligands are 
significantly different from amides of carboxylic acids and solid state structures 
contain a wide range of hydrogen-bonded motifs. The formation of inter-molecular 
hydrogen-bonds appears to contribute to their generally low solubilities which will 
limit their usefulness as reagents to recover metals by solvent extraction. Their 
relatively low pKa's are potentially useful for the development of reagents with 
anionic nitrogen donors which could operate a "pH swing" process. On the basis of 
the equilibria studies in this thesis sulfonamido ligands derived from aliphatic amines 
are unlikely to be "strong" enough to allow recovery from acidic pregnant leach 
solutions. Derivatives of aromatic amines are likely to be stronger reagents but these 
have lower solubility in solvents which are used in commercial operations. 
It is difficult to know how to try to determine the effect which self-assembly or 
ligand pre-organisation actually has on the "strength" of a metal extractant. If this 
work were continued it would be a good idea to choose a ligand system with only the 
required number of hydrogen-bond donor and acceptor groups per molecule to limit 
the number of possible hydrogen-bonding interactions and also to improve the 
solubility characteristics of the ligand. A greater ligand solubility should mean that 
solution equilibria could be determined using the nmr techniques used in chapter 4. 
Ideally two very similar ligand systems with different known solution equilibria 
would be studied. Such nmr experiments in addition to extraction experiments 
should achieve more insight into this area of work. 
Concerning the sulfonamido systems discussed in this thesis, those included in 
chapter 6 have been studied the least. Further complexation studies of these 
molecules may yield 2:2 metal:ligand complexes. It would also be interesting to try 
and design other ligand systems to accommodate metals of other geometries or even 






Vapour pressure osmometry data 
Data for sulfonamidodiamine ligands 1, 4, 5, 8 and 10 are recorded in Table I 
(ligands 1, 5 and 10), Tables il-VI (Ligand 4), Tables VII-XI (Ligand 8) and 
sulfonamido oxime ligands 28 and 33 are recorded in Table XII. 
Table I: The aggregation number (n), [where n is the average mass determined in solution 
divided by the relative molecular mass of the molecule] determined by vapour pressure 
osmometry for N-(2-amino-ethyl)-4-methyl benzenesulfonamide (1), N-(3-amino-propyl)4-














deviation of n 
1 20.54 232.18 1.08 9.07 0.027 
41.39 	268.88 	 1.25 	 6.86 0.032 
81.47 299.61 1.40 5.79 0.042 
5 20.71 252.97 1.11 7.47 0.031 
38.51 	268.82 	1.17 	 4.40 0.019 
51.54 300.96 1.32 7.07 0.033 
10 20.37 279.15 1.06 14.11 0.027 
38.28 	284.91 	1.09 	 6.42 0.024 
83.89 316.70 1.21 7.16 0.054 
Table II: VPO results for N-(N-2-ethylhexyl-2-aminoethyl)-4-methylbenzenesulfonamide 
(4) in toluene. 
Calculated 	Average mass in 	Aggregation 	Standard deviation 
osmolality solution 	number (n) of the average 
(mmolal) 	 mass 
Standard deviation 
of n 
5.01 335.21 1.03 19.59 0.060 
15.03 484.63 1.48 5.33 0.016 
25.05 473.00 1.45 10.08 0.031 
35.07 428.16 1.31 6.41 0.020 
45.10 440.66 1.35 5.93 0.018 
55.12 454.69 1.39 2.9 0.009 
65.14 485.06 1.49 7.14 0.022 
75.16 486.32 1.49 4.83 0.015 
85.18 477.64 1.46 2.77 0.008 
95.20 442.55 1.36 2.8 0.009 
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Table III: VPO results for N-(N-2-ethylhexyl-2-aminoethyl)-4-methylbenzenesulfonamide 













5.01 604.61 1.85 50.76 0.155 
15.02 513.86 1.57 58.51 0.179 
25.03 516.06 1.58 18.13 0.056 
35.04 478.27 1.46 17.17 0.053 
45.05 511.65 1.57 11.87 0.036 
55.06 531.59 1 .63 19.45 0.060 
65.07 335.43 1.66 19.76 0.061 
75.08 541.93 1.66 15.36 0.047 
85.09 569.72 1.74 9.08 0.028 
95.10 580.35 _.78 11.7 0.036 
Table IV: VPO results for N-(N-2-ethylhexyl-2-aminoethyl)-4-methylbenzenesulfoflamide 













5 1151.76 3.53 277.69 0.761 
15 347.96 1.07 23.38 0.064 
25 320.62 0.98 26.08 0.071 
35 352.13 1.08 14.71 0.040 
45 352.14 1.08 20.51 0.056 
55 356.90 1.09 19.66 0.054 
65 393.75 1.20 6.69 0.018 
75 374.09 1.15 7.39 0.020 
85 384.82 1.18 9.85 0.027 
95 403.39 1.24 12.07 0.033 
Table V: VPO results for N-(N-2-ethylhexyl-2-aminoethyl)-4-methylbenzeneSulfOflamide 













4.99 263.26 0.81 29.91 0.092 
14.97 411.86 1.26 39.96 0.122 
24.95 483.23 1.48 16.29 0.050 
34.93 427.04 1.31 18.34 0.056 
44.91 379.43 1.16 11.38 0.035 
54.89 388.6 1.19 8.9 0.027 
64.87 363.12 - 1.11 8.53 0.026 
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74.85 351.10 1.08 6.25 0.019 
84.83 341.34 1.05 8.2 0.025 
94.81 336.75 1.03 4.83 0.015 
Table VI: VPO results for N-(N-2-ethylhexyl-2-aminoethyl)-4-methylbenzefleSUlfOflamide 













4.98 826.97 2.53 74.84 0.229 
14.95 634.11 1.94 43.19 0.132 
24.92 477.08 1.46 29.38 0.090 
34.89 392.92 1.20 27.02 0.083 
44.85 407.28 1.25 13.49 0.041 
54.82 402.56 1.23 25.47 0.078 
64.79 391.56 1.20 9.93 0.030 
74.76 383.23 1.17 7.83 0.024 
84.72 360.26 1.10 12.71 0.039 
94.69 386.69 1.18 22.83 0.070 
Table 	VII: 	VPO 	results 










deviation of the 
average mass 
Standard 
deviation of n 
5.02 335.57 0.99 22.08 0.065 
15.07 442.89 1.30 22.14 0.065 
25.12 416.73 1.22 7.66 0.022 
35.17 395.01 1.16 4.23 0.012 
45.22 408.24 1.20 2.23 0.007 
55.27 410 1.20 2.64 0.008 
65.32 408.05 1.20 3.36 0.010 
75.37 417.21 1.23 2.39 0.007 
85.42 419.68 1.23 2.33 0.007 
95.47 420.89 1.24 2.54 0.007 
Table 	VIII: 	VPO 	results 	for 














5.02 434.07 1.27 14.45 0.042 
15.07 	- 517.34 1.52 22.26 0.065 
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25.11 501.95 1.47 10.87 0.032 
35.15 547.9 1.61 16.19 0.048 
45.20 540.77 1.59 22.03 0.065 
55.24 539.55 1.58 14.03 0.041 
65.29 573.81 1.69 17.37 0.051 
75.33 596.1 1.75 14.63 0.043 
85.37 640.1 1.88 15.72 0.046 
95.42 643.68 1.89 14.28 0.042 
Table IX: VPO results for N(N-2-ethylhexy1-3-aminopropyl)-4-methy1benzeneSulfonaflhide 
(8) in chloroform. 





Standard deviation Standard deviation 
of n 
5.00 479.55 1.41 16.7 0.049 
15.00 354.31 1.04 10.71 0.031 
25.00 336.69 0.99 9.51 0.028 
4.99 333.28 0.98 10.26 0.030 
44.99 334.85 0.98 6.28 0.018 
54.99 321.72 0.94 4.8 0.014 
65.99 324.39 0.95 8.49 0.025 
74.99 313.31 0.92 8.02 0.024 
84.98 328.57 0.96 5.98 0.017 
94.98 310.1 0.91 10.46 0.031 
Table X: VPO results for N(N2-ethylhexy1-3-aminopropyl)4-methy1benzenesulfOflaflude 
(8) in acetonitrile. 










5.05 213.10 0.63 6.96 0.020 
15.15 387.09 1.14 34.49 0.101 
25.25 397.34 1.17 20.77 0.061 
35.35 383.55 1.13 6.23 0.018 
45.45 365.50 1.07 17.81 0.052 
55.55 346.66 1.02 3.2 0.009 
65.66 355.80 1.04 3.93 0.011 
75.76 361.19 1.06 7.41 0.022 
85.86 343.13 1.01 2.92 0.009 
95.96 358.16 1.05 4.02 0.012 
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Table Xl: VPO results for N-(N-2-ethylhexyl-3-aminopropyl)-4-methylbeflZefleSUlfOflamide 
(8) in acetone. 
Calculated 	Average mass in 	Aggregation 	Standard deviation 	Standard deviation 
osmolality solution 	number (n) of the average of n 
(mmolal) 	 mass 
5.31 - 	 418.27 	 1.23 	 33.63 0.099 
15.94 	 497.72 1.46 31.29 0.092 
26.56 463.6 	 1.36 	 32.88 0.097 
37.19 	460.47 1.35 21.14 0.062 
47.81 495.91 	 1.46 	 13.17 0.039 
58.44 	488.17 1.43 9.56 0.028 
69.07 505.13 	 1.48 	 11.35 0.033 
79.69 	479.14 1.41 10.33 0.030 
90.32 491.13 	 1.44 	 19.08 0.056 
100.94 	491.56 1.44 16.85 0.049 
Table XII: The aggregation number (n), determined by vapour pressure osmometry for 1-
12-[N-(4-methylbenzenesulfonamido)] phenyl}ethan- 1-one oxime (28) and 2-[N-(4-
methylbenzenesulfonamido)](phenyl)methanone oxime (33). 
Ligand 	Calculated 	Average mass 	Aggregation 	Standard 
osmolality in solution number (n) deviation of the 
(mmolal) 	 average mass 
Standard 
deviation of n 
28 21.34 315.21 	 1.04 	 7.56 0.025 
41.77 	378.87 1.25 14.60 0.048 
71.60 406.47 	 1.34 	 6.38 0.021 
33 20.79 	428.96 1.41 9.82 0.032 
41.13 471.79 	 1.56 	 16.23 0.054 






Proton nmr data 
Data for sulfonamido oxime ligands 28, 31 and 33 are recorded in Table I (ligands 28 
and 33), Table 11-V (Ligand 28), Tables VI-Vill (Ligand 31). 
Table I: The change in chemical shift of the oximic protons of 1-{2-[N-(4- 
methylbenzenesulfonamido)] 	phenyl) ethan-1 -one 	oxime 	(28) 	and 	2-[N-(4- 
methylbenzenesulfonamido)](phenyl)methaflOfle oxime (33) with concentration at 297K in 
chloroform. 
Concentration 	Chemical shift of the oximic 	Chemical shift of the oximic 
(mmol) proton of 28 (ppm) 	 proton of 33 (ppm) 
20 	 10.60 	 10.57 
40 10.66 10.60 
80 	 10.74 	 10.64 
Table II: The change in chemical shift of the oximic and the sulfonamido protons of a 70 
mmolar deuterated chloroform solution of 1-{2-[N-(4-methylbenzenesulfonamido)] 
phenyl }ethan- 1-one oxime (28) with temperature. 
Temperature / K 	Chemical shift of the oximic 	Chemical shift of the 
proton (ppm) 	 sulfonamido proton (ppm)a 
298 	 10.7484 7.9362 
301 10.7236 	 7.8997 
304 	 10.6980 7.8637 
307 10.6746 	 7.8302 
310 	 10.6505 7.7972 
313 10.6269 	 7.7664 
316 	 10.6047 7.7365 
319 10.5818 	 7.7062 
322 	 10.5584 
325 10.5373 
328 	 10.5143 
° The peak of the sulfonaniido proton was sometimes hidden by peaks in the aromatic region of the spectrum. 
Table III: The change in chemical shift of the oximic and the sulfonaniido protons of 1-12- 
[N-(4-methylbenzenesulfonamido)] phenyl }ethan- 1-one oxime (28) with concentration at 
297K in chloroform. 
Concentration 	Chemical shift of the oximic 	Chemical shift of the 
(mmol) proton_(ppm) 	 sulfonamido_protona_(ppm)a 
129.099 	 10.8025 8.2697 
118.255 10.8012 	 8.2624 
107.539 	 10.7853 8.2127 
96.8242 10.7774 	 8.186 
85.9799 	 10.7586 8.1241 
75.2647 10.7455 	 8.083 
64.5495 	 10.7278 8.0279 
53.8342 10.7069 	 7.9602 
42.9899 	 10.6849 7.8947 
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32.2747 10.6658 7.832 
21.4304 10.6249 7.718 
10.7152 10.5792 
8.52053 10.5661 
6.45495 10.5562 7.5739 
4.26026 10.5372 7.4742 
2.19468 10.5415 
'The peak of the sulfonamido proton was sometimes hidden by peaks in the aromatic region of the spectrum. 
Table IV: The change in chemical shift of the oximic and the sulfonamido protons of 1-12-
[N-(4-methylbenzenesulfonamido)] phenyl}ethan- 1-one oxime (28) with concentration at 
307K in chloroform. 
Concentration 
(mmol) 
Chemical shift of the oximic 
proton (ppm) 
Chemical shift of the 
sulfonamido proton' (ppm) 
129.066 10.734 8.1562 
118.224 10.7362 8.1568 
107.512 10.7752 8.1626 
96.7995 10.7085 8.0697 
85.9579 10.6943 8.0254 
75.2454 10.6795 7.9808 
64.533 10.66 7.9237 
53.8205 10.644 7.8775 
42.979 10.6723 7.9092 
32.2665 10.5849 7.7058 
21.4249 10.5528 
10.7125 10.5048 7.4852 
8.51835 10.4985 7.4645 
6.4533 10.4789 7.4223 
4.25918 10.4751 7.401 
2.19412 10.5034 7.4587 
" The peak of the sulfonamido proton was sometimes hidden by peaks in the aromatic region of the spectrum. 
Table V: The change in chemical shift of the oximic and the sulfonamido protons of 1-{2-
[N-(4-methylbenzenesulfonamido)] phenyl}ethan-1-one oxime (28) with concentration at 
317K in chloroform. 
Concentration 
(mmol) 
Chemical shift of the oximic 
proton (ppm) 
Chemical shift of the 
sulfonamido proton' (ppm) 
129.066 10.656 8.0434 
118.224 10.6574 8.0407 
107.512 10.7207 8.1086 
96.7995 10.6303 7.957 
85.9579 10.6151 7.9136 
75.2454 10.602 7.872 
64.533 10.5829 7.8169 
53.8205 10.5677 7.7743 
42.979 10.5881 7.7905 
32.2665 10.5117 
21.4249 10.4843 
10.7125 10.4533 7.4362 
8.51835 10.435 7.4047 
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6.4533 10.4188 7.3708 
4.25918 10.4148 7.3525 
2.19412 10.4376 7.397 
The peak of the sulfonamido proton was sometimes hidden by peaks in the aromatic region of the spectrum. 
Table VI: The change in chemical shift of the oximic and the sulfonamido protons of 1-{2-
[N-(4-pentylbenzenesulfonamido)]phenyl}ethan- 1-one oxime (31) with concentration in 
chloroform. 
Concen- Chemical shifts at 297K 	Chemical shifts at 307K Chemical shifts at 317K 
tratson 
(mmol) C=N-OH 
1,4H0 	C=N-OH NIH C=N-OH NHa 
120.47 10.8325 8.3834 	10.7556 8.2538 10.6813 8.1371 
110.43 10.8246 8.3637 10.7526 8.2453 10.6799 8.1293 
100.39 10.8122 8.3203 	10.7397 8.2031 10.667 8.0901 
90.35 10.7983 8.2734 10.7246 8.1534 10.653 8.0433 
80.31 10.7804 8.2171 	10.7054 8.0973 10.6349 7.9915 
70.27 10.7756 8.2146 10.7013 8.0948 10.6286 7.9841 
60.24 10.7496 8.1184 	10.6789 8.0099 10.6099 7.9075 
50.20 10.7243 8.0388 10.65 7.9255 10.5796 7.8234 
40.16 10.7042 7.9756 	10.6325 7.8708 10.5646 7.7769 
30.12 10.678 7.9061 10.6105 7.8125 10.5483 7.73 
20.08 10.6502 7.8154 	10.579 10.5147 
10.04 10.6055 10.543 10.4875 7.5517 
8.03 10.598 10.5366 10.4844 7.5352 
6.02 10.5744 10.5173 7.5419 10.4559 7.4743 
4.02 10.5778 10.5126 7.5244 10.4593 7.4729 
2.01 10.5633 10.4983 7.4922 10.445 7.4413 
'The peak of the sulfonamido proton was sometimes hidden by peaks in the aromatic region of the spectrum. 
Table VII: The change in chemical shift of the oximic and the sulfonamido protons of 1 -{2-





Chemical shifts at 297K 	Chemical shifts at 307K 
C=N-OH 	IM -N OH 	
NH 0 
C  
Chemical shifts at 317K 
CN-OH 	TM  
119.70 11.2816 8.2361 	11.1777 8.051 11.0773 
109.72 11.2641 8.1608 11.1539 7.96 11.0548 7.792 
99.75 11.256 8.1189 	11.148 11.048 7.757 
89.77 11.2341 8.0206 11.1277 7.837 11.0267 
79.80 11.2169 11.1039 7.746 11.0038 7.5848 
69.82 11.1933 7.8498 	11.0844 10.9965 7.5151 
59.85 11.1755 7.7805 11.0621 7.579 10.9628 7.4243 
49.87 11.1395 11.0303 7.447 10.9324 7.3003 
39.90 11.1022 7.49 	10.9952 7.3182 10.8999 7.182 
29.92 11.0584 7.3218 10.9527 7.1593 10.8594 
19.95 11.0151 7.1527 	10.9127 10.8227 
9.97 10.9346 10.8357 10.7499 
7.98 10.916 10.8196 10.7411 




3.99 	10.8704 	 10.7771 	 10.7922 	6.5256 
1.99 10.8496 10.7625 10.6909 6.3911 
" The peak of the sulfonamido proton was sometimes hidden by peaks in the aromatic region of the 
spectrum. 
Table VIII: The change 	in 	chemical 	shift of the 	oximic 	proton of 1-{2-[N-(4- 




Chemical shifts at 297K 	Chemical shifts at 307K 	Chemical shifts at 317K 
124.13 10.9389 10.8952 10.8573 
113.79 10.9371 10.8939 10.8559 
103.44 10.9346 10.8924 10.8539 
93.10 10.9335 10.8905 10.853 
82.75 10.9315 10.889 10.8508 
72.41 10.9297 10.8865 10.8489 
62.06 10.9279 10.886 10.8484 
51.72 10.9263 10.884 10.8449 
41.38 10.9243 10.8832 10.8459 
31.03 10.9226 10.8816 10.8444 
20.69 10.9209 10.8797 10.8413 
10.34 10.9193 10.8771 10.8398 
8.28 10.9185 10.8774 10.8391 
6.21 10.9182 10.878 10.8398 
4.14 10.9179 10.8765 10.8393 
2.07 10.9146. 10.8735 10.8372 
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